Split (1)

train · ~2.9M rows (showing the first 729k)

Unnamed: 0 stringlengths 3 8	Date stringlengths 23 23	Article_title stringlengths 1 250	Stock_symbol stringlengths 1 5	Url stringlengths 44 135	Publisher stringclasses 1 value	Author stringclasses 1 value	Article stringlengths 1 343k	Lsa_summary stringlengths 3 53.9k	Luhn_summary stringlengths 1 53.9k	Textrank_summary stringlengths 1 53.9k	Lexrank_summary stringlengths 1 53.9k	uuid stringlengths 36 36
716200.0	2021-02-16 00:00:00 UTC	Can DuPont Stock Rebound After A 13% Drop In 10 Days?	DD	https://www.nasdaq.com/articles/can-dupont-stock-rebound-after-a-13-drop-in-10-days-2021-02-16	nan	nan	The stock price of DuPont de Nemours Inc. (NYSE:DD) has seen a 9% decline over the last five trading days, while it is down 13% over the last ten trading days, and we believe the stock will likely rebound from the current levels in the near term. The decline can largely be attributed to profit booking at higher levels after the company announced its Q4 results. Note that the DD stock rallied roughly 50% from levels of under $60 in mid August 2020 to over $85 in mid-January 2021, before dropping to $73 currently. The outperformance can be attributed to M&A arbitrage related to the IFF deal. IFF recently completed the previously-announced merger of IFF and DuPont’s Nutrition & Biosciences business, in a Reverse Morris Trust transaction. Last month, some of the brokerages downgraded the stock from “Buy” to “Hold” after a strong rally. That said, the stock has now corrected 15% from its recent highs, and its Q4 earnings of $0.95 per share were better than the consensus estimates of $0.89. Not only did the company beat in Q4, DuPont’s guidance for 2021 was also above the consensus estimates. The 9% drop for DD stock compares with 1% gains seen in the broader S&P 500 index. Now, after the recent drop, we believe that DD stock is poised to gain in the near term, given its upbeat guidance. In fact, we believe that there is a 74% chance of a rise in DD stock over the next month (twenty one trading days) based on our machine learning analysis of trends in the stock price over the last few years. See our analysis on DuPont Stock Chances of Rise for more details. Curious about the possibility of rising over the next quarter? Check out the DD Stock AI Dashboard: Chances Of Rise And Fall for a variety of scenarios on how DD stock could move. Five Days: DD -8.7%, vs. S&P500 1.2%; Underperformed market (3% likelihood event) DuPont stock declined 8.7% over a five-day trading period ending 2/11/2021, compared to broader market (S&P500) rise of 1.2% A change of -8.7% or more over five trading days is a 3% likelihood event, which has occurred 41 times out of 1256 in the last five years Ten Days: DD -13%, vs. S&P500 3.5%; Underperformed market (3% likelihood event) DuPont stock declined 13% over the last ten trading days (2 weeks), compared to broader market (S&P500) rise of 3.5% A change of -13% or more over 10 trading days is a 3% likelihood event, which has occurred 43 times out of 1240 in the last five years What if you’re looking for a more balanced portfolio instead? Here’s a high quality portfolio to beat the market, with over 100% return since 2016, versus 55% for the S&P 500. Comprised of companies with strong revenue growth, healthy profits, lots of cash, and low risk, it has outperformed the broader market year after year, consistently. See all Trefis Price Estimates and Download Trefis Data here What’s behind Trefis? See How It’s Powering New Collaboration and What-Ifs For CFOs and Finance Teams \| Product, R&D, and Marketing Teams The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	Note that the DD stock rallied roughly 50% from levels of under $60 in mid August 2020 to over $85 in mid-January 2021, before dropping to $73 currently. Now, after the recent drop, we believe that DD stock is poised to gain in the near term, given its upbeat guidance. The stock price of DuPont de Nemours Inc. (NYSE:DD) has seen a 9% decline over the last five trading days, while it is down 13% over the last ten trading days, and we believe the stock will likely rebound from the current levels in the near term.	Five Days: DD -8.7%, vs. S&P500 1.2%; Underperformed market (3% likelihood event) DuPont stock declined 8.7% over a five-day trading period ending 2/11/2021, compared to broader market (S&P500) rise of 1.2% A change of -8.7% or more over five trading days is a 3% likelihood event, which has occurred 41 times out of 1256 in the last five years Ten Days: DD -13%, vs. S&P500 3.5%; Underperformed market (3% likelihood event) DuPont stock declined 13% over the last ten trading days (2 weeks), compared to broader market (S&P500) rise of 3.5% A change of -13% or more over 10 trading days is a 3% likelihood event, which has occurred 43 times out of 1240 in the last five years What if you’re looking for a more balanced portfolio instead? The stock price of DuPont de Nemours Inc. (NYSE:DD) has seen a 9% decline over the last five trading days, while it is down 13% over the last ten trading days, and we believe the stock will likely rebound from the current levels in the near term. Note that the DD stock rallied roughly 50% from levels of under $60 in mid August 2020 to over $85 in mid-January 2021, before dropping to $73 currently.	The stock price of DuPont de Nemours Inc. (NYSE:DD) has seen a 9% decline over the last five trading days, while it is down 13% over the last ten trading days, and we believe the stock will likely rebound from the current levels in the near term. In fact, we believe that there is a 74% chance of a rise in DD stock over the next month (twenty one trading days) based on our machine learning analysis of trends in the stock price over the last few years. Five Days: DD -8.7%, vs. S&P500 1.2%; Underperformed market (3% likelihood event) DuPont stock declined 8.7% over a five-day trading period ending 2/11/2021, compared to broader market (S&P500) rise of 1.2% A change of -8.7% or more over five trading days is a 3% likelihood event, which has occurred 41 times out of 1256 in the last five years Ten Days: DD -13%, vs. S&P500 3.5%; Underperformed market (3% likelihood event) DuPont stock declined 13% over the last ten trading days (2 weeks), compared to broader market (S&P500) rise of 3.5% A change of -13% or more over 10 trading days is a 3% likelihood event, which has occurred 43 times out of 1240 in the last five years What if you’re looking for a more balanced portfolio instead?	Now, after the recent drop, we believe that DD stock is poised to gain in the near term, given its upbeat guidance. In fact, we believe that there is a 74% chance of a rise in DD stock over the next month (twenty one trading days) based on our machine learning analysis of trends in the stock price over the last few years. Five Days: DD -8.7%, vs. S&P500 1.2%; Underperformed market (3% likelihood event) DuPont stock declined 8.7% over a five-day trading period ending 2/11/2021, compared to broader market (S&P500) rise of 1.2% A change of -8.7% or more over five trading days is a 3% likelihood event, which has occurred 41 times out of 1256 in the last five years Ten Days: DD -13%, vs. S&P500 3.5%; Underperformed market (3% likelihood event) DuPont stock declined 13% over the last ten trading days (2 weeks), compared to broader market (S&P500) rise of 3.5% A change of -13% or more over 10 trading days is a 3% likelihood event, which has occurred 43 times out of 1240 in the last five years What if you’re looking for a more balanced portfolio instead?	3e87bd62-236a-463b-b893-bd945324af7a
716201.0	2021-02-09 00:00:00 UTC	DuPont sees strong 2021 on robust demand from chip, smartphone makers	DD	https://www.nasdaq.com/articles/dupont-sees-strong-2021-on-robust-demand-from-chip-smartphone-makers-2021-02-09	nan	nan	Adds CEO comments from conference call, shares Feb 9 (Reuters) - DuPont DD.N on Tuesday forecast full-year profit and revenue above Wall Street expectations on the back of robust demand from chip companies and smartphone makers launching 5G handsets. Sales in the company's electronics and imaging business, which accounts for about 20% of total revenue, rose 9% to $1.02 billion in the fourth quarter from a year earlier. The industrial material maker, once part of the erstwhile chemical giant DowDuPont, forecast 2021 adjusted earnings of $3.30 to $3.45 per share, above the $3.07 analysts had estimated, according to Refinitiv IBES. Net sales estimates of between $15.40 billion and $15.60 billion also came in above analysts' expectations of $15.11 billion. DuPont's transportation and industrial business reported an about 1% rise in net sales to $1.2 billion in the fourth quarter, helped by a recovery in auto sales from the early pandemic hit. On anearnings call however, Chief Executive Officer Edward Breen warned of a $60 million to $80 million hit to the segment in the first quarter due a shortage of raw materials. DuPont expects net sales between $3.75 billion and $3.85 billion and profit of 75 cents to 77 cents per share in the first quarter. Analysts on average were expecting a profit 65 cents per share and revenue of $3.69 billion. DuPont's shares fell as much as 2.5% to $73.86, reversing from gains before the bell, after the company also said it would not make any large divestment in the year. The company plans to spend up to $2.5 billion of its $5 billion to $6 billion expected cash on mergers and acquisitions. It was working on two targets, DuPont said, adding it was more biased toward the electronics sector and to the electric vehicle space on the automotive side. (Reporting by Arathy S Nair and Arundhati Sarkar in Bengaluru; Editing by Sriraj Kalluvila) ((arathys.nair@thomsonreuters.com; +1 646 223 8780 (Extn 2726); Twitter: https://twitter.com/ArathySom;)) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	Adds CEO comments from conference call, shares Feb 9 (Reuters) - DuPont DD.N on Tuesday forecast full-year profit and revenue above Wall Street expectations on the back of robust demand from chip companies and smartphone makers launching 5G handsets. It was working on two targets, DuPont said, adding it was more biased toward the electronics sector and to the electric vehicle space on the automotive side. Sales in the company's electronics and imaging business, which accounts for about 20% of total revenue, rose 9% to $1.02 billion in the fourth quarter from a year earlier.	Adds CEO comments from conference call, shares Feb 9 (Reuters) - DuPont DD.N on Tuesday forecast full-year profit and revenue above Wall Street expectations on the back of robust demand from chip companies and smartphone makers launching 5G handsets. It was working on two targets, DuPont said, adding it was more biased toward the electronics sector and to the electric vehicle space on the automotive side. Net sales estimates of between $15.40 billion and $15.60 billion also came in above analysts' expectations of $15.11 billion.	Adds CEO comments from conference call, shares Feb 9 (Reuters) - DuPont DD.N on Tuesday forecast full-year profit and revenue above Wall Street expectations on the back of robust demand from chip companies and smartphone makers launching 5G handsets. It was working on two targets, DuPont said, adding it was more biased toward the electronics sector and to the electric vehicle space on the automotive side. Net sales estimates of between $15.40 billion and $15.60 billion also came in above analysts' expectations of $15.11 billion.	Adds CEO comments from conference call, shares Feb 9 (Reuters) - DuPont DD.N on Tuesday forecast full-year profit and revenue above Wall Street expectations on the back of robust demand from chip companies and smartphone makers launching 5G handsets. It was working on two targets, DuPont said, adding it was more biased toward the electronics sector and to the electric vehicle space on the automotive side. Sales in the company's electronics and imaging business, which accounts for about 20% of total revenue, rose 9% to $1.02 billion in the fourth quarter from a year earlier.	f74ce192-3422-4787-ad2c-5664ef4aa398
716202.0	2021-02-09 00:00:00 UTC	DuPont (DD) Q4 2020 Earnings Call Transcript	DD	https://www.nasdaq.com/articles/dupont-dd-q4-2020-earnings-call-transcript-2021-02-10	nan	nan	Image source: The Motley Fool. DuPont (NYSE: DD) Q4 2020 Earnings Call Feb 09, 2021, 8:00 a.m. ET Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: Operator Ladies and gentlemen, thank you for standing by, and welcome to the DuPont fourth-quarter 2020earnings conference call [Operator instructions] Thank you. I would now like to turn the call over to Leland Weaver to begin. Leland Weaver -- Vice President of Investor Relations Good morning, everyone. Thank you for joining us for DuPont's fourth-quarter 2020earnings conference call We are making this call available to investors and media via webcast. We have prepared slides to supplement our comments during this conference call. These slides are posted on the Investor Relations section of DuPont's website and through the link to our webcast. Joining me on the call today are Ed Breen, chief executive officer; and Lori Koch, our chief financial officer. Please read the forward-looking statement disclaimer contained in the slides. During our call, we will make forward-looking statements regarding our expectations or predictions about the future. 10 stocks we like better than DuPont de Nemours, Inc. When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.* David and Tom just revealed what they believe are the ten best stocks for investors to buy right now... and DuPont de Nemours, Inc. wasn't one of them! That's right -- they think these 10 stocks are even better buys. See the 10 stocks *Stock Advisor returns as of November 20, 2020 Because these statements are based on current assumptions and factors that involve risk and uncertainty, our actual performance and results may differ materially from our forward-looking statements. Our 2019 Form 10-K, as updated by our current and periodic reports, includes detailed discussion of principal risks and uncertainties which may cause such differences. Unless otherwise specified, all historical financial measures presented today exclude significant items. We will also refer to other non-GAAP measures, a reconciliation to the most directly comparable GAAP financial measure is included in our press release and posted to the investor relations page of our website. I'll now turn the call over to Ed. Ed Breen -- Chief Executive Officer Thanks, Leland, and good morning, everyone. I will provide comments on the tremendous progress we made on several strategic priorities during the fourth quarter of 2020 and the start of 2021. But first, let me give my appreciation to our employees and partners around the world who rose to the occasion day after day in the face of extraordinary circumstances. 2020 presented us with the challenges on the global health pandemic, social and political unrest, and the worst economic conditions in many years. Despite these challenges, our teams remained focused on health and safety, delivering for our customers, strengthening the financial position of the company, and continuing to drive our strategic priorities forward. It is because of our commitment of our employees that today we are able to announce the strong financial results, as well as significant progress on critical milestones to make DuPont a premier multi-industrial company equipped for growth and value creation. Starting on Slide 2, on February 1, we announced the completion of the merger of our N&B business with IFF, creating an $11 billion industry-leading company in the Food & Beverage, home and personal care, and health and wellness markets. The new IFF will have unmatched capabilities to deliver for customers with leading positions in markets such as nutrition, probiotics, soy proteins, flavors, and fragrances. The combination of these complementary portfolios puts IFF at the forefront of highly valued consumer ingredients companies that work closely with customers to meet the growing demand in areas such as all-natural, clean label, and sustainability. The combined management team has planned and prepared for this integration, and they are committed to delivering for all stakeholders. They are already executing on a playbook to capture both the cost and revenue synergies enabled by the combination. I am now on the IFF board, and I look forward to coming into the lead director role this spring to continue overseeing the transformation of IFF. This transaction also unlocks significant value for DuPont and our shareholders. Earlier this month, we received about 7.3 billion in cash, which enables us to further strengthen our balance sheet by reducing our long-term debt and gives us the flexibility to continue generating shareholder value. As you know, we separated the N&B business through a split-off transaction in which DuPont shareholders were given the option to tender their DuPont shares in exchange for shares in IFF at a ratio of 0.718 shares of IFF for every share of DuPont. The exchange offer was fully subscribed, and all shares that were tendered were retired by DuPont resulting in a reduction of 197 million shares or approximately 27% of our outstanding shares. This was a very efficient process for DuPont to get shares out of the market with zero cash outlay. In closing, customers are excited about the potential this strategic combination can deliver in terms of being a partner of choice, R&D capability, and innovation. Additionally, our N&B colleagues are energized by the opportunities before them, and we wish them continued success as they embark on this exciting new journey. Slide 3 highlights the impact of other actions we took throughout 2020 to strengthen our balance sheet and position the company to continue generating shareholder value through a disciplined financial policy. As Lori and I came into our roles in February of last year, and with the initial indications of a global pandemic soon thereafter, we quickly implemented actions to improve working capital and tension capital expenditures across each business and function. We achieved an 850 million improvement in working capital and reduced capital expenditures to $1 billion, a reduction of nearly $300 million from our initial targets for the year. Combined, these actions enable free cash flow conversion of more than 150% for the year. These actions, combined with proceeds from non-core divestitures, enabled us to close the year with zero commercial paper balances, a reduction of more than $1.8 billion. We expect to further reduce our debt balances by using $5 billion of the cash received from the IFF deal. We have already retired our $3 billion term loan and plan to redeem the $2 billion notes in May. We closed the year with greater than $2.5 billion of available cash, and as I mentioned, we expect to have $2.3 billion of cash remaining from the IFF transaction. Combined with the continued strong cash generation and further proceeds from non-core divestitures, we are heading into 2021 in a very favorable liquidity position with no debt maturities due until the fourth quarter of 2023. As we look to uses of our available cash in 2021, our financial policy will remain disciplined and balanced maintaining a strong balance sheet, growing the company through investments in capex and R&D, acting on strategic M&A targets, and returning value to our shareholders. We remain committed to maintaining our strong investment-grade credit rating and are pleased that we have a stable rating from all the major agencies. We also look to continue our capex at about 5% of sales, and R&D spending at about 4% of sales for 2021. With regards to dividends, we intend to maintain our current quarterly per-share dividend of $0.30 per share. Going forward, we will target a payout ratio between 35% and 45%, and we will work with our board to increase our dividend annually as we grow earnings. Finally, share repurchases remain an important component of our financial policy, and we intend to resume buybacks utilizing our existing plan, which still provides authorization up to $1 billion. We are also actively evaluating a couple of acquisition targets, which will enable even further acceleration of growth in key end markets. As we move through the year, we will redeploy our excess capital in ways which maximize shareholder value. Turning to Slide 4, we also recently signed agreements to sell our Clean Technologies and Solamet businesses, and we expect these transactions to close by mid-2021. Combined with the sale of the Biomaterials business, we anticipate more than $900 million in pre-tax proceeds from non-core divestitures this year. Our priority of active portfolio management has focused our portfolio and generated significant cash for the company. Since June 2019, we have divested or signed agreements to divest nine businesses in addition to the separation of N&B generating over $2 billion in gross proceeds. Additionally, exiting these businesses removes a significant amount of cyclicality from the DuPont portfolio and eliminates much of the volatility that was often in our noncore results. With the agreements on Clean Tech and Solamet, we have divested a substantial portion of the non-core segment. We will wind down the non-core segment reporting in the first quarter of 2021 and report our results in three reportable segments going forward, as we announced last week. I'll ask Lori to provide more color on our new segments, as well as detail on our financial performance, but let me close with a few comments on the settlement agreement that DuPont and Corteva reached with Chemours. I am pleased that we have reached an agreement that I believe is in the best interest of all three companies. For DuPont, there were a few key principles. First, it was important that any settlement agreement capped our share of any potential liabilities at a defined amount. We also have a long-term agreement with the building of an escrow account over the term to provide stakeholders of all three entities the confidence that the parties did agreement will be able to satisfy their respective obligations if they were to materialize in the future. The agreement we announced met these principles and was a key step in reducing the uncertainty around potential legacy PFOS liabilities. The other aspect of what we announced a few weeks ago was the settlement of the remaining Ohio multi-district PFOA litigation. Our portion to this settlement is $27 million. To be clear, we continue to believe any exposure for DuPont related to potential legacy PFOS liabilities is contained due to heritage DuPont's limited manufacture and use of PFOA, and the fact that we never made firefighting foam. Having agreement with Chemours and Corteva enables us to work together as we move forward. With that, let me turn it over to Lori. Lori Koch -- Chief Financial Officer Thanks, Ed, and good morning. With the completion of the N&B transaction on February 1 and the substantial progress we made on non-core divestitures, we announced our new segment reporting structure for DuPont going forward. We will be aligned around three business reporting segments: Electronics & Industrial, Water & Protection, and Mobility & Materials. Our new segment structure combines businesses with common financial characteristics, enabling clear line of sight and more effective allocation of resources across the company. Each business has a meaningful growth profile with the management team that understands how to best execute on its priorities and deliver for shareholders. We will move the following businesses to the newly named Electronics & Industrial segment: Kalrez, Vespel, Medical Silicones, and MOLYKOTE, each previously reported in our T&I segment. We will move the Teijin Films joint venture, the Micro Circuit Materials business, and the Tedlar business to our T&I segment, which will be remained Mobility & Materials. Each of these were previously reported in our non-core segment. Safety & Construction will be renamed Water & Protection to highlight our market-leading water business that we have grown both organically and inorganically over the past few years. As Ed mentioned, we will wrap up the non-core segment as part of our first core reporting. We will report the results of the Biomaterials, Clean Tech, and Solamet businesses in our corporate segment until the divestitures are complete. I'll cover our fourth-quarter results on Slide 6. As Ed did earlier, I'd like to acknowledge the significant efforts of our teams in delivering a strong fourth quarter, a capstone to what was an incredibly productive year. We set working capital and capex targets and challenged our teams to enable the reduction of commercial paper balances zero at year-end to improve our leverage heading into 2021. Our teams delivered once again. Net sales of $5.3 billion were flat versus the fourth quarter of 2019 on an organic basis and ahead of expectations we had set at the start of the quarter. Demand for our technologies in smartphones and semiconductors remained robust through the quarter with no seasonal decline in smartphones as we typically see in the fourth quarter. Also contributing to the strong fourth quarter was further recovery in the automotive market. At the start of the quarter, industry benchmark suggested fourth-quarter auto builds would be down low single digits. However, with over 23 million automobiles produced globally, the fourth quarter was the strongest production quarter of the year, up 3% versus the fourth quarter of 2019 and up about 14% versus the third quarter of 2020. Our teams navigated a challenging raw materials environment across the polymer space to deliver volume growth in line with auto-build on both a year-over-year and sequential basis. The end markets within S&C were very similar to the third quarter and consistent with our expectations. Demand for our protective garments continued to be strong, with garment sales up nearly 50% versus the fourth quarter of 2019. The aramid side of our safety business was up versus the third quarter on a sequential basis but continues to see year-over-year declines in volume as a result of the pandemic impacting demand for aerospace, oil and gas, and other select industrial applications. Similarly, the environment in Shelter Solutions remained consistent with what we saw in the third quarter, with strength in do-it-yourself applications and continued recovery in residential construction offset by softer commercial construction demand. Shelter sales were up slightly on an organic basis in the fourth quarter. And demand for water filtration technologies remained strong across the world. However, in our fourth-quarter results were impacted by the timing of some shipments at year-end, resulting primarily from orders associated with capital projects. We will capture this demand in our first-quarter results and return to mid- to high single-digit growth. Likewise, results for the N&B segment were in line with our expectations with ongoing demand strength in probiotics and home and personal care markets, offset by the continued softness in biorefinery and microbial control. From an earnings perspective, we also delivered a strong quarter, driven by improved volumes and the delivery of approximately $130 million of nonmanufacturing cost savings, which enabled expanded EBITDA margins in each of our core segments in the quarter. Excluding approximately $160 million of discrete gains in the fourth quarter of 2019, we delivered operating leverage with mid-single-digit operating EBITDA growth. From a segment perspective, E&I delivered operating EBITDA margin of 31.6% on strong volumes and cost reductions. T&I delivered 310 basis points of operating EBITDA expansion on higher volumes, tight cost control, and lower raw material costs offset by year-over-year pricing pressure. Likewise, S&C drove operating margin expansion of 40 basis points through cost control and favorable product mix, more than offsetting the impact of lower volumes. N&B operating margins expanded 100 basis points versus the fourth quarter of 2019 led by favorable product mix and nonmanufacturing cost control, more than offsetting raw material price increases, and costs associated with the planned slowdown of production across the N&B network to properly manage working capital. Adjusted EPS of $0.95 per share was flat with the prior year. Savings from both structural and temporary cost reductions and benefits from a lower tax rate were offset by pricing headwinds and a headwind of approximately $0.17 associated with the prior-year discrete items. We also delivered robust free cash flow in the fourth quarter, driven by controlled capex and working capital improvements. We closed the year with capex on target at $1 billion and approximately $850 million in working capital improvement, well above our target of $500 million for the year. Looking forward over the medium term, we continue to believe we have additional opportunity to improve our working capital turnover, primarily through better supply chain management through the use of data analytics. Slide 7 provides our financial outlook for both the first quarter and full-year 2021.Our guidance reflects DuPont on the new basics, excluding N&B as it will be reflected as discontinued operations when we report our results. We have provided recast first-quarter and full-year 2020 results excluding N&B for comparison purposes. Later this month, we will release fully recast segment results for 2018 and all quarters in 2019 and 2020, reflecting the segment realignment, the elimination of the non-core segment, and reflecting N&B as discontinued operations. Our guidance also includes a full-year results for the three non-core businesses we have signed agreements to sell, and we will reset expectations as they close. For the full year, we expect net sales of $15.4 billion to $15.6 billion, an increase of 8% at the midpoint, and operating EBITDA of $3.83 billion to $3.93 billion, an increase of 13% at the midpoint. We expect operating EBITDA margin improvement of approximately 100 basis points driven by the impact of improved volumes and the remaining benefits of our structural cost actions we put in place last year. These gains will be partially offset by anticipated return of some 2020 temporary cost reductions. Adjusted EPS of $3.30 to $3.45, an increase of 68% at the midpoint versus 2020 adjusted EPS of $2.01 per share reflects stronger segment earnings and lower interest expense, which is enabled by the paydown of our debt balances, including commercial paper. Our adjusted EPS also reflects the reduced share count resulting from the exchange offer that closed on January 29 in connection with the separation of N&B. As a reminder, this took out about 197 million DuPont shares. This results in a weighted average share count for the year of 555 million which excludes the benefit of any future buybacks. With that, let me turn it over to Leland to open the Q&A. Leland Weaver -- Vice President of Investor Relations Thanks, Lori. Before we move to the Q&A portion of our call, I would like to remind you that our forward-looking statements apply to both our prepared remarks and the following Q&A. We will allow for one question and one follow-up question per person. Operator, please provide the Q&A instructions. Questions & Answers: Operator Thank you. [Operator instructions] Our first question comes from line of Jeff Sprague of Vertical Research Partners. Jeff Sprague -- Vertical Research Partners -- Analyst Thank you. Good morning, everyone. Ed Breen -- Chief Executive Officer Good morning. Jeff Sprague -- Vertical Research Partners -- Analyst Congrats on getting a lot done in a crazy, tough pandemic year. Question for me is really just thinking about kind of the way the company now is reconfigured post N&B. And, Ed, you mentioned M&A a little bit in your prepared remarks. I just wonder if you could elaborate a little bit more on kind of the balance between opportunity for organic investment in the areas that you're strategically focused and what the M&A pipeline and/or kind of magnitude of activity on the M&A front might look like. Ed Breen -- Chief Executive Officer Yes. Thank you, Jeff. Yes, look, as Lori highlighted, we're expecting 8% revenue growth in 2021. So we feel like it's going to be a robust year for us. And key for us is our 4% spend on R&D. So that's clearly number one. And we're very focused on the secular growth areas within the portfolio where we're spending the R&D. So we feel like we're going to have very good results organically as we move forward in the new configuration. The way we're looking at M&A, I'd say, look, there's two targets that we're presently working on. I don't know if we'll be able to consummate them or not. We're not going to stretch to get them. We're going to make sure the numbers work for us, and we're going to make sure the numbers work on the cost synergy side, not taking into account revenue synergies even though the couple that we're working on do have revenue synergies. So we'll see how that plays out. We're actively in that right now. They're right down the middle of the plate in a couple of areas that we already participate in. We're not going to do anything on the M&A side that's a new segment or anything like that. We feel like there's some good consolidation opportunities right where we have our strengths and right where we have great relationships with customers. So that's how we're looking at it. And as we highlighted, even though we just took 27% of our shares out of the market not using any cash, we do have still $1 billion open on our authorization. So we're going to get back in the market and start repurchasing shares. We have a board meeting coming up in the next month. And that will be a topic that we will have with the board, a share buyback versus mix of M&A that we're planning on doing during the year. Jeff Sprague -- Vertical Research Partners -- Analyst Great. And as a follow-up, actually unrelated, different topic. this global semiconductor shortage fire drill that's going on, can you just kind of address how that impacts you? I'm sure it's going to impact auto production builds that might hurt you on one side, but then your kind of supplying the response on the other. Maybe you could just kind of tie that together for us. Ed Breen -- Chief Executive Officer Yeah. Well, I think it's going to affect auto builds. I think the forecast out there is 650,000 to 700,000 cars that will be reduced by because of the shortages out there. But I mean, Jeff, we're running full tilt on the semi side. And quite frankly, the whole electronics segment is running full tilt as Lori had mentioned. Even the smartphone demand where we have additional content now because of 5G that did not even soften up in the fourth quarter and usually seasonally that even declined. So we're pumping out as much as we can, but definitely, there's some slight slowdown, but the car production is still hot and heavy. You can look at the 650,000-unit reduction, and hopefully, that works its way. Those issues work its way through during the first quarter. So we're seeing a little bit there. But again, I think our forecast is very solid for what we're going to do in the electronics business in the semi. We're also seeing some headwinds on raw materials in the T&I business, which also somewhat relates to the auto business. So we lost a little bit of volume in the fourth quarter, and we'll lose a little bit of volume in the first quarter because of those constraints. But again, our forecast still is very solid, and we're pretty much running full tilt there also. Jeff Sprague -- Vertical Research Partners -- Analyst Great. Thank you. Ed Breen -- Chief Executive Officer Thank you. Operator Our next question comes from the line of Scott Davis of Melius. Scott Davis -- Melius Research -- Analyst Good morning, guys. Ed Breen -- Chief Executive Officer Good morning. Scott Davis -- Melius Research -- Analyst What changed that got you to keep the non-core businesses, the Micro Circuit, the Tedlar, and the films JV? Is it just a timing issue and they may still be for sale? I'll just leave it at that, let you explain. Ed Breen -- Chief Executive Officer Yeah, yeah, Scott. Look, they are businesses that are kind of down right now because of the end markets. So take the Tedlar business somewhat aerospace exposed. They're good businesses. Lori and I did really a study of all the non-core businesses and decided we have some really nice upside in the businesses we're moving into T&I. Our T&I team is really great operators, which is exactly what's needed here. So we think there's nice upside coming in these businesses. It was not -- it wouldn't have been productive to sell them. I don't think it would have been good for our shareholders and we see some good long-term trends there. So we made this decision strategically to hold on to. And don't expect them to be up for sale during the year. That's not what we're doing. We're putting them in there, and we're going to run them. Scott Davis -- Melius Research -- Analyst OK. That's helpful. And then Ed, you just talked about T&I having some challenges, obviously, with obvious things that Jeff brought up. The pricing headwinds, I mean, you're able to -- I would imagine you're able to capture some of this back in price. It just takes a little bit of time. Is much of a mix issue as price issue? And when you say pricing headwinds? Or is, in fact, just explicitly price? Ed Breen -- Chief Executive Officer No, the headwinds in T&I are really constrained, raw material constraints that we're having. By the way, we're going to have a very nice first quarter in T&I, but we could have had more upside. I think we're going to -- we think we're going to miss out on about 60 to 80 million in sales in T&I because of raw material constraints in the first quarter. Now, we think we'll get a lot of that back. We won't lose it because the whole industry is having a few issues there. But specifically to your question on pricing, things have firmed up very well. It's a constructive market for pricing as we've entered the first quarter, I think you'll see price increases in the industry across the board. But a lot of that won't kick in until you get -- by the time you put it in place with contracts, you have with customers, usually 30 days, 45 days. You'll probably see more of that kick in, in the second quarter. But it's turned very constructive at this point in time on the price front. Scott Davis -- Melius Research -- Analyst Good. All right. Well, good luck on '21. Ed Breen -- Chief Executive Officer Thank you. Operator Our next question comes from the line of Steve Tusa of J.P. Morgan. Steve Tusa -- J.P. Morgan -- Analyst Hey, guys, good morning. Ed Breen -- Chief Executive Officer Good morning, Steve. Steve Tusa -- J.P. Morgan -- Analyst Just following up on that last question from Scott on the price side. I guess for the old T&I segment, what are you assuming for price? Or if you just want to talk about the new mobility, however you want to kind of look at it, but what are you assuming for kind of price mix for the year there? Lori Koch -- Chief Financial Officer Yeah. So for the quarter, maybe hit the quarter first of what we had guided to in the slide, so the new M&M segment, we will see sequential improvement in nylon price. And so we were down about 4% in Q4. We're looking at about 2% in Q1. So there is some sequential improvement there. However, we still do expect to be down year over year just given that we were still in a bit of a nylon run in the first quarter of 2020. So as we go through the year, as Ed has mentioned, the pricing environment in nylon is constructive. We do have an awesome team that takes advantage of price. So we do expect, as we get to the full year that you could see positive price momentum as reported for the full-year basis. Keep in mind, though, there are some raw material headwinds that Ed had mentioned that we're dealing with. So some of that price most likely will be offset by escalating raws, especially as oil price is expected to tick up. There are some raw material headwinds that we will offset, but they could eat into some of the price appreciation that we would see. Steve Tusa -- J.P. Morgan -- Analyst Got it. So like flat kind of price cost for the year for you, guys. Lori Koch -- Chief Financial Officer I mean, it will depend how the nylon dynamic plays out, yes. So right now, I think we could hedge it at saying at about flat, but potentially with some upside if the nylon and the end markets in auto continue to remain tight. There's, I think, a couple of recent force majeures in the industry that's making the price environment even more conducive, though. Steve Tusa -- J.P. Morgan -- Analyst Got it, got it. And then you mentioned that you're kind of running full out to keep up with some of the demand on the electronic side. I mean, are you going to have to add capacity at all to keep up with this? Or are these just bottlenecks that are more temporary? Ed Breen -- Chief Executive Officer It's a combo both, Steve. We're cranking out more and we're freeing up capacity with a lot of moves we're making on the factory floor. But we're also in capacity with it. Our biggest single capex project is the Kapton expansion. We're running flat out on Kapton. I mean, we could definitely ship more if we had more manufacturing capability, and that comes online as we go into 2022. And that's a big move for us. The Kapton is what we use for the 5G and the smartphones and also that's a major expansion coming on that we desperately need. Steve Tusa -- J.P. Morgan -- Analyst OK. Great. Thanks a lot for the info. Appreciate it. Operator Our next question comes from the line of Jonas Oxgaard of Bernstein. Jonas Oxgaard -- Sanford C. Bernstein -- Analyst Good morning. Ed Breen -- Chief Executive Officer Good morning. Jonas Oxgaard -- Sanford C. Bernstein -- Analyst Wondering about the capital allocation. So you said you're going to seek board approval for more buybacks. Can I ask what kind of range of buybacks will you be seeking? Ed Breen -- Chief Executive Officer Jonas, I don't fully know yet. It's also partially going to be contingent on that we do some M&A during the year. I mean, look, in aggregate, I mean, we're in a really nice spot here. We've got $5 billion to $6 billion of cash available to us as we close the three non-core sales that we've made but haven't closed them yet. I think Lori mentioned, there's still $900 million gross coming in during the first half of the year. In addition to the $2.3 billion excess from the IFF transaction and the $2.5 billion we have just coming into the year from non-core sales and operating cash flow. So it's a really nice position to be in. And so partially just in general on where we end up on the M&A front, we're not going to sit on cash through the big numbers. So it will either be M&A or buyback. Jonas Oxgaard -- Sanford C. Bernstein -- Analyst OK. Appreciate that. Then if you don't mind, ask, so you think you've been focused on the transaction getting the businesses back up and running. So when you're thinking of '21, like as the CEO, what are your big focus areas for the year? Ed Breen -- Chief Executive Officer Operational excellence if I just put it in two words. I think we have still nice runway for a lot of improvement. One of the areas that Lori and I are spending a lot of time on is really our throughput at our facilities. We think we have gross margin runway to improve. I think we're best-in-class when it comes to overhead cost structure, if you benchmark us against the very best peers. So that's not our opportunity although we always look for ways to optimize that. But the key for us is the gross margin line. We want to move that up over time to 40%. We've been running kind of 35%. We're installing a lot of digital analytics at our facilities. We spent about $15 million last year in data analytics tools, this year we budgeted $30 million, so you kind of see how we're ramping there. A lot of it's on the supply chain and manufacturing efficiency. We're putting in some tools on smart demand forecasting, process optimization uptime, and we're seeing some real benefits from it. So that's a huge focus area for us this year. Jonas Oxgaard -- Sanford C. Bernstein -- Analyst OK. Thank you. Operator Our next question comes from the line of John Inch of Gordon Haskett. John Inch -- Gordon Haskett -- Analyst Thank you. Good morning, everybody. Ed Breen -- Chief Executive Officer Good morning, John. John Inch -- Gordon Haskett -- Analyst Good morning, guys. How are you thinking about working capital improvements from here? I think you had called out -- correct me if I'm wrong, $1 billion long-term potential, but you just did over or around $850 million for 2020. And does working capital have to come back, let's say, in 2021, as your businesses cycle back, which I guess is probably a good problem to have, actually? Ed Breen -- Chief Executive Officer Yeah, it is a good problem, John. But look, we look at it I think when you're going back into an up environment here, I really look at it from what are the turns doing. And we took our turns from 4.3 turns going into last year to -- we exited the year at 5.2. And that was the $850 million improvement. And our plan this year is to slightly improve our turns from the 5.2. Not a lot this year but slightly, and that would be a victory for us. John Inch -- Gordon Haskett -- Analyst With those areas where the turns are higher, correlate, Ed, with what you just stated as the sort of 5 points of runway overall for gross margin? So I was going to ask you that, too. The gross margin, is it comparable by segment, that 5 points, 35 to 40? Or how does that delineate across the three segments? Ed Breen -- Chief Executive Officer No, the biggest opportunity is S&C. It's also got our heaviest manufacturing footprint. So between Nomex, Kevlar, and Tyvek, they are our biggest opportunities in the business, they're our biggest facilities. We definitely know we can improve our uptimes, our turnaround times, and that's the No. 1 area we're working on. By the way, it's across the board, but the biggest opportunity is there. Lori Koch -- Chief Financial Officer Same goes for working capital. A lot of the opportunities still reside within inventory. I think our DSO is at a nice level and DPO working capital, we can continue to improve. And a lot of that back to the S&C or the new WMP business is where a lot of the opportunity lies. John Inch -- Gordon Haskett -- Analyst No, it makes sense. I mean, just as a follow-up, Ed, what's your appetite for doing something larger on the deal front in the next year or so? Maybe are we thinking instead of just continuing to shrink DuPont, maybe even a possible asset swap with another company? Ed Breen -- Chief Executive Officer Well, John, let me just -- we always look at every opportunity. So I don't think anything will get by us if there's something interesting. Let me just highlight though, on the M&A side, maybe just size it a little bit for you. We could spend up to $2.5 billion on M&A. Now, things don't always work out. And as I said, we're not going to stretch to get something. So you never know, but we're kind of looking in that kind of range if it were to play out. So just to kind of size a little bit for you. But look, we always look at other alternatives too. We get calls every week. If something makes sense, we'll study it. John Inch -- Gordon Haskett -- Analyst Got it. Thank you. Ed Breen -- Chief Executive Officer Thanks, John. Operator Our next question comes from the line of Steve Byrne of Bank of America. Steve Byrne -- Bank of America Merrill Lynch -- Analyst Good morning. Ed, when you were talking about the PFAS liability settlement, you also commented that it's your view that your liability will be limited to the legacy DuPont facilities, given you didn't ever manufacture firefighting foams. Is there anything you can do to solidify that view? And the reason I ask is, in the past, DuPont's supported the initiative to have the PFAS grouping regulated under CERCLA and under the old Superfund base, CERCLA allocated costs according to the ability to pay, not necessarily to the contribution to the problem. And thus, is that a potential concern for you with regard to broadening this potential cleanup liability? Ed Breen -- Chief Executive Officer Yes. So let me clarify that. We have been supportive. We've testified in front of Congress that if you designate it as a hazardous substance, we're totally in agreement with that. We'd rather have a national standard than every state doing their own thing. But remember, under the circular, the Superfund designation, it's very narrow who is responsible for it. I mean, it's where you disposed of the material. And the party responsible either had to be the site owner or the past site owner when it occurred or the person that arranged to transport it through that location. That is the definition under the CERCLA which is very narrow. You have to be one of the players that did that. DuPont, by the way, we have four sites where we used it as a manufacturing agent. And we disposed of it on our own sites with, by the way, approval to do that. One of our sites is 800 acres, one of them was 1,500 acres, and that's why we had so much ground. That's where the disposals occurred. So we're very contained where we did it. There's already cleanup going on with government authorities approving what we're doing, and that's been ongoing for quite a few years. And we never obviously disposed the firefighting foam anywhere in a dump or anything because we didn't make it. So look, as the facts keep coming out, it will get narrow and narrow here. And then we'll, as I've said before, and I don't want to get into too much detail, it's a little bit proprietary, but we'll look at a way to hopefully contain the firefighting foam issue, so our investors understand the limited or no liability that sits there based on what we did as a company. And by the way, we're very focused on it. As you can see, we said there was a three-pronged approach. We just did two of the pieces with the announcements we made with the agreement between the three companies and settling the rest of the Ohio MDL for really very little in the scheme of things. And so now, we'll focus on this firefighting foam piece of it. Remember also, we have been sued in states. We don't even have anything in the state. The state of Arizona, the state of New Hampshire, we don't even have a facility there. We didn't do anything there. So the facts will keep coming out here, and then hopefully we'll get resolution, and hopefully something by the end of 2021. Steve Byrne -- Bank of America Merrill Lynch -- Analyst OK. Thank you for that, Ed. And now that N&B has been separated and you reshuffled the segments, and you've accomplished a bunch in the last year, just curious, how long do you see yourself remaining as the CEO? And is there a process under way that that could change? Ed Breen -- Chief Executive Officer Well, I just signed a three-year contract, I don't know, a month or two ago. So at least that period of time. So no, no process in place. I'm very excited for the next few years. Steve Byrne -- Bank of America Merrill Lynch -- Analyst OK. Thank you. Ed Breen -- Chief Executive Officer Thanks. Operator Our next question comes from the line of Bob Koort of Goldman Sachs. Bob Koort -- Goldman Sachs -- Analyst Thanks very much. Good morning. Ed Breen -- Chief Executive Officer Good morning. Bob Koort -- Goldman Sachs -- Analyst Ed, I'm curious maybe it was asked in other ways, but when you think about sort of what your aspirational peer set was, and there's some pretty good variance still in the valuations of your individual businesses, even though you've obviously made some great progress, you've cleaned up some of the non-core stuff of the portfolio, you've maybe diminished the angst around PFOS, what do you sort of see as the strategic options to narrowing that variance from a valuation standpoint? Ed Breen -- Chief Executive Officer Well, Bob, it's one of the reasons we continue buying back shares because look at our multiple, whatever it is, 13 times, and I stare at ITW's and Honeywell's and Eaton, we're just as good a company. I think part of it is we got to continue to post consistent results, I think, consistency and people not having to worry I think means a lot in the multiple. I've been doing this for a long time, and I've been saying that for over 20 years. So I think we just keep posting good numbers. And I think we continue to close that gap. And I think we're going to benchmark very well this year, all our metrics vis-a-vis those other very good competitors, by the way, and multi-industry companies. So there's a gap to that peer set for us of 400 to 500 basis points. And I truly don't believe that discount should be there at all. And so we'll continue to prove that out during 2021. Bob Koort -- Goldman Sachs -- Analyst You mentioned a few markets that have been quite hot. Obviously, you've got a few in the portfolio end markets that are maybe more of a post-pandemic glide path. Can you give us some update on how you see things progressing in energy or maybe aerospace or some of these other businesses that are going to take a bit longer to recover? Ed Breen -- Chief Executive Officer Yeah. If I describe at a high level, and maybe Lori wants to give a little more detail. Some of those, the oil and gas aerospace, they dropped 30% to 40% on the revenue line. And our gut is we kind of glide back up, get half of that back in kind of 2021. That's kind of how -- if you just put them all together, that's how we would look at it. So we still would be down from 2019 levels in those end markets. And oil and gas, specifically in aerospace, as you mentioned, would be two of those. So that's kind of how I would look at it. Bob Koort -- Goldman Sachs -- Analyst Great. Thanks so much. Operator Our next question comes from the line of David Begleiter of Deutsche Bank. David Begleiter -- Deutsche Bank -- Analyst Thank you. Good morning. Ed and Lori, just on the sales guidance of up 7% to 9%, by segment, which would be above or below or in that range, do you think? Lori Koch -- Chief Financial Officer So I'll give it to you on the current segment basis, and then we'll remap it on the Q1 call when we have all of these recast done to get to the new segment basis. So from the old segment basis, we would see T&I probably at above that average 8%, just given by all the strength that we had mentioned earlier with the V-shaped recovery in automotive and potentially some pricing tailwinds that could come our way. Ed had just mentioned within S&C, is it more of a delayed recovery to full 2019 levels within a lot of the aramid end markets that sell into oil and gas and aerospace, for example. So they would be probably below that 8%. And we would see electronics right now right around that average. And so very strong in the first half as we see it. We're watching the second half to see how the trends continue across MA, across the 5G infrastructure to see how we continue to trend there. Obviously, we posted very strong results in 2020, up about 8% in that segment. So I would say that's where you put it. So T&I at the top, E&I right around the middle, and S&C probably lagging the average for the company. David Begleiter -- Deutsche Bank -- Analyst Very helpful. How was January? Was it above or in line with your expectations? And what are you expecting or seeing around Chinese Lunar New Year? Lori Koch -- Chief Financial Officer Yeah. So you hit the nail on the head with the Lunar New Year. So January, it's hard to gauge from how the quarter is going to play out because it was strong just given the timing of Lunar New Year from this year to last year. So we're still comfortable looking at January results with the Q1 guidance that we gave. And we'll see how -- we had mentioned that nylon price continues to play out, availability of raw materials within the T&I business to satisfy that demand, and we'll see how much unconstrained demand we have at the end of the quarter. David Begleiter -- Deutsche Bank -- Analyst Thank you. Operator Our next question comes from the line of Chris Parkinson of Credit Suisse. Chris Parkinson -- Credit Suisse -- Analyst Thank you very much. Naturally, there are a few moving pieces heading into '21, as well as '22. But just given the current end-market trends you're seeing and how they're setting up after that timeframe as it pertains to op leverage mix, your efforts to further improve your overhead structure and it improves your cost profile, how should we just generally think about incremental margins on a segment-by-segment basis over that period versus how we used to think of them? Are there any major differences we should really be honing in on? Thank you. Lori Koch -- Chief Financial Officer Yeah. I mean, I think on a steady-state basis, there shouldn't be material difference between them. In 2021, it will vary because of the recoveries and the different shape of post that recovery. So if we talk in a total company level, based on the guidance that we provided, you would see incremental margin sort of in the low 40s for 2021 over 2020 for the total company. Chris Parkinson -- Credit Suisse -- Analyst And just as a follow-up, in terms of your Water Solutions portfolio, where do you see your largest strengths heading into '21 and '22 in terms of product offering? And can you also comment on just any additional substrates you feel could potentially augment via M&A to further enhance the breadth of your offering? So just trying to get a better sense of the longer-term strategy within that portfolio. Thank you. Lori Koch -- Chief Financial Officer Yeah. So I think with the acquisitions that we made at the tail end of 2019, we now have probably the most complete portfolio in the industry. So we've got technologies within ultrafiltration, reverse osmosis, and ion exchange. And so as we look forward to capture opportunities there, we're looking to provide not only materials into those individual spaces but also with solution set and a solution play more along the lines of a complete offering. As we look to M&A, we look to continue to round out that portfolio from both enhancing existing businesses, as well as also potentially looking at a geographic play. So obviously, a lot of the opportunity within the water space is in more of the emerging regions, and if there's some M&A play that we can utilize to take advantage to solidify our footprint in some of those geographies. Chris Parkinson -- Credit Suisse -- Analyst Thank you very much. Operator Our next question comes from the line of John McNulty of BMO Capital Markets. John McNulty -- BMO Capital Markets -- Analyst Just a follow-up on the water treatment side, the Water Solutions side, so you indicated there were some order delays just around capital projects being delayed. I guess, can you quantify that a little bit or kind of frame it for us a little bit? And also, can you speak to the visibility that you have in this business, how far out you can actually see and how you see 2021 as a whole playing out this year? Lori Koch -- Chief Financial Officer Yes. So if we size kind of the headwinds that we saw in Q4, so as we had mentioned, the capital delays, there were also some logistical delays in the quarter, just ability to get shipping out the door. It was probably about $15 million for the fourth quarter. So as we look at January results, they were strong. They were again up about 6%. We're looking for the quarter to return to that mid- to high single-digit growth within water. And for the year, generally at that level as well. So we're confident in the go-forward portfolio there. We just had a little bit around a capital project delay and, as I had mentioned, logistics. As far as visibility is concerned, we have back-end loaded order patterns. And so a lot of the sales go into large capital projects that tend to be pushed to the back end of the quarter. And so our visibility there on those larger opportunities is a little bit more limited than some of the shorter-term opportunities of selling materials into, like I had mentioned, reverse osmosis and ion exchange. John McNulty -- BMO Capital Markets -- Analyst Got it. Fair enough. Thanks for the color on that. And then just a follow-up on -- in your comments earlier around the hope of getting the gross margins to, at some point, getting them pretty close to 40% or above, with a lot of that tied to -- or it sounds like a disproportionate amount tied to S&C, so I guess just back at the envelope that kind of says S&C starts to see margins at some point in the low to mid-30s, which is obviously a notable jump from kind of where we are. I guess what are the -- is it just operational improvement that gets you there? Is it mix improvement as some of these higher-margin businesses like water really start to accelerate? I guess how do you get to those types of levels if that's what you're really targeting, I would say, whatever, over the next two to three years? Ed Breen -- Chief Executive Officer Yes. So S&C, I would target it more toward the high 20s EBITDA margin because not all of the opportunity is in that business, but it is the biggest single piece. And obviously, the single biggest thing then in there is the factory optimization, our uptimes, our throughput on those assets. So that's the biggest area, and that's where we're putting a fair amount of focus on digital tools going in to help us there. But I think that business should be a high 20s EBITDA type of business over the medium term here. And we can definitely run it there. But it's mostly on the factory optimization piece. John McNulty -- BMO Capital Markets -- Analyst Guys, thanks very much for the call. Ed Breen -- Chief Executive Officer Thank you. Operator Our next question comes from the line of John Roberts of UBS. John Roberts -- UBS -- Analyst Thank you. Ed, do you have to reset some of your sustainability targets here with the N&B business going away? Because obviously, that was the greenest of the DuPont businesses. Ed Breen -- Chief Executive Officer Yeah. No, we don't, John. I mean, we have our targets laid out by segment and -- by the way, they're public, obviously, so you can go look at all of them. So no, it doesn't really change what we're doing and what we've laid out. But I guess, overall, it does for DuPont because you're taking 30% of the EBIT out of those businesses. But we have targets laid out by division and then totally for the company. And it's a big focus area for us this year. We've actually -- I don't think we said this publicly, that we've actually put sustainability in our bonus structure this year. It's a modifier of 10% in either direction in what the bonus payout would be for the company based on targets that we set with the board. So I'm happy and I'm glad that we put that in place also. So all our employees know the importance of it to us to hit the goals that we've laid out. John Roberts -- UBS -- Analyst And then can you quantify at all what the raw material inflation number might be for 2021? What percentage up should we expect year over year? And what are the couple of things that are going to be above the average to push that high? Lori Koch -- Chief Financial Officer Yeah. So in total, I would quantify at about $100 million of a headwind in 2021 with the predominance of it being within T&I and some of the nylon feedstock. John Roberts -- UBS -- Analyst Thank you. Operator And ladies and gentlemen, it looks like we have time for one more question. Our final question will come from the line of Mike Sison of Wells Fargo. Mike Sison -- Wells Fargo Securities -- Analyst Hey, good morning. Hope it's warmer in Wilmington than is in Cleveland. But, yeah, just one question. I guess in transportation and industrial, a lot of companies in polymer lands has talked about recycling, sustainability, recycled plastics, and that type of offering. Just maybe give us your thoughts on where you participate in that trend. And then is it may be potentially an area for acquisitions to beef up that part of your portfolio? Lori Koch -- Chief Financial Officer Yeah. I'll answer the second part first. So around the M&A opportunities right now. I would say they're more biased toward the electronics space. Within automotive, they could be biased toward getting us more of a footprint within the electric vehicle space and then obviously, as we had mentioned earlier in the water space rounding at that portfolio, taking advantage of the underlying growth trends within that space. I think as far as the recyclability within that space, I don't see that as a large challenge for our business. I think that more within the plastic space, I don't see that as a material driver of the overall new DuPont company. Mike Sison -- Wells Fargo Securities -- Analyst Great. Thank you. Lori Koch -- Chief Financial Officer Thanks. Leland Weaver -- Vice President of Investor Relations Thank you, everyone, for joining our call. For your reference, a copy of our transcript will be posted on DuPont's website. This concludes our call. Operator [Operator signoff] Duration: 59 minutes Call participants: Leland Weaver -- Vice President of Investor Relations Ed Breen -- Chief Executive Officer Lori Koch -- Chief Financial Officer Jeff Sprague -- Vertical Research Partners -- Analyst Scott Davis -- Melius Research -- Analyst Steve Tusa -- J.P. Morgan -- Analyst Jonas Oxgaard -- Sanford C. Bernstein -- Analyst John Inch -- Gordon Haskett -- Analyst Steve Byrne -- Bank of America Merrill Lynch -- Analyst Bob Koort -- Goldman Sachs -- Analyst David Begleiter -- Deutsche Bank -- Analyst Chris Parkinson -- Credit Suisse -- Analyst John McNulty -- BMO Capital Markets -- Analyst John Roberts -- UBS -- Analyst Mike Sison -- Wells Fargo Securities -- Analyst More DD analysis All earnings call transcripts This article is a transcript of this conference call produced for The Motley Fool. While we strive for our Foolish Best, there may be errors, omissions, or inaccuracies in this transcript. As with all our articles, The Motley Fool does not assume any responsibility for your use of this content, and we strongly encourage you to do your own research, including listening to the call yourself and reading the company's SEC filings. Please see our Terms and Conditions for additional details, including our Obligatory Capitalized Disclaimers of Liability. Motley Fool Transcribing has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	DuPont (NYSE: DD) Q4 2020 Earnings Call Feb 09, 2021, 8:00 a.m. Additionally, our N&B colleagues are energized by the opportunities before them, and we wish them continued success as they embark on this exciting new journey. Since June 2019, we have divested or signed agreements to divest nine businesses in addition to the separation of N&B generating over $2 billion in gross proceeds.	Operator [Operator signoff] Duration: 59 minutes Call participants: Leland Weaver -- Vice President of Investor Relations Ed Breen -- Chief Executive Officer Lori Koch -- Chief Financial Officer Jeff Sprague -- Vertical Research Partners -- Analyst Scott Davis -- Melius Research -- Analyst Steve Tusa -- J.P. Morgan -- Analyst Jonas Oxgaard -- Sanford C. Bernstein -- Analyst John Inch -- Gordon Haskett -- Analyst Steve Byrne -- Bank of America Merrill Lynch -- Analyst Bob Koort -- Goldman Sachs -- Analyst David Begleiter -- Deutsche Bank -- Analyst Chris Parkinson -- Credit Suisse -- Analyst John McNulty -- BMO Capital Markets -- Analyst John Roberts -- UBS -- Analyst Mike Sison -- Wells Fargo Securities -- Analyst More DD analysis All earnings call transcripts This article is a transcript of this conference call produced for The Motley Fool. DuPont (NYSE: DD) Q4 2020 Earnings Call Feb 09, 2021, 8:00 a.m. Additionally, our N&B colleagues are energized by the opportunities before them, and we wish them continued success as they embark on this exciting new journey.	Operator [Operator signoff] Duration: 59 minutes Call participants: Leland Weaver -- Vice President of Investor Relations Ed Breen -- Chief Executive Officer Lori Koch -- Chief Financial Officer Jeff Sprague -- Vertical Research Partners -- Analyst Scott Davis -- Melius Research -- Analyst Steve Tusa -- J.P. Morgan -- Analyst Jonas Oxgaard -- Sanford C. Bernstein -- Analyst John Inch -- Gordon Haskett -- Analyst Steve Byrne -- Bank of America Merrill Lynch -- Analyst Bob Koort -- Goldman Sachs -- Analyst David Begleiter -- Deutsche Bank -- Analyst Chris Parkinson -- Credit Suisse -- Analyst John McNulty -- BMO Capital Markets -- Analyst John Roberts -- UBS -- Analyst Mike Sison -- Wells Fargo Securities -- Analyst More DD analysis All earnings call transcripts This article is a transcript of this conference call produced for The Motley Fool. DuPont (NYSE: DD) Q4 2020 Earnings Call Feb 09, 2021, 8:00 a.m. Additionally, our N&B colleagues are energized by the opportunities before them, and we wish them continued success as they embark on this exciting new journey.	Operator [Operator signoff] Duration: 59 minutes Call participants: Leland Weaver -- Vice President of Investor Relations Ed Breen -- Chief Executive Officer Lori Koch -- Chief Financial Officer Jeff Sprague -- Vertical Research Partners -- Analyst Scott Davis -- Melius Research -- Analyst Steve Tusa -- J.P. Morgan -- Analyst Jonas Oxgaard -- Sanford C. Bernstein -- Analyst John Inch -- Gordon Haskett -- Analyst Steve Byrne -- Bank of America Merrill Lynch -- Analyst Bob Koort -- Goldman Sachs -- Analyst David Begleiter -- Deutsche Bank -- Analyst Chris Parkinson -- Credit Suisse -- Analyst John McNulty -- BMO Capital Markets -- Analyst John Roberts -- UBS -- Analyst Mike Sison -- Wells Fargo Securities -- Analyst More DD analysis All earnings call transcripts This article is a transcript of this conference call produced for The Motley Fool. DuPont (NYSE: DD) Q4 2020 Earnings Call Feb 09, 2021, 8:00 a.m. Additionally, our N&B colleagues are energized by the opportunities before them, and we wish them continued success as they embark on this exciting new journey.	a46719e7-b265-4b00-bd7f-8af8f7c706d7
716203.0	2021-02-09 00:00:00 UTC	DuPont Q4 Results Top Estimates; Sees Q1, FY21 Above View	DD	https://www.nasdaq.com/articles/dupont-q4-results-top-estimates-sees-q1-fy21-above-view-2021-02-09	nan	nan	(RTTNews) - DuPont de Nemours Inc. (DD) Tuesday reported a profit for the fourth-quarter that increased 26.1 percent from last year. Quarterly net sales rose 1 percent. Both adjusted earnings per share from continuing operations and quarterly net sales topped analysts' expectations. Looking ahead for the first-quarter, the company expects adjusted earnings per share to be in the range of $0.75 to $0.77 per share and net sales of $3.75 billion - $3.85 billion. Analysts expect the company to report earnings of $0.64 per share and revenues of $3.69 billion for the first-quarter. For 2021, the company projects adjusted earnings per share to be in the range of $3.30 to $3.45 per share, and net sales of $15.4 - $15.6 billion. Wall Street currently is looking for fiscal year 2021 earnings of $3.07 per share on annual revenues of $15.11 billion. Net income available for common stockholders for the fourth-quarter increased 26.1 percent to $222 million from the prior year's $176 million, with earnings per share improving to $0.30 from $0.24 in the previous year. The improvement was mostly attributable to the absence of a prior year net charge associated with a joint venture, a favorable income tax benefit and lower integration and separation costs partially offset by higher depreciation and amortization and lower segment earnings. Adjusted income from continuing operations available for common stockholders were $698 million or $0.95 per share compared to $704 million or $0.95 per share in the prior year. Analysts polled by Thomson Reuters expected the company to report earnings of $0.89 per share for the fourth-quarter. Analysts' estimates typically exclude special items. Net sales were $5.25 billion, up 1 percent from $5.20 billion in the prior year. Quarterly net sales were flat with last year on an organic basis. Analysts expected revenues of $5.23 billion for the fourth-quarter. Electronics & Imaging segment's net sales were $1.0 billion, up 9 percent from the year-ago period. Organic sales were up 8 percent driven by a 10 percent growth in volume offset by a 2 percent decline in price. Currency was a 2 percent benefit while portfolio was a 1 percent headwind. Nutrition & Biosciences' net sales of $1.5 billion, up 3 percent from the year-ago period. Organic sales increased 2 percent with gains in both price and volume. Currency was a 1 percent tailwind and portfolio was flat. Transportation & Industrial segment's net sales were $1.2 billion, up 1 percent from the year-ago period. Organic sales were down 1 percent as volume gains of 3 percent were more than offset by price declines of 4 percent. Currency was a 2 percent benefit and portfolio was neutral. In Tuesday pre-market trade, DD was trading at $76.10 up $0.34 or 0.45 percent. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	(RTTNews) - DuPont de Nemours Inc. (DD) Tuesday reported a profit for the fourth-quarter that increased 26.1 percent from last year. In Tuesday pre-market trade, DD was trading at $76.10 up $0.34 or 0.45 percent. Both adjusted earnings per share from continuing operations and quarterly net sales topped analysts' expectations.	(RTTNews) - DuPont de Nemours Inc. (DD) Tuesday reported a profit for the fourth-quarter that increased 26.1 percent from last year. In Tuesday pre-market trade, DD was trading at $76.10 up $0.34 or 0.45 percent. Both adjusted earnings per share from continuing operations and quarterly net sales topped analysts' expectations.	(RTTNews) - DuPont de Nemours Inc. (DD) Tuesday reported a profit for the fourth-quarter that increased 26.1 percent from last year. In Tuesday pre-market trade, DD was trading at $76.10 up $0.34 or 0.45 percent. Looking ahead for the first-quarter, the company expects adjusted earnings per share to be in the range of $0.75 to $0.77 per share and net sales of $3.75 billion - $3.85 billion.	(RTTNews) - DuPont de Nemours Inc. (DD) Tuesday reported a profit for the fourth-quarter that increased 26.1 percent from last year. In Tuesday pre-market trade, DD was trading at $76.10 up $0.34 or 0.45 percent. Net sales were $5.25 billion, up 1 percent from $5.20 billion in the prior year.	f78cbc0b-18ab-4716-9497-3f0cad9dad6c
716204.0	2021-02-09 00:00:00 UTC	EI DuPont De Nemours & Co. Q4 adjusted earnings Beat Estimates	DD	https://www.nasdaq.com/articles/ei-dupont-de-nemours-co.-q4-adjusted-earnings-beat-estimates-2021-02-09	nan	nan	(RTTNews) - EI DuPont De Nemours & Co. (DD) released a profit for its fourth quarter that rose from the same period last year. The company's bottom line came in at $222 million, or $0.30 per share. This compares with $176 million, or $0.24 per share, in last year's fourth quarter. Excluding items, EI DuPont De Nemours & Co. reported adjusted earnings of $698 million or $0.95 per share for the period. Analysts had expected the company to earn $0.89 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items. The company's revenue for the quarter rose 1.0% to $5.25 billion from $5.20 billion last year. EI DuPont De Nemours & Co. earnings at a glance: -Earnings (Q4): $698 Mln. vs. $704 Mln. last year. -EPS (Q4): $0.95 vs. $0.95 last year. -Analysts Estimate: $0.89 -Revenue (Q4): $5.25 Bln vs. $5.20 Bln last year. -Guidance: Next quarter EPS guidance: $0.75 - $0.77 Next quarter revenue guidance: $3.75 - $3.85 Bln The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	(RTTNews) - EI DuPont De Nemours & Co. (DD) released a profit for its fourth quarter that rose from the same period last year. Excluding items, EI DuPont De Nemours & Co. reported adjusted earnings of $698 million or $0.95 per share for the period. Analysts had expected the company to earn $0.89 per share, according to figures compiled by Thomson Reuters.	(RTTNews) - EI DuPont De Nemours & Co. (DD) released a profit for its fourth quarter that rose from the same period last year. Excluding items, EI DuPont De Nemours & Co. reported adjusted earnings of $698 million or $0.95 per share for the period. The company's revenue for the quarter rose 1.0% to $5.25 billion from $5.20 billion last year.	(RTTNews) - EI DuPont De Nemours & Co. (DD) released a profit for its fourth quarter that rose from the same period last year. This compares with $176 million, or $0.24 per share, in last year's fourth quarter. Excluding items, EI DuPont De Nemours & Co. reported adjusted earnings of $698 million or $0.95 per share for the period.	(RTTNews) - EI DuPont De Nemours & Co. (DD) released a profit for its fourth quarter that rose from the same period last year. Excluding items, EI DuPont De Nemours & Co. reported adjusted earnings of $698 million or $0.95 per share for the period. -Analysts Estimate: $0.89 -Revenue (Q4): $5.25 Bln vs. $5.20 Bln last year.	8ee72476-eef5-46bd-a028-b92e924dbb43
716205.0	2021-02-09 00:00:00 UTC	EI DuPont De Nemours & Co. Q4 20 Earnings Conference Call At 8:00 AM ET	DD	https://www.nasdaq.com/articles/ei-dupont-de-nemours-co.-q4-20-earnings-conference-call-at-8%3A00-am-et-2021-02-09	nan	nan	(RTTNews) - EI DuPont De Nemours & Co. (DD) will host a conference call at 8:00 AM ET on February 9, 2021, to discuss Q4 20 earnings results. To access the live webcast, log on to https://www.investors.dupont.com/investors/dupont-investors/events-and-presentations/default.aspx The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	(RTTNews) - EI DuPont De Nemours & Co. (DD) will host a conference call at 8:00 AM ET on February 9, 2021, to discuss Q4 20 earnings results. To access the live webcast, log on to https://www.investors.dupont.com/investors/dupont-investors/events-and-presentations/default.aspx The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	(RTTNews) - EI DuPont De Nemours & Co. (DD) will host a conference call at 8:00 AM ET on February 9, 2021, to discuss Q4 20 earnings results. To access the live webcast, log on to https://www.investors.dupont.com/investors/dupont-investors/events-and-presentations/default.aspx The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	(RTTNews) - EI DuPont De Nemours & Co. (DD) will host a conference call at 8:00 AM ET on February 9, 2021, to discuss Q4 20 earnings results. To access the live webcast, log on to https://www.investors.dupont.com/investors/dupont-investors/events-and-presentations/default.aspx The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	(RTTNews) - EI DuPont De Nemours & Co. (DD) will host a conference call at 8:00 AM ET on February 9, 2021, to discuss Q4 20 earnings results. To access the live webcast, log on to https://www.investors.dupont.com/investors/dupont-investors/events-and-presentations/default.aspx The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	42dccbed-43cc-4c23-810f-025cbb447e9b
716206.0	2021-02-09 00:00:00 UTC	DuPont signals strong 2021 on demand from smartphone makers, auto rebound	DD	https://www.nasdaq.com/articles/dupont-signals-strong-2021-on-demand-from-smartphone-makers-auto-rebound-2021-02-09	nan	nan	Feb 9 (Reuters) - Industrial materials maker DuPont DD.N on Tuesday forecast full-year profit and revenue above Wall Street expectations on the back of robust demand from smartphone makers launching 5G handsets and a recovery in global auto sales. The company, once part of the erstwhile chemical giant DowDupont, forecast 2021 adjusted earnings of $3.30 to $3.45 per share, above the $3.07 analysts had estimated, according to Refinitiv IBES. Net sales estimates of between $15.40 billion and $15.60 billion also came in above analysts' expectations of $15.11 billion. Sales in DuPont's electronics and imaging business rose 9% to $1.02 billion in the fourth quarter from a year earlier and was also marginally higher than the third, fueled by strong uptake for advanced materials used in smartphone and chips. DuPont, which makes everything from brake fluid to fabric used in protective garments, also pointed to higher demand for its personal protective equipment during the COVID-19 pandemic and from carmakers as several economies relaxed their lockdowns. The company this month completed the sale of its nutrition and biosciences business to International Flavors & Fragrances Inc IFF.N, while also cutting costs, including jobs, to ride out the health crisis that hammered some of its customers. DuPont said adjusted net income rose to $698 million, or 95 cents per share, in the fourth quarter ended Dec. 31, from $645 million, or 88 cents per share, in the third quarter, in line with preliminary results announced last month. For the first quarter, the company expects net sales between $3.75 billion and $3.85 billion. It projected a profit of 75 cents to 77 cents per share. Analysts on average were expecting a profit 65 cents per share and revenue of $3.69 billion. (Reporting by Arathy S Nair in Bengaluru; Editing by Sriraj Kalluvila) ((arathys.nair@thomsonreuters.com; +1 646 223 8780 (Extn 2726); Twitter: https://twitter.com/ArathySom;)) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	Feb 9 (Reuters) - Industrial materials maker DuPont DD.N on Tuesday forecast full-year profit and revenue above Wall Street expectations on the back of robust demand from smartphone makers launching 5G handsets and a recovery in global auto sales. The company, once part of the erstwhile chemical giant DowDupont, forecast 2021 adjusted earnings of $3.30 to $3.45 per share, above the $3.07 analysts had estimated, according to Refinitiv IBES. Sales in DuPont's electronics and imaging business rose 9% to $1.02 billion in the fourth quarter from a year earlier and was also marginally higher than the third, fueled by strong uptake for advanced materials used in smartphone and chips.	Feb 9 (Reuters) - Industrial materials maker DuPont DD.N on Tuesday forecast full-year profit and revenue above Wall Street expectations on the back of robust demand from smartphone makers launching 5G handsets and a recovery in global auto sales. DuPont said adjusted net income rose to $698 million, or 95 cents per share, in the fourth quarter ended Dec. 31, from $645 million, or 88 cents per share, in the third quarter, in line with preliminary results announced last month. For the first quarter, the company expects net sales between $3.75 billion and $3.85 billion.	Feb 9 (Reuters) - Industrial materials maker DuPont DD.N on Tuesday forecast full-year profit and revenue above Wall Street expectations on the back of robust demand from smartphone makers launching 5G handsets and a recovery in global auto sales. Net sales estimates of between $15.40 billion and $15.60 billion also came in above analysts' expectations of $15.11 billion. DuPont said adjusted net income rose to $698 million, or 95 cents per share, in the fourth quarter ended Dec. 31, from $645 million, or 88 cents per share, in the third quarter, in line with preliminary results announced last month.	Feb 9 (Reuters) - Industrial materials maker DuPont DD.N on Tuesday forecast full-year profit and revenue above Wall Street expectations on the back of robust demand from smartphone makers launching 5G handsets and a recovery in global auto sales. Net sales estimates of between $15.40 billion and $15.60 billion also came in above analysts' expectations of $15.11 billion. DuPont said adjusted net income rose to $698 million, or 95 cents per share, in the fourth quarter ended Dec. 31, from $645 million, or 88 cents per share, in the third quarter, in line with preliminary results announced last month.	43145dda-14c5-4c6c-88a6-6962e20549bb
716207.0	2021-02-08 00:00:00 UTC	After Hours Most Active for Feb 8, 2021 : KGC, DD, FHN, SNAP, DELL, X	DD	https://www.nasdaq.com/articles/after-hours-most-active-for-feb-8-2021-%3A-kgc-dd-fhn-snap-dell-x-2021-02-08	nan	nan	The NASDAQ 100 After Hours Indicator is down -3.8 to 13,691.22. The total After hours volume is currently 98,243,140 shares traded. The following are the most active stocks for the after hours session: Kinross Gold Corporation (KGC) is -0.01 at $7.38, with 7,228,850 shares traded.KGC is scheduled to provide an earnings report on 2/10/2021, for the fiscal quarter ending Dec2020. The consensus earnings per share forecast is 0.22 per share, which represents a 13 percent increase over the EPS one Year Ago DuPont de Nemours, Inc. (DD) is +0.44 at $76.20, with 4,091,787 shares traded. Over the last four weeks they have had 4 up revisions for the earnings forecast, for the fiscal quarter ending Dec 2020. The consensus EPS forecast is $0.92. DD is scheduled to provide an earnings report on 2/9/2021, for the fiscal quarter ending Dec2020. The consensus earnings per share forecast is 0.92 per share, which represents a 95 percent increase over the EPS one Year Ago First Horizon Corporation (FHN) is unchanged at $15.53, with 2,792,360 shares traded. Over the last four weeks they have had 3 up revisions for the earnings forecast, for the fiscal quarter ending Mar 2021. The consensus EPS forecast is $0.36. As reported by Zacks, the current mean recommendation for FHN is in the "buy range". Snap Inc. (SNAP) is -0.38 at $63.40, with 2,428,346 shares traded. As reported by Zacks, the current mean recommendation for SNAP is in the "buy range". Dell Technologies Inc. (DELL) is unchanged at $79.94, with 2,003,585 shares traded. As reported by Zacks, the current mean recommendation for DELL is in the "buy range". United States Steel Corporation (X) is +0.01 at $16.85, with 1,876,356 shares traded. X's current last sale is 210.63% of the target price of $8. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	DD is scheduled to provide an earnings report on 2/9/2021, for the fiscal quarter ending Dec2020. DuPont de Nemours, Inc. (DD) is +0.44 at $76.20, with 4,091,787 shares traded. Kinross Gold Corporation (KGC) is -0.01 at $7.38, with 7,228,850 shares traded.KGC is scheduled to provide an earnings report on 2/10/2021, for the fiscal quarter ending Dec2020.	DuPont de Nemours, Inc. (DD) is +0.44 at $76.20, with 4,091,787 shares traded. DD is scheduled to provide an earnings report on 2/9/2021, for the fiscal quarter ending Dec2020. Kinross Gold Corporation (KGC) is -0.01 at $7.38, with 7,228,850 shares traded.KGC is scheduled to provide an earnings report on 2/10/2021, for the fiscal quarter ending Dec2020.	DuPont de Nemours, Inc. (DD) is +0.44 at $76.20, with 4,091,787 shares traded. DD is scheduled to provide an earnings report on 2/9/2021, for the fiscal quarter ending Dec2020. Kinross Gold Corporation (KGC) is -0.01 at $7.38, with 7,228,850 shares traded.KGC is scheduled to provide an earnings report on 2/10/2021, for the fiscal quarter ending Dec2020.	DD is scheduled to provide an earnings report on 2/9/2021, for the fiscal quarter ending Dec2020. DuPont de Nemours, Inc. (DD) is +0.44 at $76.20, with 4,091,787 shares traded. The NASDAQ 100 After Hours Indicator is down -3.8 to 13,691.22.	87904cb7-5887-4760-ba09-62a8c1433331
716208.0	2021-02-08 00:00:00 UTC	Pre-Market Earnings Report for February 9, 2021 : FIS, SPGI, DD, CNC, TDG, WLTW, INCY, MLM, CGC, MAS, IT, J	DD	https://www.nasdaq.com/articles/pre-market-earnings-report-for-february-9-2021-%3A-fis-spgi-dd-cnc-tdg-wltw-incy-mlm-cgc-mas	nan	nan	The following companies are expected to report earnings prior to market open on 02/09/2021. Visit our Earnings Calendar for a full list of expected earnings releases. Fidelity National Information Services, Inc. (FIS) is reporting for the quarter ending December 31, 2020. The financial transactions company's consensus earnings per share forecast from the 15 analysts that follow the stock is $1.56. This value represents a 0.64% decrease compared to the same quarter last year. In the past year FIS has met analyst expectations once and beat the expectations the other three quarters. Zacks Investment Research reports that the 2020 Price to Earnings ratio for FIS is 24.44 vs. an industry ratio of 22.90, implying that they will have a higher earnings growth than their competitors in the same industry. S&P Global Inc. (SPGI) is reporting for the quarter ending December 31, 2020. The business info service company's consensus earnings per share forecast from the 7 analysts that follow the stock is $2.55. This value represents a 0.79% increase compared to the same quarter last year. In the past year SPGI has beat the expectations every quarter. The highest one was in the 3rd calendar quarter where they beat the consensus by 7.95%. Zacks Investment Research reports that the 2020 Price to Earnings ratio for SPGI is 28.15 vs. an industry ratio of 35.40. DuPont de Nemours, Inc. (DD) is reporting for the quarter ending December 31, 2020. The chemical company's consensus earnings per share forecast from the 4 analysts that follow the stock is $0.92. This value represents a 3.16% decrease compared to the same quarter last year. DD missed the consensus earnings per share in the 4th calendar quarter of 2019 by -1.04%. Zacks Investment Research reports that the 2020 Price to Earnings ratio for DD is 22.77 vs. an industry ratio of 42.60. Centene Corporation (CNC) is reporting for the quarter ending December 31, 2020. The hmo company's consensus earnings per share forecast from the 8 analysts that follow the stock is $0.45. This value represents a 38.36% decrease compared to the same quarter last year. Zacks Investment Research reports that the 2020 Price to Earnings ratio for CNC is 11.80 vs. an industry ratio of 31.10. Transdigm Group Incorporated (TDG) is reporting for the quarter ending December 31, 2020. The aerospace and defense company's consensus earnings per share forecast from the 2 analysts that follow the stock is $1.57. This value represents a 65.65% decrease compared to the same quarter last year. In the past year TDG has beat the expectations every quarter. The highest one was in the 3rd calendar quarter where they beat the consensus by 90.48%. Zacks Investment Research reports that the 2021 Price to Earnings ratio for TDG is 59.31 vs. an industry ratio of 39.30, implying that they will have a higher earnings growth than their competitors in the same industry. Willis Towers Watson Public Limited Company (WLTW) is reporting for the quarter ending December 31, 2020. The insurance brokers company's consensus earnings per share forecast from the 9 analysts that follow the stock is $5.02. This value represents a 2.45% increase compared to the same quarter last year. In the past year WLTW has beat the expectations every quarter. The highest one was in the 3rd calendar quarter where they beat the consensus by 3.91%. Zacks Investment Research reports that the 2020 Price to Earnings ratio for WLTW is 19.49 vs. an industry ratio of 25.40. Incyte Corporation (INCY) is reporting for the quarter ending December 31, 2020. The biomedical (gene) company's consensus earnings per share forecast from the 2 analysts that follow the stock is $0.64. This value represents a 28.00% increase compared to the same quarter last year. Zacks Investment Research reports that the 2020 Price to Earnings ratio for INCY is -62.67 vs. an industry ratio of 16.60. Martin Marietta Materials, Inc. (MLM) is reporting for the quarter ending December 31, 2020. The building company's consensus earnings per share forecast from the 8 analysts that follow the stock is $2.28. This value represents a 9.09% increase compared to the same quarter last year. Zacks Investment Research reports that the 2020 Price to Earnings ratio for MLM is 27.61 vs. an industry ratio of 12.40, implying that they will have a higher earnings growth than their competitors in the same industry. Canopy Growth Corporation (CGC) is reporting for the quarter ending December 31, 2020. The medical products company's consensus earnings per share forecast from the 7 analysts that follow the stock is $-0.21. This value represents a 22.22% increase compared to the same quarter last year. CGC missed the consensus earnings per share in the 1st calendar quarter of 2020 by -286.67%. Zacks Investment Research reports that the 2021 Price to Earnings ratio for CGC is -85.86 vs. an industry ratio of 58.60. Masco Corporation (MAS) is reporting for the quarter ending December 31, 2020. The building company's consensus earnings per share forecast from the 8 analysts that follow the stock is $0.74. This value represents a 37.04% increase compared to the same quarter last year. In the past year MAS has beat the expectations every quarter. The highest one was in the 3rd calendar quarter where they beat the consensus by 31.65%. Zacks Investment Research reports that the 2020 Price to Earnings ratio for MAS is 18.38 vs. an industry ratio of 20.00. Gartner, Inc. (IT) is reporting for the quarter ending December 31, 2020. The consulting company's consensus earnings per share forecast from the 5 analysts that follow the stock is $0.82. This value represents a 30.51% decrease compared to the same quarter last year. In the past year IT has beat the expectations every quarter. The highest one was in the 3rd calendar quarter where they beat the consensus by 78.43%. Zacks Investment Research reports that the 2020 Price to Earnings ratio for IT is 39.83 vs. an industry ratio of 76.30. Jacobs Engineering Group Inc. (J) is reporting for the quarter ending December 31, 2020. The engineering company's consensus earnings per share forecast from the 7 analysts that follow the stock is $1.25. This value represents a 4.17% increase compared to the same quarter last year. In the past year J has met analyst expectations once and beat the expectations the other three quarters. Zacks Investment Research reports that the 2021 Price to Earnings ratio for J is 18.69 vs. an industry ratio of 83.80. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	DuPont de Nemours, Inc. (DD) is reporting for the quarter ending December 31, 2020. DD missed the consensus earnings per share in the 4th calendar quarter of 2019 by -1.04%. Zacks Investment Research reports that the 2020 Price to Earnings ratio for DD is 22.77 vs. an industry ratio of 42.60.	DuPont de Nemours, Inc. (DD) is reporting for the quarter ending December 31, 2020. DD missed the consensus earnings per share in the 4th calendar quarter of 2019 by -1.04%. Zacks Investment Research reports that the 2020 Price to Earnings ratio for DD is 22.77 vs. an industry ratio of 42.60.	DuPont de Nemours, Inc. (DD) is reporting for the quarter ending December 31, 2020. DD missed the consensus earnings per share in the 4th calendar quarter of 2019 by -1.04%. Zacks Investment Research reports that the 2020 Price to Earnings ratio for DD is 22.77 vs. an industry ratio of 42.60.	DuPont de Nemours, Inc. (DD) is reporting for the quarter ending December 31, 2020. DD missed the consensus earnings per share in the 4th calendar quarter of 2019 by -1.04%. Zacks Investment Research reports that the 2020 Price to Earnings ratio for DD is 22.77 vs. an industry ratio of 42.60.	324627be-0ab2-4ed8-9ff9-8d37be8fd0c8
716209.0	2021-02-05 00:00:00 UTC	Investing in Agriculture Stocks: What Investors Need to Know	DD	https://www.nasdaq.com/articles/investing-in-agriculture-stocks%3A-what-investors-need-to-know-2021-02-05	nan	nan	In this episode of Industry Focus: Energy, we're discussing agriculture stocks. Host Nick Sciple is joined by Motley Fool contributor Lou Whiteman to give an overview of the industry, and to share some agriculture stocks on their radar. To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center. To get started investing, check out our quick-start guide to investing in stocks. A full transcript follows the video. 10 stocks we like better than Corteva Inc. When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.* David and Tom just revealed what they believe are the ten best stocks for investors to buy right now... and Corteva Inc. wasn't one of them! That's right -- they think these 10 stocks are even better buys. See the 10 stocks *Stock Advisor returns as of November 20, 2020 This video was recorded on January 28, 2021. Nick Sciple: Welcome to Industry Focus. I am Nick Sciple. Last week, we talked about dividend stocks and as part of that discussion, I told folks to write in if they wanted us to do a show on agriculture stocks. Well, I asked and you answered, so that's what we're talking about this week. Lou Whiteman is joining me to share some thoughts on the industry and discuss a couple of stocks on our radar. Lou, thanks for joining me. Lou Whiteman: Pleasure to be here. Sciple: Yeah, Lou, great to have you here as always. I'm excited to get into this topic today. Obviously, agriculture is a huge, complicated industry so we're not going to be able to cover it all. But we're going to do our best to give a high-level overview of the industry, spotlight a couple of companies that stand out to us as intriguing opportunities. As always, as I said at the intro, if there's a topic you'd like to hear us cover that we're not going to get into today, email us at industryfocus@fool.com and we'll do our best to get to it as soon as we can. But with that out of the way, Lou, let's just get some background on the agricultural industry. When we look at the U.S. economy, how big of a chunk does agriculture make up of that? Whiteman: This is a massive chunk of the U.S. economy. The U.S. Department of Agriculture is my source for most of these stats here. They say that Agan food is a $1.1 trillion, with a 't,' industry. American farm output alone is worth about 136 billion. That's sizable, about 1%, a little under 1% of GDP. Agan related also represents about 10% of total U.S. employment. This is also one of these rare sectors where the U.S. is a world exporter, about 25% of agriculture production is exported. That means without agriculture, all of those trade deficit numbers would look even worse. [laughs] Sciple: Right. When you look at this industry, what does it look like? I know from my own bias, you hear about the farm aid thing with Willy Nelson and all these guys, who want to protect family farmers, this idea of the rise of the factory farm. Is that really who is owning agricultural assets today? Whiteman: This is a surprise for a lot of people. There was a time in the '80s where this trend reversed, and that's where people like Willy Nelson set our expectations. But owner-operators own about 60% of U.S. farmland, and that number has been pretty stable for the last 50 years. There are fewer than 32,500 non-family health corporations that own farmland. These corporations own less than 5% of U.S. farmland. Where I think the confusion comes in is that these owner-operators have gotten a lot more sophisticated over the years. The average farm landowner owns 280 acres. These are not Ma' and Pa' and one field organizations anymore. These are sophisticated businesses. But a lot of them, it's still very fragmented and it's still a Ma' and Pa' industry. Sciple: Right. The other thing we think about a lot with agriculture is the relationship with the government. There was this tit-for-tat back with China a while back, and we said, "Hey, China, you're subsidizing your steel industry," and then China came back and said, "Hey, you're subsidizing your agricultural industry." What role does the government plan in supporting some of the operators here? Whiteman: Just to throw it back to you, I can't think of an industry that Washington loves more, and I'd challenge to do that. But definitely, if you look at most states, most elected officials deal with farmers, and I think it shows in Washington. Direct government payments to farmers and ranchers in 2020 was forecast to finish around $37 billion. You're adding CARES and all that, the Taxpayers For Common Sense estimates it will be well over $50 billion in direct aid this year alone. The $30-$40 billion number is pretty standard even without the CARES Act. This is an industry that gets a lot of support from lawmakers. Sciple: It doesn't hurt that the Iowa caucus is the first every year, so I want to make folks happy there and all those sorts of things. Helps put ethanol and fuel and all that. When we look at this agricultural sector, before we get into some of these companies, can you talk about the pros and cons of investing in the sector? What are the opportunities there and then what are some risks involved? Whiteman: The opportunities, when things go right, this is a very income rich industry. This is a good industry to hold if you are in the portion of your investing life where you are looking for dividends, you're looking for steady income. But there are risks you need to look into. This is a hugely cyclical industry and it doesn't really follow the economic cycle, so it can catch you off guard. Again, from the USDA, net farm income was $134 billion in 2013. Four years later, that had dropped $80 billion. That's a 40% drop in four years. That's the second one of these cycles we have seen so far this century. A lot of things go into this. The weather in the U.S., the weather overseas where we're competing against. Crop yields can lead to supply and demand getting out of whack. That means less money coming in. That means less money for farmers to invest in technology, chemicals, all of that. It ripples through for years and we do see, maybe not the great sort of thing, but we do see these boom and bust cycles. It is something to worry about, because you're not going to see a steady stream year after year on this. There's just too many macro factors that weigh into it. Sciple: Right, an act of God literally, I think, can impact the whole area. Sometimes there can be something that's correlated, and you mentioned the dust belt. I don't know if we're going to have something like that again in the future, but there can be things that are correlated across the whole asset that could impact things. I think one other thing to point out is just regulatory risks. One example folks to think about is Monsanto. When you throw out Monsanto now, Monsanto is the worst company ever. At one point in time, Roundup was a revolutionary chemical, and was really the game changer when it came to herbicide, that sort of thing, getting weeds out of farmland. But now, it's this huge liability, it's albatross around the company. Some of these long-lasting liabilities can impact some companies in this space. Whiteman: Yeah, I'll tell you, and I'm old enough. I was actually asked on one of the business news networks once, way back when, is Monsanto a tech stock? Should we think of it that way? You consider where it's gone now. It's a great point, there are a lot of regulatory risks. Even like, with genetically modified seeds, there's a lot of really complex issues that go into this that can really impact these companies. Sciple: You talk about genetically modified seeds, maybe some herbicide, pesticide, stuff that transitions us into this first company. I wanted to talk about it with you today, that's Corteva (NYSE: CTVA), ticker C-T-V-A. It's a company that hasn't really been on the public markets very long. Came out of the Dow-DuPont spin-off in 2019, that would've been the last time we talked about it on the podcast. Can you tell us about what Corteva does? Whiteman: Most of it is the old Dow Agrosciences businesses. As people may recall, the Dow-DuPont came together with the plan to shuffle the assets around and create three more focused companies. This is the combined scale agriculture business of those two chemical giants. The operations are pretty much split between seeds and crop protection, which they do a lot of these modified seeds, specialized seeds. Then the other side of it is not Roundup, they don't own that, but a range of fertilizers and more importantly, herbicides and other products. We can get into it in depth, but there's a lot of synergies here, because increasingly, we are moving toward crops that resist certain herbicides, which makes it easier to get rid of weeds. It's a business that has a lot of potential, there's all sorts of stories about it. If you're a soybean farmer and you plant these herbicide-resistant soybeans, and then you spray the herbicide, your next-door neighbor darn well better have that too or they're going to lose their crop. There's almost a perverse way that once a product gets popular, it stays popular and grows. We're in the early days, but that's what Corteva is going for with soybeans and a lot of other products. Sciple: These two sides of the business rhyme together. They will develop some type of, whether it's pesticide or an herbicide, or what have you. Then they'll also develop a proprietary seed that is resistant to those pesticides or herbicides. One thing you're going to talk about the business, historically Monsanto has been so dominant in the industry that Corteva is actually paying significant amounts of royalties to Monsanto for using some of their trades. But there are some opportunities for Corteva, and you talked about the investment case here, as they move more and more of their products to their own proprietary seed trades and things like that. They can take out some of those licensing fees they're paying to Monsanto, it really gives them an opportunity. You can project out over the next several years where they can expand their margins in a meaningful way. Whiteman: The idea of it. If you have a better mousetrap, it will sell. Your customers are very reliant on getting the best yield they have. That has been the business model for these chemical companies, that's why they are so involved, Nick. We have a company at scale, they're one of a few, but are really trying to do this in a coordinated way at scale where they can really dominate a market. Sciple: Just to throw some numbers out there. In 2018, about 18% of their portfolio was patented to their own existing in-house patents. They expect to have 34% of that by 2023, so really expanding the patent portion of their portfolio. Also introducing some new herbicide, pesticide products to the market. Hopefully, it can take some share from Monsanto, some of these other companies. I pulled a stat, two-thirds of Corteva's pioneer soybean seed use Monsanto's chemical trades now. A significant portion of their seeds that are subject to some of these licensing fees. But overtime, it can bring those down and hopefully expand margins as well as when they're launching some of these new products. The other thing to think about as well is, since the spin, they've been trying to get some of their costs under control, reducing headcount, those sorts of things. Can you tell us some about their efforts there, Lou? Whiteman: They've reduced their manufacturing footprint pretty substantially, I think from 29-20 facilities since 2017. Headcount is down 25%. Again, this is what you'd expect from a merger. There's a lot of efficiency to be rung out here. Frankly, they've done a decent job of it. I don't think they would say, we're going to do the [...]. They're the first to say that the job isn't over. But this is an early days company that they're still trying to put together the pieces they have and develop it out. Sciple: We talked about that margin expansion opportunity. If you look at their adjusted EBITDA margin, about half of their competitors, Bayer, Monsanto, have given about 26.9% FMC, and other competitors about 28% compared to about 14% for Corteva. We talked about this opportunity to expand margins as they introduce new products and get less reliant on some other licensed trades. However, for some investors, not happening fast enough, in particular, Starboard Value (NASDAQ: SVAC). Whiteman: Starboard is a very well-known activist fund. We started getting hands back in November that they were going to get involved, and they have now nominated eight directors to the board for the 12 places and they are seeking to oust CEO Jim Collins due to what they call mediocre performance. We should note that, since this company went off on its own, June 2019, the stock is up 32%. That's basically in line with the S&P 500 and it's a lot better than either the other two, its sibling companies that came out of Dow-DuPont. DuPont is up about maybe 19% and Dow less than that, about 10%. It's not that the company has underperformed, but there is, as you say, the margins aren't what they want. Collins, the CEO, in response to Starboard said, "Probably the only question in the whole discussion is our view of the timing of the improvement." They were first to say, there's an improvement. It's going to be interesting, as far as an investor, looking at the stock to see who's in-charge in the next few months and whether or not there is an overhaul in the strategy which could be good, could be not so good. Sciple: It'll be interesting because the management has laid out, like we talked about earlier, a path to where you can see margin expanding over time, and given the nature of the business, once you get in with these farmers, this is your core business. You have to grow these crops. Once you're in with these folks, it's going to be very difficult to dislodge them. There's clearly an opportunity there, it's going to be interesting to see with Actavis coming in, whether that is something that accelerates the pace of this transition or whether this is a distraction that gets in place of their execution. We'll see. I will say that Starboard historically has been a great allocator of capital. When they identify an opportunity, there tends to be real value there. We'll see what happens. Whiteman: I have a lot of respect for Starboard, definitely. I think for investors who are interested in this, it's really important to note: February 4th is when Corteva is supposed to do earnings. Analysts are basically right at the top in terms of their estimates compared to Corteva's range. It's possible Corteva was low balling or was being conservative. Analysts also see 30% growth in 2021. It'll be really interesting to hear what they say about that. I got to believe that they're going to try to paint a positive message, whether it is or not. But it'll be really interesting to see how the story progresses when they do release earnings and what they see for 2021 and beyond. Sciple: I don't own shares in Corteva today, but this is definitely one that's going to go on my watchlist because you can see where the story plays out. You can see how they would be ingrained with their customers out. This is something that's mission-critical to the business. Something I want to be watching and when earnings come out here next week, we'll take a look at them. Another company I wanted to talk about today, Lou, was Gladstone Land (NASDAQ: LAND). We mentioned them briefly last week on the podcast with Matt DiLallo, the ticker is LAND. Pretty easy to follow. What can you tell us about that Gladstone Land? Whiteman: This is a farming REIT. They own farmland in I believe about 13 states, they pay monthly dividends. The yield right now is about 3.3% annually, and it has been increasing. This is a business, it's a pretty straightforward business. They buy the land, they lease it back to farmers. The interesting thing here is it gives you exposure to the farms without making a bet on an initial farm with a pretty standard but yet pretty attractive setup with the way they set up their leases. Sciple: They mostly used triple-net leases, that's just kind of a finance term. But just to explain that in common sense terms for you, it means the person who's leasing the property treats it like they're the owner. So, they pay the taxes on it. They pay the licensing or whatever. They pay the maintenance, all those sorts of things. From the perspective of the REIT Gladstone Land, they lease out the property. They collect their rent payments, and they are not responsible for any of those other kinds of expenses that go into maintaining the property, that's distinguishable from another type of lease where the person who owns the property, the lesser, would be the one paying those sorts of expenses. They also have some of their leases participating. They get their income from the firm, but primarily they're doing these triple-net leases. Another thing that is interesting when you look at their focus, they talk about they're focused more on two primary areas, which is annual fresh produce and permanent crops. What's that? Annual fresh produce is stuff like fruits and vegetables, tomatoes, things like that, stuff that you plant and harvest every year. Then permanent crops are things like blueberries, nuts, things like that, that you plant and then you'll have like a 10-year life once you have that orchard or what have you up and running. They're focusing on these areas to the detriment of things like wheat and corn and those sorts of grains that are more commodity products. What they say is, for those fresh produce, you get both higher rents and lower risk than those commodity crops. They're focusing on areas where they think there's a little bit lower risk for themselves, and they can generate higher income by having that focus. Interesting opportunity to invest in farmland here in the U.S.. Whiteman: Yeah. I think one thing interesting in comparing it to other REITs, as a REIT investor, a lot of REITs are tied to the economic cycle, whether it's industrial REITs, definitely retail. We saw that in 2020. Even some of the apartment REITS. As we said, the farm could be very cyclical, but it tends to be tied to a cycle other than the economic cycle. It may fall with it, but it may be an opportunity to keep yield coming in when other sectors are in trouble, which, as far as REIT diversification, I think makes it an interesting thing to think about. Sciple: Yeah. Especially for someone looking for income, you want something that's non-correlated. Then also, they're paying dividends on a monthly basis. If you're running the stock like this so you can get regular dividend income coming in to support yourself for retirement or what have you, this is the type of company that it's unlikely you are going to experience volatility that's in line with what goes on in the stock market. Obviously, demand for farmland doesn't fluctuate in the same way that maybe the stock market does on a year-over-year basis, and they're paying you dividends on a monthly basis. So you can get this kind of steady income coming in. If you're someone who is an income investor, I think this is something you could put on your radar as something that can give you a steady, dependable income in a way that you can sleep at night relatively comfortably. One last company I wanted to talk about, Lou, and this is one I think it's -- you pay attention to, but not one I'm super excited to run in and buy. It was a company called AppHarvest. It's coming public via a REIT this year. This vertical farming space. We talked about Gladstone Land buying traditional farmland. AppHarvest is taking a very different approach, trying to lean into some of the ESG-type movements. Whiteman: Yeah. Let's look at this. It probably wouldn't surprise you that the U.S. is the biggest global farm exporter as we said, but it might surprise you that the Netherlands, the tiny little country is No. 2. The way they do that is tech greenhouse farm structure. AppHarvest has taken that model and brought it to the U.S. They have, I believe, three farms in Appalachia. The pitches can produce 30X the yields using 90% less water. Right now, it's mostly tomatoes and it is early stage. I don't own this stock either. I loved this idea. There's some reasons that I'm not buying in right now that we can get into. But this is fascinating to me. We talked about making the world a better place. This is the company that we need to be successful to make the world a better place. The warning on it is that it is a SPAC. So it's not public yet. Right now, I believe N-O-V-S. That deal should close soon. I'm not the only one excited about it. I tend not to like to buy IPOs in new companies anyway. I think the caution around buying into the excitement applies here. There is a Martha Stewart video on their website talking up the company, which I love Martha Stewart, but that's a hype level that makes me want to just watch and see what they produce. This is just three little farms in Appalachia right now and a great idea. This was all over my watchlist. I would imagine I would love to hold it at some point, but just be careful because this is, as we saw SPACs last year in other areas, people are very excited about this. Sciple: Yeah. I think, like we've said, for a lot of these companies, the prospects are great. I think when you look at the produced water usage, better environmentally friendly, all those sorts of things. I like that they are in Appalachia, someone who is from the South. I like it when more rural areas get some people actually investing money there. But again, there's a lot of execution between now and really getting to a place where this is the future of farming and they're going to reach scale and all those sorts of things. But this is a company I'm definitely going to have my radar on and pay attention to as they continue to report earnings. Because you can tell yourself a story about how this type of vertical farming, indoor farming disrupts this traditional model, can be more efficient, cleaner, etc. Something to continue paying attention to as we have more information, because this company, like you said, Lou, isn't all the way public yet. We still got to have this SPAC deal finalized and then we get all our fun SEC filings on quarterly calls and all those sorts of things. Once we have that, I will be very much looking forward to seeing what the company has to say. Whiteman: Right. Just to finish up along too, the interesting thing here is that it is a proven concept because it has worked elsewhere. The downside of that is that it needed to work there. Netherlands just doesn't have -- and this is an expensive proposition to get started, to get going. There's potential there, but in a country blessed with almost seemingly unlimited farmland for now, for long term it makes sense. But in the short-term, it could be a hard thing to really get up and running. I think you're right, just one to watch. Sciple: Yeah. I think that's something I think about a lot with the history of the U.S. is like not a lot of countries over the past 200 years have had a lot of blank space on the map to expand into, but the U.S. has definitely been a beneficiary of that. That comes with farmland and lots of other things. Whiteman: Not to mention that Mississippi River providing transportation, but yeah, but now I'm getting onto a tangent, so I'll stop [laughs]. Sciple: Before we go away Lou, just any advice for folks who are interested in investing in this kind of agriculture space? If you don't want to pick individual stocks, maybe ETFs to pay attention to, things like that. Whiteman: Yeah. I think if nothing else, the point I think we've tried to make here today is that there is value here, especially for income. There's the old expression that land is important, because they're not making more of it. It still applies. Agriculture is key to our existence. They're not making more land. This is a business that over the long term can work, but has a lot of risks. There are some interesting and awesomely tickered, I should say, ETFs in the sector. I'm really interested in the market vectors agribusiness, which has a ticker of MOO, M-O-O. I like that it's got 60 or so stocks. You get some exposure to animal health, Zoetis and IDEXX, some of those which I know are popular here. But you also get a lot of the seeds and chemicals in a pretty diverse basket. There's another one, VEGGIE, which is an ETF that's a little more concentrated. Both of them have companies like John Deere and TU, which is when we didn't get, but which is a service provider to Ag, which is very interesting. The Farmland REIT, I think looking at that, I like land. There's also Farmland Partners, which is FPI, which I think is the same idea. I don't know if it's worked out as Gladstone Land, but this is just an area where the cloud isn't working so much or if you're looking for a little more income. Some way to get into this and have some exposure for a 20-30 year portfolio, I think makes a lot of sense and it's worth looking at. Sciple: Absolutely. It gives you exposure, as we said earlier. This is an industry that is not going to trade correlated with the rest of the markets or particularly for an income investor, an area to pay attention to. Again, I don't think farming is going to go away. [laughs] An easy bet to predict. The beginning of civilization was farming. I think, if you're betting on civilization sticking around, farming is going to stick around too. Interesting area to invest in if you're looking for something uncorrelated that can give you some steady returns over time. Lou, as always, I love having you on the podcasts and I can't wait to have you on again next time. Whiteman: Always a pleasure, Nick. Sciple: As always, people on the program may own companies discussed on the show and The Motley Fool may have formal recommendations for or against the stocks discussed, so don't buy or sell anything based solely on what you hear. Thanks to Tim Sparks for mixing the show, for Lou Whiteman, I'm Nick Sciple. Thanks for listening and Fool on! Lou Whiteman has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Idexx Laboratories. The Motley Fool owns shares of Farmland Partners and Zoetis. The Motley Fool has a disclosure policy. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	You're adding CARES and all that, the Taxpayers For Common Sense estimates it will be well over $50 billion in direct aid this year alone. Host Nick Sciple is joined by Motley Fool contributor Lou Whiteman to give an overview of the industry, and to share some agriculture stocks on their radar. We can get into it in depth, but there's a lot of synergies here, because increasingly, we are moving toward crops that resist certain herbicides, which makes it easier to get rid of weeds.	You're adding CARES and all that, the Taxpayers For Common Sense estimates it will be well over $50 billion in direct aid this year alone. Host Nick Sciple is joined by Motley Fool contributor Lou Whiteman to give an overview of the industry, and to share some agriculture stocks on their radar. Another company I wanted to talk about today, Lou, was Gladstone Land (NASDAQ: LAND).	You're adding CARES and all that, the Taxpayers For Common Sense estimates it will be well over $50 billion in direct aid this year alone. Host Nick Sciple is joined by Motley Fool contributor Lou Whiteman to give an overview of the industry, and to share some agriculture stocks on their radar. I think one thing interesting in comparing it to other REITs, as a REIT investor, a lot of REITs are tied to the economic cycle, whether it's industrial REITs, definitely retail.	You're adding CARES and all that, the Taxpayers For Common Sense estimates it will be well over $50 billion in direct aid this year alone. A lot of things go into this. Interesting opportunity to invest in farmland here in the U.S.. Whiteman: Yeah.	e32d5ada-7779-428c-840c-bf960abfb64a
716210.0	2021-02-03 00:00:00 UTC	DuPont de Nemours Reaches Analyst Target Price	DD	https://www.nasdaq.com/articles/dupont-de-nemours-reaches-analyst-target-price-2021-02-03	nan	nan	In recent trading, shares of DuPont de Nemours Inc (Symbol: DD) have crossed above the average analyst 12-month target price of $76.36, changing hands for $76.45/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level. Analyst reaction may also depend on the fundamental business developments that may be responsible for driving the stock price higher — if things are looking up for the company, perhaps it is time for that target price to be raised. There are 14 different analyst targets contributing to that average for DuPont de Nemours Inc, but the average is just that — a mathematical average. There are analysts with lower targets than the average, including one looking for a price of $55.00. And then on the other side of the spectrum one analyst has a target as high as $95.00. The standard deviation is $12.634. But the whole reason to look at the average DD price target in the first place is to tap into a "wisdom of crowds" effort, putting together the contributions of all the individual minds who contributed to the ultimate number, as opposed to what just one particular expert believes. And so with DD crossing above that average target price of $76.36/share, investors in DD have been given a good signal to spend fresh time assessing the company and deciding for themselves: is $76.36 just one stop on the way to an even higher target, or has the valuation gotten stretched to the point where it is time to think about taking some chips off the table? Below is a table showing the current thinking of the analysts that cover DuPont de Nemours Inc: RECENT DD ANALYST RATINGS BREAKDOWN » Current 1 Month Ago 2 Month Ago 3 Month Ago Strong buy ratings: 6 9 10 10 Buy ratings: 1 1 1 1 Hold ratings: 7 2 2 2 Sell ratings: 0 0 0 0 Strong sell ratings: 0 0 0 0 Average rating: 2.07 1.42 1.38 1.38 The average rating presented in the last row of the above table above is from 1 to 5 where 1 is Strong Buy and 5 is Strong Sell. This article used data provided by Zacks Investment Research via Quandl.com. Get the latest Zacks research report on DD — FREE. The Top 25 Broker Analyst Picks of the S&P 500 » The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	In recent trading, shares of DuPont de Nemours Inc (Symbol: DD) have crossed above the average analyst 12-month target price of $76.36, changing hands for $76.45/share. And so with DD crossing above that average target price of $76.36/share, investors in DD have been given a good signal to spend fresh time assessing the company and deciding for themselves: is $76.36 just one stop on the way to an even higher target, or has the valuation gotten stretched to the point where it is time to think about taking some chips off the table? But the whole reason to look at the average DD price target in the first place is to tap into a "wisdom of crowds" effort, putting together the contributions of all the individual minds who contributed to the ultimate number, as opposed to what just one particular expert believes.	In recent trading, shares of DuPont de Nemours Inc (Symbol: DD) have crossed above the average analyst 12-month target price of $76.36, changing hands for $76.45/share. But the whole reason to look at the average DD price target in the first place is to tap into a "wisdom of crowds" effort, putting together the contributions of all the individual minds who contributed to the ultimate number, as opposed to what just one particular expert believes. And so with DD crossing above that average target price of $76.36/share, investors in DD have been given a good signal to spend fresh time assessing the company and deciding for themselves: is $76.36 just one stop on the way to an even higher target, or has the valuation gotten stretched to the point where it is time to think about taking some chips off the table?	And so with DD crossing above that average target price of $76.36/share, investors in DD have been given a good signal to spend fresh time assessing the company and deciding for themselves: is $76.36 just one stop on the way to an even higher target, or has the valuation gotten stretched to the point where it is time to think about taking some chips off the table? In recent trading, shares of DuPont de Nemours Inc (Symbol: DD) have crossed above the average analyst 12-month target price of $76.36, changing hands for $76.45/share. But the whole reason to look at the average DD price target in the first place is to tap into a "wisdom of crowds" effort, putting together the contributions of all the individual minds who contributed to the ultimate number, as opposed to what just one particular expert believes.	In recent trading, shares of DuPont de Nemours Inc (Symbol: DD) have crossed above the average analyst 12-month target price of $76.36, changing hands for $76.45/share. But the whole reason to look at the average DD price target in the first place is to tap into a "wisdom of crowds" effort, putting together the contributions of all the individual minds who contributed to the ultimate number, as opposed to what just one particular expert believes. And so with DD crossing above that average target price of $76.36/share, investors in DD have been given a good signal to spend fresh time assessing the company and deciding for themselves: is $76.36 just one stop on the way to an even higher target, or has the valuation gotten stretched to the point where it is time to think about taking some chips off the table?	de760d72-13ea-4e89-bb72-a0cbc6f15821
716211.0	2021-02-01 00:00:00 UTC	Private Equity Consortium To Buy Clean Technologies Unit Of DuPont - Quick Facts	DD	https://www.nasdaq.com/articles/private-equity-consortium-to-buy-clean-technologies-unit-of-dupont-quick-facts-2021-02-01	nan	nan	(RTTNews) - An international private equity consortium have agreed to purchase the Clean Technologies business of DuPont de Nemours, Inc. (DD) for $510 million. The consortium consists of BroadPeak Global, Asia Green Fund and The Saudi Arabian Industrial Investments Company. Tensile Capital Management is providing preferred equity financing. The deal is anticipated to close in the second quarter of 2021. Eli Ben-Shoshan, Global Business Director of DuPont Clean Technologies, and future CEO of the intended independent business, stated, "We believe this transaction will further strengthen our extensive global relationships to best serve our customers around the world." The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	(RTTNews) - An international private equity consortium have agreed to purchase the Clean Technologies business of DuPont de Nemours, Inc. (DD) for $510 million. The consortium consists of BroadPeak Global, Asia Green Fund and The Saudi Arabian Industrial Investments Company. Eli Ben-Shoshan, Global Business Director of DuPont Clean Technologies, and future CEO of the intended independent business, stated, "We believe this transaction will further strengthen our extensive global relationships to best serve our customers around the world."	(RTTNews) - An international private equity consortium have agreed to purchase the Clean Technologies business of DuPont de Nemours, Inc. (DD) for $510 million. Eli Ben-Shoshan, Global Business Director of DuPont Clean Technologies, and future CEO of the intended independent business, stated, "We believe this transaction will further strengthen our extensive global relationships to best serve our customers around the world." The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	(RTTNews) - An international private equity consortium have agreed to purchase the Clean Technologies business of DuPont de Nemours, Inc. (DD) for $510 million. Eli Ben-Shoshan, Global Business Director of DuPont Clean Technologies, and future CEO of the intended independent business, stated, "We believe this transaction will further strengthen our extensive global relationships to best serve our customers around the world." The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	(RTTNews) - An international private equity consortium have agreed to purchase the Clean Technologies business of DuPont de Nemours, Inc. (DD) for $510 million. The consortium consists of BroadPeak Global, Asia Green Fund and The Saudi Arabian Industrial Investments Company. Tensile Capital Management is providing preferred equity financing.	b5adc229-18e2-4b05-a905-65a82df9cb3d
716212.0	2021-02-01 00:00:00 UTC	Why International Flavors & Fragrances (IFF) Stock Jumped Today	DD	https://www.nasdaq.com/articles/why-international-flavors-fragrances-iff-stock-jumped-today-2021-02-01	nan	nan	What happened Shares of International Flavors & Fragrances (NYSE: IFF) closed 16% higher Monday. The company announced it will complete a previously announced merger with the Nutrition & Biosciences (N&B) unit of chemical giant DuPont de Nemours (NYSE: DD). Shares of DuPont were down 8% at the same time. So what The newly combined company will be a leader in the global markets for ingredients used in food and beverages, health and wellness, and personal care. Including the addition of the DuPont business, 2020 pro forma, or anticipated revenue, for the company to operate under the IFF name would have exceeded $11 billion. Image source: Getty Images. Now what DuPont was paid $7.3 billion to merge the business unit into IFF, and DuPont shareholders own 55.4% of the combined company. IFF also announced the initiation of a new brand identity and tagline -- "Where science and creativity meet" -- for the combined businesses. Last week, IFF released preliminary fourth-quarter and full-year 2020 results, saying it expects to beat its own expectations "despite continued challenges and complexity of the pandemic." Fourth-quarter sales increased 2% compared to the prior-year period, and full-year sales slightly exceeded $5 billion, the company said. With the addition of the DuPont unit, IFF will be valued at a price-to-sales ratio of approximately 1.25, down from a value of about 3 prior to folding in the additional revenue, which explains the jump in IFF shares today. 10 stocks we like better than International Flavors & Fragrances When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.* David and Tom just revealed what they believe are the ten best stocks for investors to buy right now... and International Flavors & Fragrances wasn't one of them! That's right -- they think these 10 stocks are even better buys. See the 10 stocks *Stock Advisor returns as of November 20, 2020 Howard Smith has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	Including the addition of the DuPont business, 2020 pro forma, or anticipated revenue, for the company to operate under the IFF name would have exceeded $11 billion. The company announced it will complete a previously announced merger with the Nutrition & Biosciences (N&B) unit of chemical giant DuPont de Nemours (NYSE: DD). With the addition of the DuPont unit, IFF will be valued at a price-to-sales ratio of approximately 1.25, down from a value of about 3 prior to folding in the additional revenue, which explains the jump in IFF shares today.	The company announced it will complete a previously announced merger with the Nutrition & Biosciences (N&B) unit of chemical giant DuPont de Nemours (NYSE: DD). Including the addition of the DuPont business, 2020 pro forma, or anticipated revenue, for the company to operate under the IFF name would have exceeded $11 billion. With the addition of the DuPont unit, IFF will be valued at a price-to-sales ratio of approximately 1.25, down from a value of about 3 prior to folding in the additional revenue, which explains the jump in IFF shares today.	With the addition of the DuPont unit, IFF will be valued at a price-to-sales ratio of approximately 1.25, down from a value of about 3 prior to folding in the additional revenue, which explains the jump in IFF shares today. The company announced it will complete a previously announced merger with the Nutrition & Biosciences (N&B) unit of chemical giant DuPont de Nemours (NYSE: DD). Including the addition of the DuPont business, 2020 pro forma, or anticipated revenue, for the company to operate under the IFF name would have exceeded $11 billion.	The company announced it will complete a previously announced merger with the Nutrition & Biosciences (N&B) unit of chemical giant DuPont de Nemours (NYSE: DD). Including the addition of the DuPont business, 2020 pro forma, or anticipated revenue, for the company to operate under the IFF name would have exceeded $11 billion. With the addition of the DuPont unit, IFF will be valued at a price-to-sales ratio of approximately 1.25, down from a value of about 3 prior to folding in the additional revenue, which explains the jump in IFF shares today.	3d0472d1-b372-466f-abf1-703294f9bf10
716213.0	2021-02-01 00:00:00 UTC	Consumer Sector Update for 02/01/2021: IFF,DD,THCB,GTN	DD	https://www.nasdaq.com/articles/consumer-sector-update-for-02-01-2021%3A-iffddthcbgtn-2021-02-01	nan	nan	Consumer stocks were broadly higher in Monday trading, with the SPDR Consumer Staples Select Sector ETF climbing 0.3% while the SPDR Consumer Discretionary Select Sector ETF was rising 2.0%. In company news, IFF (IFF) rose nearly 16% after Monday announcing a name change from International Flavors & Fragrances following the completion Monday of its $7.3 billion cash purchase of DuPont's (DD) nutrition and biosciences division and rebranding the combined companies to better reflect its position providing ingredients for consumer products, including the food and beverage, home and personal care and the health and wellness markets as well as the biosciences and sensorial products businesses. DuPont shareholders own 55.4% of the combined companies. Tuscan Holdings (THCB) also climbed more than 34% after the blank check company said it was merging with Microvast through a reverse merger transaction that will result in the electric vehicle components becoming a publicly traded company. After closing, the maker of specialty batteries will trade on the Nasdaq Capital Market under the MVST ticker symbol and will be supported by an oversubscribed $540 million investment and $282 million in Tuscan IPO proceeds. Gray Television (GTN) was 5.8% higher after the broadcaster announced its $925 million cash purchase of Quincy Media, adding nine more television markets and expanding its reach to roughly 25% of US households in a total of 102 markets. The deal is expected to immediately increase Gray Television's per-share free cash flow, the company said. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	In company news, IFF (IFF) rose nearly 16% after Monday announcing a name change from International Flavors & Fragrances following the completion Monday of its $7.3 billion cash purchase of DuPont's (DD) nutrition and biosciences division and rebranding the combined companies to better reflect its position providing ingredients for consumer products, including the food and beverage, home and personal care and the health and wellness markets as well as the biosciences and sensorial products businesses. Gray Television (GTN) was 5.8% higher after the broadcaster announced its $925 million cash purchase of Quincy Media, adding nine more television markets and expanding its reach to roughly 25% of US households in a total of 102 markets. The deal is expected to immediately increase Gray Television's per-share free cash flow, the company said.	In company news, IFF (IFF) rose nearly 16% after Monday announcing a name change from International Flavors & Fragrances following the completion Monday of its $7.3 billion cash purchase of DuPont's (DD) nutrition and biosciences division and rebranding the combined companies to better reflect its position providing ingredients for consumer products, including the food and beverage, home and personal care and the health and wellness markets as well as the biosciences and sensorial products businesses. Gray Television (GTN) was 5.8% higher after the broadcaster announced its $925 million cash purchase of Quincy Media, adding nine more television markets and expanding its reach to roughly 25% of US households in a total of 102 markets. Consumer stocks were broadly higher in Monday trading, with the SPDR Consumer Staples Select Sector ETF climbing 0.3% while the SPDR Consumer Discretionary Select Sector ETF was rising 2.0%.	In company news, IFF (IFF) rose nearly 16% after Monday announcing a name change from International Flavors & Fragrances following the completion Monday of its $7.3 billion cash purchase of DuPont's (DD) nutrition and biosciences division and rebranding the combined companies to better reflect its position providing ingredients for consumer products, including the food and beverage, home and personal care and the health and wellness markets as well as the biosciences and sensorial products businesses. Gray Television (GTN) was 5.8% higher after the broadcaster announced its $925 million cash purchase of Quincy Media, adding nine more television markets and expanding its reach to roughly 25% of US households in a total of 102 markets. Consumer stocks were broadly higher in Monday trading, with the SPDR Consumer Staples Select Sector ETF climbing 0.3% while the SPDR Consumer Discretionary Select Sector ETF was rising 2.0%.	In company news, IFF (IFF) rose nearly 16% after Monday announcing a name change from International Flavors & Fragrances following the completion Monday of its $7.3 billion cash purchase of DuPont's (DD) nutrition and biosciences division and rebranding the combined companies to better reflect its position providing ingredients for consumer products, including the food and beverage, home and personal care and the health and wellness markets as well as the biosciences and sensorial products businesses. Gray Television (GTN) was 5.8% higher after the broadcaster announced its $925 million cash purchase of Quincy Media, adding nine more television markets and expanding its reach to roughly 25% of US households in a total of 102 markets. Consumer stocks were broadly higher in Monday trading, with the SPDR Consumer Staples Select Sector ETF climbing 0.3% while the SPDR Consumer Discretionary Select Sector ETF was rising 2.0%.	067863e6-2718-414e-a589-9106bb49e51e
716214.0	2021-02-01 00:00:00 UTC	DuPont Completes IFF And Nutrition & Biosciences Merger; Updates Reporting Segments - Quick Facts	DD	https://www.nasdaq.com/articles/dupont-completes-iff-and-nutrition-biosciences-merger-updates-reporting-segments-quick	nan	nan	(RTTNews) - DuPont (DD) announced Monday that it is completing the merger of IFF and Nutrition & Biosciences today. In connection with the closing of the transaction with IFF, DuPont receives a special cash payment of about $7.3 billion, approximately $5 billion of which will be used to strengthen the balance sheet by retiring outstanding debt. As a result of the merger completion, DuPont will move forward with a sharpened strategic focus and is making certain targeted adjustments to its reporting structure. Effective February 1, 2021, DuPont will have three business reporting segments: Electronics & Industrial, Mobility & Materials, and Water & Protection. DuPont also announced it has concluded the strategic review of its Non-Core businesses and entered into a definitive agreement with an international private equity consortium to sell the DuPont Clean Technologies business for $510 million. The transaction is expected to close in the second quarter of 2021, subject to customary closing conditions and regulatory approvals. DuPont has also concluded that it is in the best position to drive value for Tedlar, Microcircuit Materials and the DuPont Teijin Films JV and has realigned these businesses to Mobility & Materials. Following the re-arrangements, DuPont will dissolve its Biomaterials and Clean Technologies, effective February 1, 2021. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	(RTTNews) - DuPont (DD) announced Monday that it is completing the merger of IFF and Nutrition & Biosciences today. As a result of the merger completion, DuPont will move forward with a sharpened strategic focus and is making certain targeted adjustments to its reporting structure. Effective February 1, 2021, DuPont will have three business reporting segments: Electronics & Industrial, Mobility & Materials, and Water & Protection.	(RTTNews) - DuPont (DD) announced Monday that it is completing the merger of IFF and Nutrition & Biosciences today. Effective February 1, 2021, DuPont will have three business reporting segments: Electronics & Industrial, Mobility & Materials, and Water & Protection. DuPont also announced it has concluded the strategic review of its Non-Core businesses and entered into a definitive agreement with an international private equity consortium to sell the DuPont Clean Technologies business for $510 million.	(RTTNews) - DuPont (DD) announced Monday that it is completing the merger of IFF and Nutrition & Biosciences today. In connection with the closing of the transaction with IFF, DuPont receives a special cash payment of about $7.3 billion, approximately $5 billion of which will be used to strengthen the balance sheet by retiring outstanding debt. DuPont also announced it has concluded the strategic review of its Non-Core businesses and entered into a definitive agreement with an international private equity consortium to sell the DuPont Clean Technologies business for $510 million.	(RTTNews) - DuPont (DD) announced Monday that it is completing the merger of IFF and Nutrition & Biosciences today. Effective February 1, 2021, DuPont will have three business reporting segments: Electronics & Industrial, Mobility & Materials, and Water & Protection. Following the re-arrangements, DuPont will dissolve its Biomaterials and Clean Technologies, effective February 1, 2021.	7590e5b2-212c-4add-81ce-34e45d8d39da
716215.0	2021-02-01 00:00:00 UTC	S&P 500 Movers: DD, IFF	DD	https://www.nasdaq.com/articles/sp-500-movers%3A-dd-iff-2021-02-01	nan	nan	In early trading on Monday, shares of International Flavors & Fragrances topped the list of the day's best performing components of the S&P 500 index, trading up 7.0%. Year to date, International Flavors & Fragrances registers a 10.5% gain. And the worst performing S&P 500 component thus far on the day is DuPont, trading down 4.0%. DuPont is showing a gain of 7.2% looking at the year to date performance. Two other components making moves today are Lumen Technologies, trading down 3.9%, and Skyworks Solutions, trading up 5.3% on the day. VIDEO: S&P 500 Movers: DD, IFF The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	VIDEO: S&P 500 Movers: DD, IFF The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Year to date, International Flavors & Fragrances registers a 10.5% gain. And the worst performing S&P 500 component thus far on the day is DuPont, trading down 4.0%.	VIDEO: S&P 500 Movers: DD, IFF The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. In early trading on Monday, shares of International Flavors & Fragrances topped the list of the day's best performing components of the S&P 500 index, trading up 7.0%. Year to date, International Flavors & Fragrances registers a 10.5% gain.	VIDEO: S&P 500 Movers: DD, IFF The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. In early trading on Monday, shares of International Flavors & Fragrances topped the list of the day's best performing components of the S&P 500 index, trading up 7.0%. Two other components making moves today are Lumen Technologies, trading down 3.9%, and Skyworks Solutions, trading up 5.3% on the day.	VIDEO: S&P 500 Movers: DD, IFF The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. In early trading on Monday, shares of International Flavors & Fragrances topped the list of the day's best performing components of the S&P 500 index, trading up 7.0%. And the worst performing S&P 500 component thus far on the day is DuPont, trading down 4.0%.	3bd502f3-428a-4fd4-873c-281613c1e0ef
716216.0	2021-01-26 00:00:00 UTC	What's Happening With Corning Stock?	DD	https://www.nasdaq.com/articles/whats-happening-with-corning-stock-2021-01-27	nan	nan	[Updated 1/25/2021] Corning Update Corning (NYSE: GLW), best known for its display glass, has been reportedly working on ultra-thin glass that can be used for cover glass in foldable devices. Both Samsung and Apple could potentially launch foldable mobile devices over the coming years. The touch screen display market itself is expected to be worth $51 billion by 2027, growing at a CAGR of 8.5% between 2020 and 2027. Corning will greatly benefit from the overall market expansion, given its strong hold in mobile devices glasses. Note that Corning’s Gorilla glass is used in several touch screen devices manufactured by Samsung, Sony, and LG. Apple’s iPhone 12 comes with Ceramic Shield display, also manufactured by Corning. Corning stock will be in focus this week, as it will announce its Q4 results on Wednesday, January 27. We expect Corning to report mixed results with revenues estimated to be $3.23 Bil, slightly above the $3.18 Bil consensus estimates, while the adjusted earnings to be $0.45 per share slightly below the consensus estimate of $0.48. Corning is expected to benefit from 5G expansion as well as higher demand for premium glasses. We expect the company to navigate well based on these trends over the latest quarter. Our forecast indicates that Corning’s valuation is around $36 per share, which is 5% below than the current market price of around $38. Our interactive dashboard analysis on Corning Pre-Earnings has additional details. [Updated 12/14/2020] Buy Or Sell Corning Stock After a solid 2x rise since the March 23 levels of this year, at the current price of around $36 per share we believe Corning stock (NYSE: GLW), has reached its near-term potential. GLW stock has rallied from $18 to $36 off the recent bottom, outperforming the S&P which moved 64% over the same period, with the resumption of economic activities as lockdowns are gradually lifted. This outperformance can be attributed to better than estimated quarterly results and increased demand for premium glass products, primarily related to IT products given the work from home trend, including Valor, which are medical glass vials that can be used for Covid-19 vaccines. GLW stock is also up 11% from levels of $32 seen in early 2018, two years ago. Some of the 11% rise of the last 2 years is justified by the 13.7% growth seen in Corning’s revenues from 2017 to 2019. The company saw a 14.9% growth in total shares outstanding due to share issuances, resulting in a -1% change in revenue per share (RPS) to $13.30 in 2019, compared to $13.43 in 2017. With a modest decline in RPS, the company’s P/S (price-to-sales) ratio also contracted. We believe the stock is likely to see downside after the recent uptick and the potential weakness from a recession-driven by the Covid outbreak. Our dashboard, ‘What Factors Drove 11% Change in Corning Stock between 2017 and now?, has the underlying numbers. Corning’s P/S multiple changed from 2.4x in 2017 to 2.2x in 2019. While the company’s P/S is 2.7x now, any significant growth is unlikely, when the current P/S is compared to levels seen in the past years, P/S of around 2.4x at the end of 2018 and 2.2x as recently as late 2019. So what’s the likely trigger for Corning? The global spread of Coronavirus has impacted the sales of Corning due to a decline in capital spending from some of its customers as well as pricing pressure for its display glass products. That said, the company is now seeing a rebound in demand, and it posted a 2% y-o-y sales growth in Q3. The company’s total revenue in the first three quarters of 2020 was down 8.4% y-o-y to $8.0 billion, while the adjusted earnings of $0.25 per share reflect a 77% decline over the $1.10 figure reported in the prior year period, primarily led by higher operating costs owing to the pandemic. Looking forward, with economies opening up gradually and availability of vaccines, the capital spending on 5G is expected to rise, boding well for Corning’s optical fiber business, while the company will also see higher sales of its glass vials that are being used for Covid-19 vaccines. Also, the new Apple iPhone 12 uses ceramic shield, manufactured by Corning, and iPhone 12 sales alone are touted to be in the range of 80 to 100 million units by October 2021, again boding well for Corning. That said, much of these factors appear to be priced in the current stock value of $36, despite the expected recovery in demand post Covid. In reality, 2020 full year revenues are estimated to see a decline of 3% to $11.3 billion, while earnings are expected to be down 22% to $1.37. Looking at the broader economy, the actual recovery and its timing hinge on the containment of the coronavirus spread. Our dashboard Trends In U.S. Covid-19 Cases provides an overview of how the pandemic has been spreading in the U.S. and contrasts with trends in Brazil and Russia. Following the Fed stimulus — which set a floor on fear — the market has been willing to “look through” the current weak period and take a longer-term view. With investors focusing their attention on 2021 results, the valuations become important in finding value. Though market sentiment can be fickle, and evidence of an uptick in new cases could spook investors once again. At levels of around $36, GLW stock is trading at 2.4x its 2020 expected RPS of $14.83. This compares with P/S of 2.4x seen in 2017 and 2018 and 2.2x seen in late 2019, making the stock seem fully priced. What if you’re looking for a more balanced portfolio instead? Here’s a high quality portfolio to beat the market, with over 100% return since 2016, versus 55% for the S&P 500. Comprised of companies with strong revenue growth, healthy profits, lots of cash, and low risk, it has outperformed the broader market year after year, consistently. See all Trefis Price Estimates and Download Trefis Data here What’s behind Trefis? See How It’s Powering New Collaboration and What-Ifs For CFOs and Finance Teams \| Product, R&D, and Marketing Teams The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	Our interactive dashboard analysis on Corning Pre-Earnings has additional details. GLW stock has rallied from $18 to $36 off the recent bottom, outperforming the S&P which moved 64% over the same period, with the resumption of economic activities as lockdowns are gradually lifted. The global spread of Coronavirus has impacted the sales of Corning due to a decline in capital spending from some of its customers as well as pricing pressure for its display glass products.	Our interactive dashboard analysis on Corning Pre-Earnings has additional details. [Updated 1/25/2021] Corning Update Corning (NYSE: GLW), best known for its display glass, has been reportedly working on ultra-thin glass that can be used for cover glass in foldable devices. We expect Corning to report mixed results with revenues estimated to be $3.23 Bil, slightly above the $3.18 Bil consensus estimates, while the adjusted earnings to be $0.45 per share slightly below the consensus estimate of $0.48.	Our interactive dashboard analysis on Corning Pre-Earnings has additional details. [Updated 1/25/2021] Corning Update Corning (NYSE: GLW), best known for its display glass, has been reportedly working on ultra-thin glass that can be used for cover glass in foldable devices. We expect Corning to report mixed results with revenues estimated to be $3.23 Bil, slightly above the $3.18 Bil consensus estimates, while the adjusted earnings to be $0.45 per share slightly below the consensus estimate of $0.48.	Our interactive dashboard analysis on Corning Pre-Earnings has additional details. [Updated 12/14/2020] Buy Or Sell Corning Stock After a solid 2x rise since the March 23 levels of this year, at the current price of around $36 per share we believe Corning stock (NYSE: GLW), has reached its near-term potential. The company saw a 14.9% growth in total shares outstanding due to share issuances, resulting in a -1% change in revenue per share (RPS) to $13.30 in 2019, compared to $13.43 in 2017.	380eec31-6fee-4db0-b376-1e151eeabfdb
716217.0	2021-01-26 00:00:00 UTC	DuPont raises full-year forecasts as global demand recovers	DD	https://www.nasdaq.com/articles/dupont-raises-full-year-forecasts-as-global-demand-recovers-2021-01-26	nan	nan	Adds full year forecast, fourth quarter sales, background Jan 26 (Reuters) - Industrial materials maker DuPont DD.N on Tuesday raised its full-year profit and sales forecasts as demand picks up in its end markets on the back of global economies recovering from last year's COVID-19 pandemic shock. The company, which makes everything from brake fluid to fabric used in protective garments, made aggressive cost cuts last year after several of its customers across different industries got hit by the pandemic. The company's full-year estimate for adjusted earnings of between $3.34 and $3.36 on net sales of about $20.40 billion, were well above its prior forecast in October for profit of $3.17 to $3.21 per share on sales of $20.1 billion to $20.2 billion. On an adjusted basis, the company expects profit to range between 93 cents per share and 95 cents per share in the fourth quarter, compared with a third-quarter profit of 88 cents. It expects to report sales of $5.25 billion in the three months ended December 31, about 3% above the third quarter. DuPont is scheduled to report its fourth-quarter results on Feb. 9. (Reporting by Shariq Khan in Bengaluru; Editing by Ramakrishnan M. And Shinjini Ganguli) ((Shariq.Khan@thomsonreuters.com; Within U.S.+1 646 223 8780, outside U.S. +91 80 6182 2681; Twitter: @shariqrtrs;)) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	Adds full year forecast, fourth quarter sales, background Jan 26 (Reuters) - Industrial materials maker DuPont DD.N on Tuesday raised its full-year profit and sales forecasts as demand picks up in its end markets on the back of global economies recovering from last year's COVID-19 pandemic shock. The company, which makes everything from brake fluid to fabric used in protective garments, made aggressive cost cuts last year after several of its customers across different industries got hit by the pandemic. It expects to report sales of $5.25 billion in the three months ended December 31, about 3% above the third quarter.	Adds full year forecast, fourth quarter sales, background Jan 26 (Reuters) - Industrial materials maker DuPont DD.N on Tuesday raised its full-year profit and sales forecasts as demand picks up in its end markets on the back of global economies recovering from last year's COVID-19 pandemic shock. On an adjusted basis, the company expects profit to range between 93 cents per share and 95 cents per share in the fourth quarter, compared with a third-quarter profit of 88 cents. It expects to report sales of $5.25 billion in the three months ended December 31, about 3% above the third quarter.	Adds full year forecast, fourth quarter sales, background Jan 26 (Reuters) - Industrial materials maker DuPont DD.N on Tuesday raised its full-year profit and sales forecasts as demand picks up in its end markets on the back of global economies recovering from last year's COVID-19 pandemic shock. The company's full-year estimate for adjusted earnings of between $3.34 and $3.36 on net sales of about $20.40 billion, were well above its prior forecast in October for profit of $3.17 to $3.21 per share on sales of $20.1 billion to $20.2 billion. On an adjusted basis, the company expects profit to range between 93 cents per share and 95 cents per share in the fourth quarter, compared with a third-quarter profit of 88 cents.	Adds full year forecast, fourth quarter sales, background Jan 26 (Reuters) - Industrial materials maker DuPont DD.N on Tuesday raised its full-year profit and sales forecasts as demand picks up in its end markets on the back of global economies recovering from last year's COVID-19 pandemic shock. The company's full-year estimate for adjusted earnings of between $3.34 and $3.36 on net sales of about $20.40 billion, were well above its prior forecast in October for profit of $3.17 to $3.21 per share on sales of $20.1 billion to $20.2 billion. DuPont is scheduled to report its fourth-quarter results on Feb. 9.	3735f31c-fc2f-4e78-97c6-bd00e1dfa4a8
716218.0	2021-01-26 00:00:00 UTC	DuPont Reports Preliminary Q4 Results - Quick Facts	DD	https://www.nasdaq.com/articles/dupont-reports-preliminary-q4-results-quick-facts-2021-01-26	nan	nan	(RTTNews) - DuPont (DD) said it expects fourth quarter adjusted EPS to be in the range of $0.93 to $0.95 on net sales of approximately $5.25 billion. For full year 2020, the company anticipates adjusted EPS to be in the range of $3.34 to $3.36 on net sales of approximately $20.40 billion. On December 31, 2020, the company commenced its exchange offer whereby DuPont stockholders can elect to tender shares of DuPont common stock in exchange for shares of Nutrition & Biosciences, Inc. common stock. The Exchange Offer will expire on January 29, 2021. DuPont will announce its financial results for the fourth quarter and full year on February 9, 2021. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	(RTTNews) - DuPont (DD) said it expects fourth quarter adjusted EPS to be in the range of $0.93 to $0.95 on net sales of approximately $5.25 billion. For full year 2020, the company anticipates adjusted EPS to be in the range of $3.34 to $3.36 on net sales of approximately $20.40 billion. DuPont will announce its financial results for the fourth quarter and full year on February 9, 2021.	(RTTNews) - DuPont (DD) said it expects fourth quarter adjusted EPS to be in the range of $0.93 to $0.95 on net sales of approximately $5.25 billion. For full year 2020, the company anticipates adjusted EPS to be in the range of $3.34 to $3.36 on net sales of approximately $20.40 billion. On December 31, 2020, the company commenced its exchange offer whereby DuPont stockholders can elect to tender shares of DuPont common stock in exchange for shares of Nutrition & Biosciences, Inc. common stock.	(RTTNews) - DuPont (DD) said it expects fourth quarter adjusted EPS to be in the range of $0.93 to $0.95 on net sales of approximately $5.25 billion. On December 31, 2020, the company commenced its exchange offer whereby DuPont stockholders can elect to tender shares of DuPont common stock in exchange for shares of Nutrition & Biosciences, Inc. common stock. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	(RTTNews) - DuPont (DD) said it expects fourth quarter adjusted EPS to be in the range of $0.93 to $0.95 on net sales of approximately $5.25 billion. For full year 2020, the company anticipates adjusted EPS to be in the range of $3.34 to $3.36 on net sales of approximately $20.40 billion. On December 31, 2020, the company commenced its exchange offer whereby DuPont stockholders can elect to tender shares of DuPont common stock in exchange for shares of Nutrition & Biosciences, Inc. common stock.	66bf60d6-d501-4f31-b7e8-0bb10229bde6
716219.0	2021-01-22 00:00:00 UTC	DuPont, Corteva, Chemours Reach Settlement Agreement Related To Legacy PFAS Liabilities	DD	https://www.nasdaq.com/articles/dupont-corteva-chemours-reach-settlement-agreement-related-to-legacy-pfas-liabilities-2021	nan	nan	(RTTNews) - DuPont de Nemours, Inc. (DD), Corteva, Inc. (CTVA) and The Chemours Company (CC) have reached a binding memorandum of understanding containing a settlement to resolve legal disputes originating from the 2015 spin-off of Chemours from E. I. du Pont de Nemours and Company (EID). The companies will establish a cost sharing arrangement and an escrow account to be used to support and manage potential future legacy PFAS liabilities. According to this, DuPont and Corteva together, on one hand, and Chemours, on the other hand, agree to a 50-50 split of certain qualified expenses incurred over a term not to exceed twenty years or $4 billion of qualified spend and escrow contributions in the aggregate. DuPont and Corteva's 50 percent will be limited to $2 billion. DuPont's share of the potential $2 billion would be approximately $1.36 billion and Corteva's approximately $640 million. The companies have agreed to resolve the matters in the Ohio multi-district PFOA litigation for $83 million. DuPont will contribute $27 million, Corteva will contribute $27 million and Chemours will contribute $29 million to the settlement. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	(RTTNews) - DuPont de Nemours, Inc. (DD), Corteva, Inc. (CTVA) and The Chemours Company (CC) have reached a binding memorandum of understanding containing a settlement to resolve legal disputes originating from the 2015 spin-off of Chemours from E. I. du Pont de Nemours and Company (EID). The companies will establish a cost sharing arrangement and an escrow account to be used to support and manage potential future legacy PFAS liabilities. The companies have agreed to resolve the matters in the Ohio multi-district PFOA litigation for $83 million.	(RTTNews) - DuPont de Nemours, Inc. (DD), Corteva, Inc. (CTVA) and The Chemours Company (CC) have reached a binding memorandum of understanding containing a settlement to resolve legal disputes originating from the 2015 spin-off of Chemours from E. I. du Pont de Nemours and Company (EID). DuPont's share of the potential $2 billion would be approximately $1.36 billion and Corteva's approximately $640 million. DuPont will contribute $27 million, Corteva will contribute $27 million and Chemours will contribute $29 million to the settlement.	(RTTNews) - DuPont de Nemours, Inc. (DD), Corteva, Inc. (CTVA) and The Chemours Company (CC) have reached a binding memorandum of understanding containing a settlement to resolve legal disputes originating from the 2015 spin-off of Chemours from E. I. du Pont de Nemours and Company (EID). According to this, DuPont and Corteva together, on one hand, and Chemours, on the other hand, agree to a 50-50 split of certain qualified expenses incurred over a term not to exceed twenty years or $4 billion of qualified spend and escrow contributions in the aggregate. DuPont will contribute $27 million, Corteva will contribute $27 million and Chemours will contribute $29 million to the settlement.	(RTTNews) - DuPont de Nemours, Inc. (DD), Corteva, Inc. (CTVA) and The Chemours Company (CC) have reached a binding memorandum of understanding containing a settlement to resolve legal disputes originating from the 2015 spin-off of Chemours from E. I. du Pont de Nemours and Company (EID). DuPont's share of the potential $2 billion would be approximately $1.36 billion and Corteva's approximately $640 million. DuPont will contribute $27 million, Corteva will contribute $27 million and Chemours will contribute $29 million to the settlement.	3a40d8ea-ecee-48d2-a9a9-a31e453dc206
716220.0	2021-01-21 00:00:00 UTC	Notable Thursday Option Activity: GOOG, TGT, DD	DD	https://www.nasdaq.com/articles/notable-thursday-option-activity%3A-goog-tgt-dd-2021-01-21	nan	nan	Looking at options trading activity among components of the S&P 500 index, there is noteworthy activity today in Alphabet Inc (Symbol: GOOG), where a total volume of 36,932 contracts has been traded thus far today, a contract volume which is representative of approximately 3.7 million underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 250.1% of GOOG's average daily trading volume over the past month, of 1.5 million shares. Especially high volume was seen for the $1890 strike call option expiring January 22, 2021, with 2,297 contracts trading so far today, representing approximately 229,700 underlying shares of GOOG. Below is a chart showing GOOG's trailing twelve month trading history, with the $1890 strike highlighted in orange: Target Corp (Symbol: TGT) saw options trading volume of 31,610 contracts, representing approximately 3.2 million underlying shares or approximately 82.9% of TGT's average daily trading volume over the past month, of 3.8 million shares. Particularly high volume was seen for the $200 strike call option expiring January 22, 2021, with 3,363 contracts trading so far today, representing approximately 336,300 underlying shares of TGT. Below is a chart showing TGT's trailing twelve month trading history, with the $200 strike highlighted in orange: And DuPont (Symbol: DD) options are showing a volume of 82,773 contracts thus far today. That number of contracts represents approximately 8.3 million underlying shares, working out to a sizeable 72.3% of DD's average daily trading volume over the past month, of 11.5 million shares. Particularly high volume was seen for the $105 strike call option expiring February 19, 2021, with 22,169 contracts trading so far today, representing approximately 2.2 million underlying shares of DD. Below is a chart showing DD's trailing twelve month trading history, with the $105 strike highlighted in orange: For the various different available expirations for GOOG options, TGT options, or DD options, visit StockOptionsChannel.com. Today's Most Active Call & Put Options of the S&P 500 » The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	Particularly high volume was seen for the $105 strike call option expiring February 19, 2021, with 22,169 contracts trading so far today, representing approximately 2.2 million underlying shares of DD. Below is a chart showing TGT's trailing twelve month trading history, with the $200 strike highlighted in orange: And DuPont (Symbol: DD) options are showing a volume of 82,773 contracts thus far today. That number of contracts represents approximately 8.3 million underlying shares, working out to a sizeable 72.3% of DD's average daily trading volume over the past month, of 11.5 million shares.	Below is a chart showing TGT's trailing twelve month trading history, with the $200 strike highlighted in orange: And DuPont (Symbol: DD) options are showing a volume of 82,773 contracts thus far today. That number of contracts represents approximately 8.3 million underlying shares, working out to a sizeable 72.3% of DD's average daily trading volume over the past month, of 11.5 million shares. Particularly high volume was seen for the $105 strike call option expiring February 19, 2021, with 22,169 contracts trading so far today, representing approximately 2.2 million underlying shares of DD.	Particularly high volume was seen for the $105 strike call option expiring February 19, 2021, with 22,169 contracts trading so far today, representing approximately 2.2 million underlying shares of DD. Below is a chart showing TGT's trailing twelve month trading history, with the $200 strike highlighted in orange: And DuPont (Symbol: DD) options are showing a volume of 82,773 contracts thus far today. That number of contracts represents approximately 8.3 million underlying shares, working out to a sizeable 72.3% of DD's average daily trading volume over the past month, of 11.5 million shares.	Below is a chart showing DD's trailing twelve month trading history, with the $105 strike highlighted in orange: For the various different available expirations for GOOG options, TGT options, or DD options, visit StockOptionsChannel.com. Below is a chart showing TGT's trailing twelve month trading history, with the $200 strike highlighted in orange: And DuPont (Symbol: DD) options are showing a volume of 82,773 contracts thus far today. That number of contracts represents approximately 8.3 million underlying shares, working out to a sizeable 72.3% of DD's average daily trading volume over the past month, of 11.5 million shares.	cab010b9-0a4f-4182-9ebd-c25ceb919063
716221.0	2021-01-15 00:00:00 UTC	Notable ETF Outflow Detected - IYM, DD, DOW, FCX	DD	https://www.nasdaq.com/articles/notable-etf-outflow-detected-iym-dd-dow-fcx-2021-01-15	nan	nan	Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares U.S. Basic Materials ETF (Symbol: IYM) where we have detected an approximate $194.3 million dollar outflow -- that's a 23.9% decrease week over week (from 6,700,000 to 5,100,000). Among the largest underlying components of IYM, in trading today DuPont (Symbol: DD) is off about 2.2%, Dow Inc (Symbol: DOW) is down about 3.3%, and Freeport-McMoran Copper & Gold (Symbol: FCX) is lower by about 5.1%. For a complete list of holdings, visit the IYM Holdings page » The chart below shows the one year price performance of IYM, versus its 200 day moving average: Looking at the chart above, IYM's low point in its 52 week range is $59.49 per share, with $123.10 as the 52 week high point — that compares with a last trade of $118.47. Comparing the most recent share price to the 200 day moving average can also be a useful technical analysis technique -- learn more about the 200 day moving average ». Free Report: Top 7%+ Dividends (paid monthly) Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units'' can be traded back and forth just like stocks, but can also be created or destroyed to accommodate investor demand. Each week we monitor the week-over-week change in shares outstanding data, to keep a lookout for those ETFs experiencing notable inflows (many new units created) or outflows (many old units destroyed). Creation of new units will mean the underlying holdings of the ETF need to be purchased, while destruction of units involves selling underlying holdings, so large flows can also impact the individual components held within ETFs. Click here to find out which 9 other ETFs experienced notable outflows » The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	Among the largest underlying components of IYM, in trading today DuPont (Symbol: DD) is off about 2.2%, Dow Inc (Symbol: DOW) is down about 3.3%, and Freeport-McMoran Copper & Gold (Symbol: FCX) is lower by about 5.1%. For a complete list of holdings, visit the IYM Holdings page » The chart below shows the one year price performance of IYM, versus its 200 day moving average: Looking at the chart above, IYM's low point in its 52 week range is $59.49 per share, with $123.10 as the 52 week high point — that compares with a last trade of $118.47. These ''units'' can be traded back and forth just like stocks, but can also be created or destroyed to accommodate investor demand.	Among the largest underlying components of IYM, in trading today DuPont (Symbol: DD) is off about 2.2%, Dow Inc (Symbol: DOW) is down about 3.3%, and Freeport-McMoran Copper & Gold (Symbol: FCX) is lower by about 5.1%. For a complete list of holdings, visit the IYM Holdings page » The chart below shows the one year price performance of IYM, versus its 200 day moving average: Looking at the chart above, IYM's low point in its 52 week range is $59.49 per share, with $123.10 as the 52 week high point — that compares with a last trade of $118.47. Each week we monitor the week-over-week change in shares outstanding data, to keep a lookout for those ETFs experiencing notable inflows (many new units created) or outflows (many old units destroyed).	Among the largest underlying components of IYM, in trading today DuPont (Symbol: DD) is off about 2.2%, Dow Inc (Symbol: DOW) is down about 3.3%, and Freeport-McMoran Copper & Gold (Symbol: FCX) is lower by about 5.1%. For a complete list of holdings, visit the IYM Holdings page » The chart below shows the one year price performance of IYM, versus its 200 day moving average: Looking at the chart above, IYM's low point in its 52 week range is $59.49 per share, with $123.10 as the 52 week high point — that compares with a last trade of $118.47. Each week we monitor the week-over-week change in shares outstanding data, to keep a lookout for those ETFs experiencing notable inflows (many new units created) or outflows (many old units destroyed).	Among the largest underlying components of IYM, in trading today DuPont (Symbol: DD) is off about 2.2%, Dow Inc (Symbol: DOW) is down about 3.3%, and Freeport-McMoran Copper & Gold (Symbol: FCX) is lower by about 5.1%. Basic Materials ETF (Symbol: IYM) where we have detected an approximate $194.3 million dollar outflow -- that's a 23.9% decrease week over week (from 6,700,000 to 5,100,000). For a complete list of holdings, visit the IYM Holdings page » The chart below shows the one year price performance of IYM, versus its 200 day moving average: Looking at the chart above, IYM's low point in its 52 week range is $59.49 per share, with $123.10 as the 52 week high point — that compares with a last trade of $118.47.	040144bf-5a55-44e1-8d32-2159329b9574
716222.0	2021-01-13 00:00:00 UTC	Notable Wednesday Option Activity: ESPR, CFR, DD	DD	https://www.nasdaq.com/articles/notable-wednesday-option-activity%3A-espr-cfr-dd-2021-01-13	nan	nan	Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Esperion Therapeutics Inc (Symbol: ESPR), where a total volume of 5,331 contracts has been traded thus far today, a contract volume which is representative of approximately 533,100 underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 78.4% of ESPR's average daily trading volume over the past month, of 679,950 shares. Particularly high volume was seen for the $22.50 strike put option expiring February 19, 2021, with 2,029 contracts trading so far today, representing approximately 202,900 underlying shares of ESPR. Below is a chart showing ESPR's trailing twelve month trading history, with the $22.50 strike highlighted in orange: Cullen/Frost Bankers, Inc. (Symbol: CFR) options are showing a volume of 2,580 contracts thus far today. That number of contracts represents approximately 258,000 underlying shares, working out to a sizeable 77% of CFR's average daily trading volume over the past month, of 335,220 shares. Especially high volume was seen for the $95 strike call option expiring January 15, 2021, with 1,202 contracts trading so far today, representing approximately 120,200 underlying shares of CFR. Below is a chart showing CFR's trailing twelve month trading history, with the $95 strike highlighted in orange: And DuPont (Symbol: DD) options are showing a volume of 74,658 contracts thus far today. That number of contracts represents approximately 7.5 million underlying shares, working out to a sizeable 76.7% of DD's average daily trading volume over the past month, of 9.7 million shares. Particularly high volume was seen for the $105 strike put option expiring February 12, 2021, with 12,305 contracts trading so far today, representing approximately 1.2 million underlying shares of DD. Below is a chart showing DD's trailing twelve month trading history, with the $105 strike highlighted in orange: For the various different available expirations for ESPR options, CFR options, or DD options, visit StockOptionsChannel.com. Today's Most Active Call & Put Options of the S&P 500 » The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	Particularly high volume was seen for the $105 strike put option expiring February 12, 2021, with 12,305 contracts trading so far today, representing approximately 1.2 million underlying shares of DD. Below is a chart showing CFR's trailing twelve month trading history, with the $95 strike highlighted in orange: And DuPont (Symbol: DD) options are showing a volume of 74,658 contracts thus far today. That number of contracts represents approximately 7.5 million underlying shares, working out to a sizeable 76.7% of DD's average daily trading volume over the past month, of 9.7 million shares.	Below is a chart showing CFR's trailing twelve month trading history, with the $95 strike highlighted in orange: And DuPont (Symbol: DD) options are showing a volume of 74,658 contracts thus far today. That number of contracts represents approximately 7.5 million underlying shares, working out to a sizeable 76.7% of DD's average daily trading volume over the past month, of 9.7 million shares. Particularly high volume was seen for the $105 strike put option expiring February 12, 2021, with 12,305 contracts trading so far today, representing approximately 1.2 million underlying shares of DD.	Particularly high volume was seen for the $105 strike put option expiring February 12, 2021, with 12,305 contracts trading so far today, representing approximately 1.2 million underlying shares of DD. Below is a chart showing CFR's trailing twelve month trading history, with the $95 strike highlighted in orange: And DuPont (Symbol: DD) options are showing a volume of 74,658 contracts thus far today. That number of contracts represents approximately 7.5 million underlying shares, working out to a sizeable 76.7% of DD's average daily trading volume over the past month, of 9.7 million shares.	Particularly high volume was seen for the $105 strike put option expiring February 12, 2021, with 12,305 contracts trading so far today, representing approximately 1.2 million underlying shares of DD. Below is a chart showing DD's trailing twelve month trading history, with the $105 strike highlighted in orange: For the various different available expirations for ESPR options, CFR options, or DD options, visit StockOptionsChannel.com. Below is a chart showing CFR's trailing twelve month trading history, with the $95 strike highlighted in orange: And DuPont (Symbol: DD) options are showing a volume of 74,658 contracts thus far today.	c8c6a4ac-527e-4ed1-abc1-126a029c8f27
716223.0	2021-01-11 00:00:00 UTC	Monday Sector Leaders: Energy, Materials	DD	https://www.nasdaq.com/articles/monday-sector-leaders%3A-energy-materials-2021-01-11	nan	nan	Looking at the sectors faring best as of midday Monday, shares of Energy companies are outperforming other sectors, higher by 1.4%. Within that group, Cabot Oil & Gas Corp. (Symbol: COG) and Exxon Mobil Corp (Symbol: XOM) are two large stocks leading the way, showing a gain of 4.0% and 3.2%, respectively. Among energy ETFs, one ETF following the sector is the Energy Select Sector SPDR ETF (Symbol: XLE), which is up 1.6% on the day, and up 11.03% year-to-date. Cabot Oil & Gas Corp., meanwhile, is up 10.32% year-to-date, and Exxon Mobil Corp is up 13.83% year-to-date. Combined, COG and XOM make up approximately 24.5% of the underlying holdings of XLE. The next best performing sector is the Materials sector, higher by 0.6%. Among large Materials stocks, DuPont (Symbol: DD) and International Flavors & Fragrances Inc. (Symbol: IFF) are the most notable, showing a gain of 4.3% and 4.2%, respectively. One ETF closely tracking Materials stocks is the Materials Select Sector SPDR ETF (XLB), which is up 0.2% in midday trading, and up 5.93% on a year-to-date basis. DuPont, meanwhile, is up 19.95% year-to-date, and International Flavors & Fragrances Inc. is up 13.87% year-to-date. Combined, DD and IFF make up approximately 8.7% of the underlying holdings of XLB. Comparing these stocks and ETFs on a trailing twelve month basis, below is a relative stock price performance chart, with each of the symbols shown in a different color as labeled in the legend at the bottom: Here's a snapshot of how the S&P 500 components within the various sectors are faring in afternoon trading on Monday. As you can see, three sectors are up on the day, while six sectors are down. SECTOR % CHANGE Energy +1.4% Materials +0.6% Services +0.3% Technology & Communications -0.1% Healthcare -0.2% Financial -0.3% Industrial -0.3% Consumer Products -0.5% Utilities -1.1% 25 Dividend Giants Widely Held By ETFs » The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	Combined, DD and IFF make up approximately 8.7% of the underlying holdings of XLB. Looking at the sectors faring best as of midday Monday, shares of Energy companies are outperforming other sectors, higher by 1.4%. Among large Materials stocks, DuPont (Symbol: DD) and International Flavors & Fragrances Inc. (Symbol: IFF) are the most notable, showing a gain of 4.3% and 4.2%, respectively.	Among large Materials stocks, DuPont (Symbol: DD) and International Flavors & Fragrances Inc. (Symbol: IFF) are the most notable, showing a gain of 4.3% and 4.2%, respectively. Looking at the sectors faring best as of midday Monday, shares of Energy companies are outperforming other sectors, higher by 1.4%. One ETF closely tracking Materials stocks is the Materials Select Sector SPDR ETF (XLB), which is up 0.2% in midday trading, and up 5.93% on a year-to-date basis.	One ETF closely tracking Materials stocks is the Materials Select Sector SPDR ETF (XLB), which is up 0.2% in midday trading, and up 5.93% on a year-to-date basis. Looking at the sectors faring best as of midday Monday, shares of Energy companies are outperforming other sectors, higher by 1.4%. Among large Materials stocks, DuPont (Symbol: DD) and International Flavors & Fragrances Inc. (Symbol: IFF) are the most notable, showing a gain of 4.3% and 4.2%, respectively.	Looking at the sectors faring best as of midday Monday, shares of Energy companies are outperforming other sectors, higher by 1.4%. Among large Materials stocks, DuPont (Symbol: DD) and International Flavors & Fragrances Inc. (Symbol: IFF) are the most notable, showing a gain of 4.3% and 4.2%, respectively. One ETF closely tracking Materials stocks is the Materials Select Sector SPDR ETF (XLB), which is up 0.2% in midday trading, and up 5.93% on a year-to-date basis.	e463f806-d1d2-4877-83be-e900fa676e53
716224.0	2021-01-05 00:00:00 UTC	Tuesday Sector Leaders: Energy, Materials	DD	https://www.nasdaq.com/articles/tuesday-sector-leaders%3A-energy-materials-2021-01-05	nan	nan	In afternoon trading on Tuesday, Energy stocks are the best performing sector, higher by 7.8%. Within that group, Marathon Oil Corp. (Symbol: MRO) and Occidental Petroleum Corp (Symbol: OXY) are two large stocks leading the way, showing a gain of 14.1% and 13.6%, respectively. Among energy ETFs, one ETF following the sector is the Energy Select Sector SPDR ETF (Symbol: XLE), which is up 7.1% on the day, and up 7.23% year-to-date. Marathon Oil Corp., meanwhile, is up 16.79% year-to-date, and Occidental Petroleum Corp is up 14.53% year-to-date. Combined, MRO and OXY make up approximately 3.1% of the underlying holdings of XLE. The next best performing sector is the Materials sector, up 2.8%. Among large Materials stocks, Albemarle Corp. (Symbol: ALB) and DuPont (Symbol: DD) are the most notable, showing a gain of 7.3% and 5.1%, respectively. One ETF closely tracking Materials stocks is the Materials Select Sector SPDR ETF (XLB), which is up 2.3% in midday trading, and up 1.37% on a year-to-date basis. Albemarle Corp., meanwhile, is up 11.04% year-to-date, and DuPont is up 3.97% year-to-date. Combined, ALB and DD make up approximately 8.3% of the underlying holdings of XLB. Comparing these stocks and ETFs on a trailing twelve month basis, below is a relative stock price performance chart, with each of the symbols shown in a different color as labeled in the legend at the bottom: Here's a snapshot of how the S&P 500 components within the various sectors are faring in afternoon trading on Tuesday. As you can see, nine sectors are up on the day, while none of the sectors are down. SECTOR % CHANGE Energy +7.8% Materials +2.8% Industrial +1.3% Healthcare +1.1% Technology & Communications +0.9% Consumer Products +0.8% Services +0.8% Financial +0.8% Utilities +0.1% 25 Dividend Giants Widely Held By ETFs » The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	Among large Materials stocks, Albemarle Corp. (Symbol: ALB) and DuPont (Symbol: DD) are the most notable, showing a gain of 7.3% and 5.1%, respectively. One ETF closely tracking Materials stocks is the Materials Select Sector SPDR ETF (XLB), which is up 2.3% in midday trading, and up 1.37% on a year-to-date basis. Combined, ALB and DD make up approximately 8.3% of the underlying holdings of XLB.	Among large Materials stocks, Albemarle Corp. (Symbol: ALB) and DuPont (Symbol: DD) are the most notable, showing a gain of 7.3% and 5.1%, respectively. One ETF closely tracking Materials stocks is the Materials Select Sector SPDR ETF (XLB), which is up 2.3% in midday trading, and up 1.37% on a year-to-date basis. Combined, ALB and DD make up approximately 8.3% of the underlying holdings of XLB.	One ETF closely tracking Materials stocks is the Materials Select Sector SPDR ETF (XLB), which is up 2.3% in midday trading, and up 1.37% on a year-to-date basis. Among large Materials stocks, Albemarle Corp. (Symbol: ALB) and DuPont (Symbol: DD) are the most notable, showing a gain of 7.3% and 5.1%, respectively. Combined, ALB and DD make up approximately 8.3% of the underlying holdings of XLB.	Among large Materials stocks, Albemarle Corp. (Symbol: ALB) and DuPont (Symbol: DD) are the most notable, showing a gain of 7.3% and 5.1%, respectively. One ETF closely tracking Materials stocks is the Materials Select Sector SPDR ETF (XLB), which is up 2.3% in midday trading, and up 1.37% on a year-to-date basis. Combined, ALB and DD make up approximately 8.3% of the underlying holdings of XLB.	d3dbc427-45e8-4c21-8567-adc565a0625d
716225.0	2021-01-03 00:00:00 UTC	Philippine bourse targets more IPOs, REITs this year on recovery hope	DD	https://www.nasdaq.com/articles/philippine-bourse-targets-more-ipos-reits-this-year-on-recovery-hope-2021-01-03	nan	nan	MANILA, Jan 4 (Reuters) - Seven Philippine firms plan to go public or offer real estate investment trusts (REIT) this year, the stock exchange said on Monday, representing a spurt in capital market activity in an economy still shaken by the impact of the COVID-19 pandemic. The Philippines, one of Asia's fastest-growing economies before the pandemic, has long struggled to attract firms to its stock market, with just seven initial public offerings (IPOs) in the past three years. However in 2021, at least three companies will go public and four property firms will conduct REIT offerings, Philippine Stock Exchange Inc PSE.PS President and Chief Executive Ramon Monzon said in a statement, without identifying the companies. Last November, DoubleDragon Properties Corp DD.PS said it planned raise as much as 14.7 billion pesos ($306 million) through a REIT in February. REITs manage real estate assets such as hotels, office buildings and shopping malls that regularly generate profit. They are attractive to investors seeking regular dividends. "Although the current economic environment remains fragile because of the unpredictability of the COVID-19 situation, we choose to be optimistic," Monzon said, adding that restoring investor confidence will continue to be a challenge. The bourse will relax listing rules this year to attract more companies, Monzon said. Also, new features will include short-selling, added sector classifications and indices, and a data analytics platform, he said. At 272, the bourse lists the lowest number of companies among major Southeast Asian peers. Funds raised through the bourse rose 2.9% in 2020 to 104 billion pesos ($2.17 billion), mainly through IPOs and follow-on share sales, bourse data showed. The Philippines' broader stock index .PSI declined 8.6% last year, plunging as much as 41% in March during the novel coronavirus-inducedglobal marketsell-down. ($1 = 48.0100 Philippine pesos) (Reporting by Neil Jerome Morales; Editing by Christopher Cushing) ((neiljerome.morales@thomsonreuters.com; +632 8841 8914;)) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	"Although the current economic environment remains fragile because of the unpredictability of the COVID-19 situation, we choose to be optimistic," Monzon said, adding that restoring investor confidence will continue to be a challenge. Last November, DoubleDragon Properties Corp DD.PS said it planned raise as much as 14.7 billion pesos ($306 million) through a REIT in February. Also, new features will include short-selling, added sector classifications and indices, and a data analytics platform, he said.	Last November, DoubleDragon Properties Corp DD.PS said it planned raise as much as 14.7 billion pesos ($306 million) through a REIT in February. "Although the current economic environment remains fragile because of the unpredictability of the COVID-19 situation, we choose to be optimistic," Monzon said, adding that restoring investor confidence will continue to be a challenge. Also, new features will include short-selling, added sector classifications and indices, and a data analytics platform, he said.	Last November, DoubleDragon Properties Corp DD.PS said it planned raise as much as 14.7 billion pesos ($306 million) through a REIT in February. "Although the current economic environment remains fragile because of the unpredictability of the COVID-19 situation, we choose to be optimistic," Monzon said, adding that restoring investor confidence will continue to be a challenge. Also, new features will include short-selling, added sector classifications and indices, and a data analytics platform, he said.	Last November, DoubleDragon Properties Corp DD.PS said it planned raise as much as 14.7 billion pesos ($306 million) through a REIT in February. "Although the current economic environment remains fragile because of the unpredictability of the COVID-19 situation, we choose to be optimistic," Monzon said, adding that restoring investor confidence will continue to be a challenge. Also, new features will include short-selling, added sector classifications and indices, and a data analytics platform, he said.	701a7b55-26c0-4646-ab45-ce1da638a8e7
716226.0	2021-01-03 00:00:00 UTC	DuPont Commences Split-off Exchange Offer For N&B Business, Street Is Bullish	DD	https://www.nasdaq.com/articles/dupont-commences-split-off-exchange-offer-for-nb-business-street-is-bullish-2021-01-03	nan	nan	DuPont (DD) announced the commencement of its planned split-off exchange offer for its Nutrition & Biosciences (N&B) business. The exchange offer provides DuPont common shareholders with an option to exchange all or a portion of their shares for shares of N&B, which will be later converted into shares of International Flavors & Fragrances (IFF). The company stated that the exchange offer would expire on January 29, 2021. The offer forms a part of DuPont’s “Reverse Morris Trust” arrangement with International Flavors & Fragrances, which was announced a year ago. Under the arrangement, DuPont had agreed to split-off its N&B business and then combine it with IFF. DuPont said, “Following the exchange offer, N&B will merge with a subsidiary of IFF and become a wholly-owned subsidiary of IFF, and shares of N&B common stock will be converted into shares of IFF common stock. In the merger the N&B shares will convert into IFF shares on a 1.0:1.0 basis, so participants in the exchange offer will instead receive shares of IFF common stock in the merger.” Last month, Delaware’s Supreme Court upheld a March 2020 judgement of the dismissal of a lawsuit against DuPont wherein the company was accused of massively downplaying the cost of environmental liabilities imposed on spin-off company Chemours. (See DD stock analysis on TipRanks) Following the ruling, Deutsche Bank analyst David Begleiter raised the stock’s price target to $90 (26.6% upside potential) from $65 and reiterated a Buy rating. Begleiter believes that the ruling will lead to a new cost arrangement between the two companies, which will lessen investors’ concern over DuPont’s PFOA (Perfluorooctanoic Acid) exposure. Like Begleiter, the rest of the Street also has a bullish outlook on the stock. The Strong Buy analyst consensus is based on 6 unanimous Buys. Meanwhile, the average analyst price target stands at $74, and implies 4.1% upside potential at current levels. Shares were up 10.8% in 2020. Related News: Gold Resource In Leadership Reshuffle After NMU Spinoff; Shares Drop 5% Ford Calls Off Joint Venture With Mahindra; Street Says Hold Southwest Airlines Signs Agreement with Sabre; Street Sees 14% Upside The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	DuPont (DD) announced the commencement of its planned split-off exchange offer for its Nutrition & Biosciences (N&B) business. (See DD stock analysis on TipRanks) Following the ruling, Deutsche Bank analyst David Begleiter raised the stock’s price target to $90 (26.6% upside potential) from $65 and reiterated a Buy rating. The offer forms a part of DuPont’s “Reverse Morris Trust” arrangement with International Flavors & Fragrances, which was announced a year ago.	(See DD stock analysis on TipRanks) Following the ruling, Deutsche Bank analyst David Begleiter raised the stock’s price target to $90 (26.6% upside potential) from $65 and reiterated a Buy rating. DuPont (DD) announced the commencement of its planned split-off exchange offer for its Nutrition & Biosciences (N&B) business. The exchange offer provides DuPont common shareholders with an option to exchange all or a portion of their shares for shares of N&B, which will be later converted into shares of International Flavors & Fragrances (IFF).	DuPont (DD) announced the commencement of its planned split-off exchange offer for its Nutrition & Biosciences (N&B) business. (See DD stock analysis on TipRanks) Following the ruling, Deutsche Bank analyst David Begleiter raised the stock’s price target to $90 (26.6% upside potential) from $65 and reiterated a Buy rating. The exchange offer provides DuPont common shareholders with an option to exchange all or a portion of their shares for shares of N&B, which will be later converted into shares of International Flavors & Fragrances (IFF).	(See DD stock analysis on TipRanks) Following the ruling, Deutsche Bank analyst David Begleiter raised the stock’s price target to $90 (26.6% upside potential) from $65 and reiterated a Buy rating. DuPont (DD) announced the commencement of its planned split-off exchange offer for its Nutrition & Biosciences (N&B) business. The exchange offer provides DuPont common shareholders with an option to exchange all or a portion of their shares for shares of N&B, which will be later converted into shares of International Flavors & Fragrances (IFF).	f472e546-c8a2-4cd7-a15a-93de85e0c4cb
716227.0	2020-12-31 00:00:00 UTC	Interesting DD Put And Call Options For February 2021	DD	https://www.nasdaq.com/articles/interesting-dd-put-and-call-options-for-february-2021-2020-12-31	nan	nan	Investors in DuPont (Symbol: DD) saw new options begin trading today, for the February 2021 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the DD options chain for the new February 2021 contracts and identified one put and one call contract of particular interest. The put contract at the $67.50 strike price has a current bid of $1.03. If an investor was to sell-to-open that put contract, they are committing to purchase the stock at $67.50, but will also collect the premium, putting the cost basis of the shares at $66.47 (before broker commissions). To an investor already interested in purchasing shares of DD, that could represent an attractive alternative to paying $71.18/share today. Because the $67.50 strike represents an approximate 5% discount to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the put contract would expire worthless. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 65%. Stock Options Channel will track those odds over time to see how they change, publishing a chart of those numbers on our website under the contract detail page for this contract. Should the contract expire worthless, the premium would represent a 1.53% return on the cash commitment, or 12.95% annualized — at Stock Options Channel we call this the YieldBoost. Below is a chart showing the trailing twelve month trading history for DuPont, and highlighting in green where the $67.50 strike is located relative to that history: Turning to the calls side of the option chain, the call contract at the $77.00 strike price has a current bid of 3 cents. If an investor was to purchase shares of DD stock at the current price level of $71.18/share, and then sell-to-open that call contract as a "covered call," they are committing to sell the stock at $77.00. Considering the call seller will also collect the premium, that would drive a total return (excluding dividends, if any) of 8.22% if the stock gets called away at the February 2021 expiration (before broker commissions). Of course, a lot of upside could potentially be left on the table if DD shares really soar, which is why looking at the trailing twelve month trading history for DuPont, as well as studying the business fundamentals becomes important. Below is a chart showing DD's trailing twelve month trading history, with the $77.00 strike highlighted in red: Considering the fact that the $77.00 strike represents an approximate 8% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 64%. On our website under the contract detail page for this contract, Stock Options Channel will track those odds over time to see how they change and publish a chart of those numbers (the trading history of the option contract will also be charted). Should the covered call contract expire worthless, the premium would represent a 0.04% boost of extra return to the investor, or 0.36% annualized, which we refer to as the YieldBoost. The implied volatility in the put contract example is 60%, while the implied volatility in the call contract example is 53%. Meanwhile, we calculate the actual trailing twelve month volatility (considering the last 252 trading day closing values as well as today's price of $71.18) to be 51%. For more put and call options contract ideas worth looking at, visit StockOptionsChannel.com. Top YieldBoost Calls of the S&P 500 » The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	Of course, a lot of upside could potentially be left on the table if DD shares really soar, which is why looking at the trailing twelve month trading history for DuPont, as well as studying the business fundamentals becomes important. Below is a chart showing DD's trailing twelve month trading history, with the $77.00 strike highlighted in red: Considering the fact that the $77.00 strike represents an approximate 8% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected. Investors in DuPont (Symbol: DD) saw new options begin trading today, for the February 2021 expiration.	The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 65%. Below is a chart showing DD's trailing twelve month trading history, with the $77.00 strike highlighted in red: Considering the fact that the $77.00 strike represents an approximate 8% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 64%.	Below is a chart showing DD's trailing twelve month trading history, with the $77.00 strike highlighted in red: Considering the fact that the $77.00 strike represents an approximate 8% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected. On our website under the contract detail page for this contract, Stock Options Channel will track those odds over time to see how they change and publish a chart of those numbers (the trading history of the option contract will also be charted). Investors in DuPont (Symbol: DD) saw new options begin trading today, for the February 2021 expiration.	At Stock Options Channel, our YieldBoost formula has looked up and down the DD options chain for the new February 2021 contracts and identified one put and one call contract of particular interest. Below is a chart showing DD's trailing twelve month trading history, with the $77.00 strike highlighted in red: Considering the fact that the $77.00 strike represents an approximate 8% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected. Investors in DuPont (Symbol: DD) saw new options begin trading today, for the February 2021 expiration.	d5f680a0-08a1-4c92-b833-ac258e2a3fae
716228.0	2020-12-30 00:00:00 UTC	7 Nanotech Stocks To Buy With Huge Returns in Store	DD	https://www.nasdaq.com/articles/7-nanotech-stocks-to-buy-with-huge-returns-in-store-2020-12-30	nan	nan	InvestorPlace - Stock Market News, Stock Advice & Trading Tips Nanotechnology is as compelling as it sounds: a field of research dedicated to building devices and materials at the molecular and atomic levels. At that dimension, materials behave differently. And in practical terms, nanotechnology could help increase manufacturing production while cutting costs. The stock market is keen to find the next biggest technology boom, with investors looking for nanotech stocks to buy. That group includes many names in the semiconductor and industrial sectors. Companies that spent years researching developing nanotechnology-based solutions have huge return potential for investors. Some are familiar names, while others less so. The 7 Safest Stocks to Start Off 2021 on the Right Foot Here are seven companies that investors should look at today: Thermo Fisher Scientific (NYSE:TMO) Intel (NASDAQ:INTC) Arrowhead Pharmaceuticals (NASDAQ:ARWR) Veeco Instruments (NASDAQ:VECO) Onto Innovation (NYSE:ONTO) International Business Machines (NYSE:IBM) DuPont de Nemours (NYSE:DD) Thermo Fisher Scientific (TMO) TMO) sign out front of an office in Silicon Valley, California." width="300" height="169">Source: Michael Vi / Shutterstock.com Thermo Fisher Scientific is a diagnostics and research firm with deep interests in material sciences. Its work in transmission electron microscopy and energy-dispersive X-ray spectroscopy will further its understanding of the textile industry. The company said that its nanotechnology studies will lead to adaptable clothing that repels stains, odors, and water. Smartphones use transistors that are getting smaller and faster. And in medicine, nanoparticles will deliver next-generation drugs and vaccines. In the third quarter, TMO advanced its cryo-EM for structural biology applications in its electron microscope business. Its new POROS Oligo resin is used to purify and isolate mRNA. Already, the development of mRNA-based vaccines and therapies reached a milestone. The distribution of novel coronavirus vaccines will increase the demand for mRNA production. For 2020, TMO forecast revenue growing by 20% to around $30.5 billion. Its full-year adjusted earnings per share will increase by 48% to $18.27. TMO stock has high scores in three out of the four categories Chart courtesy of Stock Rover The chart above shows TMO stock’s strong quality and growth score. Its nanotech developments will only lift the company’s growth prospects next year. Intel (INTC) Source: dennizn / Shutterstock.com Falling behind in the chip processors race for personal computers, Intel is not yet out of the race. The company’s chief technology officer, Mike Mayberry, discussed its nanotech ambitions at the international VLSI conference. Intel will use nanowire/nanoribbon transitions in volume in five years. That timeline will feel like an eternity, especially after the company announced delays in its next-generation chips. Still, these are considered the future of computing. By going beyond FinFET to Gate-All-Around structures, it increases density and high-performance logic. 9 Long-Term Stocks for the Next Decade Investors should note that Intel did not give a clear timeline for this implementation. Besides, its new 7-nanometer process node is still behind schedule. This delay will give its competitors, including Advanced Micro Devices (NASDAQ:AMD) and Taiwan Semiconductor Manufacturing (NYSE:TSM) a sizeable lead. INTC Industry S&P 500 Quality Score 98 66 79 Gross Margin 56.50% 47.00% 28.80% Operating Margin 31.80% 21.50% 12.30% Net Margin 28.10% 18.90% 7.50% Data from Stock Rover As the table above shows, INTC stock is high on quality because of its strong gross margins. That is sustainable, as long as the company catches up in its product refresh. Arrowhead Pharmaceuticals (ARWR) Source: luchschenF / Shutterstock.com Arrowhead Pharmaceuticals is focused on discoveries that produced integrated systems of nanotech devices. The Global Nanobiotechnology Industry report said the market has an estimated size of $18.4 billion this year. It cited this company as one of the competitors in this market. In its core business, the company spent around a decade in bringing RNAi outside the liver. It is building a library of linker chemistry which is used to optimize delivery. By designing potent RNAi triggers, Arrowhead has a TRiM Platform that can treat more patients with its drug candidates. President and CEO Christopher Anzalone said, “RNAi doesn’t care what gene has been silenced once we validate our ability to reduce expression of a given gene in a given cell type, we have confidence that we can replicate that in other gene targets.“ So, if this approach bears fruit, the value of its drug pipeline increases as they get approved, fueling ARWR stock. Veeco Instruments (VECO) Source: Shutterstock Veeco Instruments is a semiconductor equipment and materials firm specializing in manufacturing 3D transistors and 3D memory. The company decreased its development risks by seeking partners to develop 3nm and 5nm technology node research. In the third quarter, Veeco’s data storage unit lifted its revenue to $122 million and non-GAAPS EPS to 22 cents. Although nanotech is not a driver to its growth, VECO stock investors should not get deterred. The company won a deal with Aledia to supply Veeco’s Propel 300 millimeter MOCVD (metal-organic chemical vapor deposition ) system. MOCVD is a technology used to deposit thin layers of atoms onto a semiconductor wafer. Wafers are made of sapphire or silicon. The customer will use this to manufacture 3D nanowire Micro LED displays. The 7 Safest Stocks to Start Off 2021 on the Right Foot In the five-year discounted cash flow growth exit model below, the fair value is $21.90: Metrics Range Conclusion Discount Rate 11.0% – 10.0% 10.50% Perpetuity Growth Rate 3.5% – 4.5% 4.00% Fair Value $19.13 – $25.68 $21.90 Model courtesy of finbox Readers may change the discount or growth rate to re-calculate the stock’s price target. CEO Bill Miller said that its early state micro LED applications will drive its growth in 2022 and beyond. Continued news on this development will likely give VECO stock another lift in the next year. Onto Innovation (ONTO) Source: Shutterstock Last year, Onto Innovation completed a merger that combined Rudolph Technology with Nanometrics. The deal sought to reduce costs and increase both device performance and product cycle times. Onto develops process controls. This includes 3D metrology on chips from the nanometer-scale transistors to micro-level die-interconnects. In the third quarter, the company posted revenue of $126.5 million up 101% from last year. It earned 40 cents a share (non-GAAP). In the quarter, customers started using early versions of its Atlas V for the development of node generation as small as 2 nanometers. In Q4, CEO Michael Plisinski expects growth to accelerate. Demand for the inspection, specialty device, and advanced packaging will remain strong. Its metrology business will also enjoy a rebound in demand. Based on three analysts, the average price target for ONTO stock is ~$50.00 (per Tipranks). International Business Machines (IBM) Source: JHVEPhoto / Shutterstock.com IBM has at least a two-decade history in nanotechnology research. Its IBM Research division worked in partnership with Singapore’s Institute of Bioengineering and Nanotechnology. The two firms developed a synthetic polymer that may help increase the effectiveness of existing antibiotics. IBM stock does reflect the value of the Research division. Despite being a major player in the fields of polymer and materials chemistry, investors are more interested in its developments in artificial intelligence and DevOps. In the near-term, IBM’s decision to spin-off its managed infrastructure services business will unlock the stock price discount. 9 Long-Term Stocks for the Next Decade The company is also pivoting to the hybrid cloud market. As it does so, its pace of innovation will increase. And as it creates a competitive advantage, differentiating itself from its peers, investors will buy the stock. So, for now, markets will not notice IBM’s contributions to the nanotech segment. DuPont de Nemours (DD) Source: Shutterstock Trading at close to 52-week highs, basic materials firm DuPont de Nemours may have huge returns ahead. Markets may associate the company with the progress in nanomaterials development. DuPont’s Nutrition and Biosciences division, which it is spinning off through an exchange offer, will interest nanotech investors. Silvadur is a nanoparticle-based silver product. It has silver metal particles that do not easily dissolve in water. This gives it a less uniform finish. These days, the pandemic is raising awareness of warding away viruses and bacteria. So, demand for Silvadur’s antimicrobial fabric surfaces property may increase. Not only is DD stock a potential winning name for investors but so is the spinoff. Stock Industry S&P 500 Value Score 67 67 74 Price / Earnings – – 38.5 Price / Sales 2.6 1.5 2.7 Data from Stock Rover In the table above, the value score suggests that DD stock is trading above fair value. Investors may want to consider holding the Nutrition and Biosciences spinoff instead. Disclosure: On the date of publication, Chris Lau did not have (either directly or indirectly) any positions in the securities mentioned in this article. Chris Lau is a contributing author for InvestorPlace.com and numerous other financial sites. Chris has over 20 years of investing experience in the stock market and runs the Do-It-Yourself Value Investing Marketplace on Seeking Alpha. He shares his stock picks so readers get original insight that helps improve investment returns. The post 7 Nanotech Stocks To Buy With Huge Returns in Store appeared first on InvestorPlace. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	The 7 Safest Stocks to Start Off 2021 on the Right Foot Here are seven companies that investors should look at today: Thermo Fisher Scientific (NYSE:TMO) Intel (NASDAQ:INTC) Arrowhead Pharmaceuticals (NASDAQ:ARWR) Veeco Instruments (NASDAQ:VECO) Onto Innovation (NYSE:ONTO) International Business Machines (NYSE:IBM) DuPont de Nemours (NYSE:DD) Thermo Fisher Scientific (TMO) TMO) sign out front of an office in Silicon Valley, California." DuPont de Nemours (DD) Source: Shutterstock Trading at close to 52-week highs, basic materials firm DuPont de Nemours may have huge returns ahead. Not only is DD stock a potential winning name for investors but so is the spinoff.	The 7 Safest Stocks to Start Off 2021 on the Right Foot Here are seven companies that investors should look at today: Thermo Fisher Scientific (NYSE:TMO) Intel (NASDAQ:INTC) Arrowhead Pharmaceuticals (NASDAQ:ARWR) Veeco Instruments (NASDAQ:VECO) Onto Innovation (NYSE:ONTO) International Business Machines (NYSE:IBM) DuPont de Nemours (NYSE:DD) Thermo Fisher Scientific (TMO) TMO) sign out front of an office in Silicon Valley, California." DuPont de Nemours (DD) Source: Shutterstock Trading at close to 52-week highs, basic materials firm DuPont de Nemours may have huge returns ahead. Not only is DD stock a potential winning name for investors but so is the spinoff.	The 7 Safest Stocks to Start Off 2021 on the Right Foot Here are seven companies that investors should look at today: Thermo Fisher Scientific (NYSE:TMO) Intel (NASDAQ:INTC) Arrowhead Pharmaceuticals (NASDAQ:ARWR) Veeco Instruments (NASDAQ:VECO) Onto Innovation (NYSE:ONTO) International Business Machines (NYSE:IBM) DuPont de Nemours (NYSE:DD) Thermo Fisher Scientific (TMO) TMO) sign out front of an office in Silicon Valley, California." Stock Industry S&P 500 Value Score 67 67 74 Price / Earnings – – 38.5 Price / Sales 2.6 1.5 2.7 Data from Stock Rover In the table above, the value score suggests that DD stock is trading above fair value. DuPont de Nemours (DD) Source: Shutterstock Trading at close to 52-week highs, basic materials firm DuPont de Nemours may have huge returns ahead.	The 7 Safest Stocks to Start Off 2021 on the Right Foot Here are seven companies that investors should look at today: Thermo Fisher Scientific (NYSE:TMO) Intel (NASDAQ:INTC) Arrowhead Pharmaceuticals (NASDAQ:ARWR) Veeco Instruments (NASDAQ:VECO) Onto Innovation (NYSE:ONTO) International Business Machines (NYSE:IBM) DuPont de Nemours (NYSE:DD) Thermo Fisher Scientific (TMO) TMO) sign out front of an office in Silicon Valley, California." DuPont de Nemours (DD) Source: Shutterstock Trading at close to 52-week highs, basic materials firm DuPont de Nemours may have huge returns ahead. Not only is DD stock a potential winning name for investors but so is the spinoff.	0b6d9c4b-b678-46f2-94b1-acb67f9bb1e9
716229.0	2020-12-22 00:00:00 UTC	Noteworthy Tuesday Option Activity: DD, GS, HUM	DD	https://www.nasdaq.com/articles/noteworthy-tuesday-option-activity%3A-dd-gs-hum-2020-12-22	nan	nan	Among the underlying components of the S&P 500 index, we saw noteworthy options trading volume today in DuPont (Symbol: DD), where a total of 56,280 contracts have traded so far, representing approximately 5.6 million underlying shares. That amounts to about 109.5% of DD's average daily trading volume over the past month of 5.1 million shares. Especially high volume was seen for the $100 strike call option expiring February 19, 2021, with 19,239 contracts trading so far today, representing approximately 1.9 million underlying shares of DD. Below is a chart showing DD's trailing twelve month trading history, with the $100 strike highlighted in orange: Goldman Sachs Group Inc (the (Symbol: GS) saw options trading volume of 29,271 contracts, representing approximately 2.9 million underlying shares or approximately 106.4% of GS's average daily trading volume over the past month, of 2.8 million shares. Particularly high volume was seen for the $260 strike call option expiring December 24, 2020, with 2,224 contracts trading so far today, representing approximately 222,400 underlying shares of GS. Below is a chart showing GS's trailing twelve month trading history, with the $260 strike highlighted in orange: And Humana Inc. (Symbol: HUM) saw options trading volume of 7,909 contracts, representing approximately 790,900 underlying shares or approximately 92.1% of HUM's average daily trading volume over the past month, of 858,520 shares. Especially high volume was seen for the $340 strike put option expiring January 15, 2021, with 5,206 contracts trading so far today, representing approximately 520,600 underlying shares of HUM. Below is a chart showing HUM's trailing twelve month trading history, with the $340 strike highlighted in orange: For the various different available expirations for DD options, GS options, or HUM options, visit StockOptionsChannel.com. Today's Most Active Call & Put Options of the S&P 500 » The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	Especially high volume was seen for the $100 strike call option expiring February 19, 2021, with 19,239 contracts trading so far today, representing approximately 1.9 million underlying shares of DD. Among the underlying components of the S&P 500 index, we saw noteworthy options trading volume today in DuPont (Symbol: DD), where a total of 56,280 contracts have traded so far, representing approximately 5.6 million underlying shares. That amounts to about 109.5% of DD's average daily trading volume over the past month of 5.1 million shares.	Especially high volume was seen for the $100 strike call option expiring February 19, 2021, with 19,239 contracts trading so far today, representing approximately 1.9 million underlying shares of DD. Below is a chart showing DD's trailing twelve month trading history, with the $100 strike highlighted in orange: Goldman Sachs Group Inc (the (Symbol: GS) saw options trading volume of 29,271 contracts, representing approximately 2.9 million underlying shares or approximately 106.4% of GS's average daily trading volume over the past month, of 2.8 million shares. Among the underlying components of the S&P 500 index, we saw noteworthy options trading volume today in DuPont (Symbol: DD), where a total of 56,280 contracts have traded so far, representing approximately 5.6 million underlying shares.	Among the underlying components of the S&P 500 index, we saw noteworthy options trading volume today in DuPont (Symbol: DD), where a total of 56,280 contracts have traded so far, representing approximately 5.6 million underlying shares. Below is a chart showing DD's trailing twelve month trading history, with the $100 strike highlighted in orange: Goldman Sachs Group Inc (the (Symbol: GS) saw options trading volume of 29,271 contracts, representing approximately 2.9 million underlying shares or approximately 106.4% of GS's average daily trading volume over the past month, of 2.8 million shares. That amounts to about 109.5% of DD's average daily trading volume over the past month of 5.1 million shares.	Especially high volume was seen for the $100 strike call option expiring February 19, 2021, with 19,239 contracts trading so far today, representing approximately 1.9 million underlying shares of DD. Below is a chart showing DD's trailing twelve month trading history, with the $100 strike highlighted in orange: Goldman Sachs Group Inc (the (Symbol: GS) saw options trading volume of 29,271 contracts, representing approximately 2.9 million underlying shares or approximately 106.4% of GS's average daily trading volume over the past month, of 2.8 million shares. Among the underlying components of the S&P 500 index, we saw noteworthy options trading volume today in DuPont (Symbol: DD), where a total of 56,280 contracts have traded so far, representing approximately 5.6 million underlying shares.	b2825330-5d26-47f7-9077-c863efff40a3
716230.0	2020-12-18 00:00:00 UTC	DuPont Board Approves Separation Of Nutrition & Biosciences Unit Through Split-off	DD	https://www.nasdaq.com/articles/dupont-board-approves-separation-of-nutrition-biosciences-unit-through-split-off-2020-12	nan	nan	(RTTNews) - DuPont (DD) announced that its Board of Directors has approved the separation of its Nutrition & Biosciences business through an exchange offer. In the split-off, DuPont stockholders can elect to tender shares of DuPont common stock in exchange for shares of Nutrition & Biosciences, Inc. or N&B common stock. The separation will be followed by the simultaneous combination of N&B with International Flavors & Fragrances or IFF in a Reverse Morris Trust transaction in which shares of N&B common stock will be converted into shares of IFF common stock. DuPont said it will announce the offer terms at launch of the exchange offer. If the split-off is not fully subscribed, the remaining shares of N&B common stock will be distributed through a pro rata spin-off to DuPont stockholders. DuPont plans a target closing, subject to customary closing conditions, of February 1, 2021 for the IFF and N&B combination. It was in December last year that IFF and DuPont agreed to merge IFF with N&B business in a Reverse Morris Trust transaction. The deal then valued the combined company at $45.4 billion on an enterprise value basis. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	(RTTNews) - DuPont (DD) announced that its Board of Directors has approved the separation of its Nutrition & Biosciences business through an exchange offer. The separation will be followed by the simultaneous combination of N&B with International Flavors & Fragrances or IFF in a Reverse Morris Trust transaction in which shares of N&B common stock will be converted into shares of IFF common stock. If the split-off is not fully subscribed, the remaining shares of N&B common stock will be distributed through a pro rata spin-off to DuPont stockholders.	(RTTNews) - DuPont (DD) announced that its Board of Directors has approved the separation of its Nutrition & Biosciences business through an exchange offer. In the split-off, DuPont stockholders can elect to tender shares of DuPont common stock in exchange for shares of Nutrition & Biosciences, Inc. or N&B common stock. The separation will be followed by the simultaneous combination of N&B with International Flavors & Fragrances or IFF in a Reverse Morris Trust transaction in which shares of N&B common stock will be converted into shares of IFF common stock.	(RTTNews) - DuPont (DD) announced that its Board of Directors has approved the separation of its Nutrition & Biosciences business through an exchange offer. In the split-off, DuPont stockholders can elect to tender shares of DuPont common stock in exchange for shares of Nutrition & Biosciences, Inc. or N&B common stock. The separation will be followed by the simultaneous combination of N&B with International Flavors & Fragrances or IFF in a Reverse Morris Trust transaction in which shares of N&B common stock will be converted into shares of IFF common stock.	(RTTNews) - DuPont (DD) announced that its Board of Directors has approved the separation of its Nutrition & Biosciences business through an exchange offer. In the split-off, DuPont stockholders can elect to tender shares of DuPont common stock in exchange for shares of Nutrition & Biosciences, Inc. or N&B common stock. The separation will be followed by the simultaneous combination of N&B with International Flavors & Fragrances or IFF in a Reverse Morris Trust transaction in which shares of N&B common stock will be converted into shares of IFF common stock.	edc8fa84-f5e4-4874-a85b-2b660bec5f6a
716231.0	2020-12-16 00:00:00 UTC	Should You Buy Corning Stock At $36?	DD	https://www.nasdaq.com/articles/should-you-buy-corning-stock-at-%2436-2020-12-16	nan	nan	After a solid 2x rise since the March 23 levels of this year, at the current price of around $36 per share we believe Corning stock (NYSE: GLW), has reached its near-term potential. GLW stock has rallied from $18 to $36 off the recent bottom, outperforming the S&P which moved 64% over the same period, with the resumption of economic activities as lockdowns are gradually lifted. This outperformance can be attributed to better than estimated quarterly results and increased demand for premium glass products, primarily related to IT products given the work from home trend, including Valor, which are medical glass vials that can be used for Covid-19 vaccines. GLW stock is also up 11% from levels of $32 seen in early 2018, two years ago. Some of the 11% rise of the last 2 years is justified by the 13.7% growth seen in Corning’s revenues from 2017 to 2019. The company saw a 14.9% growth in total shares outstanding due to share issuances, resulting in a -1% change in revenue per share (RPS) to $13.30 in 2019, compared to $13.43 in 2017. With a modest decline in RPS, the company’s P/S (price-to-sales) ratio also contracted. We believe the stock is likely to see downside after the recent uptick and the potential weakness from a recession-driven by the Covid outbreak. Our dashboard, ‘What Factors Drove 11% Change in Corning Stock between 2017 and now?, has the underlying numbers. Corning’s P/S multiple changed from 2.4x in 2017 to 2.2x in 2019. While the company’s P/S is 2.7x now, any significant growth is unlikely, when the current P/S is compared to levels seen in the past years, P/S of around 2.4x at the end of 2018 and 2.2x as recently as late 2019. So what’s the likely trigger for Corning? The global spread of Coronavirus has impacted the sales of Corning due to a decline in capital spending from some of its customers as well as pricing pressure for its display glass products. That said, the company is now seeing a rebound in demand, and it posted a 2% y-o-y sales growth in Q3. The company’s total revenue in the first three quarters of 2020 was down 8.4% y-o-y to $8.0 billion, while the adjusted earnings of $0.25 per share reflect a 77% decline over the $1.10 figure reported in the prior year period, primarily led by higher operating costs owing to the pandemic. Looking forward, with economies opening up gradually and availability of vaccines, the capital spending on 5G is expected to rise, boding well for Corning’s optical fiber business, while the company will also see higher sales of its glass vials that are being used for Covid-19 vaccines. Also, the new Apple iPhone 12 uses ceramic shield, manufactured by Corning, and iPhone 12 sales alone are touted to be in the range of 80 to 100 million units by October 2021, again boding well for Corning. That said, much of these factors appear to be priced in the current stock value of $36, despite the expected recovery in demand post Covid. In reality, 2020 full year revenues are estimated to see a decline of 3% to $11.3 billion, while earnings are expected to be down 22% to $1.37. Looking at the broader economy, the actual recovery and its timing hinge on the containment of the coronavirus spread. Our dashboard Trends In U.S. Covid-19 Cases provides an overview of how the pandemic has been spreading in the U.S. and contrasts with trends in Brazil and Russia. Following the Fed stimulus — which set a floor on fear — the market has been willing to “look through” the current weak period and take a longer-term view. With investors focusing their attention on 2021 results, the valuations become important in finding value. Though market sentiment can be fickle, and evidence of an uptick in new cases could spook investors once again. At levels of around $36, GLW stock is trading at 2.4x its 2020 expected RPS of $14.83. This compares with P/S of 2.4x seen in 2017 and 2018 and 2.2x seen in late 2019, making the stock seem fully priced. What if you’re looking for a more balanced portfolio instead? Here’s a high quality portfolio to beat the market, with over 100% return since 2016, versus 55% for the S&P 500. Comprised of companies with strong revenue growth, healthy profits, lots of cash, and low risk, it has outperformed the broader market year after year, consistently. See all Trefis Price Estimates and Download Trefis Data here What’s behind Trefis? See How It’s Powering New Collaboration and What-Ifs For CFOs and Finance Teams \| Product, R&D, and Marketing Teams The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	After a solid 2x rise since the March 23 levels of this year, at the current price of around $36 per share we believe Corning stock (NYSE: GLW), has reached its near-term potential. The global spread of Coronavirus has impacted the sales of Corning due to a decline in capital spending from some of its customers as well as pricing pressure for its display glass products. The company’s total revenue in the first three quarters of 2020 was down 8.4% y-o-y to $8.0 billion, while the adjusted earnings of $0.25 per share reflect a 77% decline over the $1.10 figure reported in the prior year period, primarily led by higher operating costs owing to the pandemic.	This outperformance can be attributed to better than estimated quarterly results and increased demand for premium glass products, primarily related to IT products given the work from home trend, including Valor, which are medical glass vials that can be used for Covid-19 vaccines. The company saw a 14.9% growth in total shares outstanding due to share issuances, resulting in a -1% change in revenue per share (RPS) to $13.30 in 2019, compared to $13.43 in 2017. That said, much of these factors appear to be priced in the current stock value of $36, despite the expected recovery in demand post Covid.	After a solid 2x rise since the March 23 levels of this year, at the current price of around $36 per share we believe Corning stock (NYSE: GLW), has reached its near-term potential. Looking forward, with economies opening up gradually and availability of vaccines, the capital spending on 5G is expected to rise, boding well for Corning’s optical fiber business, while the company will also see higher sales of its glass vials that are being used for Covid-19 vaccines. Comprised of companies with strong revenue growth, healthy profits, lots of cash, and low risk, it has outperformed the broader market year after year, consistently.	Some of the 11% rise of the last 2 years is justified by the 13.7% growth seen in Corning’s revenues from 2017 to 2019. While the company’s P/S is 2.7x now, any significant growth is unlikely, when the current P/S is compared to levels seen in the past years, P/S of around 2.4x at the end of 2018 and 2.2x as recently as late 2019. That said, much of these factors appear to be priced in the current stock value of $36, despite the expected recovery in demand post Covid.	43fd1979-ea91-4059-9639-2f67cb3df7f4
716232.0	2020-12-11 00:00:00 UTC	Notable Friday Option Activity: FEYE, FGEN, DD	DD	https://www.nasdaq.com/articles/notable-friday-option-activity%3A-feye-fgen-dd-2020-12-11	nan	nan	Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in FireEye Inc (Symbol: FEYE), where a total volume of 38,820 contracts has been traded thus far today, a contract volume which is representative of approximately 3.9 million underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 83.1% of FEYE's average daily trading volume over the past month, of 4.7 million shares. Especially high volume was seen for the $13 strike call option expiring January 15, 2021, with 5,164 contracts trading so far today, representing approximately 516,400 underlying shares of FEYE. Below is a chart showing FEYE's trailing twelve month trading history, with the $13 strike highlighted in orange: FibroGen Inc (Symbol: FGEN) saw options trading volume of 4,194 contracts, representing approximately 419,400 underlying shares or approximately 75.1% of FGEN's average daily trading volume over the past month, of 558,455 shares. Particularly high volume was seen for the $60 strike call option expiring January 15, 2021, with 1,594 contracts trading so far today, representing approximately 159,400 underlying shares of FGEN. Below is a chart showing FGEN's trailing twelve month trading history, with the $60 strike highlighted in orange: And DuPont (Symbol: DD) options are showing a volume of 27,884 contracts thus far today. That number of contracts represents approximately 2.8 million underlying shares, working out to a sizeable 71.9% of DD's average daily trading volume over the past month, of 3.9 million shares. Particularly high volume was seen for the $63 strike put option expiring December 18, 2020, with 10,908 contracts trading so far today, representing approximately 1.1 million underlying shares of DD. Below is a chart showing DD's trailing twelve month trading history, with the $63 strike highlighted in orange: For the various different available expirations for FEYE options, FGEN options, or DD options, visit StockOptionsChannel.com. Today's Most Active Call & Put Options of the S&P 500 » The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	Particularly high volume was seen for the $63 strike put option expiring December 18, 2020, with 10,908 contracts trading so far today, representing approximately 1.1 million underlying shares of DD. Below is a chart showing FGEN's trailing twelve month trading history, with the $60 strike highlighted in orange: And DuPont (Symbol: DD) options are showing a volume of 27,884 contracts thus far today. That number of contracts represents approximately 2.8 million underlying shares, working out to a sizeable 71.9% of DD's average daily trading volume over the past month, of 3.9 million shares.	Below is a chart showing FGEN's trailing twelve month trading history, with the $60 strike highlighted in orange: And DuPont (Symbol: DD) options are showing a volume of 27,884 contracts thus far today. That number of contracts represents approximately 2.8 million underlying shares, working out to a sizeable 71.9% of DD's average daily trading volume over the past month, of 3.9 million shares. Particularly high volume was seen for the $63 strike put option expiring December 18, 2020, with 10,908 contracts trading so far today, representing approximately 1.1 million underlying shares of DD.	Particularly high volume was seen for the $63 strike put option expiring December 18, 2020, with 10,908 contracts trading so far today, representing approximately 1.1 million underlying shares of DD. Below is a chart showing FGEN's trailing twelve month trading history, with the $60 strike highlighted in orange: And DuPont (Symbol: DD) options are showing a volume of 27,884 contracts thus far today. That number of contracts represents approximately 2.8 million underlying shares, working out to a sizeable 71.9% of DD's average daily trading volume over the past month, of 3.9 million shares.	Below is a chart showing DD's trailing twelve month trading history, with the $63 strike highlighted in orange: For the various different available expirations for FEYE options, FGEN options, or DD options, visit StockOptionsChannel.com. Below is a chart showing FGEN's trailing twelve month trading history, with the $60 strike highlighted in orange: And DuPont (Symbol: DD) options are showing a volume of 27,884 contracts thus far today. That number of contracts represents approximately 2.8 million underlying shares, working out to a sizeable 71.9% of DD's average daily trading volume over the past month, of 3.9 million shares.	ddadf0cc-65ba-4c7f-9255-499ea5cf2973
716233.0	2020-12-02 00:00:00 UTC	After Hours Most Active for Dec 2, 2020 : AAPL, NIO, BSX, EVK, BAC, INTC, FOXA, TSLA, PFE, DD, MSFT, F	DD	https://www.nasdaq.com/articles/after-hours-most-active-for-dec-2-2020-%3A-aapl-nio-bsx-evk-bac-intc-foxa-tsla-pfe-dd-msft-f	nan	nan	The NASDAQ 100 After Hours Indicator is up 7.88 to 12,475.01. The total After hours volume is currently 177,273,650 shares traded. The following are the most active stocks for the after hours session: Apple Inc. (AAPL) is +0.15 at $123.23, with 7,604,631 shares traded. As reported by Zacks, the current mean recommendation for AAPL is in the "buy range". NIO Inc. (NIO) is -1.73 at $46.25, with 5,742,478 shares traded. NIO's current last sale is 140.15% of the target price of $33. Boston Scientific Corporation (BSX) is +0.17 at $34.32, with 5,741,147 shares traded. As reported by Zacks, the current mean recommendation for BSX is in the "buy range". Ever-Glory International Group, Inc. (EVK) is +1.65 at $3.75, with 4,784,019 shares traded. Bank of America Corporation (BAC) is -0.02 at $29.04, with 4,138,683 shares traded. As reported by Zacks, the current mean recommendation for BAC is in the "buy range". Intel Corporation (INTC) is +0.03 at $49.93, with 4,081,072 shares traded. INTC's current last sale is 89.16% of the target price of $56. Fox Corporation (FOXA) is unchanged at $30.60, with 3,052,991 shares traded. FOXA's current last sale is 103.73% of the target price of $29.5. Tesla, Inc. (TSLA) is +14.11 at $582.93, with 2,663,094 shares traded. TSLA's current last sale is 128.82% of the target price of $452.5. Pfizer, Inc. (PFE) is +0.7 at $41.50, with 2,605,017 shares traded. PFE's current last sale is 98.81% of the target price of $42. DuPont de Nemours, Inc. (DD) is unchanged at $63.96, with 2,222,311 shares traded. As reported by Zacks, the current mean recommendation for DD is in the "buy range". Microsoft Corporation (MSFT) is +0.01 at $215.38, with 2,210,593 shares traded. As reported by Zacks, the current mean recommendation for MSFT is in the "buy range". Ford Motor Company (F) is +0.01 at $9.21, with 2,157,755 shares traded. F's current last sale is 102.33% of the target price of $9. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	DuPont de Nemours, Inc. (DD) is unchanged at $63.96, with 2,222,311 shares traded. As reported by Zacks, the current mean recommendation for DD is in the "buy range". As reported by Zacks, the current mean recommendation for AAPL is in the "buy range".	DuPont de Nemours, Inc. (DD) is unchanged at $63.96, with 2,222,311 shares traded. As reported by Zacks, the current mean recommendation for DD is in the "buy range". As reported by Zacks, the current mean recommendation for AAPL is in the "buy range".	DuPont de Nemours, Inc. (DD) is unchanged at $63.96, with 2,222,311 shares traded. As reported by Zacks, the current mean recommendation for DD is in the "buy range". The total After hours volume is currently 177,273,650 shares traded.	DuPont de Nemours, Inc. (DD) is unchanged at $63.96, with 2,222,311 shares traded. As reported by Zacks, the current mean recommendation for DD is in the "buy range". The NASDAQ 100 After Hours Indicator is up 7.88 to 12,475.01.	6957868f-6d7a-4402-9706-12afd3062b45
716234.0	2020-12-02 00:00:00 UTC	After Hours Most Active for Dec 2, 2020 : AAPL, BSX, INTC, BAC, F, MSFT, EBAY, SABR, VIAC, DD, ALLY, UBER	DD	https://www.nasdaq.com/articles/after-hours-most-active-for-dec-2-2020-%3A-aapl-bsx-intc-bac-f-msft-ebay-sabr-viac-dd-ally	nan	nan	The NASDAQ 100 After Hours Indicator is down -1.28 to 12,455.13. The total After hours volume is currently 101,650,601 shares traded. The following are the most active stocks for the after hours session: Apple Inc. (AAPL) is +0.1 at $123.18, with 6,090,209 shares traded. As reported by Zacks, the current mean recommendation for AAPL is in the "buy range". Boston Scientific Corporation (BSX) is -0.0301 at $34.12, with 5,641,371 shares traded. As reported by Zacks, the current mean recommendation for BSX is in the "buy range". Intel Corporation (INTC) is +0.03 at $49.93, with 4,017,256 shares traded. INTC's current last sale is 89.16% of the target price of $56. Bank of America Corporation (BAC) is -0.1 at $28.96, with 2,718,021 shares traded. As reported by Zacks, the current mean recommendation for BAC is in the "buy range". Ford Motor Company (F) is -0.0098 at $9.19, with 1,897,419 shares traded. F's current last sale is 102.11% of the target price of $9. Microsoft Corporation (MSFT) is unchanged at $215.37, with 1,894,959 shares traded. As reported by Zacks, the current mean recommendation for MSFT is in the "buy range". eBay Inc. (EBAY) is +0.15 at $51.50, with 1,821,045 shares traded. EBAY's current last sale is 86.55% of the target price of $59.5. Sabre Corporation (SABR) is unchanged at $11.57, with 1,717,649 shares traded. SABR's current last sale is 115.65% of the target price of $10. ViacomCBS Inc. (VIAC) is unchanged at $36.37, with 1,715,036 shares traded. As reported in the last short interest update the days to cover for VIAC is 10.028195; this calculation is based on the average trading volume of the stock. DuPont de Nemours, Inc. (DD) is unchanged at $63.96, with 1,713,847 shares traded. As reported by Zacks, the current mean recommendation for DD is in the "buy range". Ally Financial Inc. (ALLY) is unchanged at $31.05, with 1,628,785 shares traded. As reported by Zacks, the current mean recommendation for ALLY is in the "buy range". Uber Technologies, Inc. (UBER) is +0.21 at $53.30, with 1,434,649 shares traded. Over the last four weeks they have had 3 up revisions for the earnings forecast, for the fiscal quarter ending Dec 2020. The consensus EPS forecast is $-0.54. , following a 52-week high recorded in today's regular session. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	DuPont de Nemours, Inc. (DD) is unchanged at $63.96, with 1,713,847 shares traded. As reported by Zacks, the current mean recommendation for DD is in the "buy range". As reported in the last short interest update the days to cover for VIAC is 10.028195; this calculation is based on the average trading volume of the stock.	DuPont de Nemours, Inc. (DD) is unchanged at $63.96, with 1,713,847 shares traded. As reported by Zacks, the current mean recommendation for DD is in the "buy range". The total After hours volume is currently 101,650,601 shares traded.	DuPont de Nemours, Inc. (DD) is unchanged at $63.96, with 1,713,847 shares traded. As reported by Zacks, the current mean recommendation for DD is in the "buy range". The total After hours volume is currently 101,650,601 shares traded.	DuPont de Nemours, Inc. (DD) is unchanged at $63.96, with 1,713,847 shares traded. As reported by Zacks, the current mean recommendation for DD is in the "buy range". The following are the most active stocks for the after hours session:	f860e872-dfc6-453e-86e1-acc861eb5b77
716235.0	2020-11-30 00:00:00 UTC	Notable Monday Option Activity: GM, DD, IBM	DD	https://www.nasdaq.com/articles/notable-monday-option-activity%3A-gm-dd-ibm-2020-11-30	nan	nan	Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in General Motors Co (Symbol: GM), where a total volume of 91,658 contracts has been traded thus far today, a contract volume which is representative of approximately 9.2 million underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 49.3% of GM's average daily trading volume over the past month, of 18.6 million shares. Especially high volume was seen for the $55 strike call option expiring June 18, 2021, with 12,053 contracts trading so far today, representing approximately 1.2 million underlying shares of GM. Below is a chart showing GM's trailing twelve month trading history, with the $55 strike highlighted in orange: DuPont (Symbol: DD) options are showing a volume of 19,165 contracts thus far today. That number of contracts represents approximately 1.9 million underlying shares, working out to a sizeable 48.7% of DD's average daily trading volume over the past month, of 3.9 million shares. Especially high volume was seen for the $67 strike call option expiring December 18, 2020, with 9,446 contracts trading so far today, representing approximately 944,600 underlying shares of DD. Below is a chart showing DD's trailing twelve month trading history, with the $67 strike highlighted in orange: And International Business Machines Corp (Symbol: IBM) options are showing a volume of 25,167 contracts thus far today. That number of contracts represents approximately 2.5 million underlying shares, working out to a sizeable 47.7% of IBM's average daily trading volume over the past month, of 5.3 million shares. Particularly high volume was seen for the $125 strike call option expiring April 16, 2021, with 1,729 contracts trading so far today, representing approximately 172,900 underlying shares of IBM. Below is a chart showing IBM's trailing twelve month trading history, with the $125 strike highlighted in orange: For the various different available expirations for GM options, DD options, or IBM options, visit StockOptionsChannel.com. Today's Most Active Call & Put Options of the S&P 500 » The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	Especially high volume was seen for the $67 strike call option expiring December 18, 2020, with 9,446 contracts trading so far today, representing approximately 944,600 underlying shares of DD. Below is a chart showing GM's trailing twelve month trading history, with the $55 strike highlighted in orange: DuPont (Symbol: DD) options are showing a volume of 19,165 contracts thus far today. That number of contracts represents approximately 1.9 million underlying shares, working out to a sizeable 48.7% of DD's average daily trading volume over the past month, of 3.9 million shares.	Below is a chart showing GM's trailing twelve month trading history, with the $55 strike highlighted in orange: DuPont (Symbol: DD) options are showing a volume of 19,165 contracts thus far today. That number of contracts represents approximately 1.9 million underlying shares, working out to a sizeable 48.7% of DD's average daily trading volume over the past month, of 3.9 million shares. Especially high volume was seen for the $67 strike call option expiring December 18, 2020, with 9,446 contracts trading so far today, representing approximately 944,600 underlying shares of DD.	That number of contracts represents approximately 1.9 million underlying shares, working out to a sizeable 48.7% of DD's average daily trading volume over the past month, of 3.9 million shares. Below is a chart showing GM's trailing twelve month trading history, with the $55 strike highlighted in orange: DuPont (Symbol: DD) options are showing a volume of 19,165 contracts thus far today. Especially high volume was seen for the $67 strike call option expiring December 18, 2020, with 9,446 contracts trading so far today, representing approximately 944,600 underlying shares of DD.	Below is a chart showing IBM's trailing twelve month trading history, with the $125 strike highlighted in orange: For the various different available expirations for GM options, DD options, or IBM options, visit StockOptionsChannel.com. Below is a chart showing GM's trailing twelve month trading history, with the $55 strike highlighted in orange: DuPont (Symbol: DD) options are showing a volume of 19,165 contracts thus far today. That number of contracts represents approximately 1.9 million underlying shares, working out to a sizeable 48.7% of DD's average daily trading volume over the past month, of 3.9 million shares.	280296cd-aa56-4e37-b342-70c506e9f5c1
716236.0	2020-11-25 00:00:00 UTC	Interesting DD Put And Call Options For January 2021	DD	https://www.nasdaq.com/articles/interesting-dd-put-and-call-options-for-january-2021-2020-11-25	nan	nan	Investors in DuPont (Symbol: DD) saw new options become available today, for the January 2021 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the DD options chain for the new January 2021 contracts and identified one put and one call contract of particular interest. The put contract at the $62.00 strike price has a current bid of 53 cents. If an investor was to sell-to-open that put contract, they are committing to purchase the stock at $62.00, but will also collect the premium, putting the cost basis of the shares at $61.47 (before broker commissions). To an investor already interested in purchasing shares of DD, that could represent an attractive alternative to paying $64.85/share today. Because the $62.00 strike represents an approximate 4% discount to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the put contract would expire worthless. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 62%. Stock Options Channel will track those odds over time to see how they change, publishing a chart of those numbers on our website under the contract detail page for this contract. Should the contract expire worthless, the premium would represent a 0.85% return on the cash commitment, or 7.09% annualized — at Stock Options Channel we call this the YieldBoost. Below is a chart showing the trailing twelve month trading history for DuPont, and highlighting in green where the $62.00 strike is located relative to that history: Turning to the calls side of the option chain, the call contract at the $66.50 strike price has a current bid of 50 cents. If an investor was to purchase shares of DD stock at the current price level of $64.85/share, and then sell-to-open that call contract as a "covered call," they are committing to sell the stock at $66.50. Considering the call seller will also collect the premium, that would drive a total return (excluding dividends, if any) of 3.32% if the stock gets called away at the January 2021 expiration (before broker commissions). Of course, a lot of upside could potentially be left on the table if DD shares really soar, which is why looking at the trailing twelve month trading history for DuPont, as well as studying the business fundamentals becomes important. Below is a chart showing DD's trailing twelve month trading history, with the $66.50 strike highlighted in red: Considering the fact that the $66.50 strike represents an approximate 3% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 54%. On our website under the contract detail page for this contract, Stock Options Channel will track those odds over time to see how they change and publish a chart of those numbers (the trading history of the option contract will also be charted). Should the covered call contract expire worthless, the premium would represent a 0.77% boost of extra return to the investor, or 6.40% annualized, which we refer to as the YieldBoost. The implied volatility in the put contract example is 56%, while the implied volatility in the call contract example is 52%. Meanwhile, we calculate the actual trailing twelve month volatility (considering the last 252 trading day closing values as well as today's price of $64.85) to be 51%. For more put and call options contract ideas worth looking at, visit StockOptionsChannel.com. Top YieldBoost Calls of the S&P 500 » The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	Of course, a lot of upside could potentially be left on the table if DD shares really soar, which is why looking at the trailing twelve month trading history for DuPont, as well as studying the business fundamentals becomes important. Below is a chart showing DD's trailing twelve month trading history, with the $66.50 strike highlighted in red: Considering the fact that the $66.50 strike represents an approximate 3% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected. Investors in DuPont (Symbol: DD) saw new options become available today, for the January 2021 expiration.	The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 62%. Below is a chart showing DD's trailing twelve month trading history, with the $66.50 strike highlighted in red: Considering the fact that the $66.50 strike represents an approximate 3% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 54%.	Below is a chart showing DD's trailing twelve month trading history, with the $66.50 strike highlighted in red: Considering the fact that the $66.50 strike represents an approximate 3% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected. On our website under the contract detail page for this contract, Stock Options Channel will track those odds over time to see how they change and publish a chart of those numbers (the trading history of the option contract will also be charted). Investors in DuPont (Symbol: DD) saw new options become available today, for the January 2021 expiration.	At Stock Options Channel, our YieldBoost formula has looked up and down the DD options chain for the new January 2021 contracts and identified one put and one call contract of particular interest. Below is a chart showing DD's trailing twelve month trading history, with the $66.50 strike highlighted in red: Considering the fact that the $66.50 strike represents an approximate 3% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected. Investors in DuPont (Symbol: DD) saw new options become available today, for the January 2021 expiration.	c0bf85be-dcb9-406c-9ae4-fca8e6c1aef6
716237.0	2020-11-24 00:00:00 UTC	Ciena Stock Looks Attractive Compared To Corning	DD	https://www.nasdaq.com/articles/ciena-stock-looks-attractive-compared-to-corning-2020-11-24	nan	nan	Ciena Corporation (NYSE: CIEN), best known for its network hardware, software, and services, trades at about 1.8x trailing Revenues, compared to 2.4x for Corning (NYSE: GLW), which manufactures glass products and optical fiber, among other products. Does this difference in valuation make sense? While both the companies have benefited from 5G expansion over the recent past, Ciena is being weighed down by cautious guidance due to continued pressure in the pandemic. However, there is more to the comparison. Let’s step back to look at the fuller picture of the relative valuation of the two companies by looking at historical Revenue Growth, Returns (ability to generate profits from growth), and Risk (sustainability of profits). Our dashboard Corning vs. Ciena: Is GLW Stock Appropriately Valued Given Its significantly higher P/S Multiple Compared to CIEN? has more details on this. Parts of the analysis are summarized below. 1. Revenue Growth Between 2016 and 2019, Corning’s Revenues grew by about 22%, rising from around $9.4 billion to $11.5 billion, partly driven by the acquisition of 3M’s communications business, and strong growth at the company’s Environmental Technologies, which includes ceramic substrate and filter products for gasoline and diesel applications in the automotive industry, and Life Sciences, which includes consumables, such as plastic vessels, specialty surfaces, and general labware and equipment for pharmaceutical companies. On the other hand, Ciena’s Revenues grew by about 38% between 2016 to 2019, rising from around $2.6 billion to $3.6 billion, driven by relatively steady growth at networking platforms and associated services. 2. Returns (Profits) While Corning’s Free cash flows as a % of Revenues stood at about 18% in 2019, dropping from around 27% in 2016, Ciena’s Free cash flows as a % of Revenues stood at about 12%, up from around 8% in 2016. While the Return on Invested Capital metric for both companies has been volatile, Corning’s ROIC was slightly higher compared to Ciena’s in 2019, standing at about 6.5% versus about 5.1%. Ciena’s Total Shareholder Returns (TSR) have been much higher, driven by a surging stock price though the company has never paid dividends. Corning raised its dividend per share by 48% between 2016 and 2019, but its stock has underperformed. 3. Risk Corning’s Debt load is higher with its Debt to Equity ratio standing at about 31% as of 2019, rising from 15% in 2016, as its total debt increased from $3.9 billion to $7.7 billion. Ciena’s Debt to Equity ratio has declined from 52% to about 10% over the same period, as it reduced its debt from $1.3 billion to $0.7 billion. Overall, neither company appears to have very meaningful financial risk. The Net Of It All Ciena’s Revenue Growth, Returns, and Risk metrics compare quite favorably with Corning, and we don’t think this really justifies the difference in the Ciena’s P/S multiple of 1.8x versus 2.4x for Corning. The valuation for Corning is being driven by investor interest in its gorilla glass and expansion of 5G. The increased penetration of smartphones globally along with the recent 5G rollouts has meant an increase in demand for Corning products. On the other hand, Ciena’s valuation is likely weighed down by the downbeat guidance in the wake of the current pandemic. However, the impact on Ciena’s sales was minimal given the challenging environment. The company reported sales growth of 1.6% in Q3 while its bottom line surged 64% to $0.92 on a per share basis. This compares with 2.2% sales growth for Corning and a 32% growth in earnings to $0.53 on a per share basis. Ciena provides networking equipment and services to telecom operators for deployment of 5G networks, and this will likely bode well for the stock in the near term. Overall, Ciena appears to be a more attractive bet compared to Corning based on historical performance as well as the current valuation. What if you’re looking for a more balanced portfolio instead? Here’s a high-quality portfolio to beat the market, with over 100% return since 2016, versus about 55% for the S&P 500. Comprised of companies with strong revenue growth, healthy profits, lots of cash, and low risk, it has outperformed the broader market year after year, consistently. See all Trefis Price Estimates and Download Trefis Data here What’s behind Trefis? See How It’s Powering New Collaboration and What-Ifs For CFOs and Finance Teams \| Product, R&D, and Marketing Teams The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	Revenue Growth Between 2016 and 2019, Corning’s Revenues grew by about 22%, rising from around $9.4 billion to $11.5 billion, partly driven by the acquisition of 3M’s communications business, and strong growth at the company’s Environmental Technologies, which includes ceramic substrate and filter products for gasoline and diesel applications in the automotive industry, and Life Sciences, which includes consumables, such as plastic vessels, specialty surfaces, and general labware and equipment for pharmaceutical companies. While the Return on Invested Capital metric for both companies has been volatile, Corning’s ROIC was slightly higher compared to Ciena’s in 2019, standing at about 6.5% versus about 5.1%. Ciena’s Total Shareholder Returns (TSR) have been much higher, driven by a surging stock price though the company has never paid dividends.	Revenue Growth Between 2016 and 2019, Corning’s Revenues grew by about 22%, rising from around $9.4 billion to $11.5 billion, partly driven by the acquisition of 3M’s communications business, and strong growth at the company’s Environmental Technologies, which includes ceramic substrate and filter products for gasoline and diesel applications in the automotive industry, and Life Sciences, which includes consumables, such as plastic vessels, specialty surfaces, and general labware and equipment for pharmaceutical companies. Returns (Profits) While Corning’s Free cash flows as a % of Revenues stood at about 18% in 2019, dropping from around 27% in 2016, Ciena’s Free cash flows as a % of Revenues stood at about 12%, up from around 8% in 2016. The Net Of It All Ciena’s Revenue Growth, Returns, and Risk metrics compare quite favorably with Corning, and we don’t think this really justifies the difference in the Ciena’s P/S multiple of 1.8x versus 2.4x for Corning.	Revenue Growth Between 2016 and 2019, Corning’s Revenues grew by about 22%, rising from around $9.4 billion to $11.5 billion, partly driven by the acquisition of 3M’s communications business, and strong growth at the company’s Environmental Technologies, which includes ceramic substrate and filter products for gasoline and diesel applications in the automotive industry, and Life Sciences, which includes consumables, such as plastic vessels, specialty surfaces, and general labware and equipment for pharmaceutical companies. Returns (Profits) While Corning’s Free cash flows as a % of Revenues stood at about 18% in 2019, dropping from around 27% in 2016, Ciena’s Free cash flows as a % of Revenues stood at about 12%, up from around 8% in 2016. The Net Of It All Ciena’s Revenue Growth, Returns, and Risk metrics compare quite favorably with Corning, and we don’t think this really justifies the difference in the Ciena’s P/S multiple of 1.8x versus 2.4x for Corning.	On the other hand, Ciena’s Revenues grew by about 38% between 2016 to 2019, rising from around $2.6 billion to $3.6 billion, driven by relatively steady growth at networking platforms and associated services. Risk Corning’s Debt load is higher with its Debt to Equity ratio standing at about 31% as of 2019, rising from 15% in 2016, as its total debt increased from $3.9 billion to $7.7 billion. The Net Of It All Ciena’s Revenue Growth, Returns, and Risk metrics compare quite favorably with Corning, and we don’t think this really justifies the difference in the Ciena’s P/S multiple of 1.8x versus 2.4x for Corning.	e0330fc4-256f-449c-8c1d-2e8d80a943bc
716238.0	2020-11-22 00:00:00 UTC	Here's Why We're Wary Of Buying DuPont de Nemours' (NYSE:DD) For Its Upcoming Dividend	DD	https://www.nasdaq.com/articles/heres-why-were-wary-of-buying-dupont-de-nemours-nyse%3Add-for-its-upcoming-dividend-2020-11	nan	nan	Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see DuPont de Nemours, Inc. (NYSE:DD) is about to trade ex-dividend in the next four days. You will need to purchase shares before the 27th of November to receive the dividend, which will be paid on the 15th of December. DuPont de Nemours's next dividend payment will be US$0.30 per share, and in the last 12 months, the company paid a total of US$1.20 per share. Looking at the last 12 months of distributions, DuPont de Nemours has a trailing yield of approximately 1.9% on its current stock price of $62.55. Dividends are an important source of income to many shareholders, but the health of the business is crucial to maintaining those dividends. So we need to investigate whether DuPont de Nemours can afford its dividend, and if the dividend could grow. Dividends are typically paid out of company income, so if a company pays out more than it earned, its dividend is usually at a higher risk of being cut. DuPont de Nemours's dividend is not well covered by earnings, as the company lost money last year. This is not a sustainable state of affairs, so it would be worth investigating if earnings are expected to recover. Given that the company reported a loss last year, we now need to see if it generated enough free cash flow to fund the dividend. If DuPont de Nemours didn't generate enough cash to pay the dividend, then it must have either paid from cash in the bank or by borrowing money, neither of which is sustainable in the long term. Thankfully its dividend payments took up just 48% of the free cash flow it generated, which is a comfortable payout ratio. Click here to see the company's payout ratio, plus analyst estimates of its future dividends. NYSE:DD Historic Dividend November 22nd 2020 Have Earnings And Dividends Been Growing? Businesses with shrinking earnings are tricky from a dividend perspective. If business enters a downturn and the dividend is cut, the company could see its value fall precipitously. DuPont de Nemours reported a loss last year, and the general trend suggests its earnings have also been declining in recent years, making us wonder if the dividend is at risk. Another key way to measure a company's dividend prospects is by measuring its historical rate of dividend growth. DuPont de Nemours's dividend payments per share have declined at 4.0% per year on average over the past 10 years, which is uninspiring. It's never nice to see earnings and dividends falling, but at least management has cut the dividend rather than potentially risk the company's health in an attempt to maintain it. The Bottom Line From a dividend perspective, should investors buy or avoid DuPont de Nemours? We're a bit uncomfortable with it paying a dividend while being loss-making. However, we note that the dividend was covered by cash flow. With the way things are shaping up from a dividend perspective, we'd be inclined to steer clear of DuPont de Nemours. Having said that, if you're looking at this stock without much concern for the dividend, you should still be familiar of the risks involved with DuPont de Nemours. We've identified 3 warning signs with DuPont de Nemours (at least 1 which doesn't sit too well with us), and understanding them should be part of your investment process. We wouldn't recommend just buying the first dividend stock you see, though. Here's a list of interesting dividend stocks with a greater than 2% yield and an upcoming dividend. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see DuPont de Nemours, Inc. (NYSE:DD) is about to trade ex-dividend in the next four days. NYSE:DD Historic Dividend November 22nd 2020 Have Earnings And Dividends Been Growing? Looking at the last 12 months of distributions, DuPont de Nemours has a trailing yield of approximately 1.9% on its current stock price of $62.55.	NYSE:DD Historic Dividend November 22nd 2020 Have Earnings And Dividends Been Growing? Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see DuPont de Nemours, Inc. (NYSE:DD) is about to trade ex-dividend in the next four days. If DuPont de Nemours didn't generate enough cash to pay the dividend, then it must have either paid from cash in the bank or by borrowing money, neither of which is sustainable in the long term.	Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see DuPont de Nemours, Inc. (NYSE:DD) is about to trade ex-dividend in the next four days. NYSE:DD Historic Dividend November 22nd 2020 Have Earnings And Dividends Been Growing? So we need to investigate whether DuPont de Nemours can afford its dividend, and if the dividend could grow.	Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see DuPont de Nemours, Inc. (NYSE:DD) is about to trade ex-dividend in the next four days. NYSE:DD Historic Dividend November 22nd 2020 Have Earnings And Dividends Been Growing? Dividends are typically paid out of company income, so if a company pays out more than it earned, its dividend is usually at a higher risk of being cut.	6e9b0e2b-61cb-4c93-b83d-ffd913769287
716239.0	2020-11-19 00:00:00 UTC	Corteva sticks with CEO amid Starboard pressure -sources	DD	https://www.nasdaq.com/articles/corteva-sticks-with-ceo-amid-starboard-pressure-sources-2020-11-19	nan	nan	By Svea Herbst-Bayliss BOSTON, Nov 19 (Reuters) - Corteva Inc's CTVA.N board of directors decided to back chief executive officer James Collins after activist investor Starboard Value LP took issue with the performance of the agricultural products company's management, people familiar with the matter said on Thursday. Corteva, valued at $27 billion, became a publicly traded company last year after it was spun out of chemical giant DowDuPont DD.N. Starboard, which owns 11.7 million shares or 1.6% of Corteva, has said that the company has not lived up to its potential and is lagging behind its peers. Corteva's board discussed Collins' future at a recent meeting and is fully supportive of him and management, the sources said, requesting anonymity because the matter is confidential. A representative for Corteva declined to comment and Starboard did not return a call seeking comment. Starboard CEO Jeffrey Smith has criticized Corteva's financial performance, noting that its cash flow margin of 14.4% lags behind peers, and that its share price, now at $36.96, could be closer to $55. The company's shares have climbed 44% in the last 52 weeks compared with a 14.35% in the S&P 500 Index. Collins, who had previously been chief operating officer for the Agriculture Division of DowDuPont, was asked about performance on a quarterlyearnings callearlier this month. "We agree there is tremendous (cash flow) margin potential in this business. I don't have to go out and invent that future. It's sitting here right now. What we have to do is execute it," Collins said. Investors will soon have a chance to nominate directors at Corteva. Starboard is known for its operational know-how and often proposes to add new directors to a company's board. It won 17 board seats at four companies in the first half of 2020. (Reporting by Svea Herbst-Bayliss in Boston; Editing by Stephen Coates) ((svea.herbst@thomsonreuters.com; +617 856 4331; Reuters Messaging: svea.herbst.thomsonreuters.com@reuters.net)) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	Corteva, valued at $27 billion, became a publicly traded company last year after it was spun out of chemical giant DowDuPont DD.N. Starboard is known for its operational know-how and often proposes to add new directors to a company's board. By Svea Herbst-Bayliss BOSTON, Nov 19 (Reuters) - Corteva Inc's CTVA.N board of directors decided to back chief executive officer James Collins after activist investor Starboard Value LP took issue with the performance of the agricultural products company's management, people familiar with the matter said on Thursday.	Corteva, valued at $27 billion, became a publicly traded company last year after it was spun out of chemical giant DowDuPont DD.N. Starboard is known for its operational know-how and often proposes to add new directors to a company's board. By Svea Herbst-Bayliss BOSTON, Nov 19 (Reuters) - Corteva Inc's CTVA.N board of directors decided to back chief executive officer James Collins after activist investor Starboard Value LP took issue with the performance of the agricultural products company's management, people familiar with the matter said on Thursday.	Corteva, valued at $27 billion, became a publicly traded company last year after it was spun out of chemical giant DowDuPont DD.N. Starboard is known for its operational know-how and often proposes to add new directors to a company's board. By Svea Herbst-Bayliss BOSTON, Nov 19 (Reuters) - Corteva Inc's CTVA.N board of directors decided to back chief executive officer James Collins after activist investor Starboard Value LP took issue with the performance of the agricultural products company's management, people familiar with the matter said on Thursday.	Starboard is known for its operational know-how and often proposes to add new directors to a company's board. Corteva, valued at $27 billion, became a publicly traded company last year after it was spun out of chemical giant DowDuPont DD.N. By Svea Herbst-Bayliss BOSTON, Nov 19 (Reuters) - Corteva Inc's CTVA.N board of directors decided to back chief executive officer James Collins after activist investor Starboard Value LP took issue with the performance of the agricultural products company's management, people familiar with the matter said on Thursday.	a78a8c2a-5b81-422f-99c2-cefcfdd924d6
716240.0	2020-11-16 00:00:00 UTC	The Renewable Energy Push Makes NextEra Energy Stock a Must Own	DD	https://www.nasdaq.com/articles/the-renewable-energy-push-makes-nextera-energy-stock-a-must-own-2020-11-16	nan	nan	InvestorPlace - Stock Market News, Stock Advice & Trading Tips It’s hard to believe, but way back in January 2017, I suggested that NextEra Energy (NYSE:NEE) should replace DuPont de Nemours (NYSE:DD) in the Dow Jones Industrial Average. I thought NextEra Energy stock was a buy. NEE) website on a mobile phone screen" width="300" height="169"> Source: madamF / Shutterstock.com And I still do. Here’s why. Renewable Energy Is Not Going Away Before I get into the gist of my argument, I want to pat myself on the back. Since my January 2017 article, DD has lost 27% of its value — it’s likely a closer race if you add in the Dow (NYSE:DOW) and Corteeva (NYSE:CTVA) stock received in its complicated three-way split in 2019 — while NEE is up 157% in the nearly four years since. 7 Value Stocks That Could Make You the Next Warren Buffett NextEra really could have helped the Dow’s performance. It still could, but that’s a subject for another day. What gets me revved up about the Florida utility is the commitment it has to renewable energy. It reported excellent third-quarter results on Oct. 21 with adjusted earnings of $2.66 per share, 11.3% higher than a year earlier. “NextEra Energy delivered strong third-quarter results and remains well-positioned to meet our 2020 and longer-term growth prospects,” said Jim Robo, its chief executive officer. “We grew adjusted earnings per share by more than 11% year-over-year, reflecting strong execution across all of our businesses.” Breaking out the various business units: Florida Power & Light (FPL) generated $1.54 per share or 54% of its overall profits, Gulf Power contributed 18 cents (7%), and NextEra Energy Resources generated $1.12 (39%). Referred to as NEER, this is the company’s clean and renewable energy business. The $1.12 per share was 23% higher than a year ago. “NextEra Energy Resources had another excellent period of origination during the third quarter, adding nearly 2,200 MW to its renewables backlog. Since the second-quarter financial results call in July, NextEra Energy Resources added 580 MW of wind, 911 MW of solar, 594 MW of battery storage and 86 MW of wind repowering to its renewables backlog,” its Q3 2020 press release stated. The most impressive highlight of its earnings report was that it finished the quarter with a backlog at NEER of more than 15,000 megawatts, which is more than the current renewables portfolio. Between NEER, FPL’s major contribution, and the savings it will achieve from merging Gulf Power into FPL, it expects to earn between $2.77 and $2.97 a share in adjusted earnings by 2023. That’s based on a four-for-one stock split in October and 6% to 8% growth. Considering the third-quarter growth rate was 11% higher, I expect it to deliver the goods, with renewable energy leading the charge. I’m Not the Only One That Likes NextEra Energy Stock InvestorPlace’s Neil George recently called NextEra an ESG buy post-election. “This has led the poster child of the ESG utility market,” NextEra Energy, “in the Total Return model portfolio of Profitable Investing to really perform. NextEra Energy is one of the largest wind and solar power companies in the U.S. and the world,” George wrote on Nov. 12. “It has it deployed in its regulated market in Florida and has expanded around the nation and beyond in its unregulated business. The stock has generated a return since added to the Total Return Portfolio of Profitable Investing of 684.90%, and for the trailing year it has returned 42.57% — which is well above the return of the S&P 500 Index.” There isn’t a utility that can keep up with NextEra. Over the past 15 years, it has had an annualized total return of 15.3%, five times its peers in the utilities sector, and 554 basis points higher than the entire U.S. markets. In early November, CNBC had an interesting article that discussed how it surpassed Exxon Mobil (NYSE:XOM) in the fall in terms of market capitalization for the first time. This despite still having a big chunk of its FPL power generation from coal and natural gas. “As the economy becomes more electrified and power fleets transition increasingly away from coal and to renewables, NextEra benefits from both: a growing utility customer rate base with more demand for electricity in the future from industries like autos, which helps them grow business and invest in the grid, while also being a major player in renewable energy project development,” CNBC contributor Eric Rosenbaum commented. He’s absolutely right. The company is ideally positioned to handle whatever comes down the pike in the next two to three years. That’s excellent news if you’re a shareholder. NextEra Energy is a long-term buy. On the date of publication, Will Ashworth did not have (either directly or indirectly) any positions in the securities mentioned in this article. Will Ashworth has written about investments full-time since 2008. Publications where he’s appeared include InvestorPlace, The Motley Fool Canada, Investopedia, Kiplinger, and several others in both the U.S. and Canada. He particularly enjoys creating model portfolios that stand the test of time. He lives in Halifax, Nova Scotia. At the time of this writing Will Ashworth did not hold a position in any of the aforementioned securities. The post The Renewable Energy Push Makes NextEra Energy Stock a Must Own appeared first on InvestorPlace. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	InvestorPlace - Stock Market News, Stock Advice & Trading Tips It’s hard to believe, but way back in January 2017, I suggested that NextEra Energy (NYSE:NEE) should replace DuPont de Nemours (NYSE:DD) in the Dow Jones Industrial Average. Since my January 2017 article, DD has lost 27% of its value — it’s likely a closer race if you add in the Dow (NYSE:DOW) and Corteeva (NYSE:CTVA) stock received in its complicated three-way split in 2019 — while NEE is up 157% in the nearly four years since. “NextEra Energy Resources had another excellent period of origination during the third quarter, adding nearly 2,200 MW to its renewables backlog.	Since the second-quarter financial results call in July, NextEra Energy Resources added 580 MW of wind, 911 MW of solar, 594 MW of battery storage and 86 MW of wind repowering to its renewables backlog,” its Q3 2020 press release stated. InvestorPlace - Stock Market News, Stock Advice & Trading Tips It’s hard to believe, but way back in January 2017, I suggested that NextEra Energy (NYSE:NEE) should replace DuPont de Nemours (NYSE:DD) in the Dow Jones Industrial Average. Since my January 2017 article, DD has lost 27% of its value — it’s likely a closer race if you add in the Dow (NYSE:DOW) and Corteeva (NYSE:CTVA) stock received in its complicated three-way split in 2019 — while NEE is up 157% in the nearly four years since.	InvestorPlace - Stock Market News, Stock Advice & Trading Tips It’s hard to believe, but way back in January 2017, I suggested that NextEra Energy (NYSE:NEE) should replace DuPont de Nemours (NYSE:DD) in the Dow Jones Industrial Average. Since my January 2017 article, DD has lost 27% of its value — it’s likely a closer race if you add in the Dow (NYSE:DOW) and Corteeva (NYSE:CTVA) stock received in its complicated three-way split in 2019 — while NEE is up 157% in the nearly four years since. “NextEra Energy Resources had another excellent period of origination during the third quarter, adding nearly 2,200 MW to its renewables backlog.	InvestorPlace - Stock Market News, Stock Advice & Trading Tips It’s hard to believe, but way back in January 2017, I suggested that NextEra Energy (NYSE:NEE) should replace DuPont de Nemours (NYSE:DD) in the Dow Jones Industrial Average. Since my January 2017 article, DD has lost 27% of its value — it’s likely a closer race if you add in the Dow (NYSE:DOW) and Corteeva (NYSE:CTVA) stock received in its complicated three-way split in 2019 — while NEE is up 157% in the nearly four years since. “NextEra Energy Resources had another excellent period of origination during the third quarter, adding nearly 2,200 MW to its renewables backlog.	18c2279c-895c-4fb4-acd7-061ea23519cb
716241.0	2020-11-15 00:00:00 UTC	Philippines' DoubleDragon Properties plans $305 mln REIT listing	DD	https://www.nasdaq.com/articles/philippines-doubledragon-properties-plans-%24305-mln-reit-listing-2020-11-15	nan	nan	MANILA, Nov 16 (Reuters) - Philippine developer DoubleDragon Properties Corp DD.PS said on Monday it is planning a 14.7 bln pesos ($305 mln) real estate investment trust (REIT) listing, the second offering of the asset class in the country. DoubleDragon has hired six foreign and three domestic underwriters as it seeks regulatory approval this week, the property firm told the local bourse. REITs, which manage real estate assets such as hotels, office buildings and malls that regularly generate profits, are attractive to investors seeking regular dividends. (Reporting by Neil Jerome Morales Editing by Ed Davies) ((neiljerome.morales@thomsonreuters.com; +632 8841 8914)) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	MANILA, Nov 16 (Reuters) - Philippine developer DoubleDragon Properties Corp DD.PS said on Monday it is planning a 14.7 bln pesos ($305 mln) real estate investment trust (REIT) listing, the second offering of the asset class in the country. DoubleDragon has hired six foreign and three domestic underwriters as it seeks regulatory approval this week, the property firm told the local bourse. REITs, which manage real estate assets such as hotels, office buildings and malls that regularly generate profits, are attractive to investors seeking regular dividends.	MANILA, Nov 16 (Reuters) - Philippine developer DoubleDragon Properties Corp DD.PS said on Monday it is planning a 14.7 bln pesos ($305 mln) real estate investment trust (REIT) listing, the second offering of the asset class in the country. REITs, which manage real estate assets such as hotels, office buildings and malls that regularly generate profits, are attractive to investors seeking regular dividends. (Reporting by Neil Jerome Morales Editing by Ed Davies) ((neiljerome.morales@thomsonreuters.com; +632 8841 8914)) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	MANILA, Nov 16 (Reuters) - Philippine developer DoubleDragon Properties Corp DD.PS said on Monday it is planning a 14.7 bln pesos ($305 mln) real estate investment trust (REIT) listing, the second offering of the asset class in the country. REITs, which manage real estate assets such as hotels, office buildings and malls that regularly generate profits, are attractive to investors seeking regular dividends. (Reporting by Neil Jerome Morales Editing by Ed Davies) ((neiljerome.morales@thomsonreuters.com; +632 8841 8914)) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	MANILA, Nov 16 (Reuters) - Philippine developer DoubleDragon Properties Corp DD.PS said on Monday it is planning a 14.7 bln pesos ($305 mln) real estate investment trust (REIT) listing, the second offering of the asset class in the country. DoubleDragon has hired six foreign and three domestic underwriters as it seeks regulatory approval this week, the property firm told the local bourse. REITs, which manage real estate assets such as hotels, office buildings and malls that regularly generate profits, are attractive to investors seeking regular dividends.	21ca74bc-9d5d-41d3-a21a-e57d03063e44
716242.0	2020-11-13 00:00:00 UTC	Analysts See 10% Gains Ahead For JKF	DD	https://www.nasdaq.com/articles/analysts-see-10-gains-ahead-for-jkf-2020-11-13	nan	nan	Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the iShares Morningstar Large-Cap Value ETF (Symbol: JKF), we found that the implied analyst target price for the ETF based upon its underlying holdings is $115.08 per unit. With JKF trading at a recent price near $104.90 per unit, that means that analysts see 9.71% upside for this ETF looking through to the average analyst targets of the underlying holdings. Three of JKF's underlying holdings with notable upside to their analyst target prices are Gilead Sciences Inc (Symbol: GILD), DuPont de Nemours Inc (Symbol: DD), and Comcast Corp (Symbol: CMCSA). Although GILD has traded at a recent price of $59.98/share, the average analyst target is 25.48% higher at $75.26/share. Similarly, DD has 14.20% upside from the recent share price of $59.98 if the average analyst target price of $68.50/share is reached, and analysts on average are expecting CMCSA to reach a target price of $52.88/share, which is 10.20% above the recent price of $47.98. Below is a twelve month price history chart comparing the stock performance of GILD, DD, and CMCSA: Combined, GILD, DD, and CMCSA represent 5.01% of the iShares Morningstar Large-Cap Value ETF. Below is a summary table of the current analyst target prices discussed above: NAME SYMBOL RECENT PRICE AVG. ANALYST 12-MO. TARGET % UPSIDE TO TARGET iShares Morningstar Large-Cap Value ETF JKF $104.90 $115.08 9.71% Gilead Sciences Inc GILD $59.98 $75.26 25.48% DuPont de Nemours Inc DD $59.98 $68.50 14.20% Comcast Corp CMCSA $47.98 $52.88 10.20% Are analysts justified in these targets, or overly optimistic about where these stocks will be trading 12 months from now? Do the analysts have a valid justification for their targets, or are they behind the curve on recent company and industry developments? A high price target relative to a stock's trading price can reflect optimism about the future, but can also be a precursor to target price downgrades if the targets were a relic of the past. These are questions that require further investor research. 10 ETFs With Most Upside To Analyst Targets » The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	Below is a twelve month price history chart comparing the stock performance of GILD, DD, and CMCSA: Combined, GILD, DD, and CMCSA represent 5.01% of the iShares Morningstar Large-Cap Value ETF. iShares Morningstar Large-Cap Value ETF JKF $104.90 $115.08 9.71% Gilead Sciences Inc GILD $59.98 $75.26 25.48% DuPont de Nemours Inc DD $59.98 $68.50 14.20% Comcast Corp CMCSA $47.98 $52.88 10.20% Are analysts justified in these targets, or overly optimistic about where these stocks will be trading 12 months from now? Three of JKF's underlying holdings with notable upside to their analyst target prices are Gilead Sciences Inc (Symbol: GILD), DuPont de Nemours Inc (Symbol: DD), and Comcast Corp (Symbol: CMCSA).	Three of JKF's underlying holdings with notable upside to their analyst target prices are Gilead Sciences Inc (Symbol: GILD), DuPont de Nemours Inc (Symbol: DD), and Comcast Corp (Symbol: CMCSA). Below is a twelve month price history chart comparing the stock performance of GILD, DD, and CMCSA: Combined, GILD, DD, and CMCSA represent 5.01% of the iShares Morningstar Large-Cap Value ETF. iShares Morningstar Large-Cap Value ETF JKF $104.90 $115.08 9.71% Gilead Sciences Inc GILD $59.98 $75.26 25.48% DuPont de Nemours Inc DD $59.98 $68.50 14.20% Comcast Corp CMCSA $47.98 $52.88 10.20% Are analysts justified in these targets, or overly optimistic about where these stocks will be trading 12 months from now?	Similarly, DD has 14.20% upside from the recent share price of $59.98 if the average analyst target price of $68.50/share is reached, and analysts on average are expecting CMCSA to reach a target price of $52.88/share, which is 10.20% above the recent price of $47.98. Three of JKF's underlying holdings with notable upside to their analyst target prices are Gilead Sciences Inc (Symbol: GILD), DuPont de Nemours Inc (Symbol: DD), and Comcast Corp (Symbol: CMCSA). Below is a twelve month price history chart comparing the stock performance of GILD, DD, and CMCSA: Combined, GILD, DD, and CMCSA represent 5.01% of the iShares Morningstar Large-Cap Value ETF.	Below is a twelve month price history chart comparing the stock performance of GILD, DD, and CMCSA: Combined, GILD, DD, and CMCSA represent 5.01% of the iShares Morningstar Large-Cap Value ETF. Three of JKF's underlying holdings with notable upside to their analyst target prices are Gilead Sciences Inc (Symbol: GILD), DuPont de Nemours Inc (Symbol: DD), and Comcast Corp (Symbol: CMCSA). Similarly, DD has 14.20% upside from the recent share price of $59.98 if the average analyst target price of $68.50/share is reached, and analysts on average are expecting CMCSA to reach a target price of $52.88/share, which is 10.20% above the recent price of $47.98.	e1d2ad89-4b88-465a-b2f3-e5c97fec0571
716243.0	2020-11-12 00:00:00 UTC	S&P 500 Analyst Moves: DD	DD	https://www.nasdaq.com/articles/sp-500-analyst-moves%3A-dd-2020-11-12	nan	nan	The latest tally of analyst opinions from the major brokerage houses shows that among the components of the S&P 500 index, DuPont is now the #52 analyst pick, moving up by 1 spot. This rank is formed by averaging the analyst opinions for each component from each broker, and then ranking the 500 components by those average opinion values. Looking at the stock price movement year to date, DuPont is lower by about 5.0%. VIDEO: S&P 500 Analyst Moves: DD The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	VIDEO: S&P 500 Analyst Moves: DD The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. The latest tally of analyst opinions from the major brokerage houses shows that among the components of the S&P 500 index, DuPont is now the #52 analyst pick, moving up by 1 spot. This rank is formed by averaging the analyst opinions for each component from each broker, and then ranking the 500 components by those average opinion values.	VIDEO: S&P 500 Analyst Moves: DD The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. The latest tally of analyst opinions from the major brokerage houses shows that among the components of the S&P 500 index, DuPont is now the #52 analyst pick, moving up by 1 spot. This rank is formed by averaging the analyst opinions for each component from each broker, and then ranking the 500 components by those average opinion values.	VIDEO: S&P 500 Analyst Moves: DD The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. The latest tally of analyst opinions from the major brokerage houses shows that among the components of the S&P 500 index, DuPont is now the #52 analyst pick, moving up by 1 spot. This rank is formed by averaging the analyst opinions for each component from each broker, and then ranking the 500 components by those average opinion values.	VIDEO: S&P 500 Analyst Moves: DD The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. The latest tally of analyst opinions from the major brokerage houses shows that among the components of the S&P 500 index, DuPont is now the #52 analyst pick, moving up by 1 spot. This rank is formed by averaging the analyst opinions for each component from each broker, and then ranking the 500 components by those average opinion values.	b4b96b1d-7bea-4c65-ba5c-65dfc10ef1a7
716244.0	2020-10-29 00:00:00 UTC	EARNINGS-DuPont results, annual forecast beat estimates on cost-cutting push	DD	https://www.nasdaq.com/articles/earnings-dupont-results-annual-forecast-beat-estimates-on-cost-cutting-push-2020-10-29	nan	nan	By Taru Jain Oct 29 (Reuters) - DuPont DD.N forecast annual profit above expectations on Thursday as a tight check on costs and a recovery in the automotive industry, one of its biggest markets, helped the industrial materials maker's quarterly results beat estimates. The company, which makes everything from brake fluid to fabric used in protective garments, has been cutting costs to battle weak demand in several industries due to the COVID-19 pandemic. DuPont raised its cost-cut target, saying it expects to save $280 million for the year, $100 million more than its prior forecast, as it renegotiated some contracts and speeded up its workforce reduction plans. The company, which is heavily exposed to the auto industry, is also benefiting from a revival in sales for car makers after a relaxation to lockdowns in several economies. Its third-quarter sales in transportation and industrial business fell 14%, but rose 20% from the prior quarter. Sales in its electronics and imaging business rose 7%, helped by builds in semiconductor technologies ahead of the launch of some premium smartphones. It forecast full-year profit of $3.17 to $3.21 per share, well above estimates of $3.03, according to Refinitiv data. Net sales forecast of $20.1 billion to $20.2 billion was at its midpoint, marginally above estimates of $20.1 billion. DuPont's adjusted earnings per share of 88 cents for the quarter beat estimates of 75 cents. Sales of $5.1 billion also surpassed $5 billion estimated by analysts. (Reporting by Taru Jain in Bengaluru; Editing by Arun Koyyur) ((Taru.Jain@thomsonreuters.com;)) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	By Taru Jain Oct 29 (Reuters) - DuPont DD.N forecast annual profit above expectations on Thursday as a tight check on costs and a recovery in the automotive industry, one of its biggest markets, helped the industrial materials maker's quarterly results beat estimates. The company, which makes everything from brake fluid to fabric used in protective garments, has been cutting costs to battle weak demand in several industries due to the COVID-19 pandemic. The company, which is heavily exposed to the auto industry, is also benefiting from a revival in sales for car makers after a relaxation to lockdowns in several economies.	By Taru Jain Oct 29 (Reuters) - DuPont DD.N forecast annual profit above expectations on Thursday as a tight check on costs and a recovery in the automotive industry, one of its biggest markets, helped the industrial materials maker's quarterly results beat estimates. Sales in its electronics and imaging business rose 7%, helped by builds in semiconductor technologies ahead of the launch of some premium smartphones. DuPont's adjusted earnings per share of 88 cents for the quarter beat estimates of 75 cents.	By Taru Jain Oct 29 (Reuters) - DuPont DD.N forecast annual profit above expectations on Thursday as a tight check on costs and a recovery in the automotive industry, one of its biggest markets, helped the industrial materials maker's quarterly results beat estimates. Net sales forecast of $20.1 billion to $20.2 billion was at its midpoint, marginally above estimates of $20.1 billion. Sales of $5.1 billion also surpassed $5 billion estimated by analysts.	By Taru Jain Oct 29 (Reuters) - DuPont DD.N forecast annual profit above expectations on Thursday as a tight check on costs and a recovery in the automotive industry, one of its biggest markets, helped the industrial materials maker's quarterly results beat estimates. The company, which makes everything from brake fluid to fabric used in protective garments, has been cutting costs to battle weak demand in several industries due to the COVID-19 pandemic. DuPont raised its cost-cut target, saying it expects to save $280 million for the year, $100 million more than its prior forecast, as it renegotiated some contracts and speeded up its workforce reduction plans.	4b64eb47-ba07-4b2b-b58a-0d3593392e67
716245.0	2020-10-29 00:00:00 UTC	DuPont Reinstates FY20 Adj. EPS Outlook Above View - Quick Facts	DD	https://www.nasdaq.com/articles/dupont-reinstates-fy20-adj.-eps-outlook-above-view-quick-facts-2020-10-29	nan	nan	(RTTNews) - While reporting financial results for the third quarter on Thursday, DuPont (DD) reinstated its adjusted earnings and net sales guidance for the full year 2020. The company had suspended its financial guidance for the full-year 2020 in April, due to global softening in automotive, oil & gas and select industrial end-markets as well as the unknown duration and intensity of the pandemic. For fiscal 2020, the company now projects adjusted earnings in a range of $3.17 to $3.21 per share on net sales between $20.1 billion and $20.2 billion. On average, analysts polled by Thomson Reuters expect the company to report earnings of $3.03 per share on net sales of $20.10 billion for the year. Analysts' estimates typically exclude special items. "With a continued focus on execution, we anticipate a fourth quarter underscored by additional cash generation and operating leverage across our core segments driven by additional cost savings," said Lori Koch, Chief Financial Officer of DuPont. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	(RTTNews) - While reporting financial results for the third quarter on Thursday, DuPont (DD) reinstated its adjusted earnings and net sales guidance for the full year 2020. "With a continued focus on execution, we anticipate a fourth quarter underscored by additional cash generation and operating leverage across our core segments driven by additional cost savings," said Lori Koch, Chief Financial Officer of DuPont. The company had suspended its financial guidance for the full-year 2020 in April, due to global softening in automotive, oil & gas and select industrial end-markets as well as the unknown duration and intensity of the pandemic.	(RTTNews) - While reporting financial results for the third quarter on Thursday, DuPont (DD) reinstated its adjusted earnings and net sales guidance for the full year 2020. "With a continued focus on execution, we anticipate a fourth quarter underscored by additional cash generation and operating leverage across our core segments driven by additional cost savings," said Lori Koch, Chief Financial Officer of DuPont. For fiscal 2020, the company now projects adjusted earnings in a range of $3.17 to $3.21 per share on net sales between $20.1 billion and $20.2 billion.	(RTTNews) - While reporting financial results for the third quarter on Thursday, DuPont (DD) reinstated its adjusted earnings and net sales guidance for the full year 2020. "With a continued focus on execution, we anticipate a fourth quarter underscored by additional cash generation and operating leverage across our core segments driven by additional cost savings," said Lori Koch, Chief Financial Officer of DuPont. For fiscal 2020, the company now projects adjusted earnings in a range of $3.17 to $3.21 per share on net sales between $20.1 billion and $20.2 billion.	(RTTNews) - While reporting financial results for the third quarter on Thursday, DuPont (DD) reinstated its adjusted earnings and net sales guidance for the full year 2020. "With a continued focus on execution, we anticipate a fourth quarter underscored by additional cash generation and operating leverage across our core segments driven by additional cost savings," said Lori Koch, Chief Financial Officer of DuPont. The company had suspended its financial guidance for the full-year 2020 in April, due to global softening in automotive, oil & gas and select industrial end-markets as well as the unknown duration and intensity of the pandemic.	6a6cd0b4-023b-4062-a85c-bc9f683ad891
716246.0	2020-10-29 00:00:00 UTC	EI DuPont De Nemours & Co. Q3 adjusted earnings Beat Estimates	DD	https://www.nasdaq.com/articles/ei-dupont-de-nemours-co.-q3-adjusted-earnings-beat-estimates-2020-10-29	nan	nan	(RTTNews) - Below are the earnings highlights for EI DuPont De Nemours & Co. (DD): -Earnings: -$79 million in Q3 vs. $372 million in the same period last year. -EPS: -$0.11 in Q3 vs. $0.50 in the same period last year. -Excluding items, EI DuPont De Nemours & Co. reported adjusted earnings of $645 million or $0.88 per share for the period. -Analysts projected $0.75 per share -Revenue: $5.10 billion in Q3 vs. $5.43 billion in the same period last year. -Guidance: Full year EPS guidance: $3.17 - $3.21 Full year revenue guidance: $20.1 - $20.1 Bln The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	(RTTNews) - Below are the earnings highlights for EI DuPont De Nemours & Co. (DD): -Earnings: -$79 million in Q3 vs. $372 million in the same period last year. -Excluding items, EI DuPont De Nemours & Co. reported adjusted earnings of $645 million or $0.88 per share for the period. -Guidance: Full year EPS guidance: $3.17 - $3.21 Full year revenue guidance: $20.1 - $20.1 Bln The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	(RTTNews) - Below are the earnings highlights for EI DuPont De Nemours & Co. (DD): -Earnings: -$79 million in Q3 vs. $372 million in the same period last year. -Excluding items, EI DuPont De Nemours & Co. reported adjusted earnings of $645 million or $0.88 per share for the period. -Guidance: Full year EPS guidance: $3.17 - $3.21 Full year revenue guidance: $20.1 - $20.1 Bln The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	(RTTNews) - Below are the earnings highlights for EI DuPont De Nemours & Co. (DD): -Earnings: -$79 million in Q3 vs. $372 million in the same period last year. -Excluding items, EI DuPont De Nemours & Co. reported adjusted earnings of $645 million or $0.88 per share for the period. -Guidance: Full year EPS guidance: $3.17 - $3.21 Full year revenue guidance: $20.1 - $20.1 Bln The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	(RTTNews) - Below are the earnings highlights for EI DuPont De Nemours & Co. (DD): -Earnings: -$79 million in Q3 vs. $372 million in the same period last year. -Excluding items, EI DuPont De Nemours & Co. reported adjusted earnings of $645 million or $0.88 per share for the period. -Analysts projected $0.75 per share -Revenue: $5.10 billion in Q3 vs. $5.43 billion in the same period last year.	82f5625e-f30d-490f-9e70-9c64942efaac
716247.0	2020-10-29 00:00:00 UTC	DuPont sees strong annual profit as auto sector recovers, signals more cost cuts	DD	https://www.nasdaq.com/articles/dupont-sees-strong-annual-profit-as-auto-sector-recovers-signals-more-cost-cuts-2020-10-29	nan	nan	By Taru Jain Oct 29 (Reuters) - Industrial materials maker DuPont DD.N on Thursday forecast full-year profit above Wall Street expectations as it kept a tight check on costs and benefited from a recovery in the automotive industry, one of it biggest markets. The company, which makes everything from brake fluid to fabric used in protective garments, has been cutting costs to battle weak demand in several industries due to the COVID-19 pandemic. DuPont is heavily exposed to the auto industry, which has picked up momentum with car makers seeing a revival in sales after relaxation of lockdowns in several economies. The company said its third-quarter sales in transportation and industrial business fell 14%, but rose 20% from the prior quarter. Sales in its electronics and imaging business rose 7%, helped by builds in semiconductor technologies ahead of the launch of some premium smartphones. Meanwhile, the industrial giant further raised its target to cut expenses by $280 million for the year, $100 million more than its previous forecast. It forecast full-year profit of $3.17 to $3.21 per share, well above estimates of $3.03, according to Refinitiv data. The company's adjusted profit, however, fell about 10% to $645 million, or 88 cents per share, as lower demand hit volumes in the nutrition, transportation and construction businesses. (Reporting by Taru Jain in Bengaluru; Editing by Arun Koyyur) ((Taru.Jain@thomsonreuters.com;)) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	By Taru Jain Oct 29 (Reuters) - Industrial materials maker DuPont DD.N on Thursday forecast full-year profit above Wall Street expectations as it kept a tight check on costs and benefited from a recovery in the automotive industry, one of it biggest markets. The company, which makes everything from brake fluid to fabric used in protective garments, has been cutting costs to battle weak demand in several industries due to the COVID-19 pandemic. DuPont is heavily exposed to the auto industry, which has picked up momentum with car makers seeing a revival in sales after relaxation of lockdowns in several economies.	By Taru Jain Oct 29 (Reuters) - Industrial materials maker DuPont DD.N on Thursday forecast full-year profit above Wall Street expectations as it kept a tight check on costs and benefited from a recovery in the automotive industry, one of it biggest markets. The company said its third-quarter sales in transportation and industrial business fell 14%, but rose 20% from the prior quarter. The company's adjusted profit, however, fell about 10% to $645 million, or 88 cents per share, as lower demand hit volumes in the nutrition, transportation and construction businesses.	By Taru Jain Oct 29 (Reuters) - Industrial materials maker DuPont DD.N on Thursday forecast full-year profit above Wall Street expectations as it kept a tight check on costs and benefited from a recovery in the automotive industry, one of it biggest markets. The company said its third-quarter sales in transportation and industrial business fell 14%, but rose 20% from the prior quarter. The company's adjusted profit, however, fell about 10% to $645 million, or 88 cents per share, as lower demand hit volumes in the nutrition, transportation and construction businesses.	By Taru Jain Oct 29 (Reuters) - Industrial materials maker DuPont DD.N on Thursday forecast full-year profit above Wall Street expectations as it kept a tight check on costs and benefited from a recovery in the automotive industry, one of it biggest markets. The company said its third-quarter sales in transportation and industrial business fell 14%, but rose 20% from the prior quarter. It forecast full-year profit of $3.17 to $3.21 per share, well above estimates of $3.03, according to Refinitiv data.	ecca9ee1-06fa-4eae-b40d-8f83a3ea8e2f
716248.0	2020-10-26 00:00:00 UTC	IX Water: The Water Can Be Fixed, But With Whose Money?	DD	https://www.nasdaq.com/articles/ix-water%3A-the-water-can-be-fixed-but-with-whose-money-2020-10-26	nan	nan	InvestorPlace - Stock Market News, Stock Advice & Trading Tips In Colorado, a company called IX Water has launched a crowdfunding program on StartEngine, hoping to raise $1 million via private investing to commercialize its brackish water treatment system. Source: Shutterstock So far, $425,000 had been raised, at a $13.1 million valuation. The company wants to build a collection of components to clean water used in oil drilling or other manufacturing processes. These include devices to clean out particles, metals, and volatile chemicals like benzene and toluene. The company can also clear out salt and sulfur, or the salt water can be used to produce chlorine derivatives through electrolysis. 7 Unhealthy Biotech Stocks To Sell Before They Sicken Your Portfolio It’s a great idea. The oil and petrochemical industries have wasted a lot of water. The problem is making the numbers work. The Opportunity IX Water was launched with technology spun out of the Los Alamos National Laboratory in New Mexico. They have plants in Golden, Colorado and Calgary, Alberta, along with a manufacturing partner in Dalian, China. (Dalian is on the North Korea side of the Yellow Sea in northern China, opposite Beijing.) The CEO is John (Grizz) Deal. He has extensive experience dealing with Los Alamos spinoffs and the energy industry. His sister, Deborah Deal-Blackwell, is vice president for marketing. Co-founder Randall Wilson worked at a foundation owned by Lockheed Martin (NYSE:LMT) to commercialize its technology, and has done the same around the Sandia Labs. This is not their first rodeo. According to Crunchbase, IX Water has been working since 2012 to reach this point. It has the technology, it has the team, it has the manufacturing all lined up. What it needs are customers; people who will pay for treating their wastewater. Out of Money In theory, oil and chemical companies should pay for treatment as part of their operations. They would make up some of the cost by reselling the water. But then the oilpatch went broke. When oil operators are operating, they make bold promises about cleaning up their mess someday. When they go broke, they walk away. They don’t produce brackish water with their wastewater, and they don’t use the brackish water, either. Olin (NYSE:OLN), which uses the kind of salt water IX Water would produce to make chlorine and other products, recently shut its chlor-alkali plant in Freeport, Texas, at the center of brackish water supply. When the oil and gas industry was hopping Olin had happy days. Since the business began faltering two years ago the stock has been cut in half. Regular readers at InvestorPlace will recall that the Olin process can also produce hydrogen, with some additional technology. Olin had taken chlor-alkali assets from Dow Chemical as that firm merged with DuPont to create Dow Dupont (NYSE:DD). Now, with the oilpatch and petrochemical industries flat on their backs, there’s no money to pay for treatment, even with the simplified IX Water system. There’s also going to be a limited hydrogen supply for companies like Plug Power (NASDAQ:PLUG), which piggyback on chlor-alkali production to produce hydrogen. The Bottom Line IX Water notes that oil and gas production results in 150 billion barrels of wastewater per year. Fracking uses water-soluble chemicals, pushing them deep underground, at pressure, to fraction rock. Dealing with the resulting wastewater is a huge problem. Someone should deal with it. IX Water can. But without an industry to pay for treatment, where is the money going to come from? Deal is a Democrat, who ran two years ago to chair the local party. He lost. The party’s platform supports wastewater treatment. A Democratic administration might even help IX Water get the money it needs, buying wastewater, supporting treatment, creating a market. If that happens, Deal and IX Water can make a deal. If it doesn’t, I don’t know. On the date of publication, Dana Blankenhorn did not have (either directly or indirectly) any positions in any of the securities mentioned in this article. Dana Blankenhorn has been a financial and technology journalist since 1978. He is the author of the environmental thriller Bridget O’Flynn and the Bear, available at the Amazon Kindle store. Write him at danablankenhorn@gmail.com or follow him on Twitter at @danablankenhorn. Investing through equity and real estate crowdfunding or asset tokenization requires a high degree of risk tolerance. Despite what individual companies may promise, there’s always the chance of losing a portion, or the entirety, of your investment. These risks include: 1) Greater chance of failure 2) Risk of fraudulent activity 3) Lack of liquidity 4) Economic downturns 5) Dearth of investor education Read more: Private Investing Risks More From InvestorPlace Why Everyone Is Investing in 5G All WRONG Top Stock Picker Reveals His Next 1,000% Winner Radical New Battery Could Dismantle Oil Markets Revolutionary Tech Behind 5G Rollout Is Being Pioneered By This 1 Company The post IX Water: The Water Can Be Fixed, But With Whose Money? appeared first on InvestorPlace. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	Regular readers at InvestorPlace will recall that the Olin process can also produce hydrogen, with some additional technology. Olin had taken chlor-alkali assets from Dow Chemical as that firm merged with DuPont to create Dow Dupont (NYSE:DD). Co-founder Randall Wilson worked at a foundation owned by Lockheed Martin (NYSE:LMT) to commercialize its technology, and has done the same around the Sandia Labs.	Regular readers at InvestorPlace will recall that the Olin process can also produce hydrogen, with some additional technology. Olin had taken chlor-alkali assets from Dow Chemical as that firm merged with DuPont to create Dow Dupont (NYSE:DD). InvestorPlace - Stock Market News, Stock Advice & Trading Tips In Colorado, a company called IX Water has launched a crowdfunding program on StartEngine, hoping to raise $1 million via private investing to commercialize its brackish water treatment system.	Regular readers at InvestorPlace will recall that the Olin process can also produce hydrogen, with some additional technology. Olin had taken chlor-alkali assets from Dow Chemical as that firm merged with DuPont to create Dow Dupont (NYSE:DD). InvestorPlace - Stock Market News, Stock Advice & Trading Tips In Colorado, a company called IX Water has launched a crowdfunding program on StartEngine, hoping to raise $1 million via private investing to commercialize its brackish water treatment system.	Regular readers at InvestorPlace will recall that the Olin process can also produce hydrogen, with some additional technology. Olin had taken chlor-alkali assets from Dow Chemical as that firm merged with DuPont to create Dow Dupont (NYSE:DD). Olin (NYSE:OLN), which uses the kind of salt water IX Water would produce to make chlorine and other products, recently shut its chlor-alkali plant in Freeport, Texas, at the center of brackish water supply.	ab5da6f2-627c-4d35-8705-bb7bebd89dd3
716249.0	2020-10-15 00:00:00 UTC	5 Nanotech Stocks to Buy for Huge Innovation	DD	https://www.nasdaq.com/articles/5-nanotech-stocks-to-buy-for-huge-innovation-2020-10-15	nan	nan	InvestorPlace - Stock Market News, Stock Advice & Trading Tips Before diving into nanotech stocks to watch it’s important to consider what “nano” is and what it promises. Nano means billionth. Micro, which we are more familiar with, means millionth. Thus, nanotech exists on a scale 1,000 times smaller than the scale on which microtechnology does. Because of this, companies that compete in nanotechnology represent revolutionary advancements. It’s also important to understand how truly small nanoscale measurements are. The nanoscale is down to the atomic and molecular level. And not to get overly technical, but the nanoscale is truly different. Science as you and I know it, is different on the nanoscale. Physical and chemical properties change. This is part of the reason why nanotech stocks are interesting. The science of nanotech allows advancements in ways that are currently unfathomable. The rules change. Atoms and molecules operate differently than they would on the microscopic level. And it’s because of this that technology opens up new horizons. It is also worth noting that nanotechnology has its detractors. Some claim that because the science is completely new, we may be unprepared. The argument is that because we don’t fully understand the physical and chemical interactions that nanotechnology allows, we should not proceed. I for one believe humans have nothing to fear. The applications of nanotechnology are many. Many already exist today, and many others will exist decades from now. Nanotech is already being actively used in the computers, microchips, chemicals and devices we use each day. The future holds the promise of applications including nanobots, nanomedicine and chemicals with unique properties. All that said, let’s look at five stocks which will lead this nanotech innovation. Applied Materials (NASDAQ:AMAT) CMC Materials (NASDAQ:CCMP) Taiwan Semiconductor (NYSE:TSM) Thermo Fisher Scientific (NYSE:TMO) DuPont (NYSE:DD) Nanotech Stocks: Applied Materials (AMAT) Source: michelmond / Shutterstock.com Applied Materials makes engineered materials for chips and displays. The company is heavily involved in the microchip industry. Microchip competition is itself heavily driven by the ability to reduce sizes and apply films on an atom-by-atom basis. A recent development from the company in nanotechnology highlights how it will lead innovation in semiconductors. The breakthrough is called selective tungsten deposition. Essentially, Applied Materials has developed this process to give chipmakers a new way to build transistor contacts. It helps them eliminate the liner-barrier and nucleation layers — allowing greater transistor density, decreasing resistance and increasing performance. Taking away the jargon, the company says it is like 3D printing at the atomic scale. My opinion is that Applied Materials will be a nanotech stock to watch for years to come. From a financial and overall stock perspective, analysts favor AMAT stock as a buy. CMC Materials (CCMP) Source: Shutterstock CMC Materials is a pioneer in the chemical mechanical planarization field. Essentially, this means that it uses slurries — mixtures of fine particles like cement suspended in water — to smooth the surface of materials through chemical and mechanical forces. Why does this matter? Well, the semiconductor industry widely uses these slurries. As the semiconductor industry continues to require ever increasing precision on the nanoscale, CMC Materials will be there. Analysts are not particularly enthusiastic about CCMP stock — rating it as a hold. However it does provide a dividend of 44 cents. While it may or may not be a stock which appreciates, it does again have a dividend which has been continuously increasing since 2016. And whether investors choose to buy or not, the company will remain a nanotechnology pioneer in its niche within the semiconductor industry. Nanotech Stocks: Taiwan Semiconductor (TSM) Source: Sundry Photography / Shutterstock.com Taiwan Semiconductor is a company to watch for both nanotechnology innovation and gains. TSM was the first foundry to manufacture 7-nanometer chip production in scale volumes. That gives the company an edge when it comes securing a foothold in emerging sectors like 5G, artificial intelligence and cloud computing. The company has risen significantly in 2020 but it is still overwhelmingly rated a buy. Taiwan Semiconductor announced back in May that it was going to spend $12 billion to build a semiconductor manufacturing plant in Arizona. The plant will be operational in 2024 and produce 5-nanometer semiconductors. TSM began 5-nanometer semiconductor production in Taiwan early this year. Taiwan Semiconductor has shown that it is the leading foundry in terms of iterating semiconductors on a smaller and smaller scale. This is a major factor in semiconductor success. Thus, it is clear that along with U.S. national security considerations TSM stock can benefit from simply being an innovation leader. Thermo Fisher Scientific (TMO) TMO) sign out front of an office in Silicon Valley, California." width="300" height="169">Source: Michael Vi / Shutterstock.com Thermo Fisher Scientific is a company to keep an eye on for innovation in the electron microscopy field. What is that? Electron microscopes allow image creation down to the level of the individual atom. Thus, electron microscopy allows us to view worlds we simply couldn’t previously. This allows exciting developments to occur across life sciences, materials, semiconductors and other industries. The applications and potential for paradigm-changing developments are many. One example of Thermo Fisher’s nanotechnology application is in electrical failure analysis of semiconductors. The companies website explains why its imaging technology is increasingly relevant industrially: “Shrinking technologies, new materials, and more complex structures are driving defectivity, especially where the circuit design is particularly sensitive to process variation. These non-visual defects reveal themselves as electrical faults that downgrade device performance, threaten reliability, and destroy yield. The problem becomes even more complex when failures occur at the device packaging stage. High-density interconnects, wafer-level stacking, flexible electronics, and integral substrates mean that failure-inducing defects have more places to hide — making characterization more difficult, and more critical, than ever.” From a financial perspective, TMO stock is strong. Fifteen analysts rate it a buy while only three recommend it as a hold. The company is a giant in scientific equipment, and is an interesting one to follow for innovation alone. Nanotech Stocks: DuPont de Nemours (DD) Source: Shutterstock DuPont is a materials leader, operating across many industries and niches. The company is famous for being the creator of Kevlar. What is that? Kevlar is an aramid, which is a word meaning aromatic polyamides. Importantly, Kevlar has big potential. According to the company, it improves performance, strength and protection. It is perhaps most famous for some of its uses in personal defense — as Dupont says it is stronger than steel, it is used in ballistic body armor. Thanks to the nanotechnology behind the material, there is just so much for investors to appreciate. DuPont also has several other materials which it has developed for commercialization based on nanotech. The company is absolutely a leader in this space. In addition to Kevlar, the company also manufactures Tyvek and Nomex. Investors interested in nanotech should really consider simply browsing DuPont’s website to gain an understanding of its products and their potential. There are a few encouraging signs making DuPont an equity to consider buying. Analysts strongly rate DuPont as a buy with 18 giving it a buy rating and only four rating it a hold. Another strong positive is that insider purchases favor DD stock as a buy. In the last three months there were four insider purchases, which lends credibility to the idea that company can succeed and the stock can appreciate. On the date of publication, Alex Sirois did not have (either directly or indirectly) any positions in the securities mentioned in this article. Alex Sirois is a freelance contributor to InvestorPlace whose personal stock investing style is focused on long-term, buy-and-hold, wealth-building stock picks. Having worked in several industries from e-commerce to translation to education and utilizing his MBA from George Washington University, he brings a diverse set of skills through which he filters his writing. More From InvestorPlace Forget The Election… Pick These Stocks for the Win in 2021 Why Everyone Is Investing in 5G All WRONG America’s #1 Stock Picker Reveals His Next 1,000% Winner Revolutionary Tech Behind 5G Rollout Is Being Pioneered By This 1 Company The post 5 Nanotech Stocks to Buy for Huge Innovation appeared first on InvestorPlace. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	Applied Materials (NASDAQ:AMAT) CMC Materials (NASDAQ:CCMP) Taiwan Semiconductor (NYSE:TSM) Thermo Fisher Scientific (NYSE:TMO) DuPont (NYSE:DD) Nanotech Stocks: Applied Materials (AMAT) Source: michelmond / Shutterstock.com Applied Materials makes engineered materials for chips and displays. Nanotech Stocks: DuPont de Nemours (DD) Source: Shutterstock DuPont is a materials leader, operating across many industries and niches. In addition to Kevlar, the company also manufactures Tyvek and Nomex.	Applied Materials (NASDAQ:AMAT) CMC Materials (NASDAQ:CCMP) Taiwan Semiconductor (NYSE:TSM) Thermo Fisher Scientific (NYSE:TMO) DuPont (NYSE:DD) Nanotech Stocks: Applied Materials (AMAT) Source: michelmond / Shutterstock.com Applied Materials makes engineered materials for chips and displays. Nanotech Stocks: DuPont de Nemours (DD) Source: Shutterstock DuPont is a materials leader, operating across many industries and niches. In addition to Kevlar, the company also manufactures Tyvek and Nomex.	Applied Materials (NASDAQ:AMAT) CMC Materials (NASDAQ:CCMP) Taiwan Semiconductor (NYSE:TSM) Thermo Fisher Scientific (NYSE:TMO) DuPont (NYSE:DD) Nanotech Stocks: Applied Materials (AMAT) Source: michelmond / Shutterstock.com Applied Materials makes engineered materials for chips and displays. Nanotech Stocks: DuPont de Nemours (DD) Source: Shutterstock DuPont is a materials leader, operating across many industries and niches. In addition to Kevlar, the company also manufactures Tyvek and Nomex.	Nanotech Stocks: DuPont de Nemours (DD) Source: Shutterstock DuPont is a materials leader, operating across many industries and niches. Applied Materials (NASDAQ:AMAT) CMC Materials (NASDAQ:CCMP) Taiwan Semiconductor (NYSE:TSM) Thermo Fisher Scientific (NYSE:TMO) DuPont (NYSE:DD) Nanotech Stocks: Applied Materials (AMAT) Source: michelmond / Shutterstock.com Applied Materials makes engineered materials for chips and displays. In addition to Kevlar, the company also manufactures Tyvek and Nomex.	54d22f96-4a9b-4dc6-aa57-e5c41cc3a9e5
716250.0	2020-09-27 00:00:00 UTC	3 Cheap Stocks to Buy After the Market Sell-Off	DD	https://www.nasdaq.com/articles/3-cheap-stocks-to-buy-after-the-market-sell-off-2020-09-27	nan	nan	When the stock market tumbles, your first reaction is probably to check your portfolio and see how much you've lost. That's natural, but your next step should be to start bargain-hunting through the wreckage. So far in September, theÂ S&P 500Â is down 7.6%, so it's time to go shopping. We asked three Motley Fool contributors what stocks they think are worth buying at these prices. They came back withÂ Dow Chemical (NYSE: DOW), Danaher (NYSE: DHR), and SolarEdge TechnologiesÂ (NASDAQ: SEDG). Here's why. Image source: Getty Images. A low price and a high yield John Bromels (Dow Chemical): The market has never liked boring stocks, and chemical and materials company Dow is about as unexciting as they come. The hundred-plus-year-old company merged with rivalÂ DuPont in 2017 and was spun off in 2019 with a portfolio of "performance chemicals." Basically, that means Dow doesn't really sell products to consumers, but makes chemicals and materials that are used in other products or processes. Think automotive coatings, packaging for medical supplies, and lubricants for heavy machinery. Try not to yawn. Dow's products are used in a large number of industries by customers around the globe. That diversification has helped the company during the pandemic. In the second quarter of 2020, for example, sales to shuttered auto manufacturing plants slumped, but increased shipments of home medical equipment and pharmaceuticals helped pick up the slack. Dow still saw a slight revenue decline -- and a much bigger drop in net income -- but its cash flow remained strong. Strong enough, in fact, for the company to pay down $600 million in debt while still fully funding its generous dividend. That dividend is the big reason Dow looks like a buy after the market sell-off, as its yield has now risen to 6%. Shares look cheap, too, having fallen about 15% year to date. That makes this an excellent time to consider investing in this boring but reliable dividend payer. A high-quality company to buy in a market sell-off Lee Samaha (Danaher): Just as a rising tide lifts all boats, a pronounced sell-off in the markets will lead to quality stocks being sold off too. That's the theory and the reality with Danaher. As you can see below, the stock was sold off in the market rout in the spring. Image source: YCharts. The interesting thing about Danaher is that its earnings prospects may well be enhanced by the possible reasons behind a future market fall. If a second wave of the pandemic causes more disruption to the economy, then it's a safe bet that Danaher will be a net winner. The excitement around the company comes from its diagnostics and life sciences equipment segments. The diagnostics segment is currently seeing very strong growth for its COVID-19 test. In addition, the boost coming from instrumentation sales caused by the pandemic is likely to generate new customers and lead to sales of Danaher's other tests in the future. The life sciences segment's sales suffered as a consequence of non-COVID-19 related research facilities being shut down. However, that's a relatively temporary phenomenon and few people will argue that research into life sciences will be curtailed after the shock of the pandemic. Moreover, the segment has significant growth prospects from the integration of the former GE biopharma business acquired in 2020. Danaher's valuation is not superficially cheap right now but it's definitely the sort of stock investors should be looking to pick up during any concerted market sell-off. Amid the darkness of the market dipping lower, this solar stock shines bright Scott Levine (SolarEdge Technologies): More than doubling the nearly 8% decline of the S&P 500 in September, shares of SolarEdge have tumbled more than 17% lower. While the stock hasn't hit a rock-bottom valuation, it certainly seems more attractive now than it has at other times during 2020. Currently, shares are trading hands at about $184 -- about 20% lower than their 52-week high of $229. Although investors initially celebrated the company's Q2 2020 earnings report in August, it seems that the blights in the report, paired with the market's downturn, have shaken their resolve. In the second quarter, for example, SolarEdge reported revenue of $332 million, representing a notable quarter-over-quarter decline of 23%, as the company faced challenges from the effects of COVID-19. Similarly, SolarEdge faced margin compression last quarter. Whereas the company reported a gross margin of 34.2% in the fourth quarter of 2019, it subsequently contracted to 32.5% and 31% in the first and second quarters, respectively. Undeniably, there were clouds hanging on the company's earnings report; however, it shined in other ways. For one, the company reported growth in its generation of operational cash flow from $51 million in Q2 2019 to $59 million in Q2 2020. This helped the company end the quarter with a strong balance sheet, featuring a net cash position of $577.4 million as opposed to the net cash position of $351.6 million that it had at the same time last year -- something that will help the company to weather the still-present COVID-19 headwinds. While investors may feel unsettled with the market's volatility and find comfort in eschewing growth stocks like SolarEdge, savvy investors have the opportunity to pick up shares of this leading alternative energy stock at a discount. Between the company's leading position as a provider of power optimizers and inverters for the solar market and its expansion into energy storage solutions, there are a lot of reasons to suspect that this stock can power patient investors' portfolios. Find out why SolarEdge Technologies is one of the 10 best stocks to buy now Motley Fool co-founders Tom and David Gardner have spent more than a decade beating the market. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.* Tom and David just revealed their ten top stock picks for investors to buy right now. SolarEdge Technologies is on the list -- but there are nine others you may be overlooking. Click here to get access to the full list! Â *Stock Advisor returns as of August 1, 2020 Â John Bromels owns shares of DuPont de Nemours, Inc. and The Dow Chemical Company. Lee Samaha has no position in any of the stocks mentioned. Scott Levine has no position in any of the stocks mentioned. The Motley Fool recommends SolarEdge Technologies. The Motley Fool has a disclosure policy. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	In addition, the boost coming from instrumentation sales caused by the pandemic is likely to generate new customers and lead to sales of Danaher's other tests in the future. In the second quarter of 2020, for example, sales to shuttered auto manufacturing plants slumped, but increased shipments of home medical equipment and pharmaceuticals helped pick up the slack. In the second quarter, for example, SolarEdge reported revenue of $332 million, representing a notable quarter-over-quarter decline of 23%, as the company faced challenges from the effects of COVID-19.	In addition, the boost coming from instrumentation sales caused by the pandemic is likely to generate new customers and lead to sales of Danaher's other tests in the future. They came back withÂ Dow Chemical (NYSE: DOW), Danaher (NYSE: DHR), and SolarEdge TechnologiesÂ (NASDAQ: SEDG). A low price and a high yield John Bromels (Dow Chemical): The market has never liked boring stocks, and chemical and materials company Dow is about as unexciting as they come.	In addition, the boost coming from instrumentation sales caused by the pandemic is likely to generate new customers and lead to sales of Danaher's other tests in the future. A low price and a high yield John Bromels (Dow Chemical): The market has never liked boring stocks, and chemical and materials company Dow is about as unexciting as they come. This helped the company end the quarter with a strong balance sheet, featuring a net cash position of $577.4 million as opposed to the net cash position of $351.6 million that it had at the same time last year -- something that will help the company to weather the still-present COVID-19 headwinds.	In addition, the boost coming from instrumentation sales caused by the pandemic is likely to generate new customers and lead to sales of Danaher's other tests in the future. A low price and a high yield John Bromels (Dow Chemical): The market has never liked boring stocks, and chemical and materials company Dow is about as unexciting as they come. Amid the darkness of the market dipping lower, this solar stock shines bright Scott Levine (SolarEdge Technologies): More than doubling the nearly 8% decline of the S&P 500 in September, shares of SolarEdge have tumbled more than 17% lower.	11c41364-f1e0-4ffe-83ec-7898e1a5bf01
716251.0	2020-09-04 00:00:00 UTC	Notable Friday Option Activity: SPOT, DD, GBT	DD	https://www.nasdaq.com/articles/notable-friday-option-activity%3A-spot-dd-gbt-2020-09-04	nan	nan	Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Spotify Technology SA (Symbol: SPOT), where a total volume of 13,759 contracts has been traded thus far today, a contract volume which is representative of approximately 1.4 million underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 93.1% of SPOT's average daily trading volume over the past month, of 1.5 million shares. Especially high volume was seen for the $320 strike call option expiring September 18, 2020, with 803 contracts trading so far today, representing approximately 80,300 underlying shares of SPOT. Below is a chart showing SPOT's trailing twelve month trading history, with the $320 strike highlighted in orange: DuPont (Symbol: DD) saw options trading volume of 35,672 contracts, representing approximately 3.6 million underlying shares or approximately 88.9% of DD's average daily trading volume over the past month, of 4.0 million shares. Particularly high volume was seen for the $67.50 strike call option expiring October 16, 2020, with 16,003 contracts trading so far today, representing approximately 1.6 million underlying shares of DD. Below is a chart showing DD's trailing twelve month trading history, with the $67.50 strike highlighted in orange: And Global Blood Therapeutics Inc (Symbol: GBT) options are showing a volume of 5,701 contracts thus far today. That number of contracts represents approximately 570,100 underlying shares, working out to a sizeable 86.3% of GBT's average daily trading volume over the past month, of 660,275 shares. Particularly high volume was seen for the $70 strike call option expiring September 18, 2020, with 2,041 contracts trading so far today, representing approximately 204,100 underlying shares of GBT. Below is a chart showing GBT's trailing twelve month trading history, with the $70 strike highlighted in orange: For the various different available expirations for SPOT options, DD options, or GBT options, visit StockOptionsChannel.com. Today's Most Active Call & Put Options of the S&P 500 » The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	Particularly high volume was seen for the $67.50 strike call option expiring October 16, 2020, with 16,003 contracts trading so far today, representing approximately 1.6 million underlying shares of DD. Below is a chart showing SPOT's trailing twelve month trading history, with the $320 strike highlighted in orange: DuPont (Symbol: DD) saw options trading volume of 35,672 contracts, representing approximately 3.6 million underlying shares or approximately 88.9% of DD's average daily trading volume over the past month, of 4.0 million shares. Below is a chart showing DD's trailing twelve month trading history, with the $67.50 strike highlighted in orange: And Global Blood Therapeutics Inc (Symbol: GBT) options are showing a volume of 5,701 contracts thus far today.	Below is a chart showing SPOT's trailing twelve month trading history, with the $320 strike highlighted in orange: DuPont (Symbol: DD) saw options trading volume of 35,672 contracts, representing approximately 3.6 million underlying shares or approximately 88.9% of DD's average daily trading volume over the past month, of 4.0 million shares. Particularly high volume was seen for the $67.50 strike call option expiring October 16, 2020, with 16,003 contracts trading so far today, representing approximately 1.6 million underlying shares of DD. Below is a chart showing DD's trailing twelve month trading history, with the $67.50 strike highlighted in orange: And Global Blood Therapeutics Inc (Symbol: GBT) options are showing a volume of 5,701 contracts thus far today.	Below is a chart showing SPOT's trailing twelve month trading history, with the $320 strike highlighted in orange: DuPont (Symbol: DD) saw options trading volume of 35,672 contracts, representing approximately 3.6 million underlying shares or approximately 88.9% of DD's average daily trading volume over the past month, of 4.0 million shares. Particularly high volume was seen for the $67.50 strike call option expiring October 16, 2020, with 16,003 contracts trading so far today, representing approximately 1.6 million underlying shares of DD. Below is a chart showing DD's trailing twelve month trading history, with the $67.50 strike highlighted in orange: And Global Blood Therapeutics Inc (Symbol: GBT) options are showing a volume of 5,701 contracts thus far today.	Below is a chart showing SPOT's trailing twelve month trading history, with the $320 strike highlighted in orange: DuPont (Symbol: DD) saw options trading volume of 35,672 contracts, representing approximately 3.6 million underlying shares or approximately 88.9% of DD's average daily trading volume over the past month, of 4.0 million shares. Below is a chart showing GBT's trailing twelve month trading history, with the $70 strike highlighted in orange: For the various different available expirations for SPOT options, DD options, or GBT options, visit StockOptionsChannel.com. Particularly high volume was seen for the $67.50 strike call option expiring October 16, 2020, with 16,003 contracts trading so far today, representing approximately 1.6 million underlying shares of DD.	c72ba133-f27d-4593-8e79-d4ce01a2d6a2
716252.0	2020-08-22 00:00:00 UTC	2 Cheap Dividend Stocks You Can Buy Right Now	DD	https://www.nasdaq.com/articles/2-cheap-dividend-stocks-you-can-buy-right-now-2020-08-22	nan	nan	As the market flirts with new record highs, bargains seem to be harder and harder to find. Many reliable dividend payers have seen their share prices soar, knocking their yields down to unexciting levels. Although you may have to dig to find cheap dividend stocks, there are still a few around. Two dividend payers that look cheap right now are Dow (NYSE: DOW) and BP (NYSE: BP). Here's why they look like buys at their current prices. Image source: Getty Images. A young old company Chemical heavyweight Dow just emerged from its four-year stint as part of merged company DowDuPont in 2019. However, in the year since, it has proven that its streamlined portfolio of "performance chemicals" like coatings, adhesives, and lubricants is perfect for supporting a high-yielding dividend. Dow's product line mostly consists of chemicals used in industrial applications, and it serves a diversified group of industries, including manufacturing, construction, tech, and healthcare. That diversification allowed it to grow its free cash flow, even during the second quarter of 2020, as outperforming industries like healthcare counterbalanced underperformers like construction and manufacturing. Dow is also looking undervalued compared to other chemical companies right now. Its price-to-sales ratio and its price-to-free cash flow ratio are at or near the bottom of its peer group, and well below those of the other former DowDuPont components DuPont (NYSE: DD) and Corteva: DOW PS Ratio data by YCharts Meanwhile, Dow's 6.2% current dividend yield is higher than almost all of its peers' -- only German behemoth BASF's is higher at 6.3%. With a high yield, a low valuation compared to its peers, and consistent cash flow generation, Dow looks like a dividend stock worth buying. A new direction The oil industry has seen better days. After March's oil price collapse -- the second major oil price downturn in the last six years -- the oil and gas sector has been hit with a wave of dividend cuts, reduced spending, and bankruptcies. One company that cut costs and slashed its dividend in half was oil supermajor BP. Unlike its peers, however, BP announced a major new initiative, shifting its focus away from oil toward renewable energy. By 2030, BP intends to cut its oil production by 40% and refocus its investments away from oil exploration toward renewable power generation and services. The company will invest about $5 billion per year on renewables over the next ten years, and intends to develop 50 gigawatts (GW) of renewable generation capacity by 2030. By comparison, the world's current top renewable energy generator, NextEra Energy, only has about 24 GW of total renewable capacity (with another 14.4 GW of growth projects in its backlog). Management believes this shift will support the company's newly reduced dividend. At BP's current share price, that dividend still yields about 5.5%. And speaking of share price, BP's looks undervalued right now. With all the oil majors posting negative net income in Q2 2020, we can't compare price to earnings, but BP's price-to-sales and price-to-cash from operations ratios compare favorably to those of its peers: BP PS Ratio data by YCharts With its dividend cut behind it, a low valuation, and a radical plan to improve performance, BP looks like a buy. Are these stocks smart buys right now? Not all "cheap" stocks are worth buying, and certainly there are some risks associated with these two stocks as well. In its current form, Dow is a young company, without an established track record of performance in different kinds of market environments. For its part, BP cut its dividend in 2010 in the wake of the Deepwater Horizon oil spill in the Gulf of Mexico, and just slashed it again. Meanwhile, there's no guarantee that its new renewables-focused strategy will work out as planned. In spite of that, both of these companies' current payouts look sustainable, and their share prices are cheap. They look like risks worth taking for dividend-focused investors. 10 stocks we like better than BP When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.* David and Tom just revealed what they believe are the ten best stocks for investors to buy right now... and BP wasn't one of them! That's right -- they think these 10 stocks are even better buys. See the 10 stocks *Stock Advisor returns as of August 1, 2020 John Bromels owns shares of BP, DuPont de Nemours, Inc., and The Dow Chemical Company. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	Its price-to-sales ratio and its price-to-free cash flow ratio are at or near the bottom of its peer group, and well below those of the other former DowDuPont components DuPont (NYSE: DD) and Corteva: DOW PS Ratio data by YCharts Meanwhile, Dow's 6.2% current dividend yield is higher than almost all of its peers' -- only German behemoth BASF's is higher at 6.3%. However, in the year since, it has proven that its streamlined portfolio of "performance chemicals" like coatings, adhesives, and lubricants is perfect for supporting a high-yielding dividend. That diversification allowed it to grow its free cash flow, even during the second quarter of 2020, as outperforming industries like healthcare counterbalanced underperformers like construction and manufacturing.	Its price-to-sales ratio and its price-to-free cash flow ratio are at or near the bottom of its peer group, and well below those of the other former DowDuPont components DuPont (NYSE: DD) and Corteva: DOW PS Ratio data by YCharts Meanwhile, Dow's 6.2% current dividend yield is higher than almost all of its peers' -- only German behemoth BASF's is higher at 6.3%. With a high yield, a low valuation compared to its peers, and consistent cash flow generation, Dow looks like a dividend stock worth buying. With all the oil majors posting negative net income in Q2 2020, we can't compare price to earnings, but BP's price-to-sales and price-to-cash from operations ratios compare favorably to those of its peers: BP PS Ratio data by YCharts With its dividend cut behind it, a low valuation, and a radical plan to improve performance, BP looks like a buy.	Its price-to-sales ratio and its price-to-free cash flow ratio are at or near the bottom of its peer group, and well below those of the other former DowDuPont components DuPont (NYSE: DD) and Corteva: DOW PS Ratio data by YCharts Meanwhile, Dow's 6.2% current dividend yield is higher than almost all of its peers' -- only German behemoth BASF's is higher at 6.3%. With all the oil majors posting negative net income in Q2 2020, we can't compare price to earnings, but BP's price-to-sales and price-to-cash from operations ratios compare favorably to those of its peers: BP PS Ratio data by YCharts With its dividend cut behind it, a low valuation, and a radical plan to improve performance, BP looks like a buy. See the 10 stocks *Stock Advisor returns as of August 1, 2020 John Bromels owns shares of BP, DuPont de Nemours, Inc., and The Dow Chemical Company.	Its price-to-sales ratio and its price-to-free cash flow ratio are at or near the bottom of its peer group, and well below those of the other former DowDuPont components DuPont (NYSE: DD) and Corteva: DOW PS Ratio data by YCharts Meanwhile, Dow's 6.2% current dividend yield is higher than almost all of its peers' -- only German behemoth BASF's is higher at 6.3%. Here's why they look like buys at their current prices. Not all "cheap" stocks are worth buying, and certainly there are some risks associated with these two stocks as well.	8fd57654-9038-4851-80af-6a80559b6bda
716253.0	2020-08-18 00:00:00 UTC	VAW, ECL, NEM, DD: ETF Outflow Alert	DD	https://www.nasdaq.com/articles/vaw-ecl-nem-dd%3A-etf-outflow-alert-2020-08-18	nan	nan	Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Vanguard Materials ETF (Symbol: VAW) where we have detected an approximate $148.9 million dollar outflow -- that's a 8.2% decrease week over week (from 13,376,411 to 12,276,411). Among the largest underlying components of VAW, in trading today Ecolab Inc (Symbol: ECL) is off about 0.3%, Newmont Corp (Symbol: NEM) is off about 1.9%, and DuPont (Symbol: DD) is lower by about 0.5%. For a complete list of holdings, visit the VAW Holdings page » The chart below shows the one year price performance of VAW, versus its 200 day moving average: Looking at the chart above, VAW's low point in its 52 week range is $81.10 per share, with $136.30 as the 52 week high point — that compares with a last trade of $135.39. Comparing the most recent share price to the 200 day moving average can also be a useful technical analysis technique -- learn more about the 200 day moving average ». Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units'' can be traded back and forth just like stocks, but can also be created or destroyed to accommodate investor demand. Each week we monitor the week-over-week change in shares outstanding data, to keep a lookout for those ETFs experiencing notable inflows (many new units created) or outflows (many old units destroyed). Creation of new units will mean the underlying holdings of the ETF need to be purchased, while destruction of units involves selling underlying holdings, so large flows can also impact the individual components held within ETFs. Click here to find out which 9 other ETFs experienced notable outflows » The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	Among the largest underlying components of VAW, in trading today Ecolab Inc (Symbol: ECL) is off about 0.3%, Newmont Corp (Symbol: NEM) is off about 1.9%, and DuPont (Symbol: DD) is lower by about 0.5%. For a complete list of holdings, visit the VAW Holdings page » The chart below shows the one year price performance of VAW, versus its 200 day moving average: Looking at the chart above, VAW's low point in its 52 week range is $81.10 per share, with $136.30 as the 52 week high point — that compares with a last trade of $135.39. These ''units'' can be traded back and forth just like stocks, but can also be created or destroyed to accommodate investor demand.	Among the largest underlying components of VAW, in trading today Ecolab Inc (Symbol: ECL) is off about 0.3%, Newmont Corp (Symbol: NEM) is off about 1.9%, and DuPont (Symbol: DD) is lower by about 0.5%. For a complete list of holdings, visit the VAW Holdings page » The chart below shows the one year price performance of VAW, versus its 200 day moving average: Looking at the chart above, VAW's low point in its 52 week range is $81.10 per share, with $136.30 as the 52 week high point — that compares with a last trade of $135.39. Each week we monitor the week-over-week change in shares outstanding data, to keep a lookout for those ETFs experiencing notable inflows (many new units created) or outflows (many old units destroyed).	Among the largest underlying components of VAW, in trading today Ecolab Inc (Symbol: ECL) is off about 0.3%, Newmont Corp (Symbol: NEM) is off about 1.9%, and DuPont (Symbol: DD) is lower by about 0.5%. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Vanguard Materials ETF (Symbol: VAW) where we have detected an approximate $148.9 million dollar outflow -- that's a 8.2% decrease week over week (from 13,376,411 to 12,276,411). For a complete list of holdings, visit the VAW Holdings page » The chart below shows the one year price performance of VAW, versus its 200 day moving average: Looking at the chart above, VAW's low point in its 52 week range is $81.10 per share, with $136.30 as the 52 week high point — that compares with a last trade of $135.39.	Among the largest underlying components of VAW, in trading today Ecolab Inc (Symbol: ECL) is off about 0.3%, Newmont Corp (Symbol: NEM) is off about 1.9%, and DuPont (Symbol: DD) is lower by about 0.5%. For a complete list of holdings, visit the VAW Holdings page » The chart below shows the one year price performance of VAW, versus its 200 day moving average: Looking at the chart above, VAW's low point in its 52 week range is $81.10 per share, with $136.30 as the 52 week high point — that compares with a last trade of $135.39. Each week we monitor the week-over-week change in shares outstanding data, to keep a lookout for those ETFs experiencing notable inflows (many new units created) or outflows (many old units destroyed).	0d280bd1-f361-44fb-a404-c737cc2c6e5c
716254.0	2020-08-10 00:00:00 UTC	3 Top Industrial Stocks to Buy Right Now	DD	https://www.nasdaq.com/articles/3-top-industrial-stocks-to-buy-right-now-2020-08-10	nan	nan	Industrial stocks may not be the most exciting companies to buy, but in a volatile market like this one, excitement isn't always a good thing. What many industrials do offer is low-key but reliable performance, saving the excitement for their dividend payouts, which can be well above average. Three high-yielding industrials that are looking strong in light of their second-quarter 2020 results are Brookfield Infrastructure Partners (NYSE: BIP), Dow (NYSE: DOW), and Stag Industrial (NYSE: STAG). Here's why you might want to put these boring yet impressive outperformers into your portfolio -- and their dividends into your pocket. Image source: Getty Images. Resilient cash flows Things were tough all over the stock market in Q2 2020, and it was the rare company that even came close to maintaining its Q2 2019 performance. One company that did so in many ways was master limited partnership (MLP) Brookfield Infrastructure Partners. For example, its revenue increased 15.5% year over year, to $1.9 billion. As Brookfield's CFO Bahir Manios put it on the Q2 2020 earnings call: "While many industries have been hard-hit, the infrastructure sector has demonstrated one of its most coveted characteristics, being its highly resilient cash flows." Sure enough, Brookfield churned out $333 million in funds from operations in Q2, which was down just 1.2% from Q2 2019. That number would have been $30 million higher -- and a 7.7% gain over the prior-year quarter -- if not for unfavorable currency effects due to depreciation of the Brazilian real. That resilient cash flow supports the MLP's generous distribution, currently yielding 4.7%. Management sees opportunity in the current economic environment, and plans to sell some mature assets for an expected $700 million, while keeping an eye out for bargains in distressed sectors like U.S. energy transportation and storage. Now looks like a great time to hop on board this outperformer. Making diversification work Businesses have trended away from diversification in recent years. Once seen as a way to protect against weakness in one business unit, excess diversification is now often faulted for weighing down companywide performance. For example, slumping industrial conglomerate General Electric has pared down its once-sprawling portfolio into just four core businesses (it hasn't helped much). The diversified chemical and materials companies Dow and DuPont (NYSE: DD) recently streamlined their businesses through a unique merger-and-split arrangement. They combined to form DowDuPont in 2015. In 2019, they spun off Corteva as an agricultural science pure-play, and split the rest of the portfolio between themselves. Dow kept the "performance chemicals" portfolio, which consists mostly of industrial chemicals like lubricants, adhesives, paints, and coatings. The thing is, despite this streamlining, Dow's portfolio is still quite diversified, and it's helping the company outperform. In Q2 2020, some of Dow's sales suffered due to the pandemic. Sales of big-ticket items like new homes, furniture, and cars plummeted, and so did sales of the industrial chemicals used to make them. However, sales of cleaning and disinfecting products, which also use Dow's chemicals, increased. As more people began cooking at home, food packaging demand went up. And even though professional construction chemical sales dropped, do-it-yourself home improvement rose, which benefited Dow's paints and coatings businesses. This diversified portfolio allowed Dow to outperform expectations, and to generate plenty of cash to fund its dividend, currently yielding 6.7%. Dow looks like an excellent buy right now for income investors. A bet on e-commerce E-commerce exploded in the U.S. as stay-at-home or similar orders affected more than 90% of the U.S. population this spring. And e-commerce intersects with the industrial sector in one important place -- the warehouse. Warehouses and distribution centers are critical for e-commerce companies, and as more retailers beef up their online sales, demand for these facilities should see tremendous growth. That growth was already boosting industrial real estate investment trust (REIT) Stag Industrial in Q2 2020. Stag owns industrial properties used for manufacturing, warehousing, and distribution across the country. Unlike other industrial REITs, Stag has deliberately avoided expensive metropolitan areas like New York City, preferring to buy cheaper properties in smaller cities and markets. That strategy paid off in Q2: Stag signed an 11-year lease for a 350,000-square-foot building in Taunton, Massachusetts -- about 40 miles south of Boston -- to an unidentified "dominant e-commerce tenant." It also leased a 250,000-square-foot building in Burlington, New Jersey -- about 20 miles northeast of Philadelphia -- to another (or maybe the same) unidentified "dominant e-commerce tenant." Perhaps relatedly, on the Q2 2020 earnings call, management revealed that Amazon was now the company's largest tenant, accounting for 2.5% of Stag's revenue, up from 1.9% in the first quarter. When you're in the distribution center business, that's a good tenant to have. With a 4.3% dividend yield and more property acquisitions expected in the second half of the year, now looks like a great time to buy into this unconventional industrial play. Boring can be exciting Famed investor Peter Lynch liked to buy boring companies. He believed they were often overlooked by the market and could thus be good bargains. Brookfield Infrastructure Partners, Dow, and Stag Industrial, with boring-but-reliable business models and above-average dividend yields, may not make for great cocktail party conversation, but they should add value to your portfolio. And that should be excitement enough for any investor. 10 stocks we like better than Stag Industrial When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.* David and Tom just revealed what they believe are the ten best stocks for investors to buy right now... and Stag Industrial wasn't one of them! That's right -- they think these 10 stocks are even better buys. See the 10 stocks *Stock Advisor returns as of June 2, 2020 John Mackey, CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool's board of directors. John Bromels owns shares of Amazon, Brookfield Infrastructure Partners, DuPont de Nemours, Inc., General Electric, and The Dow Chemical Company. The Motley Fool owns shares of and recommends Amazon and Stag Industrial. The Motley Fool recommends Brookfield Infrastructure Partners and recommends the following options: long January 2022 $1920 calls on Amazon and short January 2022 $1940 calls on Amazon. The Motley Fool has a disclosure policy. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	Brookfield Infrastructure Partners, Dow, and Stag Industrial, with boring-but-reliable business models and above-average dividend yields, may not make for great cocktail party conversation, but they should add value to your portfolio. The diversified chemical and materials companies Dow and DuPont (NYSE: DD) recently streamlined their businesses through a unique merger-and-split arrangement. As Brookfield's CFO Bahir Manios put it on the Q2 2020 earnings call: "While many industries have been hard-hit, the infrastructure sector has demonstrated one of its most coveted characteristics, being its highly resilient cash flows."	The diversified chemical and materials companies Dow and DuPont (NYSE: DD) recently streamlined their businesses through a unique merger-and-split arrangement. Brookfield Infrastructure Partners, Dow, and Stag Industrial, with boring-but-reliable business models and above-average dividend yields, may not make for great cocktail party conversation, but they should add value to your portfolio. Three high-yielding industrials that are looking strong in light of their second-quarter 2020 results are Brookfield Infrastructure Partners (NYSE: BIP), Dow (NYSE: DOW), and Stag Industrial (NYSE: STAG).	Brookfield Infrastructure Partners, Dow, and Stag Industrial, with boring-but-reliable business models and above-average dividend yields, may not make for great cocktail party conversation, but they should add value to your portfolio. The diversified chemical and materials companies Dow and DuPont (NYSE: DD) recently streamlined their businesses through a unique merger-and-split arrangement. Industrial stocks may not be the most exciting companies to buy, but in a volatile market like this one, excitement isn't always a good thing.	The diversified chemical and materials companies Dow and DuPont (NYSE: DD) recently streamlined their businesses through a unique merger-and-split arrangement. Brookfield Infrastructure Partners, Dow, and Stag Industrial, with boring-but-reliable business models and above-average dividend yields, may not make for great cocktail party conversation, but they should add value to your portfolio. Industrial stocks may not be the most exciting companies to buy, but in a volatile market like this one, excitement isn't always a good thing.	f6bf4de4-cb96-4020-ae62-5edf95f577e3
716255.0	2020-08-05 00:00:00 UTC	Noteworthy Wednesday Option Activity: DD, ADSK, GS	DD	https://www.nasdaq.com/articles/noteworthy-wednesday-option-activity%3A-dd-adsk-gs-2020-08-05	nan	nan	Looking at options trading activity among components of the S&P 500 index, there is noteworthy activity today in DuPont (Symbol: DD), where a total volume of 23,707 contracts has been traded thus far today, a contract volume which is representative of approximately 2.4 million underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 58.5% of DD's average daily trading volume over the past month, of 4.1 million shares. Especially high volume was seen for the $50 strike put option expiring August 21, 2020, with 10,048 contracts trading so far today, representing approximately 1.0 million underlying shares of DD. Below is a chart showing DD's trailing twelve month trading history, with the $50 strike highlighted in orange: Autodesk Inc (Symbol: ADSK) options are showing a volume of 6,435 contracts thus far today. That number of contracts represents approximately 643,500 underlying shares, working out to a sizeable 58.2% of ADSK's average daily trading volume over the past month, of 1.1 million shares. Particularly high volume was seen for the $250 strike call option expiring August 21, 2020, with 1,430 contracts trading so far today, representing approximately 143,000 underlying shares of ADSK. Below is a chart showing ADSK's trailing twelve month trading history, with the $250 strike highlighted in orange: And Goldman Sachs Group Inc (the (Symbol: GS) options are showing a volume of 21,752 contracts thus far today. That number of contracts represents approximately 2.2 million underlying shares, working out to a sizeable 56.6% of GS's average daily trading volume over the past month, of 3.8 million shares. Especially high volume was seen for the $210 strike call option expiring August 07, 2020, with 2,319 contracts trading so far today, representing approximately 231,900 underlying shares of GS. Below is a chart showing GS's trailing twelve month trading history, with the $210 strike highlighted in orange: For the various different available expirations for DD options, ADSK options, or GS options, visit StockOptionsChannel.com. Today's Most Active Call & Put Options of the S&P 500 » The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	Especially high volume was seen for the $50 strike put option expiring August 21, 2020, with 10,048 contracts trading so far today, representing approximately 1.0 million underlying shares of DD. Looking at options trading activity among components of the S&P 500 index, there is noteworthy activity today in DuPont (Symbol: DD), where a total volume of 23,707 contracts has been traded thus far today, a contract volume which is representative of approximately 2.4 million underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 58.5% of DD's average daily trading volume over the past month, of 4.1 million shares.	Below is a chart showing DD's trailing twelve month trading history, with the $50 strike highlighted in orange: Autodesk Inc (Symbol: ADSK) options are showing a volume of 6,435 contracts thus far today. Looking at options trading activity among components of the S&P 500 index, there is noteworthy activity today in DuPont (Symbol: DD), where a total volume of 23,707 contracts has been traded thus far today, a contract volume which is representative of approximately 2.4 million underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 58.5% of DD's average daily trading volume over the past month, of 4.1 million shares.	Looking at options trading activity among components of the S&P 500 index, there is noteworthy activity today in DuPont (Symbol: DD), where a total volume of 23,707 contracts has been traded thus far today, a contract volume which is representative of approximately 2.4 million underlying shares (given that every 1 contract represents 100 underlying shares). Especially high volume was seen for the $50 strike put option expiring August 21, 2020, with 10,048 contracts trading so far today, representing approximately 1.0 million underlying shares of DD. That number works out to 58.5% of DD's average daily trading volume over the past month, of 4.1 million shares.	Especially high volume was seen for the $50 strike put option expiring August 21, 2020, with 10,048 contracts trading so far today, representing approximately 1.0 million underlying shares of DD. Below is a chart showing GS's trailing twelve month trading history, with the $210 strike highlighted in orange: For the various different available expirations for DD options, ADSK options, or GS options, visit StockOptionsChannel.com. Looking at options trading activity among components of the S&P 500 index, there is noteworthy activity today in DuPont (Symbol: DD), where a total volume of 23,707 contracts has been traded thus far today, a contract volume which is representative of approximately 2.4 million underlying shares (given that every 1 contract represents 100 underlying shares).	83f12208-6104-4e3b-902b-f995fe23c92b
716256.0	2020-08-05 00:00:00 UTC	3 Dividend Stocks That Should Pay You for the Rest of Your Life	DD	https://www.nasdaq.com/articles/3-dividend-stocks-that-should-pay-you-for-the-rest-of-your-life-2020-08-05	nan	nan	It was a rude awakening for dividend investors when many companies slashed or suspended their dividends due to the economic fallout from the coronavirus pandemic. What had once been reliable income streams suddenly looked a lot less reliable. But for every company that cut its payout, there were others that kept the dividends coming...and seem likely to do so for years into the future. Three companies that should keep paying you a dividend for the rest of your life are NextEra Energy (NYSE: NEE), Dow Chemical (NYSE: DOW), and Apple (NASDAQ: AAPL). Here's why these look like solid dividend picks. Image source: Getty Images. Sunshine to cash Electricity giant NextEra Energy is one of the world's largest energy companies, and the biggest electrical utility in North America by number of customers. Its subsidiaries, Florida Power & Light and Gulf Power, provide electricity to about 5.5 million customers across the Sunshine State. All that air-conditioning uses up a lot of juice and provides the parent company with a lot of cash. Most of NextEra's electricity is generated from renewable sources like wind and solar farms across the U.S. Only about half of it goes to NextEra's utility customers; the rest is sold to third-party utilities, which puts even more cash at NextEra's disposal. What does it do with all that cash? NextEra invests some of it in growth projects to increase the amount of clean electricity it can generate (and sell). The company currently expects its earnings per share will grow at a compound annual rate of 6% to 8% through 2022. Much of the rest of that cash gets returned to shareholders in the form of a dividend, currently yielding 1.9%. That's expected to grow, too, at 10% per year through 2022. But even beyond 2022, NextEra looks likely to continue rewarding dividend-focused shareholders for a long time. Chemicals to cash Chemical company Dow has undergone a big transformation recently, but it's one that should benefit dividend investors for years to come. In 2015, the 118-year-old company merged with rival DuPont (NYSE: DD) to form DowDuPont. After the merger, the new company started divvying up its huge stable of products into three categories: specialty products, agriculture, and performance chemicals. In 2019, Dow was spun off with the last product group. Performance chemicals are basically chemicals used as part of a product or process. These include lubricants, coatings, packaging, and adhesives. Dow's performance chemicals are crucial to a number of industries, and that diversification makes the company a reliable generator of cash to fund its generous dividend. For example, even in Q2 2020, when demand for automotive and industrial chemicals was low, Dow churned out an impressive $1.6 billion in operating cash flow thanks to outsize demand for food packaging and health and hygiene applications. It also paid down about $600 million in debt while fully funding its dividend, currently yielding 6.6%. Dow's mature product portfolio may not lead to explosive growth, but it should continue funding a reliable dividend payout for decades to come. iPhones to cash You're probably used to thinking of people forking over cash to get an iPhone, but tech company Apple has been paying a dividend since 2012. Right now, the company's share price is at an all-time high, and its dividend yield of 0.8% is at a five-year low, which might discourage value investors. There's no question, though, about Apple's commitment to its dividend and its shareholders. Apple cranked out almost $59 billion in free cash flow in 2019. It has $93 billion in cash and marketable securities on its books, plus another "noncurrent" $100.6 billion of marketable securities. That means Apple could buy NextEra and Dow outright and still have some cash left over. It makes the $14.1 billion the company paid out in dividends in 2019 look absolutely puny by comparison. It has reduced its share count by more than 1 billion over the last five years, and demand for its products and services is still strong and seems likely to stay that way. Apple is a dividend payer for the long haul. The long term Instead of chasing after high yields, smart dividend investors go for reliable dividends. After all, a high-yielding company that's unreliable could cut or even eliminate its dividend. But shareholder-friendly companies with a strong history of cranking out impressive cash flow (like NextEra Energy, Dow, and Apple) could very well continue paying you for the rest of your life. 10 stocks we like better than Apple When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.* David and Tom just revealed what they believe are the ten best stocks for investors to buy right now... and Apple wasn't one of them! That's right -- they think these 10 stocks are even better buys. See the 10 stocks *Stock Advisor returns as of June 2, 2020 John Bromels owns shares of Apple, DowDuPont Inc., and The Dow Chemical Company. The Motley Fool owns shares of and recommends Apple. The Motley Fool recommends NextEra Energy. The Motley Fool has a disclosure policy. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	What had once been reliable income streams suddenly looked a lot less reliable. In 2015, the 118-year-old company merged with rival DuPont (NYSE: DD) to form DowDuPont. Dow's performance chemicals are crucial to a number of industries, and that diversification makes the company a reliable generator of cash to fund its generous dividend.	What had once been reliable income streams suddenly looked a lot less reliable. In 2015, the 118-year-old company merged with rival DuPont (NYSE: DD) to form DowDuPont. Three companies that should keep paying you a dividend for the rest of your life are NextEra Energy (NYSE: NEE), Dow Chemical (NYSE: DOW), and Apple (NASDAQ: AAPL).	What had once been reliable income streams suddenly looked a lot less reliable. In 2015, the 118-year-old company merged with rival DuPont (NYSE: DD) to form DowDuPont. Three companies that should keep paying you a dividend for the rest of your life are NextEra Energy (NYSE: NEE), Dow Chemical (NYSE: DOW), and Apple (NASDAQ: AAPL).	What had once been reliable income streams suddenly looked a lot less reliable. In 2015, the 118-year-old company merged with rival DuPont (NYSE: DD) to form DowDuPont. What does it do with all that cash?	b2934c24-6845-4ed2-9c68-19b7c962b92e
716257.0	2020-08-04 00:00:00 UTC	Look Under The Hood: EQWL Has 10% Upside	DD	https://www.nasdaq.com/articles/look-under-the-hood%3A-eqwl-has-10-upside-2020-08-04	nan	nan	Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Invesco S&P 100 Equal Weight ETF (Symbol: EQWL), we found that the implied analyst target price for the ETF based upon its underlying holdings is $64.79 per unit. With EQWL trading at a recent price near $58.67 per unit, that means that analysts see 10.43% upside for this ETF looking through to the average analyst targets of the underlying holdings. Three of EQWL's underlying holdings with notable upside to their analyst target prices are Chevron Corporation (Symbol: CVX), Exelon Corp (Symbol: EXC), and DuPont de Nemours Inc (Symbol: DD). Although CVX has traded at a recent price of $84.81/share, the average analyst target is 25.30% higher at $106.27/share. Similarly, EXC has 22.52% upside from the recent share price of $37.99 if the average analyst target price of $46.55/share is reached, and analysts on average are expecting DD to reach a target price of $62.77/share, which is 19.65% above the recent price of $52.46. Below is a twelve month price history chart comparing the stock performance of CVX, EXC, and DD: Below is a summary table of the current analyst target prices discussed above: NAME SYMBOL RECENT PRICE AVG. ANALYST 12-MO. TARGET % UPSIDE TO TARGET Invesco S&P 100 Equal Weight ETF EQWL $58.67 $64.79 10.43% Chevron Corporation CVX $84.81 $106.27 25.30% Exelon Corp EXC $37.99 $46.55 22.52% DuPont de Nemours Inc DD $52.46 $62.77 19.65% Are analysts justified in these targets, or overly optimistic about where these stocks will be trading 12 months from now? Do the analysts have a valid justification for their targets, or are they behind the curve on recent company and industry developments? A high price target relative to a stock's trading price can reflect optimism about the future, but can also be a precursor to target price downgrades if the targets were a relic of the past. These are questions that require further investor research. 10 ETFs With Most Upside To Analyst Targets » The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	Invesco S&P 100 Equal Weight ETF EQWL $58.67 $64.79 10.43% Chevron Corporation CVX $84.81 $106.27 25.30% Exelon Corp EXC $37.99 $46.55 22.52% DuPont de Nemours Inc DD $52.46 $62.77 19.65% Are analysts justified in these targets, or overly optimistic about where these stocks will be trading 12 months from now? Three of EQWL's underlying holdings with notable upside to their analyst target prices are Chevron Corporation (Symbol: CVX), Exelon Corp (Symbol: EXC), and DuPont de Nemours Inc (Symbol: DD). Similarly, EXC has 22.52% upside from the recent share price of $37.99 if the average analyst target price of $46.55/share is reached, and analysts on average are expecting DD to reach a target price of $62.77/share, which is 19.65% above the recent price of $52.46.	Three of EQWL's underlying holdings with notable upside to their analyst target prices are Chevron Corporation (Symbol: CVX), Exelon Corp (Symbol: EXC), and DuPont de Nemours Inc (Symbol: DD). Invesco S&P 100 Equal Weight ETF EQWL $58.67 $64.79 10.43% Chevron Corporation CVX $84.81 $106.27 25.30% Exelon Corp EXC $37.99 $46.55 22.52% DuPont de Nemours Inc DD $52.46 $62.77 19.65% Are analysts justified in these targets, or overly optimistic about where these stocks will be trading 12 months from now? Similarly, EXC has 22.52% upside from the recent share price of $37.99 if the average analyst target price of $46.55/share is reached, and analysts on average are expecting DD to reach a target price of $62.77/share, which is 19.65% above the recent price of $52.46.	Similarly, EXC has 22.52% upside from the recent share price of $37.99 if the average analyst target price of $46.55/share is reached, and analysts on average are expecting DD to reach a target price of $62.77/share, which is 19.65% above the recent price of $52.46. Three of EQWL's underlying holdings with notable upside to their analyst target prices are Chevron Corporation (Symbol: CVX), Exelon Corp (Symbol: EXC), and DuPont de Nemours Inc (Symbol: DD). Below is a twelve month price history chart comparing the stock performance of CVX, EXC, and DD: Below is a summary table of the current analyst target prices discussed above:	Invesco S&P 100 Equal Weight ETF EQWL $58.67 $64.79 10.43% Chevron Corporation CVX $84.81 $106.27 25.30% Exelon Corp EXC $37.99 $46.55 22.52% DuPont de Nemours Inc DD $52.46 $62.77 19.65% Are analysts justified in these targets, or overly optimistic about where these stocks will be trading 12 months from now? Three of EQWL's underlying holdings with notable upside to their analyst target prices are Chevron Corporation (Symbol: CVX), Exelon Corp (Symbol: EXC), and DuPont de Nemours Inc (Symbol: DD). Similarly, EXC has 22.52% upside from the recent share price of $37.99 if the average analyst target price of $46.55/share is reached, and analysts on average are expecting DD to reach a target price of $62.77/share, which is 19.65% above the recent price of $52.46.	ad200d9c-1896-44d3-b8ae-85cfc1c05d5d
716258.0	2020-07-30 00:00:00 UTC	DuPont (DD) Shares Cross Below 200 DMA	DD	https://www.nasdaq.com/articles/dupont-dd-shares-cross-below-200-dma-2020-07-30	nan	nan	In trading on Thursday, shares of DuPont (Symbol: DD) crossed below their 200 day moving average of $53.33, changing hands as low as $52.16 per share. DuPont shares are currently trading off about 3.6% on the day. The chart below shows the one year performance of DD shares, versus its 200 day moving average: Looking at the chart above, DD's low point in its 52 week range is $28.33 per share, with $73.80 as the 52 week high point — that compares with a last trade of $53.21. The DD DMA information above was sourced from TechnicalAnalysisChannel.com Click here to find out which 9 other stocks recently crossed below their 200 day moving average » The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	In trading on Thursday, shares of DuPont (Symbol: DD) crossed below their 200 day moving average of $53.33, changing hands as low as $52.16 per share. The chart below shows the one year performance of DD shares, versus its 200 day moving average: Looking at the chart above, DD's low point in its 52 week range is $28.33 per share, with $73.80 as the 52 week high point — that compares with a last trade of $53.21. The DD DMA information above was sourced from TechnicalAnalysisChannel.com Click here to find out which 9 other stocks recently crossed below their 200 day moving average » The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	In trading on Thursday, shares of DuPont (Symbol: DD) crossed below their 200 day moving average of $53.33, changing hands as low as $52.16 per share. The chart below shows the one year performance of DD shares, versus its 200 day moving average: Looking at the chart above, DD's low point in its 52 week range is $28.33 per share, with $73.80 as the 52 week high point — that compares with a last trade of $53.21. The DD DMA information above was sourced from TechnicalAnalysisChannel.com Click here to find out which 9 other stocks recently crossed below their 200 day moving average » The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	In trading on Thursday, shares of DuPont (Symbol: DD) crossed below their 200 day moving average of $53.33, changing hands as low as $52.16 per share. The chart below shows the one year performance of DD shares, versus its 200 day moving average: Looking at the chart above, DD's low point in its 52 week range is $28.33 per share, with $73.80 as the 52 week high point — that compares with a last trade of $53.21. The DD DMA information above was sourced from TechnicalAnalysisChannel.com Click here to find out which 9 other stocks recently crossed below their 200 day moving average » The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	In trading on Thursday, shares of DuPont (Symbol: DD) crossed below their 200 day moving average of $53.33, changing hands as low as $52.16 per share. The chart below shows the one year performance of DD shares, versus its 200 day moving average: Looking at the chart above, DD's low point in its 52 week range is $28.33 per share, with $73.80 as the 52 week high point — that compares with a last trade of $53.21. The DD DMA information above was sourced from TechnicalAnalysisChannel.com Click here to find out which 9 other stocks recently crossed below their 200 day moving average » The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	73de50bd-05ec-4482-ac99-1ad6b20a624b
716259.0	2020-07-30 00:00:00 UTC	DuPont takes $2.5 bln charge tied to auto business, posts wider loss	DD	https://www.nasdaq.com/articles/dupont-takes-%242.5-bln-charge-tied-to-auto-business-posts-wider-loss-2020-07-30-0	nan	nan	Compares with estimates, share price July 30 (Reuters) - DuPont DD.N reported a bigger second-quarter loss on Thursday and wrote down the value of its automotive business by $2.5 billion as the industrial materials giant struggles with a prolonged weakness in one of its biggest markets. DuPont, which makes materials used in products ranging from engine covers to brake fluid, is heavily exposed to the auto industry, which has been among the hardest hit after the coronavirus lockdowns emptied roads and shuttered car showrooms. The company, however, beat estimates for both adjusted profit and sales, helped by cost cuts and higher organic sales in its nutrition and electronics units, which benefited from a surge in demand for food ingredients and memory chips. DuPont shares were flat in early trade. The company booked the impairment charge under its Transportation & Industrial segment, which reported the sharpest decline in sales at 34%, saying the business was now worth less because of continued weakness in global automotive production. Even before the outbreak, DuPont had been grappling with lower sales in the unit, particularly due to lower prices for nylon, a stiff plastic used in making auto parts and industrial equipment. Expecting a modest revival in automotive and residential construction industries, DuPont projected adjusted earnings between 71 and 73 cents for the current quarter, marginally above the 71 cents estimated by analysts according to Refinitiv IBES data. Net loss available to shareholders, which included the hefty charge, was $2.48 billion, or $3.37 per share, in the three months ended June 30 compared to a loss of $571 million, or 76 cents per share, a year earlier. On an adjusted basis, DuPont posted earnings of 70 cents per share, handily beating 59 cents estimated by analysts. The Wilmington, Delaware-based company, once part of the conglomerate DowDuPont that was split up last year, reported sales of $4.8 billion, just above estimates of $4.7 billion. (Reporting by Taru Jain in Bengaluru Editing by Arathy Nair and Tomasz Janowski Editing by Arathy Nair and Tomasz Janowski) ((Taru.Jain@thomsonreuters.com;)) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	Compares with estimates, share price July 30 (Reuters) - DuPont DD.N reported a bigger second-quarter loss on Thursday and wrote down the value of its automotive business by $2.5 billion as the industrial materials giant struggles with a prolonged weakness in one of its biggest markets. DuPont, which makes materials used in products ranging from engine covers to brake fluid, is heavily exposed to the auto industry, which has been among the hardest hit after the coronavirus lockdowns emptied roads and shuttered car showrooms. The company booked the impairment charge under its Transportation & Industrial segment, which reported the sharpest decline in sales at 34%, saying the business was now worth less because of continued weakness in global automotive production.	Compares with estimates, share price July 30 (Reuters) - DuPont DD.N reported a bigger second-quarter loss on Thursday and wrote down the value of its automotive business by $2.5 billion as the industrial materials giant struggles with a prolonged weakness in one of its biggest markets. On an adjusted basis, DuPont posted earnings of 70 cents per share, handily beating 59 cents estimated by analysts. (Reporting by Taru Jain in Bengaluru Editing by Arathy Nair and Tomasz Janowski Editing by Arathy Nair and Tomasz Janowski) ((Taru.Jain@thomsonreuters.com;)) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	Compares with estimates, share price July 30 (Reuters) - DuPont DD.N reported a bigger second-quarter loss on Thursday and wrote down the value of its automotive business by $2.5 billion as the industrial materials giant struggles with a prolonged weakness in one of its biggest markets. Expecting a modest revival in automotive and residential construction industries, DuPont projected adjusted earnings between 71 and 73 cents for the current quarter, marginally above the 71 cents estimated by analysts according to Refinitiv IBES data. On an adjusted basis, DuPont posted earnings of 70 cents per share, handily beating 59 cents estimated by analysts.	Compares with estimates, share price July 30 (Reuters) - DuPont DD.N reported a bigger second-quarter loss on Thursday and wrote down the value of its automotive business by $2.5 billion as the industrial materials giant struggles with a prolonged weakness in one of its biggest markets. Net loss available to shareholders, which included the hefty charge, was $2.48 billion, or $3.37 per share, in the three months ended June 30 compared to a loss of $571 million, or 76 cents per share, a year earlier. On an adjusted basis, DuPont posted earnings of 70 cents per share, handily beating 59 cents estimated by analysts.	b74702ea-f7e3-44d1-ba41-d00dca578d7c
716260.0	2020-07-30 00:00:00 UTC	DuPont Guides Q3 Adj. EPS In Line With View - Quick Facts	DD	https://www.nasdaq.com/articles/dupont-guides-q3-adj.-eps-in-line-with-view-quick-facts-2020-07-30	nan	nan	(RTTNews) - While reporting financial results for the second quarter on Thursday, DuPont (DD) provided adjusted earnings and sales growth guidance for the third quarter. For the third quarter, the company projects adjusted earnings in a range of $0.71 to $0.73 per share on a slight sequential growth in sales. On average, 13 analysts polled by Thomson Reuters expect the company to report earnings of $0.71 per share on a sales decline of 7.5 percent to $5.02 billion for the quarter. Analysts' estimates typically exclude special items. The company expects sales to improve in automotive and residential construction mostly offset by seasonal patterns in Nutrition & Biosciences as well as the impact of supply constraints across its Tyvek enterprise as it performs routine maintenance on the assets. Oil & gas, aerospace, industrial, and commercial construction markets will remain challenged. The company had suspended its financial guidance for the full-year 2020 in April, due to global softening in automotive, oil & gas and select industrial end-markets as well as the unknown duration and intensity of the pandemic. Over the next six months, the company will continue the integration planning work with IFF to enable a smooth, successful launch and position the future combined company to achieve its committed cost and revenue synergies. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	(RTTNews) - While reporting financial results for the second quarter on Thursday, DuPont (DD) provided adjusted earnings and sales growth guidance for the third quarter. On average, 13 analysts polled by Thomson Reuters expect the company to report earnings of $0.71 per share on a sales decline of 7.5 percent to $5.02 billion for the quarter. The company expects sales to improve in automotive and residential construction mostly offset by seasonal patterns in Nutrition & Biosciences as well as the impact of supply constraints across its Tyvek enterprise as it performs routine maintenance on the assets.	(RTTNews) - While reporting financial results for the second quarter on Thursday, DuPont (DD) provided adjusted earnings and sales growth guidance for the third quarter. For the third quarter, the company projects adjusted earnings in a range of $0.71 to $0.73 per share on a slight sequential growth in sales. On average, 13 analysts polled by Thomson Reuters expect the company to report earnings of $0.71 per share on a sales decline of 7.5 percent to $5.02 billion for the quarter.	(RTTNews) - While reporting financial results for the second quarter on Thursday, DuPont (DD) provided adjusted earnings and sales growth guidance for the third quarter. On average, 13 analysts polled by Thomson Reuters expect the company to report earnings of $0.71 per share on a sales decline of 7.5 percent to $5.02 billion for the quarter. The company had suspended its financial guidance for the full-year 2020 in April, due to global softening in automotive, oil & gas and select industrial end-markets as well as the unknown duration and intensity of the pandemic.	(RTTNews) - While reporting financial results for the second quarter on Thursday, DuPont (DD) provided adjusted earnings and sales growth guidance for the third quarter. For the third quarter, the company projects adjusted earnings in a range of $0.71 to $0.73 per share on a slight sequential growth in sales. On average, 13 analysts polled by Thomson Reuters expect the company to report earnings of $0.71 per share on a sales decline of 7.5 percent to $5.02 billion for the quarter.	a3dc14b8-c140-4d29-997a-1078aaf0b7a4
716261.0	2020-07-30 00:00:00 UTC	EI DuPont De Nemours & Co. Q2 adjusted earnings Beat Estimates	DD	https://www.nasdaq.com/articles/ei-dupont-de-nemours-co.-q2-adjusted-earnings-beat-estimates-2020-07-30	nan	nan	(RTTNews) - Below are the earnings highlights for EI DuPont De Nemours & Co. (DD): -Earnings: -$2.48 billion in Q2 vs. -$0.57 billion in the same period last year. -EPS: -$3.37 in Q2 vs. -$0.76 in the same period last year. -Excluding items, EI DuPont De Nemours & Co. reported adjusted earnings of $514 million or $0.70 per share for the period. -Analysts projected $0.59 per share -Revenue: $4.83 billion in Q2 vs. $5.47 billion in the same period last year. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	(RTTNews) - Below are the earnings highlights for EI DuPont De Nemours & Co. (DD): -Earnings: -$2.48 billion in Q2 vs. -$0.57 billion in the same period last year. -Excluding items, EI DuPont De Nemours & Co. reported adjusted earnings of $514 million or $0.70 per share for the period. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	(RTTNews) - Below are the earnings highlights for EI DuPont De Nemours & Co. (DD): -Earnings: -$2.48 billion in Q2 vs. -$0.57 billion in the same period last year. -Excluding items, EI DuPont De Nemours & Co. reported adjusted earnings of $514 million or $0.70 per share for the period. -Analysts projected $0.59 per share -Revenue: $4.83 billion in Q2 vs. $5.47 billion in the same period last year.	(RTTNews) - Below are the earnings highlights for EI DuPont De Nemours & Co. (DD): -Earnings: -$2.48 billion in Q2 vs. -$0.57 billion in the same period last year. -Analysts projected $0.59 per share -Revenue: $4.83 billion in Q2 vs. $5.47 billion in the same period last year. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	(RTTNews) - Below are the earnings highlights for EI DuPont De Nemours & Co. (DD): -Earnings: -$2.48 billion in Q2 vs. -$0.57 billion in the same period last year. -EPS: -$3.37 in Q2 vs. -$0.76 in the same period last year. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	7e64b3e6-36eb-4e0a-a5ac-8c88719a59a0
716262.0	2020-07-30 00:00:00 UTC	DuPont takes $2.5 bln charge tied to auto business, posts wider loss	DD	https://www.nasdaq.com/articles/dupont-takes-%242.5-bln-charge-tied-to-auto-business-posts-wider-loss-2020-07-30	nan	nan	July 30 (Reuters) - DuPont DD.N reported a wider second-quarter loss on Thursday and wrote down the value of its automotive business by $2.5 billion as the industrial materials giant struggles with a prolonged weakness in one of its biggest end-markets. DuPont, which makes materials used in products ranging from engine covers to brake fluid, is heavily exposed to the auto industry, which has been among the hardest hit after the coronavirus lockdowns emptied roads and shuttered car showrooms. The company booked the impairment charge under its Transportation & Industrial segment, which reported the sharpest decline in sales at 34%, saying the business was now worth less because of continued weakness in global automotive production. Even before the outbreak, DuPont had been grappling with lower sales in the unit, particularly due to lower prices for nylon, a stiff plastic used in making auto parts and industrial equipment. However, its nutrition and electronics units benefited from robust demand for food ingredients and memory chips with both businesses reporting growth in organic sales. Expecting a modest revival in automotive and residential construction industries, DuPont projected adjusted earnings between 71 and 73 cents for the current quarter, marginally above the 71 cents estimated by analysts according to Refinitiv IBES data. Net loss available to shareholders, which included the hefty charge, was $2.48 billion, or $3.37 per share, in the three months ended June 30 compared to a loss of $571 million, or 76 cents per share, a year earlier. On an adjusted basis, DuPont posted earnings of 70 cents per share, a fall of about 28% as the company idled some of its plants to match lower demand levels. The Wilmington, Delaware-based company, once part of the conglomerate DowDuPont that was split up last year, reported a 12% fall in sales to $4.8 billion. (Reporting by Taru Jain in Bengaluru Editing by Arathy Nair and Tomasz Janowski) ((Taru.Jain@thomsonreuters.com;)) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	July 30 (Reuters) - DuPont DD.N reported a wider second-quarter loss on Thursday and wrote down the value of its automotive business by $2.5 billion as the industrial materials giant struggles with a prolonged weakness in one of its biggest end-markets. DuPont, which makes materials used in products ranging from engine covers to brake fluid, is heavily exposed to the auto industry, which has been among the hardest hit after the coronavirus lockdowns emptied roads and shuttered car showrooms. The company booked the impairment charge under its Transportation & Industrial segment, which reported the sharpest decline in sales at 34%, saying the business was now worth less because of continued weakness in global automotive production.	July 30 (Reuters) - DuPont DD.N reported a wider second-quarter loss on Thursday and wrote down the value of its automotive business by $2.5 billion as the industrial materials giant struggles with a prolonged weakness in one of its biggest end-markets. Even before the outbreak, DuPont had been grappling with lower sales in the unit, particularly due to lower prices for nylon, a stiff plastic used in making auto parts and industrial equipment. On an adjusted basis, DuPont posted earnings of 70 cents per share, a fall of about 28% as the company idled some of its plants to match lower demand levels.	July 30 (Reuters) - DuPont DD.N reported a wider second-quarter loss on Thursday and wrote down the value of its automotive business by $2.5 billion as the industrial materials giant struggles with a prolonged weakness in one of its biggest end-markets. The company booked the impairment charge under its Transportation & Industrial segment, which reported the sharpest decline in sales at 34%, saying the business was now worth less because of continued weakness in global automotive production. Expecting a modest revival in automotive and residential construction industries, DuPont projected adjusted earnings between 71 and 73 cents for the current quarter, marginally above the 71 cents estimated by analysts according to Refinitiv IBES data.	July 30 (Reuters) - DuPont DD.N reported a wider second-quarter loss on Thursday and wrote down the value of its automotive business by $2.5 billion as the industrial materials giant struggles with a prolonged weakness in one of its biggest end-markets. DuPont, which makes materials used in products ranging from engine covers to brake fluid, is heavily exposed to the auto industry, which has been among the hardest hit after the coronavirus lockdowns emptied roads and shuttered car showrooms. On an adjusted basis, DuPont posted earnings of 70 cents per share, a fall of about 28% as the company idled some of its plants to match lower demand levels.	851132ce-7ea3-45d5-8ded-3e7923dcd36d
716263.0	2020-07-17 00:00:00 UTC	Notable Friday Option Activity: APD, DD, AZO	DD	https://www.nasdaq.com/articles/notable-friday-option-activity%3A-apd-dd-azo-2020-07-17	nan	nan	Looking at options trading activity among components of the S&P 500 index, there is noteworthy activity today in Air Products & Chemicals Inc (Symbol: APD), where a total volume of 10,759 contracts has been traded thus far today, a contract volume which is representative of approximately 1.1 million underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 77.7% of APD's average daily trading volume over the past month, of 1.4 million shares. Especially high volume was seen for the $250 strike call option expiring August 21, 2020, with 7,501 contracts trading so far today, representing approximately 750,100 underlying shares of APD. Below is a chart showing APD's trailing twelve month trading history, with the $250 strike highlighted in orange: DuPont (Symbol: DD) saw options trading volume of 34,865 contracts, representing approximately 3.5 million underlying shares or approximately 73.1% of DD's average daily trading volume over the past month, of 4.8 million shares. Particularly high volume was seen for the $50 strike put option expiring August 21, 2020, with 15,027 contracts trading so far today, representing approximately 1.5 million underlying shares of DD. Below is a chart showing DD's trailing twelve month trading history, with the $50 strike highlighted in orange: And AutoZone, Inc. (Symbol: AZO) options are showing a volume of 969 contracts thus far today. That number of contracts represents approximately 96,900 underlying shares, working out to a sizeable 46.1% of AZO's average daily trading volume over the past month, of 210,175 shares. Especially high volume was seen for the $1125 strike call option expiring July 17, 2020, with 189 contracts trading so far today, representing approximately 18,900 underlying shares of AZO. Below is a chart showing AZO's trailing twelve month trading history, with the $1125 strike highlighted in orange: For the various different available expirations for APD options, DD options, or AZO options, visit StockOptionsChannel.com. Today's Most Active Call & Put Options of the S&P 500 » The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	Particularly high volume was seen for the $50 strike put option expiring August 21, 2020, with 15,027 contracts trading so far today, representing approximately 1.5 million underlying shares of DD. Below is a chart showing APD's trailing twelve month trading history, with the $250 strike highlighted in orange: DuPont (Symbol: DD) saw options trading volume of 34,865 contracts, representing approximately 3.5 million underlying shares or approximately 73.1% of DD's average daily trading volume over the past month, of 4.8 million shares. Below is a chart showing DD's trailing twelve month trading history, with the $50 strike highlighted in orange: And AutoZone, Inc. (Symbol: AZO) options are showing a volume of 969 contracts thus far today.	Below is a chart showing APD's trailing twelve month trading history, with the $250 strike highlighted in orange: DuPont (Symbol: DD) saw options trading volume of 34,865 contracts, representing approximately 3.5 million underlying shares or approximately 73.1% of DD's average daily trading volume over the past month, of 4.8 million shares. Particularly high volume was seen for the $50 strike put option expiring August 21, 2020, with 15,027 contracts trading so far today, representing approximately 1.5 million underlying shares of DD. Below is a chart showing DD's trailing twelve month trading history, with the $50 strike highlighted in orange: And AutoZone, Inc. (Symbol: AZO) options are showing a volume of 969 contracts thus far today.	Below is a chart showing APD's trailing twelve month trading history, with the $250 strike highlighted in orange: DuPont (Symbol: DD) saw options trading volume of 34,865 contracts, representing approximately 3.5 million underlying shares or approximately 73.1% of DD's average daily trading volume over the past month, of 4.8 million shares. Particularly high volume was seen for the $50 strike put option expiring August 21, 2020, with 15,027 contracts trading so far today, representing approximately 1.5 million underlying shares of DD. Below is a chart showing DD's trailing twelve month trading history, with the $50 strike highlighted in orange: And AutoZone, Inc. (Symbol: AZO) options are showing a volume of 969 contracts thus far today.	Below is a chart showing APD's trailing twelve month trading history, with the $250 strike highlighted in orange: DuPont (Symbol: DD) saw options trading volume of 34,865 contracts, representing approximately 3.5 million underlying shares or approximately 73.1% of DD's average daily trading volume over the past month, of 4.8 million shares. Particularly high volume was seen for the $50 strike put option expiring August 21, 2020, with 15,027 contracts trading so far today, representing approximately 1.5 million underlying shares of DD. Below is a chart showing AZO's trailing twelve month trading history, with the $1125 strike highlighted in orange: For the various different available expirations for APD options, DD options, or AZO options, visit StockOptionsChannel.com.	b9b53123-1faf-4ce7-aa70-66938156349b
716264.0	2020-06-30 00:00:00 UTC	Notable Tuesday Option Activity: HUM, DD, RGR	DD	https://www.nasdaq.com/articles/notable-tuesday-option-activity%3A-hum-dd-rgr-2020-06-30	nan	nan	Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Humana Inc. (Symbol: HUM), where a total volume of 4,331 contracts has been traded thus far today, a contract volume which is representative of approximately 433,100 underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 45.9% of HUM's average daily trading volume over the past month, of 942,890 shares. Particularly high volume was seen for the $380 strike put option expiring July 02, 2020, with 852 contracts trading so far today, representing approximately 85,200 underlying shares of HUM. Below is a chart showing HUM's trailing twelve month trading history, with the $380 strike highlighted in orange: DuPont (Symbol: DD) saw options trading volume of 28,080 contracts, representing approximately 2.8 million underlying shares or approximately 45.2% of DD's average daily trading volume over the past month, of 6.2 million shares. Especially high volume was seen for the $60 strike call option expiring October 16, 2020, with 11,644 contracts trading so far today, representing approximately 1.2 million underlying shares of DD. Below is a chart showing DD's trailing twelve month trading history, with the $60 strike highlighted in orange: And Sturm, Ruger & Co., Inc. (Symbol: RGR) saw options trading volume of 1,828 contracts, representing approximately 182,800 underlying shares or approximately 43.6% of RGR's average daily trading volume over the past month, of 419,165 shares. Especially high volume was seen for the $85 strike call option expiring July 17, 2020, with 306 contracts trading so far today, representing approximately 30,600 underlying shares of RGR. Below is a chart showing RGR's trailing twelve month trading history, with the $85 strike highlighted in orange: For the various different available expirations for HUM options, DD options, or RGR options, visit StockOptionsChannel.com. Today's Most Active Call & Put Options of the S&P 500 » The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	Especially high volume was seen for the $60 strike call option expiring October 16, 2020, with 11,644 contracts trading so far today, representing approximately 1.2 million underlying shares of DD. Below is a chart showing HUM's trailing twelve month trading history, with the $380 strike highlighted in orange: DuPont (Symbol: DD) saw options trading volume of 28,080 contracts, representing approximately 2.8 million underlying shares or approximately 45.2% of DD's average daily trading volume over the past month, of 6.2 million shares. Below is a chart showing DD's trailing twelve month trading history, with the $60 strike highlighted in orange: And Sturm, Ruger & Co., Inc. (Symbol: RGR) saw options trading volume of 1,828 contracts, representing approximately 182,800 underlying shares or approximately 43.6% of RGR's average daily trading volume over the past month, of 419,165 shares.	Below is a chart showing HUM's trailing twelve month trading history, with the $380 strike highlighted in orange: DuPont (Symbol: DD) saw options trading volume of 28,080 contracts, representing approximately 2.8 million underlying shares or approximately 45.2% of DD's average daily trading volume over the past month, of 6.2 million shares. Below is a chart showing DD's trailing twelve month trading history, with the $60 strike highlighted in orange: And Sturm, Ruger & Co., Inc. (Symbol: RGR) saw options trading volume of 1,828 contracts, representing approximately 182,800 underlying shares or approximately 43.6% of RGR's average daily trading volume over the past month, of 419,165 shares. Especially high volume was seen for the $60 strike call option expiring October 16, 2020, with 11,644 contracts trading so far today, representing approximately 1.2 million underlying shares of DD.	Below is a chart showing HUM's trailing twelve month trading history, with the $380 strike highlighted in orange: DuPont (Symbol: DD) saw options trading volume of 28,080 contracts, representing approximately 2.8 million underlying shares or approximately 45.2% of DD's average daily trading volume over the past month, of 6.2 million shares. Below is a chart showing DD's trailing twelve month trading history, with the $60 strike highlighted in orange: And Sturm, Ruger & Co., Inc. (Symbol: RGR) saw options trading volume of 1,828 contracts, representing approximately 182,800 underlying shares or approximately 43.6% of RGR's average daily trading volume over the past month, of 419,165 shares. Especially high volume was seen for the $60 strike call option expiring October 16, 2020, with 11,644 contracts trading so far today, representing approximately 1.2 million underlying shares of DD.	Below is a chart showing HUM's trailing twelve month trading history, with the $380 strike highlighted in orange: DuPont (Symbol: DD) saw options trading volume of 28,080 contracts, representing approximately 2.8 million underlying shares or approximately 45.2% of DD's average daily trading volume over the past month, of 6.2 million shares. Below is a chart showing DD's trailing twelve month trading history, with the $60 strike highlighted in orange: And Sturm, Ruger & Co., Inc. (Symbol: RGR) saw options trading volume of 1,828 contracts, representing approximately 182,800 underlying shares or approximately 43.6% of RGR's average daily trading volume over the past month, of 419,165 shares. Especially high volume was seen for the $60 strike call option expiring October 16, 2020, with 11,644 contracts trading so far today, representing approximately 1.2 million underlying shares of DD.	a4a97399-be13-4b66-83b0-64c519bb0bc3
716265.0	2020-06-18 00:00:00 UTC	Notable Thursday Option Activity: KMX, BA, DD	DD	https://www.nasdaq.com/articles/notable-thursday-option-activity%3A-kmx-ba-dd-2020-06-18	nan	nan	Looking at options trading activity among components of the S&P 500 index, there is noteworthy activity today in Carmax Inc. (Symbol: KMX), where a total volume of 9,430 contracts has been traded thus far today, a contract volume which is representative of approximately 943,000 underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 57.7% of KMX's average daily trading volume over the past month, of 1.6 million shares. Particularly high volume was seen for the $100 strike call option expiring June 19, 2020, with 1,375 contracts trading so far today, representing approximately 137,500 underlying shares of KMX. Below is a chart showing KMX's trailing twelve month trading history, with the $100 strike highlighted in orange: Boeing Co. (Symbol: BA) options are showing a volume of 307,605 contracts thus far today. That number of contracts represents approximately 30.8 million underlying shares, working out to a sizeable 53.6% of BA's average daily trading volume over the past month, of 57.3 million shares. Particularly high volume was seen for the $200 strike call option expiring June 19, 2020, with 27,427 contracts trading so far today, representing approximately 2.7 million underlying shares of BA. Below is a chart showing BA's trailing twelve month trading history, with the $200 strike highlighted in orange: And DuPont (Symbol: DD) options are showing a volume of 33,498 contracts thus far today. That number of contracts represents approximately 3.3 million underlying shares, working out to a sizeable 53% of DD's average daily trading volume over the past month, of 6.3 million shares. Particularly high volume was seen for the $52.50 strike put option expiring June 19, 2020, with 8,738 contracts trading so far today, representing approximately 873,800 underlying shares of DD. Below is a chart showing DD's trailing twelve month trading history, with the $52.50 strike highlighted in orange: For the various different available expirations for KMX options, BA options, or DD options, visit StockOptionsChannel.com. Today's Most Active Call & Put Options of the S&P 500 » The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	Particularly high volume was seen for the $52.50 strike put option expiring June 19, 2020, with 8,738 contracts trading so far today, representing approximately 873,800 underlying shares of DD. Below is a chart showing BA's trailing twelve month trading history, with the $200 strike highlighted in orange: And DuPont (Symbol: DD) options are showing a volume of 33,498 contracts thus far today. That number of contracts represents approximately 3.3 million underlying shares, working out to a sizeable 53% of DD's average daily trading volume over the past month, of 6.3 million shares.	That number of contracts represents approximately 3.3 million underlying shares, working out to a sizeable 53% of DD's average daily trading volume over the past month, of 6.3 million shares. Below is a chart showing BA's trailing twelve month trading history, with the $200 strike highlighted in orange: And DuPont (Symbol: DD) options are showing a volume of 33,498 contracts thus far today. Particularly high volume was seen for the $52.50 strike put option expiring June 19, 2020, with 8,738 contracts trading so far today, representing approximately 873,800 underlying shares of DD.	That number of contracts represents approximately 3.3 million underlying shares, working out to a sizeable 53% of DD's average daily trading volume over the past month, of 6.3 million shares. Below is a chart showing BA's trailing twelve month trading history, with the $200 strike highlighted in orange: And DuPont (Symbol: DD) options are showing a volume of 33,498 contracts thus far today. Particularly high volume was seen for the $52.50 strike put option expiring June 19, 2020, with 8,738 contracts trading so far today, representing approximately 873,800 underlying shares of DD.	Particularly high volume was seen for the $52.50 strike put option expiring June 19, 2020, with 8,738 contracts trading so far today, representing approximately 873,800 underlying shares of DD. Below is a chart showing DD's trailing twelve month trading history, with the $52.50 strike highlighted in orange: For the various different available expirations for KMX options, BA options, or DD options, visit StockOptionsChannel.com. Below is a chart showing BA's trailing twelve month trading history, with the $200 strike highlighted in orange: And DuPont (Symbol: DD) options are showing a volume of 33,498 contracts thus far today.	959483ae-c9c8-4fe9-8e03-af74ed795c0e
716266.0	2020-06-12 00:00:00 UTC	Corteva Stock Is a Buy Should Shares Slip to $25	DD	https://www.nasdaq.com/articles/corteva-stock-is-a-buy-should-shares-slip-to-%2425-2020-06-12	nan	nan	InvestorPlace - Stock Market News, Stock Advice & Trading Tips Agricultural giant Corteva (NYSE:CTVA) stock is getting considerable interest, especially from passive income seeking investors as well as those interested in agricultural shares in a post-coronavirus world. Source: Jonathan Weiss / Shutterstock Analysts are debating whether now is a good time to invest in agricultural stocks. After all, we all need to eat, whatever the health and economic realities are of the novel coronavirus pandemic. The dividend yield of CTVA stock stands at 1.7% and shares are down 8% so far this year. Investors with a two- to three-year time horizon may consider buying the dips in the shares. CTVA Stock at a Glance Corteva is one of the firms formed as a result of the 2019 split of DowDuPont, a company which was originally born from the merger of chemical giants Dow and DuPont, into three separate companies: Corteva, currently one of the world’s largest agrochemical companies. DuPont de Nemours (NYSE:DD), the new name that DowDuPont acquired. Dow (NYSE:DOW), which is dubbed the ‘new’ Dow. Following the three-way spin-off, each of these companies started their respective journeys as an independent entity. CTVA initially started trading in June 2019 around $25 and traded for months in a range from about $24 to $32 per share. The 9 Best Cryptocurrencies to Watch for the Rest of 2020 In February, investors in CTVA stock were beginning to believe in the strength of the shares when they went over $32. Yet on March 18, the shares hit an all-time low of $20.38. Now they’re hovering near $27. So, CTVA has been a great range-trading stock, mostly between $25 and $30. First-Quarter Earnings In early May, Corteva reported robust first-quarter results. Net sales were $3.96 billion, up 16% versus the year-ago period, with double-digit organic sales growth in every region. Close to half the revenue comes from North America. The bottom line totaled $272 million, or 36 cents per share. This compares with $164 million, or 22 cents per share, in last year’s first quarter. Two main segments bring in the revenue: Seed (62% of total revenue), which includes most corn, soybean and other oilseeds. Crop protection (38%), which includes mostly herbicides, insecticides, and fungicides. The seed segment develops commercial seeds for farmers around the world. Quarterly seed sales rose 27% on an organic basis, primarily due to increased corn deliveries in North America, coupled with strong sunflower and corn sales in Europe. The crop protection segment has products that protect against weeds, insects and disease, and that improve overall crop health. In the first quarter, crop protection sales also improved 10% on an organic basis, due to increased demand for new products globally. Latin America especially saw strong demand thanks to product launches. Yet management suspended full-year 2020 guidance in light of uncertainty from the novel coronavirus pandemic. CTVA shares have been in the green over the past month. The Bottom Line on CTVA Stock Now that a full year has passed since the spin-off, I believe Corteva’s business operations and earnings are likely to get on more solid footing in the coming months. It is a leader in the development of seeds and crop chemical products. Despite the lockdown and the ensuing uncertainty about life after coronavirus, one thing that is crucial for everyone globally is food. And agricultural commodities play a big role in the food consumed. Therefore the sector is likely to be promising in the near future. Even if you are not ready to invest in CTVA stock yet, I suggest you at least keep it on your list for the time being. Any price slip toward $25 level would make the shares rather attractive. Alternatively, you may consider starting an at-the-money or slightly in-the-money covered calls with Aug 21 expiry. You’d also be able to benefit from the company’s dividend. You may also consider investing in an exchange-traded fund that has CTVA stock as holding. Examples would include the Materials Select Sector SPDR Fund (NYSEARCA:XLB), Wide MPAT Vaneck ETF (NYSEARCA:MOAT) or the Invesco S&P Spin-Off ETF (NYSEARCA:CSD). Tezcan Gecgil has worked in investment management for over two decades in the U.S. and U.K. In addition to formal higher education in the field, she has also completed all 3 levels of the Chartered Market Technician (CMT) examination. Her passion is for options trading based on technical analysis of fundamentally strong companies. She especially enjoys setting up weekly covered calls for income generation. As of this writing, Tezcan Gecgil did not hold a position in any of the aforementioned securities. The post Corteva Stock Is a Buy Should Shares Slip to $25 appeared first on InvestorPlace. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	In addition to formal higher education in the field, she has also completed all 3 levels of the Chartered Market Technician (CMT) examination. DuPont de Nemours (NYSE:DD), the new name that DowDuPont acquired. In the first quarter, crop protection sales also improved 10% on an organic basis, due to increased demand for new products globally.	DuPont de Nemours (NYSE:DD), the new name that DowDuPont acquired. In addition to formal higher education in the field, she has also completed all 3 levels of the Chartered Market Technician (CMT) examination. InvestorPlace - Stock Market News, Stock Advice & Trading Tips Agricultural giant Corteva (NYSE:CTVA) stock is getting considerable interest, especially from passive income seeking investors as well as those interested in agricultural shares in a post-coronavirus world.	DuPont de Nemours (NYSE:DD), the new name that DowDuPont acquired. In addition to formal higher education in the field, she has also completed all 3 levels of the Chartered Market Technician (CMT) examination. InvestorPlace - Stock Market News, Stock Advice & Trading Tips Agricultural giant Corteva (NYSE:CTVA) stock is getting considerable interest, especially from passive income seeking investors as well as those interested in agricultural shares in a post-coronavirus world.	DuPont de Nemours (NYSE:DD), the new name that DowDuPont acquired. In addition to formal higher education in the field, she has also completed all 3 levels of the Chartered Market Technician (CMT) examination. InvestorPlace - Stock Market News, Stock Advice & Trading Tips Agricultural giant Corteva (NYSE:CTVA) stock is getting considerable interest, especially from passive income seeking investors as well as those interested in agricultural shares in a post-coronavirus world.	02cfa81c-eaac-4b20-b59d-f8083810c745
716267.0	2020-06-05 00:00:00 UTC	DD Makes Bullish Cross Above Critical Moving Average	DD	https://www.nasdaq.com/articles/dd-makes-bullish-cross-above-critical-moving-average-2020-06-05	nan	nan	In trading on Friday, shares of DuPont (Symbol: DD) crossed above their 200 day moving average of $56.20, changing hands as high as $58.66 per share. DuPont shares are currently trading up about 3.2% on the day. The chart below shows the one year performance of DD shares, versus its 200 day moving average: Looking at the chart above, DD's low point in its 52 week range is $28.33 per share, with $77.03 as the 52 week high point — that compares with a last trade of $56.73. The DD DMA information above was sourced from TechnicalAnalysisChannel.com Click here to find out which 9 other stocks recently crossed above their 200 day moving average » The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	In trading on Friday, shares of DuPont (Symbol: DD) crossed above their 200 day moving average of $56.20, changing hands as high as $58.66 per share. The chart below shows the one year performance of DD shares, versus its 200 day moving average: Looking at the chart above, DD's low point in its 52 week range is $28.33 per share, with $77.03 as the 52 week high point — that compares with a last trade of $56.73. The DD DMA information above was sourced from TechnicalAnalysisChannel.com Click here to find out which 9 other stocks recently crossed above their 200 day moving average » The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	In trading on Friday, shares of DuPont (Symbol: DD) crossed above their 200 day moving average of $56.20, changing hands as high as $58.66 per share. The chart below shows the one year performance of DD shares, versus its 200 day moving average: Looking at the chart above, DD's low point in its 52 week range is $28.33 per share, with $77.03 as the 52 week high point — that compares with a last trade of $56.73. The DD DMA information above was sourced from TechnicalAnalysisChannel.com Click here to find out which 9 other stocks recently crossed above their 200 day moving average » The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	In trading on Friday, shares of DuPont (Symbol: DD) crossed above their 200 day moving average of $56.20, changing hands as high as $58.66 per share. The chart below shows the one year performance of DD shares, versus its 200 day moving average: Looking at the chart above, DD's low point in its 52 week range is $28.33 per share, with $77.03 as the 52 week high point — that compares with a last trade of $56.73. The DD DMA information above was sourced from TechnicalAnalysisChannel.com Click here to find out which 9 other stocks recently crossed above their 200 day moving average » The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	In trading on Friday, shares of DuPont (Symbol: DD) crossed above their 200 day moving average of $56.20, changing hands as high as $58.66 per share. The chart below shows the one year performance of DD shares, versus its 200 day moving average: Looking at the chart above, DD's low point in its 52 week range is $28.33 per share, with $77.03 as the 52 week high point — that compares with a last trade of $56.73. The DD DMA information above was sourced from TechnicalAnalysisChannel.com Click here to find out which 9 other stocks recently crossed above their 200 day moving average » The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	3adfba04-4917-46a2-994b-a360e202df05
716268.0	2020-06-03 00:00:00 UTC	Notable Wednesday Option Activity: NOW, DD, STAY	DD	https://www.nasdaq.com/articles/notable-wednesday-option-activity%3A-now-dd-stay-2020-06-03	nan	nan	Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in ServiceNow Inc (Symbol: NOW), where a total volume of 12,497 contracts has been traded thus far today, a contract volume which is representative of approximately 1.2 million underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 59.2% of NOW's average daily trading volume over the past month, of 2.1 million shares. Especially high volume was seen for the $400 strike call option expiring June 05, 2020, with 4,757 contracts trading so far today, representing approximately 475,700 underlying shares of NOW. Below is a chart showing NOW's trailing twelve month trading history, with the $400 strike highlighted in orange: DuPont (Symbol: DD) saw options trading volume of 34,153 contracts, representing approximately 3.4 million underlying shares or approximately 57.8% of DD's average daily trading volume over the past month, of 5.9 million shares. Particularly high volume was seen for the $52.50 strike put option expiring June 12, 2020, with 10,010 contracts trading so far today, representing approximately 1.0 million underlying shares of DD. Below is a chart showing DD's trailing twelve month trading history, with the $52.50 strike highlighted in orange: And Extended Stay America Inc (Symbol: STAY) saw options trading volume of 16,366 contracts, representing approximately 1.6 million underlying shares or approximately 57.1% of STAY's average daily trading volume over the past month, of 2.9 million shares. Especially high volume was seen for the $13 strike call option expiring October 16, 2020, with 8,479 contracts trading so far today, representing approximately 847,900 underlying shares of STAY. Below is a chart showing STAY's trailing twelve month trading history, with the $13 strike highlighted in orange: For the various different available expirations for NOW options, DD options, or STAY options, visit StockOptionsChannel.com. Today's Most Active Call & Put Options of the S&P 500 » The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	Particularly high volume was seen for the $52.50 strike put option expiring June 12, 2020, with 10,010 contracts trading so far today, representing approximately 1.0 million underlying shares of DD. Below is a chart showing NOW's trailing twelve month trading history, with the $400 strike highlighted in orange: DuPont (Symbol: DD) saw options trading volume of 34,153 contracts, representing approximately 3.4 million underlying shares or approximately 57.8% of DD's average daily trading volume over the past month, of 5.9 million shares. Below is a chart showing DD's trailing twelve month trading history, with the $52.50 strike highlighted in orange: And Extended Stay America Inc (Symbol: STAY) saw options trading volume of 16,366 contracts, representing approximately 1.6 million underlying shares or approximately 57.1% of STAY's average daily trading volume over the past month, of 2.9 million shares.	Below is a chart showing NOW's trailing twelve month trading history, with the $400 strike highlighted in orange: DuPont (Symbol: DD) saw options trading volume of 34,153 contracts, representing approximately 3.4 million underlying shares or approximately 57.8% of DD's average daily trading volume over the past month, of 5.9 million shares. Particularly high volume was seen for the $52.50 strike put option expiring June 12, 2020, with 10,010 contracts trading so far today, representing approximately 1.0 million underlying shares of DD. Below is a chart showing DD's trailing twelve month trading history, with the $52.50 strike highlighted in orange: And Extended Stay America Inc (Symbol: STAY) saw options trading volume of 16,366 contracts, representing approximately 1.6 million underlying shares or approximately 57.1% of STAY's average daily trading volume over the past month, of 2.9 million shares.	Below is a chart showing NOW's trailing twelve month trading history, with the $400 strike highlighted in orange: DuPont (Symbol: DD) saw options trading volume of 34,153 contracts, representing approximately 3.4 million underlying shares or approximately 57.8% of DD's average daily trading volume over the past month, of 5.9 million shares. Below is a chart showing DD's trailing twelve month trading history, with the $52.50 strike highlighted in orange: And Extended Stay America Inc (Symbol: STAY) saw options trading volume of 16,366 contracts, representing approximately 1.6 million underlying shares or approximately 57.1% of STAY's average daily trading volume over the past month, of 2.9 million shares. Particularly high volume was seen for the $52.50 strike put option expiring June 12, 2020, with 10,010 contracts trading so far today, representing approximately 1.0 million underlying shares of DD.	Below is a chart showing NOW's trailing twelve month trading history, with the $400 strike highlighted in orange: DuPont (Symbol: DD) saw options trading volume of 34,153 contracts, representing approximately 3.4 million underlying shares or approximately 57.8% of DD's average daily trading volume over the past month, of 5.9 million shares. Particularly high volume was seen for the $52.50 strike put option expiring June 12, 2020, with 10,010 contracts trading so far today, representing approximately 1.0 million underlying shares of DD. Below is a chart showing DD's trailing twelve month trading history, with the $52.50 strike highlighted in orange: And Extended Stay America Inc (Symbol: STAY) saw options trading volume of 16,366 contracts, representing approximately 1.6 million underlying shares or approximately 57.1% of STAY's average daily trading volume over the past month, of 2.9 million shares.	1e9aa7ea-196e-426f-bbaa-81e168a3b6fa
716269.0	2020-06-01 00:00:00 UTC	Surprising Analyst 12-Month Target For IVE	DD	https://www.nasdaq.com/articles/surprising-analyst-12-month-target-for-ive-2020-06-01	nan	nan	Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the iShares S&P 500 Value ETF (Symbol: IVE), we found that the implied analyst target price for the ETF based upon its underlying holdings is $121.63 per unit. With IVE trading at a recent price near $109.93 per unit, that means that analysts see 10.65% upside for this ETF looking through to the average analyst targets of the underlying holdings. Three of IVE's underlying holdings with notable upside to their analyst target prices are Ralph Lauren Corp (Symbol: RL), DuPont de Nemours Inc (Symbol: DD), and Medtronic PLC (Symbol: MDT). Although RL has traded at a recent price of $75.51/share, the average analyst target is 21.12% higher at $91.46/share. Similarly, DD has 15.88% upside from the recent share price of $50.73 if the average analyst target price of $58.78/share is reached, and analysts on average are expecting MDT to reach a target price of $112.43/share, which is 14.05% above the recent price of $98.58. Below is a twelve month price history chart comparing the stock performance of RL, DD, and MDT: Below is a summary table of the current analyst target prices discussed above: NAME SYMBOL RECENT PRICE AVG. ANALYST 12-MO. TARGET % UPSIDE TO TARGET iShares S&P 500 Value ETF IVE $109.93 $121.63 10.65% Ralph Lauren Corp RL $75.51 $91.46 21.12% DuPont de Nemours Inc DD $50.73 $58.78 15.88% Medtronic PLC MDT $98.58 $112.43 14.05% Are analysts justified in these targets, or overly optimistic about where these stocks will be trading 12 months from now? Do the analysts have a valid justification for their targets, or are they behind the curve on recent company and industry developments? A high price target relative to a stock's trading price can reflect optimism about the future, but can also be a precursor to target price downgrades if the targets were a relic of the past. These are questions that require further investor research. 10 ETFs With Most Upside To Analyst Targets » The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	iShares S&P 500 Value ETF IVE $109.93 $121.63 10.65% Ralph Lauren Corp RL $75.51 $91.46 21.12% DuPont de Nemours Inc DD $50.73 $58.78 15.88% Medtronic PLC MDT $98.58 $112.43 14.05% Are analysts justified in these targets, or overly optimistic about where these stocks will be trading 12 months from now? Three of IVE's underlying holdings with notable upside to their analyst target prices are Ralph Lauren Corp (Symbol: RL), DuPont de Nemours Inc (Symbol: DD), and Medtronic PLC (Symbol: MDT). Similarly, DD has 15.88% upside from the recent share price of $50.73 if the average analyst target price of $58.78/share is reached, and analysts on average are expecting MDT to reach a target price of $112.43/share, which is 14.05% above the recent price of $98.58.	Three of IVE's underlying holdings with notable upside to their analyst target prices are Ralph Lauren Corp (Symbol: RL), DuPont de Nemours Inc (Symbol: DD), and Medtronic PLC (Symbol: MDT). Similarly, DD has 15.88% upside from the recent share price of $50.73 if the average analyst target price of $58.78/share is reached, and analysts on average are expecting MDT to reach a target price of $112.43/share, which is 14.05% above the recent price of $98.58. iShares S&P 500 Value ETF IVE $109.93 $121.63 10.65% Ralph Lauren Corp RL $75.51 $91.46 21.12% DuPont de Nemours Inc DD $50.73 $58.78 15.88% Medtronic PLC MDT $98.58 $112.43 14.05% Are analysts justified in these targets, or overly optimistic about where these stocks will be trading 12 months from now?	Similarly, DD has 15.88% upside from the recent share price of $50.73 if the average analyst target price of $58.78/share is reached, and analysts on average are expecting MDT to reach a target price of $112.43/share, which is 14.05% above the recent price of $98.58. Three of IVE's underlying holdings with notable upside to their analyst target prices are Ralph Lauren Corp (Symbol: RL), DuPont de Nemours Inc (Symbol: DD), and Medtronic PLC (Symbol: MDT). Below is a twelve month price history chart comparing the stock performance of RL, DD, and MDT: Below is a summary table of the current analyst target prices discussed above:	iShares S&P 500 Value ETF IVE $109.93 $121.63 10.65% Ralph Lauren Corp RL $75.51 $91.46 21.12% DuPont de Nemours Inc DD $50.73 $58.78 15.88% Medtronic PLC MDT $98.58 $112.43 14.05% Are analysts justified in these targets, or overly optimistic about where these stocks will be trading 12 months from now? Three of IVE's underlying holdings with notable upside to their analyst target prices are Ralph Lauren Corp (Symbol: RL), DuPont de Nemours Inc (Symbol: DD), and Medtronic PLC (Symbol: MDT). Similarly, DD has 15.88% upside from the recent share price of $50.73 if the average analyst target price of $58.78/share is reached, and analysts on average are expecting MDT to reach a target price of $112.43/share, which is 14.05% above the recent price of $98.58.	4b6a0e3d-178b-4c7f-9cca-8c67301849b2
716270.0	2020-05-28 00:00:00 UTC	DuPont To Present At Bernstein's Strategic Decisions Conference; Webcast At 10:00 AM ET	DD	https://www.nasdaq.com/articles/dupont-to-present-at-bernsteins-strategic-decisions-conference-webcast-at-10%3A00-am-et-2020	nan	nan	(RTTNews) - EI DuPont De Nemours & Co. (DD) will present at Bernstein''s 36th Annual Strategic Decisions Conference. The event is scheduled to begin at 10:00 AM ET on May 28, 2020 To access the live webcast, log on to http://www.investors.dupont.com The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	(RTTNews) - EI DuPont De Nemours & Co. (DD) will present at Bernstein''s 36th Annual Strategic Decisions Conference. The event is scheduled to begin at 10:00 AM ET on May 28, 2020 To access the live webcast, log on to http://www.investors.dupont.com The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	(RTTNews) - EI DuPont De Nemours & Co. (DD) will present at Bernstein''s 36th Annual Strategic Decisions Conference. The event is scheduled to begin at 10:00 AM ET on May 28, 2020 To access the live webcast, log on to http://www.investors.dupont.com The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	(RTTNews) - EI DuPont De Nemours & Co. (DD) will present at Bernstein''s 36th Annual Strategic Decisions Conference. The event is scheduled to begin at 10:00 AM ET on May 28, 2020 To access the live webcast, log on to http://www.investors.dupont.com The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	(RTTNews) - EI DuPont De Nemours & Co. (DD) will present at Bernstein''s 36th Annual Strategic Decisions Conference. The event is scheduled to begin at 10:00 AM ET on May 28, 2020 To access the live webcast, log on to http://www.investors.dupont.com The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	6c43d9d5-3cf6-4ec1-9020-32dd4f4b307d
716271.0	2020-05-26 00:00:00 UTC	Ex-Dividend Reminder: DuPont, Stepan and Barrick Gold	DD	https://www.nasdaq.com/articles/ex-dividend-reminder%3A-dupont-stepan-and-barrick-gold-2020-05-26	nan	nan	Looking at the universe of stocks we cover at Dividend Channel, on 5/28/20, DuPont (Symbol: DD), Stepan Co. (Symbol: SCL), and Barrick Gold Corp. (Symbol: GOLD) will all trade ex-dividend for their respective upcoming dividends. DuPont will pay its quarterly dividend of $0.30 on 6/15/20, Stepan Co. will pay its quarterly dividend of $0.275 on 6/15/20, and Barrick Gold Corp. will pay its quarterly dividend of $0.07 on 6/15/20. As a percentage of DD's recent stock price of $50.57, this dividend works out to approximately 0.59%, so look for shares of DuPont to trade 0.59% lower — all else being equal — when DD shares open for trading on 5/28/20. Similarly, investors should look for SCL to open 0.28% lower in price and for GOLD to open 0.27% lower, all else being equal. Below are dividend history charts for DD, SCL, and GOLD, showing historical dividends prior to the most recent ones declared. DuPont (Symbol: DD): Stepan Co. (Symbol: SCL): Barrick Gold Corp. (Symbol: GOLD): In general, dividends are not always predictable, following the ups and downs of company profits over time. Therefore, a good first due diligence step in forming an expectation of annual yield going forward, is looking at the history above, for a sense of stability over time. This can help in judging whether the most recent dividends from these companies are likely to continue. If they do continue, the current estimated yields on annualized basis would be 2.37% for DuPont, 1.12% for Stepan Co., and 1.10% for Barrick Gold Corp.. In Tuesday trading, DuPont shares are currently up about 3.9%, Stepan Co. shares are up about 2.9%, and Barrick Gold Corp. shares are down about 3.1% on the day. Click here to learn which 25 S.A.F.E. dividend stocks should be on your radar screen » The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	As a percentage of DD's recent stock price of $50.57, this dividend works out to approximately 0.59%, so look for shares of DuPont to trade 0.59% lower — all else being equal — when DD shares open for trading on 5/28/20. Looking at the universe of stocks we cover at Dividend Channel, on 5/28/20, DuPont (Symbol: DD), Stepan Co. (Symbol: SCL), and Barrick Gold Corp. (Symbol: GOLD) will all trade ex-dividend for their respective upcoming dividends. Below are dividend history charts for DD, SCL, and GOLD, showing historical dividends prior to the most recent ones declared.	Looking at the universe of stocks we cover at Dividend Channel, on 5/28/20, DuPont (Symbol: DD), Stepan Co. (Symbol: SCL), and Barrick Gold Corp. (Symbol: GOLD) will all trade ex-dividend for their respective upcoming dividends. DuPont (Symbol: DD): Stepan Co. (Symbol: SCL): Barrick Gold Corp. (Symbol: GOLD): In general, dividends are not always predictable, following the ups and downs of company profits over time. As a percentage of DD's recent stock price of $50.57, this dividend works out to approximately 0.59%, so look for shares of DuPont to trade 0.59% lower — all else being equal — when DD shares open for trading on 5/28/20.	Looking at the universe of stocks we cover at Dividend Channel, on 5/28/20, DuPont (Symbol: DD), Stepan Co. (Symbol: SCL), and Barrick Gold Corp. (Symbol: GOLD) will all trade ex-dividend for their respective upcoming dividends. DuPont (Symbol: DD): Stepan Co. (Symbol: SCL): Barrick Gold Corp. (Symbol: GOLD): In general, dividends are not always predictable, following the ups and downs of company profits over time. As a percentage of DD's recent stock price of $50.57, this dividend works out to approximately 0.59%, so look for shares of DuPont to trade 0.59% lower — all else being equal — when DD shares open for trading on 5/28/20.	As a percentage of DD's recent stock price of $50.57, this dividend works out to approximately 0.59%, so look for shares of DuPont to trade 0.59% lower — all else being equal — when DD shares open for trading on 5/28/20. Looking at the universe of stocks we cover at Dividend Channel, on 5/28/20, DuPont (Symbol: DD), Stepan Co. (Symbol: SCL), and Barrick Gold Corp. (Symbol: GOLD) will all trade ex-dividend for their respective upcoming dividends. Below are dividend history charts for DD, SCL, and GOLD, showing historical dividends prior to the most recent ones declared.	c663bb5f-812a-4e24-b8ac-45f7d86aafa9
716272.0	2020-05-20 00:00:00 UTC	Dow shuts Midland operations after flood waters sweep in	DD	https://www.nasdaq.com/articles/dow-shuts-midland-operations-after-flood-waters-sweep-in-2020-05-20	nan	nan	May 20 (Reuters) - Dow Inc DOW.N said on Wednesday it has shut down all operating units at its headquarters in Midland, Michigan, after flood waters breached its sites following the collapse of two dams. "At approximately 10:00 a.m. Eastern it was confirmed there were flood waters commingling with on-site containment ponds," the chemical maker said in a Facebook post. The company said it was deploying its flood preparedness plan and no employees had been injured so far. Michigan Governor Gretchen Whitmer on Tuesday declared an emergency for Midland county after the Edenville and Sanford dams collapsed due to heavy rain in the past few days and said residents nearby had been told to evacuate immediately. DuPont DD.N and Corteva CTVA.N, spun off from DowDuPont, also have manufacturing facilities in Dow's industrial complex in Midland. (Reporting by Shanti S Nair and Taru Jain in Bengaluru; Editing by Aditya Soni) ((ShantiS.Nair@thomsonreuters.com;)) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	DuPont DD.N and Corteva CTVA.N, spun off from DowDuPont, also have manufacturing facilities in Dow's industrial complex in Midland. May 20 (Reuters) - Dow Inc DOW.N said on Wednesday it has shut down all operating units at its headquarters in Midland, Michigan, after flood waters breached its sites following the collapse of two dams. "At approximately 10:00 a.m. Eastern it was confirmed there were flood waters commingling with on-site containment ponds," the chemical maker said in a Facebook post.	DuPont DD.N and Corteva CTVA.N, spun off from DowDuPont, also have manufacturing facilities in Dow's industrial complex in Midland. May 20 (Reuters) - Dow Inc DOW.N said on Wednesday it has shut down all operating units at its headquarters in Midland, Michigan, after flood waters breached its sites following the collapse of two dams. "At approximately 10:00 a.m. Eastern it was confirmed there were flood waters commingling with on-site containment ponds," the chemical maker said in a Facebook post.	DuPont DD.N and Corteva CTVA.N, spun off from DowDuPont, also have manufacturing facilities in Dow's industrial complex in Midland. May 20 (Reuters) - Dow Inc DOW.N said on Wednesday it has shut down all operating units at its headquarters in Midland, Michigan, after flood waters breached its sites following the collapse of two dams. Michigan Governor Gretchen Whitmer on Tuesday declared an emergency for Midland county after the Edenville and Sanford dams collapsed due to heavy rain in the past few days and said residents nearby had been told to evacuate immediately.	DuPont DD.N and Corteva CTVA.N, spun off from DowDuPont, also have manufacturing facilities in Dow's industrial complex in Midland. May 20 (Reuters) - Dow Inc DOW.N said on Wednesday it has shut down all operating units at its headquarters in Midland, Michigan, after flood waters breached its sites following the collapse of two dams. "At approximately 10:00 a.m. Eastern it was confirmed there were flood waters commingling with on-site containment ponds," the chemical maker said in a Facebook post.	66b503a5-46ff-44fc-bcba-2deabf7f184b
716273.0	2020-05-19 00:00:00 UTC	S&P 500 Analyst Moves: DD	DD	https://www.nasdaq.com/articles/sp-500-analyst-moves%3A-dd-2020-05-19	nan	nan	The latest tally of analyst opinions from the major brokerage houses shows that among the components of the S&P 500 index, DuPont is now the #49 analyst pick, moving up by 1 spot. This rank is formed by averaging the analyst opinions for each component from each broker, and then ranking the 500 components by those average opinion values. Looking at the stock price movement year to date, DuPont is lower by about 24.4%. VIDEO: S&P 500 Analyst Moves: DD The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	VIDEO: S&P 500 Analyst Moves: DD The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. The latest tally of analyst opinions from the major brokerage houses shows that among the components of the S&P 500 index, DuPont is now the #49 analyst pick, moving up by 1 spot. This rank is formed by averaging the analyst opinions for each component from each broker, and then ranking the 500 components by those average opinion values.	VIDEO: S&P 500 Analyst Moves: DD The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. The latest tally of analyst opinions from the major brokerage houses shows that among the components of the S&P 500 index, DuPont is now the #49 analyst pick, moving up by 1 spot. This rank is formed by averaging the analyst opinions for each component from each broker, and then ranking the 500 components by those average opinion values.	VIDEO: S&P 500 Analyst Moves: DD The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. The latest tally of analyst opinions from the major brokerage houses shows that among the components of the S&P 500 index, DuPont is now the #49 analyst pick, moving up by 1 spot. This rank is formed by averaging the analyst opinions for each component from each broker, and then ranking the 500 components by those average opinion values.	VIDEO: S&P 500 Analyst Moves: DD The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. The latest tally of analyst opinions from the major brokerage houses shows that among the components of the S&P 500 index, DuPont is now the #49 analyst pick, moving up by 1 spot. This rank is formed by averaging the analyst opinions for each component from each broker, and then ranking the 500 components by those average opinion values.	15c59c19-53ec-4992-a3ea-f260eca5a241
716274.0	2020-05-14 00:00:00 UTC	DuPont To Present At The Goldman Sachs Conference; Webcast At 8:00 AM ET	DD	https://www.nasdaq.com/articles/dupont-to-present-at-the-goldman-sachs-conference-webcast-at-8%3A00-am-et-2020-05-14	nan	nan	(RTTNews) - EI DuPont De Nemours & Co. (DD) will present at Goldman Sachs Industrials and Materials Conference. The event is scheduled to begin at 8:00 AM ET on May 14, 2020 To access the live webcast, log on to https://www.investors.dupont.com/investors/dupont-investors/events-and-presentations/default.aspx The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	(RTTNews) - EI DuPont De Nemours & Co. (DD) will present at Goldman Sachs Industrials and Materials Conference. The event is scheduled to begin at 8:00 AM ET on May 14, 2020 To access the live webcast, log on to https://www.investors.dupont.com/investors/dupont-investors/events-and-presentations/default.aspx The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	(RTTNews) - EI DuPont De Nemours & Co. (DD) will present at Goldman Sachs Industrials and Materials Conference. The event is scheduled to begin at 8:00 AM ET on May 14, 2020 To access the live webcast, log on to https://www.investors.dupont.com/investors/dupont-investors/events-and-presentations/default.aspx The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	(RTTNews) - EI DuPont De Nemours & Co. (DD) will present at Goldman Sachs Industrials and Materials Conference. The event is scheduled to begin at 8:00 AM ET on May 14, 2020 To access the live webcast, log on to https://www.investors.dupont.com/investors/dupont-investors/events-and-presentations/default.aspx The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	(RTTNews) - EI DuPont De Nemours & Co. (DD) will present at Goldman Sachs Industrials and Materials Conference. The event is scheduled to begin at 8:00 AM ET on May 14, 2020 To access the live webcast, log on to https://www.investors.dupont.com/investors/dupont-investors/events-and-presentations/default.aspx The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	f9b27d5b-60cc-4fa6-a6af-7c912adf278b
716275.0	2020-05-13 00:00:00 UTC	PayPal and Square: Winners of First-Quarter Earnings Season	DD	https://www.nasdaq.com/articles/paypal-and-square%3A-winners-of-first-quarter-earnings-season-2020-05-13	nan	nan	We just got a glimpse at the latest results from PayPal (NASDAQ: PYPL) and Square (NYSE: SQ), including how both businesses performed in April as the COVID-19 pandemic shut down much of the U.S. economy. In this episode of Industry Focus: Financials, host Jason Moser and Fool.com contributor Matt Frankel, CFP, dive into the numbers that investors need to know. Then the pair answer a listener question on the seemingly irrational optimism in the stock market and discusses why they have Disney (NYSE: DIS) and Sony (NYSE: SNE) on their radar right now. To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center. To get started investing, check out our quick-start guide to investing in stocks. A full transcript follows the video. 10 stocks we like better than PayPal Holdings When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.* David and Tom just revealed what they believe are the ten best stocks for investors to buy right now… and PayPal Holdings wasn't one of them! That's right -- they think these 10 stocks are even better buys. See the 10 stocks *Stock Advisor returns as of April 16, 2020 This video was recorded on May 11, 2020. Jason Moser: It's Monday, May 11th. I'm your host Jason Moser. On today's Financials show, we're going to dig into recent earnings reports from Square and PayPal. We're going to kick around a listener question about the state of the market today. As always, we've got a couple of stocks for watching this coming week. Joining me, as always, Certified Financial Planner, Matt Frankel. Matt, how's everything going? Matt Frankel: Pretty good. The rare Spring weather in South Carolina continues, things are starting to open up a little bit down here. It's a pretty good day. Moser: Man, that's encouraging, hopefully, that's a sign of things to come. I think Spring weather is here in the sense that the pollen is all over the place. [laughs] The temperatures are still kind of cool up here in Virginia, but you know, it's actually kind of nice. I guess we need it to warm up a little bit, though. Frankel: Yeah, we had our pollen, [laughs] you know, you've seen it in South Carolina, everything turns yellow. We had that happen a couple of weeks ago, so we're pretty much past the pollen. Moser: Yeah, I think we're in the midst of that right now, so we're kind of just pushing through. But anyway, you know, it was a big week last week for the earnings season. Plenty of companies reported, but a couple of companies that you and I follow closely, a lot of listeners follow, a lot of listeners own these shares, half the War on Cash basket there, in PayPal and Square reported. And the following day, the market certainly received those reports very, very well. Let's start with PayPal first, Matt. And I think PayPal actually had the better of the two days, between the two. When I looked at this report, the report was strong, the conference call was really strong. I mean, CEO, Dan Schulman really framed this thing up in a way, it's hard not to be optimistic about what they're doing and what the future holds for a company like PayPal. The one thing that stood out to me just in the report, strong, strong quarterly results for the first quarter as usual, but this was really an interesting point here. The month of April alone, and that's their current quarter right now, in the second quarter, in the month of April, they added 7.4 million net new accounts. So, that's around 250,000 per day. Now, for context, last year, for all of the second quarter, they added 9 million net new accounts, in all of the quarter. So, you could see clearly, there is a catalyst there that is getting people to sign up for PayPal and use their services more often. I mean, we obviously know what is contributing to that in many regards, but that was one of the statistics that stood out to me, that just really, it makes me happy as a shareholder, it makes me feel like they're doing the right things. Frankel: Yeah, we mentioned a while ago that we thought companies like Square and PayPal are going to be part of the solution. And that really kind of puts that into perspective. I mean, you said, year-over-year, but in January and February, they added 3 million new subscribers a month. So, this is double what they've been adding in a typical month this year and more. So, transaction volume was up 20% in April. It was transaction volume, transaction numbers, both up 20%. So, it looks like PayPal, I don't want to say beneficiary. I don't like using that term in context of the pandemic, because no one wants to benefit from this, this isn't a good situation by any stretch of the word. But for PayPal's business, this definitely could be a tailwind in terms of shifting more payments to online. We mentioned, you know, cash is gross, no one wants to play with cash anymore. [laughs] I mean, you've been saying that for years, but it seems like people are finally understanding that cash is kind of nasty. Moser: Yeah, it is. And I don't even remember the last time I got cash from when I went into -- normally, when I go to the grocery store, I'll buy food and then they'll give me the option to get some cash back when I swipe my card. And I don't remember the last time I even bothered to get cash back, to be honest with you. And it's just I just don't need to use it. I mean, if you don't need to use it then why bother? I don't know. Frankel: And that's what you're seeing now. People need to buy more things online, especially, so you're seeing PayPal accounts pop up all over the place. And there's just a lot of use cases for them, like, a lot of people want to send their friends money who are hurting more than they are. Our fellow Industry Focus co-host Dan Kline has been -- for just to kind of name one example of how PayPal is a really big use product right now -- he's been doing these Saturday night concerts for musician friends of his, who are out of work right now, because they can't play anywhere. And the way they get their tips is through Venmo, PayPal, Cash App, things like that. So, there's a whole lot more use cases than really meets the eyes is the point of that story. And check out his concert, if you want, I could tweet out details of his next concert that would be worth checking out -- Moser: Absolutely. Yeah, we can get that out there on the Industry Focus feed. And I mean, to your point there about, getting money to people, getting it from point A. to point B.; you know, a few years back PayPal made an acquisition of a company called Xoom. Now, this is not Zoom the video communications company that we talk about today, this company was Xoom. And some listeners out there may recall, I was a big fan of that business. I actually was able to get that into Million Dollar Portfolio, a service we had here at The Motley Fool at the time, and I owned shares of it myself. They were in the business of financial remittance, and particularly outbound financial remittance from the United States to all of these different international locations, kind of, like a Western Union for the 21st century. And I think PayPal saw something in that very early on and decided, you know what, these guys are doing something that we really like, it works right into our business model. So, they went ahead and acquired Xoom, and really bought it for what we all felt like was a steal at the time. And in the call, this past quarter, they noted that they saw with Xoom, they saw a 400% increase in people using Xoom, net new actives coming onto Xoom since January. So, since the January and February timeframe. Now, I mean, that's really before a lot of the coronavirus concerns even started materializing. And certainly again, I agree with you, we don't want to say, "beneficiary" but the fact of the matter is, this point in time is going to result in companies coming out stronger than going in. But to see that Xoom has gained so much traction in such a short period of time, I mean, it is just mobile remittance, right? Instead of going to a physical location, like you would have to do with a Western Union or something of that nature, you know, Xoom just built this thing as a mobile solution and it's really, really taken off and it's starting to pay dividends for PayPal. Frankel: Yeah. And I mean, anything that is preventing people from leaving their house, you know, it's not just getting cash out, it's that people don't want to swipe their credit cards either. You know, we don't want to touch anything that other people are touching. So, PayPal is just kind of an all-around business that really facilitates that in a lot of different ways right now. And to be fair, a lot of their gains in the first quarter came from the Honey acquisition. Moser: Yeah, that was about 10.2 million users, I think, they noted, that was a one-time benefit from that acquisition. But I mean, when they make an acquisition like that, I mean, you know part of that is for that user base. I think it was less about, you know, buying what Honey can do, although that is going to be a great part of the situation, but really it was more about buying that network so they could plug all of their additional network users into that Honey product as well. I mean, you're talking about hundreds of millions of users. Frankel: The way I put it is, it wasn't about buying 10 million users from Honey, it was exposing 325 million of PayPal's users to Honey's product. And that's going to be a big tailwind going forward. And it's also worth noting that PayPal was still profitable this quarter. There wasn't just impressive growth, even after -- I mean, the quarter was pretty much normal, but all these financial companies are setting aside a lot of reserves in anticipation of losses. Even after that, PayPal earned a pretty respectable earnings per share, $0.66 per share. So, PayPal was still pretty profitable even after setting aside a bunch of loss reserves. Moser: Yeah, they quantified that, it was a $0.17 impact from those credit loss reserves. And that makes sense, I mean, the PayPal credit products, you got to be careful with stuff like that, they work in conjunction with Synchrony Bank, so they have some support there. And looking at the balance sheet of the company, cash and short-term investments around $12.5 billion, total debt around $8 billion. I mean, clearly this is just a cash flow business. They make a lot of money, and are doing a lot of great things. And they have a huge network. I mean, it really does paint a picture of a company that has just the world in front of it, which leads me to ask, what would you consider one of the challenges or red flags or something to look out for in regard to a company like PayPal or is there one? Frankel: Oh, I mean, there's definitely red flags. Obviously, it's a business that's dependent on consumers' willingness and ability to spend money, whether or not they're using cash, if people don't have money, then PayPal is going to suffer. So, right now, again, I don't want to use the word "beneficiary" but the government has been doing such a great job of putting liquidity into the system that it really has -- and for the most part, I mean, a lot of people are hurting, but for the most part, people's ability to spend really hasn't gone down, it's just their ability to go out and spend. So, if we see the pandemic drag on for longer than the government is, you know, stimulus payments, the enhanced unemployment, if the pandemic keeps going after the government support has run out, that could be a bad effect on PayPal's business. Moser: Yeah, that would feel like that could last a while, but it would still be temporary in nature. I mean, it's still at the end of the day. Frankel: Right. For the time being, July 31st is the key date, because that's when the $600 boost to unemployment benefit is set to run out then. So, that's a key date to watch when you could potentially see people, consumers start running into a little bit more trouble if this is still dragging on. But I mean, the fact that a lot of the country is opening up at least somewhat is very encouraging. And I mean, I think there's minimal risk, but there is definitely a risk to that happening. Moser: Well, moving on from PayPal to another company that we both like, I think we both own, a lot of our listeners own. I know you're a big fan. Square also reported earnings, I believe, the same day, and yeah, after the market closed. Another strong quarter. It was interesting to see the reaction initially from the market, it was a bit tepid, but the following day it opened up. And I think there's a lot of enthusiasm. And again, I see why, Square is not nearly as big as PayPal, but doing a lot of the same kinds of things that we saw from PayPal in its early days as well. I mean, that was another strong quarter. Revenue was up 44%, actually 51%, if you exclude Caviar which they recently sold off, but what stood out to you from Square's quarter, Matt? Frankel: Oh, what didn't stand out? It was a pretty solid quarter all around. I mean, let me collect my [...] I have, like, 10 things on my punch list. Well, and some were good, summer some were not, I'll get some of the bad out of the way first. Unlike PayPal that was still profitable after setting some reserves aside, Square was not. They posted a loss of $106 million in the first quarter after setting aside some loss reserves. So, there's that. And to be fair, Square is a lot more loan exposed than PayPal. Like you mentioned, PayPal's loans are pretty much made through Synchrony, whereas Square Capital makes its own loans. Square is a participant in the PPP program, the Paycheck Protection Program. So, that's kind of a new thing that's going on. And just some of the numbers in April were really impressive. Cash App direct deposit volume tripled in April month-over-month, most of that was the stimulus checks, but it's getting people into the ecosystem, getting money into the ecosystem that creates more transactions. Moser: Oh, sure. I mean, once you experience the seamlessness of that experience once, I mean then, I think, really, all it takes is one or two of those experiences and you're hooked. And then you realize, why am I doing this the hard way when there are easy solutions like the Cash App out there? Frankel: Right. And that's on top of, in the first quarter, the Cash App gross profit more than doubled year-over-year in the first quarter. So, Cash App could be a force to be reckoned with going forward. And one of the things that really stood out to me in addition to the Cash App was the Square online store initiative that's really, really small at the moment. I think that's what PayPal needs to be worried about, and if this gets big, it could be something that could eat into PayPal's revenue. Square has a platform that essentially lets sellers design and build an online store in less than a day. It's really a seamless app. Moser: And that's what that Weebly acquisition was really all about, right? Frankel: Yeah. This came from the Weebly acquisition. And what they saw when things started shutting down and you couldn't go inside stores anymore, that payment volume through the online store shot up and quintupled. It quintupled in just a couple of weeks since launching curbside pickup options and things like that. So, and again, don't want to use the word "beneficiary" but Cash App and Square's online store are two things that really could gain some traction here. Online stores are ones really to watch, because it's really new. Again, even after I said it quintupled since they launched curbside, it's still roughly $50 million of payment volume. And Square's payment volume is in the, you know, about $100 billion per year. So, still a drop in the bucket, and I could see it getting a whole lot bigger over time. Moser: Yeah, I mean that's similar to, it's kind of like they are trying to become a little bit more like Shopify in that regard. And you see Shopify trying to become a little bit more like Square on the payment side. And you know, I think we've talked about this before, it's not really having to choose one or the other, when you look at both of these businesses and then consider, they're all doing really neat stuff and they're participating in a huge market. I mean, when you look even further out, these companies like Visa and Mastercard, you know, when they're talking about these $185 trillion opportunities of just money flowing around the world. I mean, really, it's mind-bending how much money you're talking about. And really, it's not about one company winning this market, it's about companies providing excellent solutions and taking part in it, and Square just happens to be one of them. Frankel: Right. Like you said, they're kind of trying to be a little like Shopify, they're kind of trying to be a little like PayPal and moving away from their traditional brick-and-mortar business. I think this whole pandemic could kind of accelerate their plans to do that, because right now they're reliant on people being able to go to stores, and that hasn't really been the case. I mean, the Cash App certainly helps, but as far as their core payment processing business, it's pretty much an in-store payment system there, they don't have that much of an online presence yet. Moser: No. And I noticed for Square, in April, they're talking about that total payment volume and that gross payment volume that went through the system and they processed $25.7 billion in gross payment volume in the quarter, that was up 14% from a year ago, but if you look at what's going on in April, they said April seller gross payment volume was down 39% over the same quarter a year ago. And they've seen some improvement in -- and I'm not sure that has something to do with states trying to get up and up and running a little bit, but it also has a lot to do with Square rolling out all of these different features for those online stores, as more and more sellers move online. Frankel: And that's kind of like the brick-and-mortar, kind of, the stark differentiation for PayPal. PayPal is, we just talked about their transaction volumes was up 28% in April, whereas Square's was down 39% and that's kind of why you don't want to rely so much on brick-and-mortar in times like this. And I mean, this is an extreme example, it's not like you're going to get -- we don't get a pandemic like this every few years, but hopefully it is not going to happen. But there's a lot of things that really could disrupt brick-and-mortar payments that don't really affect online. Like, you know, a major hurricane goes through the Southern U.S., people need to shop online, stores are closed for a while. I mean, when I lived in the Florida Keys, there was one of the storms when retailers were closed for two weeks and we really didn't even get anything major, so, I mean. But online, like, I could still buy whatever I wanted to on Amazon. So, there's a lot that can really disrupt brick-and-mortar payments. And I mean, not to mention retail bankruptcies and things like that that we've seen. So, I could see Square focusing a lot on that going forward. I am sure someone at Square was, kind of, jealous of PayPal's number for April. Moser: [laughs] PayPal envy, it's a thing, huh! Frankel: [laughs] I mean, I would have been, if I was Square's CFO or something, I would have looked at PayPal's numbers and, you know, maybe try to realign my short-term priorities. Moser: Oh, well, I'd tell you, after listening to that PayPal call, it really struck me just -- it felt like they just won earnings season with that release and that call. It was just so good in so many ways, so. Frankel: Yeah, I would agree with that. Like we said, Square's wasn't bad at all, both stocks were handily up after that. Moser: Yeah, I think, very much the long-term picture is still very much in play, the long-term thesis there is still very much in play, just like in liking the move toward less cash, more electronic transactions and liking the investments that these businesses are making in all sorts of different ways to facilitate that movement. So, yeah, we'll keep an eye on any red flags that come out, but for now, I remain a happy shareholder of both companies. Okay, Matt, last week we got a question in from a listener, a friend of the show, Milo McMahon had sent in a little video question for us asking us how we are reviewing the market in this state of what seems like irrational exuberance today? Milo McMahon: Hey, Jason, how are you doing, buddy. Milo here. I just had a quick question for you, we've just, obviously, gone through a completely unprecedented period of economic turmoil, millions of businesses all over the world having to shut down, and yet, as we look at what's happening in the market now, we're seeing prices creeping up, in some cases almost back to where they were or even above that. I'm wondering, you know, as a Foolish investor, we are not interested in trying to time the market or anticipate what's going to happen in the short-term, but what kinds of things should we be thinking about when we see what essentially appears to amount to irrational exuberance in the market? I'm wondering what kind of things you're thinking about in terms of raising cash or trimming certain positions. Because for every Shopify or PayPal out there, there's probably 10,000 small businesses who have had the exact opposite happen. They haven't grown, they're teetering on collapse and I just don't see how we can -- I don't see a situation where we wouldn't see the ripple effects play out on earnings. So, I'm just wondering your thoughts on that, how should investors be thinking about periods like this where it seems abundantly clear that there's irrational exuberance happening in the market? Thanks a lot. I really appreciate it and I hope you're keeping well. Moser: I thought this was a really good question for a lot of reasons. It made me think about this decoupling of sorts that we're seeing. I mean, the economic picture on the ground, obviously, is extremely challenging, unemployment numbers have clocked in at 15%, there's talk of it going to 20%. You hear people throwing around the words "Great Depression," I think that's probably a little bit of an overreaction. I think, when you look at what caused the Great Depression, I mean, these are two very different points in time and I think ultimately there is a finish-line here in regard to the pandemic and COVID-19. But it was a very fair question and I wanted to get your point-of-view. How do you view the conditions in the market today? Do you feel like it's irrational exuberance or you feel like some of it is justified? Frankel: I feel like some of the moves have been irrational, but I don't feel like anything is too expensive right now, in other words. The way to kind of explain it is that the stock market is a forward indicator when it comes to the economy. It's not based on what's going on right now, obviously, if it were, I mean, unemployment spiking, you know, the stock market would be collapsing right now. The stock market is, kind of, derives its value from the expected results of businesses going forward or over, you know, infinity years from now. So, as things happen, that picture gets better. On the economic side, the day the market bottomed was the day the Congress passed the CARES Act, the big stimulus package. So, that changed the picture, there was going to be more money in the economy. When they approved the drug they just approved, Remdesivir. Don't laugh at me, if I just said that wrong. Moser: [laughs] You don't pronounce any of them right, man, those are all funky names. Frankel: [laughs] But when the news came out that that was actually helping coronavirus patients, then the market went up, and rightfully so, because the future projection changed. And nobody has a crystal ball, is kind of the point, all that investors can do is, kind of, make their best guess to where the future is headed. And the future right now looks a lot better than it did on March the 18th. Moser: It does. I think that's a really good point. It felt like the entire month of March was just one long nightmare of bad news. You could not get away from it. Frankel: Right. And the present doesn't look very good. Obviously, if you just take a snapshot of the U.S. economy and tell somebody randomly that the market was up 30% from the lows, they would ask you, why? Like, what happened? [laughs] Moser: Yeah, to that point though, we're kind of in like a little bit of a Twilight Zone right now. I mean, we've not gotten back to the levels where we were at the time that the bear market started, not even close. I mean, that was the fastest trip into bear market territory ever. Frankel: Right. I think the Dow is somewhere around in the 24,000 ballpark right now or is that 29,000. You know, it was closing in. And people were already having Dow 30,000 hats in the New York Stock Exchange. Moser: [laughs] Yeah. I mean, that's a very good point. I mean, for as much enthusiasm as it feels like there is today, it still wasn't even close to where we were when everything fell, when the bottom fell out. I mean, that is a really good point there. We fell so far, so fast, that any kind of bounce-back almost feels like irrational exuberance to a degree. But yeah, I mean, that's a good point, we're not even close to the highs where we were before the bottom fell out. Frankel: And I will say, the last time the market peaked, was the day that I was up there talking to Jason in-person. So, there may be something to that. You know, we need to make a trip to Fool HQ and just meet you at the office and the market will be, you know, react positively to that development. Moser: I like that thinking. You know, I was thinking about this over the weekend too, and there was a quote from Microsoft'searnings call I guess it was last week. But CEO, Satya Nadella, said in the call, he said, "We've seen two years' worth of digital transformation in two months." And he's right. I mean, we're seeing it even at The Motley Fool. I mean, we had to close down Fool HQ, I guess, it's been a couple of months ago. And we were quick to pivot into introducing all sorts of technology that we've tampered with, technology that we've used, but we essentially took that technology and we made it our entire workflow. So, whether it's Zoom Video Communications or whether it's Slack or whether it's Microsoft or Google [Alphabet,] I mean, we're getting all of the work done, it's just in a different way now. And it struck me that he was right, this digital transformation was really pulled forward. It's not that digital transformation wasn't happening, it was, but this really hastened the process. And I think in the process, it's really, it shone a light on the companies that are leading the way in this regard. And it's not just in any one vertical, right? I mean we talked about Zoom and Slack and Microsoft, companies like that, but look at companies, like, DocuSign, or PayPal and Square, even Teladoc Health. All of a sudden, now people are starting to get it a little bit more. I mean, even esports, for example. Now, that the entire sporting world has ground to a halt. I mean, you're seeing all sorts of different things coming to the forefront now that there were signs that they were coming to the forefront, but this really hastened the process. And so, it's one thing to look at the greater market and understand that there are plenty of companies out there that are really suffering, but within that market, within that group, there are some companies that are really, really shining. And I think a lot of that just has to do with this digital transformation that they're leading. Frankel: One of the big questions I have is, how much of that shift is going to be permanent? For example, after 9/11, people were saying, no one's going to fly again and all business is going to take place over the phone and things to that effect. So, one of my big questions is, how much of that is a permanent shift? Because, yes, e-sports is getting a big bump right now, but people aren't going to stop going to football games, and people aren't going to necessarily stop going on vacation and staying in hotels. People who are saying that virtual meetings are going to completely take the place of in-person business, are the same people who'll tell you that K-Cups are going to replace going to Starbucks. It's just not a fair comparison, it's not permanent. I'm sure a lot of people, instead of going to Starbucks are making a K-Cup or two, but it didn't replace it by any means. So, it'll be kind of curious to see the dynamics when things snap back to -- you know, how much of the videoconferencing is permanent, how much of the using PayPal or Venmo instead of using, like, credit cards in the stores is going to be permanent. So, there's going to be some interesting dynamics, but like I said, the economy definitely looks -- the future economy looks a lot rosier than it did a couple of months ago. Moser: Yeah, I think that's a good point. And, Milo, thanks for the question. I hope that was helpful. Okay, Matt, before we wrap it up here, let's jump into the ones to watch. We got stuck watching this coming week, what is your one to watch, Matt? Frankel: Well, I think neither of us are going to mention any financial stocks right now, not on purpose, there are some good deals there. But I'm looking at Disney right now. And I'll tell you why, I recently bought Disney in my kids' account for the first time. I had been wanting to buy it forever and finally had some good opportunities in recent weeks. And we all know why Disney's stock is down. The parks are closed, the cruise ships are docked, but there's also some reasons to be positive. One, they have tons of liquidity. They raised another $7 billion in debt, $5 billion on their credit line. They suspended their dividend. They have plenty of money to make it to the other side. That's No. 1. No. 2., they just reopened Shanghai Disney, their biggest one in Asia. And if that demand is any indicator, then people are not going to be afraid to go to Disney World and Disneyland when we reopen. The brand value of Disney is kind of unmatched. They are almost to their 2024 projection for Disney+, and the service launched six months ago. So, they hit 54.5 million users, they said they are on-track, they wanted to do 60 million by 2024. So, there's a lot of -- Moser: Yeah, I'd say they got that. Frankel: Yeah, they're probably going to get that this year. So, I think there's a lot to like about Disney, especially at these levels. Disney is not a stock you buy for the short-term, that's something you buy and hold for a long, long time. So, if you have some money that you want to just buy something and leave it alone for a while, Disney is one of them -- Moser: ... that's a good one, yep. I mean, this pandemic is going to be temporary, but when it's all said and done, Disney is still going to be awesome. So, that's a good thing to keep in mind. Well, so I'm actually going to be keeping an eye on Sony. And the ticker on this market here SNE. And Sony is a little bit of a financial company, believe it or not. That's not why I'm watching it, but really, I mean, they are making all sorts of investments in immersive technology from AR visors to VR gaming experiences with the PlayStation. And they're helping customers build out solutions for industrial AR uses today. So, I'm very fascinated by the immersive technology angle. But it's also a very well-diversified business. Around 35% of their operating profit comes from gaming with the PlayStation platform. But as I mentioned, there is a financial dynamic to this business. Now, it's mostly insurance, I think, most, if not all of that takes place in its home market of Japan, but that's around 14% of revenue interestingly enough, so just kind of interesting to think of Sony as a financial company in some capacity. But the stock, it's not one that's on our radar very often, I think, in our Foolish universe for whatever reason, but it's one that's been on my radar for a while now. And if you look back over time, it's actually performed quite well, and I think there are a lot of reasons for that. It's just a very well-diversified company that does a lot of different things. And as technology continues to evolve, it seems like Sony is playing a big role in that. So, earnings are out on Wednesday, I'm going to be digging into that to see what the rest of the year looks like for them. But, Matt, I think that's going to do it for us this week, I appreciate you taking the time. Frankel: Of course. Hopefully, things will start to get back to normal gradually as we go over the next few months, I'm kind of curious to see how this plays out. Moser: Fingers crossed. And remember, everybody, you can always reach out to us on Twitter @MFIndustryFocus or you can drop us an email at IndustryFocus@Fool.com. Let us know how things are going, ask us questions, tell us about stocks that you're buying, we're always interested to hear. As always, people on the program may have interests in the stocks they talk about, and The Motley Fool may have formal recommendations for or against, so don't buy or sell stocks based solely on what you hear. Thanks, as always, to our man Austin Morgan for making the magic happen. For Matt Frankel, I'm Jason Moser, thanks for listening and we'll see you next week. John Mackey, CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool's board of directors. Suzanne Frey, an executive at Alphabet, is a member of The Motley Fool's board of directors. Teresa Kersten, an employee of LinkedIn, a Microsoft subsidiary, is a member of The Motley Fool's board of directors. Jason Moser owns shares of Alphabet (C shares), Amazon, DocuSign, Mastercard, PayPal Holdings, Shopify, Square, Starbucks, Teladoc Health, and Visa. Matthew Frankel, CFP owns shares of Square and Walt Disney. The Motley Fool owns shares of and recommends Alphabet (A shares), Alphabet (C shares), Amazon, DocuSign, Mastercard, Microsoft, PayPal Holdings, Shopify, Slack Technologies, Square, Starbucks, Teladoc Health, Visa, and Walt Disney and recommends the following options: long January 2021 $60 calls on Walt Disney, long January 2021 $85 calls on Microsoft, short January 2021 $115 calls on Microsoft, short September 2020 $70 puts on Square, short January 2022 $1940 calls on Amazon, long January 2022 $1920 calls on Amazon, long January 2022 $75 calls on PayPal Holdings, and short July 2020 $115 calls on Walt Disney. The Motley Fool has a disclosure policy. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	The month of April alone, and that's their current quarter right now, in the second quarter, in the month of April, they added 7.4 million net new accounts. Now, for context, last year, for all of the second quarter, they added 9 million net new accounts, in all of the quarter. I mean, you said, year-over-year, but in January and February, they added 3 million new subscribers a month.	The month of April alone, and that's their current quarter right now, in the second quarter, in the month of April, they added 7.4 million net new accounts. Now, for context, last year, for all of the second quarter, they added 9 million net new accounts, in all of the quarter. I mean, you said, year-over-year, but in January and February, they added 3 million new subscribers a month.	The month of April alone, and that's their current quarter right now, in the second quarter, in the month of April, they added 7.4 million net new accounts. Now, for context, last year, for all of the second quarter, they added 9 million net new accounts, in all of the quarter. I mean, you said, year-over-year, but in January and February, they added 3 million new subscribers a month.	The month of April alone, and that's their current quarter right now, in the second quarter, in the month of April, they added 7.4 million net new accounts. Now, for context, last year, for all of the second quarter, they added 9 million net new accounts, in all of the quarter. I mean, you said, year-over-year, but in January and February, they added 3 million new subscribers a month.	8d96ccbd-bdda-41b9-bee7-103cbf8d2bb9
716276.0	2020-05-11 00:00:00 UTC	Why Cummins Stock Popped 20.8% in April	DD	https://www.nasdaq.com/articles/why-cummins-stock-popped-20.8-in-april-2020-05-11	nan	nan	What happened After a 10% fall in March, shares of engines manufacturer Cummins (NYSE: CMI) recovered all of their losses and some in the month of April when their value shot up 20.8%, according to data provided by S&P Global Market Intelligence. There were two key triggers for the stock: Cummins' partnerships with some big companies in response to COVID-19 and its first-quarter numbers. So what The first major announcement came on April 3 when Cummins revealed a slew of tough financial decisions to deal with the COVID-19 pandemic that's hit the transportation sector really hard. For Cummins, trucking is a key end market. Cummins primarily announced pay cuts, including a 50% slash in the CEO's salary, 25% cut in director's compensation, and 10%-25% cut in salaries for all other employees in the U.S. Image source: Getty Images. On April 28, Cummins handily beat analysts' estimates with its first-quarter numbers, although its sales and earnings per share dropped 17% and 19%, respectively, year over year. The earnings sent Cummins' shares soaring double-digit percentages. In between, Cummins announced a couple of partnerships in April to help deal with the COVID-19 pandemic. One was a partnership with diversified chemicals company DuPont de Nemours (NYSE: DD) to combine their filter technologies to make viable alternatives to N95 respirator masks, the most common particulate-filtering face respirator mask critical for healthcare workers to combat coronavirus but which is in acute shortage worldwide. Cummins said it's already sent first samples to global mask manufacturers to test their effectiveness. On April 14, Cummins announced it's also partnering with 3M (NYSE: MMM) to produce particulate filters for use in 3M's air-purifying respirators (PAPRs), which again are in shortage worldwide but are a critical protective gear for frontline coronavirus healthcare professionals. Now what It's a given that this is a difficult time for Cummins, and the stock's rally in April appears to be more a case of value buying, especially after the stock's drop in March and the government's economic stimulus package. That said, Cummins may have to deal with some tough quarters ahead. 10 stocks we like better than Cummins When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.* David and Tom just revealed what they believe are the ten best stocks for investors to buy right now... and Cummins wasn't one of them! That's right -- they think these 10 stocks are even better buys. See the 10 stocks *Stock Advisor returns as of April 16, 2020 Neha Chamaria has no position in any of the stocks mentioned. The Motley Fool recommends 3M and Cummins. The Motley Fool has a disclosure policy. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	One was a partnership with diversified chemicals company DuPont de Nemours (NYSE: DD) to combine their filter technologies to make viable alternatives to N95 respirator masks, the most common particulate-filtering face respirator mask critical for healthcare workers to combat coronavirus but which is in acute shortage worldwide. What happened After a 10% fall in March, shares of engines manufacturer Cummins (NYSE: CMI) recovered all of their losses and some in the month of April when their value shot up 20.8%, according to data provided by S&P Global Market Intelligence. So what The first major announcement came on April 3 when Cummins revealed a slew of tough financial decisions to deal with the COVID-19 pandemic that's hit the transportation sector really hard.	One was a partnership with diversified chemicals company DuPont de Nemours (NYSE: DD) to combine their filter technologies to make viable alternatives to N95 respirator masks, the most common particulate-filtering face respirator mask critical for healthcare workers to combat coronavirus but which is in acute shortage worldwide. What happened After a 10% fall in March, shares of engines manufacturer Cummins (NYSE: CMI) recovered all of their losses and some in the month of April when their value shot up 20.8%, according to data provided by S&P Global Market Intelligence. Cummins primarily announced pay cuts, including a 50% slash in the CEO's salary, 25% cut in director's compensation, and 10%-25% cut in salaries for all other employees in the U.S.	One was a partnership with diversified chemicals company DuPont de Nemours (NYSE: DD) to combine their filter technologies to make viable alternatives to N95 respirator masks, the most common particulate-filtering face respirator mask critical for healthcare workers to combat coronavirus but which is in acute shortage worldwide. Now what It's a given that this is a difficult time for Cummins, and the stock's rally in April appears to be more a case of value buying, especially after the stock's drop in March and the government's economic stimulus package. 10 stocks we like better than Cummins When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen.	One was a partnership with diversified chemicals company DuPont de Nemours (NYSE: DD) to combine their filter technologies to make viable alternatives to N95 respirator masks, the most common particulate-filtering face respirator mask critical for healthcare workers to combat coronavirus but which is in acute shortage worldwide. There were two key triggers for the stock: Cummins' partnerships with some big companies in response to COVID-19 and its first-quarter numbers. In between, Cummins announced a couple of partnerships in April to help deal with the COVID-19 pandemic.	998601f4-3c2b-45fd-a51b-953877fff12e
716277.0	2020-05-05 00:00:00 UTC	DuPont doubles cost-savings target, slashes capital expenses	DD	https://www.nasdaq.com/articles/dupont-doubles-cost-savings-target-slashes-capital-expenses-2020-05-05	nan	nan	Adds forecast and first-quarter details, company background May 5 (Reuters) - Industrial materials maker DuPont DD.N on Tuesday doubled its annual cost-savings target and slashed its capital expenditure by about $500 million, as it looks to weather the global trade uncertainties brought on by the coronavirus outbreak. As spread of the coronavirus across some of the biggest economies upended global trade, companies are increasingly axing costs and delaying non-essential expenses. DuPont now expects to save $180 million this year, compared to $90 million from steps announced in January to take out stranded costs. The industrial giant had earlier suspended its full-year forecast, citing the pandemic. The company's adjusted earnings, in line with preliminary results released earlier, came in at 84 cents per share for the first quarter, beating analysts' estimates of 75 cents, according to Refinitiv IBES. Net sales fell 4% to $5.2 billion. (Reporting by Taru Jain; Editing by Maju Samuel) ((Taru.Jain@thomsonreuters.com;)) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	Adds forecast and first-quarter details, company background May 5 (Reuters) - Industrial materials maker DuPont DD.N on Tuesday doubled its annual cost-savings target and slashed its capital expenditure by about $500 million, as it looks to weather the global trade uncertainties brought on by the coronavirus outbreak. As spread of the coronavirus across some of the biggest economies upended global trade, companies are increasingly axing costs and delaying non-essential expenses. The industrial giant had earlier suspended its full-year forecast, citing the pandemic.	Adds forecast and first-quarter details, company background May 5 (Reuters) - Industrial materials maker DuPont DD.N on Tuesday doubled its annual cost-savings target and slashed its capital expenditure by about $500 million, as it looks to weather the global trade uncertainties brought on by the coronavirus outbreak. As spread of the coronavirus across some of the biggest economies upended global trade, companies are increasingly axing costs and delaying non-essential expenses. (Reporting by Taru Jain; Editing by Maju Samuel) ((Taru.Jain@thomsonreuters.com;)) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	Adds forecast and first-quarter details, company background May 5 (Reuters) - Industrial materials maker DuPont DD.N on Tuesday doubled its annual cost-savings target and slashed its capital expenditure by about $500 million, as it looks to weather the global trade uncertainties brought on by the coronavirus outbreak. The company's adjusted earnings, in line with preliminary results released earlier, came in at 84 cents per share for the first quarter, beating analysts' estimates of 75 cents, according to Refinitiv IBES. (Reporting by Taru Jain; Editing by Maju Samuel) ((Taru.Jain@thomsonreuters.com;)) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	Adds forecast and first-quarter details, company background May 5 (Reuters) - Industrial materials maker DuPont DD.N on Tuesday doubled its annual cost-savings target and slashed its capital expenditure by about $500 million, as it looks to weather the global trade uncertainties brought on by the coronavirus outbreak. As spread of the coronavirus across some of the biggest economies upended global trade, companies are increasingly axing costs and delaying non-essential expenses. DuPont now expects to save $180 million this year, compared to $90 million from steps announced in January to take out stranded costs.	e13c80ff-59a1-4f65-9d8b-9faebc421860
716278.0	2020-05-05 00:00:00 UTC	Why Shares of Chemours Are Soaring Today	DD	https://www.nasdaq.com/articles/why-shares-of-chemours-are-soaring-today-2020-05-05	nan	nan	What happened Shares of Chemours (NYSE: CC) traded up 13% on Tuesday after former parent DuPont (NYSE: DD) said it is likely to renegotiate the companies' separation agreement. Chemours has sued DuPont over the environmental liabilities it retained in the original agreement, but the company's initial court efforts have not been promising. So what Chemours, a major supplier of titanium dioxide, was spun out of DuPont in 2015 and held on to a lot of legacy environmental liabilities as part of the separation agreement. Chemours has argued that DuPont's estimates of how much its former subsidiary would be on the hook for were off base and were not prepared in good faith. Image source: Getty Images. Chemours had gone to court to try to get DuPont to foot more of the bill, but the company on March 31 was dealt a setback when the litigation was dismissed on technical grounds. Sam Glasscock 3d of the Delaware Court of Chancery granted DuPont's dismissal request, ruling that he had no jurisdiction to hear the case because the separation agreement between the companies states that all disputes arising from the spinoff are subject to binding arbitration. Chemours has appealed that ruling. DuPont CEO Edward Breen, during his company's post-earnings call, said he was pleased with the push to go to arbitration "because it's a quicker process than going through the court system." He also predicted the two sides would be able to come to an agreement. "My opinion is, there probably will be a settlement with Chemours that will occur here at some point in time, where we will renegotiate the agreement we have between the companies," Breen said. Now what Chemours shares crashed after the late March court decision because what investors fear most is the company having to go it alone in cases involving PFOA, a chemical once used in nonstick coatings and other products. There is still a lot of risk with these suits, but it appears from Breen's comments that Chemours' former parent is not just trying to walk away from the claims. That's reason enough to send the shares flying heading into Chemours' earnings report Tuesday evening. 10 stocks we like better than Chemours When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.* David and Tom just revealed what they believe are the ten best stocks for investors to buy right now... and Chemours wasn't one of them! That's right -- they think these 10 stocks are even better buys. See the 10 stocks *Stock Advisor returns as of April 16, 2020 Lou Whiteman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	What happened Shares of Chemours (NYSE: CC) traded up 13% on Tuesday after former parent DuPont (NYSE: DD) said it is likely to renegotiate the companies' separation agreement. So what Chemours, a major supplier of titanium dioxide, was spun out of DuPont in 2015 and held on to a lot of legacy environmental liabilities as part of the separation agreement. Sam Glasscock 3d of the Delaware Court of Chancery granted DuPont's dismissal request, ruling that he had no jurisdiction to hear the case because the separation agreement between the companies states that all disputes arising from the spinoff are subject to binding arbitration.	What happened Shares of Chemours (NYSE: CC) traded up 13% on Tuesday after former parent DuPont (NYSE: DD) said it is likely to renegotiate the companies' separation agreement. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market. See the 10 stocks *Stock Advisor returns as of April 16, 2020 Lou Whiteman has no position in any of the stocks mentioned.	What happened Shares of Chemours (NYSE: CC) traded up 13% on Tuesday after former parent DuPont (NYSE: DD) said it is likely to renegotiate the companies' separation agreement. 10 stocks we like better than Chemours When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. See the 10 stocks *Stock Advisor returns as of April 16, 2020 Lou Whiteman has no position in any of the stocks mentioned.	What happened Shares of Chemours (NYSE: CC) traded up 13% on Tuesday after former parent DuPont (NYSE: DD) said it is likely to renegotiate the companies' separation agreement. That's right -- they think these 10 stocks are even better buys. The Motley Fool has no position in any of the stocks mentioned.	46b1dc9c-2e96-4770-847f-ade54594bc94
716279.0	2020-05-05 00:00:00 UTC	How to Handle Spinoff Shares	DD	https://www.nasdaq.com/articles/how-to-handle-spinoff-shares-2020-05-05	nan	nan	In this episode of Industry Focus: Energy, Nick Sciple and Motley Fool contributor Lou Whiteman do a deep dive into the spinoff of United Technologies and Raytheon Technologies (NYSE: RTX), Carrier (NYSE: CARR), and Otis (NYSE: OTIS). They rate them from most favorable to least favorable for investment and give a detailed analysis of each. They also suggest some other stocks to keep on your radar. To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center. To get started investing, check out our quick-start guide to investing in stocks. A full transcript follows the video. 10 stocks we like better than Walmart When investing geniuses David and Tom Gardner have an investing tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.* David and Tom just revealed what they believe are the ten best stocks for investors to buy right now… and Walmart wasn't one of them! That's right -- they think these 10 stocks are even better buys. See the 10 stocks Stock Advisor returns as of 2/1/20 This video was recorded on April 30, 2020. Nick Sciple: Welcome to Industry Focus. It's Thursday, April 30. I'm your host, Nick Sciple. Joining me today is Motley Fool contributor Lou Whiteman. Lou, how's it going? Lou Whiteman: I'm doing all right. How are you doing? Sciple: You know, I'm hanging in there. I know you're in Atlanta, you know, craziness going on in that neck of the woods, you know, you've got family that works for the CDC, lots of stuff going on with opening up the economy over there. How are you feeling with the current state of the world over in your neck of the woods? Whiteman: I’m going to steal this from someone on Twitter, but between us leading the way, shall we say, and reopening, and the fact that the governor just said teenagers don't need to take a driver's test to start driving to get their license. The one thing to come out of this pandemic is nobody's going to want to visit Georgia. [laughs] Sciple: There you go. Yeah, watch out, everybody on the roads in Georgia, we’re going to have a lot of inexperienced drivers driving around. Whiteman: I don't understand how that's a good idea, but yeah. [laughs] Sciple: All right. We've got a fun show today. We’re going to be diving into United Technologies. We discussed this company a few times on the show in the context of this upcoming split-out of several different companies. Raytheon Technologies, Carrier Air Conditioning, and Otis Elevators are going to be spinning off of that company. And we got a question from Vinny, asking us to dive into some of those companies. So Vinny asks, “Love the podcast, you guys are the most focused of the podcast from The Motley Fool and full of great nonconventional investment tips. I'm curious if you could do a podcast on Carrier and Otis. I'm sure many of us have inherited shares when United Technologies and Raytheon merger. I'm not sure what to make of their valuations and debt levels and whether to buy, sell or hold them. Thanks for continuing on in the age of coronavirus. Sending you a virtual Corona beer.” Vinny, thanks for sending in that question. I just want to remind everyone to find your beach in this time of coronavirus, that's [...] So I think that's an important thing. But I think one of the points Vinny touches on is the idea of you're going to be holding these shares. You held United Technologies, and now you’re going to be left with shares of Carrier and Otis. It’s this conundrum that a lot of people have when they own shares in a spinoff. And that's part of the reason why there's a lot of famous investors that call off spinoffs as an attractive area to invest in. There’s one quote from Peter Lynch that says, “Spinoff companies are often misunderstood and get little attention from Wall Street. Investors often are sent shares in the newly-created company as a bonus or a dividend for owning the parent company. And institutions, especially, tended to dismiss these shares as pocket change or found money. These are favorable omens for spinoff stocks.” That's a Peter Lynch quote. So Lou, when you look at this, obviously, there's a natural constituency of sellers for these stocks. They get these new shares that weren’t in the company originally held, but there's not a natural group of people out there to buy the stock. When you get a spinoff stock pushed to your portfolio, how do you handle those shares yourself? Whiteman: Well, I think it's important to look at the spinoff and look at what's going on in the company leading up to it. You know, we talk a lot about conglomerate discount, which is an outside looking in, where maybe the market doesn't fully value the sum of the parts. The important thing to remember with these companies is there is an internal tension too, where you have different businesses with different capital allocation needs, different growth trajectories, all kind of competing for resources and intention inside the parent. Often, a unit can get neglected, or its best interests may be sacrificed for the greater good. You see an opportunity but the capital isn't there because it's going elsewhere. These are the sort of narratives that can set up very interesting spinoffs. So when I look at spinouts, I think it's important to look at the narrative, look at what led up to it. Is this a viable stand-alone business that maybe has opportunities out on its own, or is this just a part they didn't want any more or a way to dump liabilities? It’s very important to look at the individual case and see what's going on. Sciple: Absolutely. You mentioned that increased focus, and that's part of another quote that I pulled from Michael Mauboussin, and a lot of people would be familiar with his work, he does a lot of deep research into the factors that drive returns for stocks, and he says, on the spinoffs, “As researchers who do a meta-analysis, more than 25 papers in the spinoffs literature summed up their findings this way. The main conclusion is consistent; spinoffs are associated with strongly significant abnormal returns. And they suggest the factors that explain these wealth effects include sharpened focus, better information, and in some cases, tax treatments.” So in the cases of these spinoffs, and we'll talk about some later, their position to take the cash that they're producing in their business and focus it toward the priorities relevant to that, what was once a subpart is now its own company on its own. I do want to, before we go into these three companies coming out from United Technologies -- you mentioned cases where sometimes a spinoff is some asset that the company can't find a market for, they choose to spin it out just to, kind of, get it off their books and remove that anchor from the core company. Given these new spinoff shares, how do you decide or reach the conclusion that this is an attractive company to hold on to or not? And do you have any examples of cases in the past where, “Hey, this spinoff was a clear case of the company cutting loose some deadweight?” Whiteman: Sure. Well, like I said, I think it's important to look at the narrative, to really look at what's going on. A good example from recently, in the same sort of sector, is Honeywell Technologies. In 2018 they spun-off two businesses, just like United Technologies is doing, and in a way, they were at least a little similar. Garrett was an auto company, but Resideo is somewhat similar to Carrier, and it was home automation tools, things like that. Garrett is off 71% since the spinoff. Resideo, I think, is down over 80%. The auto business wasn't where Honeywell wanted to be. They had an activist breathing down their neck, there were calls for them to sell the entire company, to do something. They took two parts of the company that were maybe less attractive and basically said, “Shareholders, it's your problem.” Garrett is in litigation with Honeywell, claiming that Honeywell basically used it to dump their asbestos liabilities on them. I mean, this was just -- hindsight is 20/20, of course, but you could look at the pressure the company was on, look at the type of business where you spun out and say, “You know what, they don't want these businesses, why should I?” And that's certainly not always the case with the spinout, but that does happen with spinoffs, and it's something that investors need to look at. Sciple: Yeah, Lou, we talked before the show. You had mentioned Ed Breen. He is someone who is known as, kind of, the king of spinoffs. How has he used spinoffs in the past? Whiteman: So yeah. Ed Breen is the god among us in this topic. Old-timers will remember, he took over Tyco International company, I think, 2002 he stepped in. That was right around the time that company was floundering. Dennis Kozlowski was famously on his way to jail. A lot of people, myself included, thought that Tyco’s best days were over. Breen came from Motorola, another company long gone, to organize the company, which was a very sprawling list of assets, split it into three companies. The one part he stayed with, he split into another three. And we have five, six companies there that most of them are still out there as independents. It's everything from security systems, healthcare. He turned what looked like manure at the time into gold. He then turned around and did the same thing. He took over DuPont a few years ago, merged it with DOW. The new DowDuPont then split into three companies, and he's still with the new DuPont, and they're looking at splitting again or divesting again. He has a real track record of -- he sees businesses that should be together and sees businesses that would be better off on their own. Frankly, given his track record, I give the benefit of doubt that anything he wants to do in terms of corporate reorganizations. [laughs] Sciple: Right. And so, Ed Breen isn’t associated directly with this United Technologies spinoff, but he's just an example of someone who, over years and years and years, can use this strategy to create lots of value for shareholders. And you know, as the quotes I mentioned earlier for Michael Mauboussin and Peter Lynch suggest, that this is an area where a lot of legendary, sophisticated investors look for value. And so, going into these United Technologies companies. Now, today, since there's three of them, I thought it would be fun to use the whole good, bad, and the ugly framework to talk through how we're viewing these companies. And that's not to say that I think all of these companies could be good investments under the right circumstances, but given the market environment today, as these companies come spinoff, if we had to force these companies into these three categories: good, bad and ugly of Otis, Carrier, and Raytheon Technology. So first, we got to start with the good news first. Who would you label the good from the United Technologies spinoff? Whiteman: Well, I think good in terms of just set it and forget it, right now it has to be Otis. This is a $13 billion-sales elevator manufacturer and maintainer. I think everybody knows the Otis name. We’ve all used their products a lot. This is a company that you know exactly what you're getting. It’s slow growth, but it is huge, huge aftermarket sales. All of their 2 million units installed internationally have to be serviced. You can't really skimp on that with regulations. Service makes up more than half of their revenue and 80% of adjusted operating profit. Their service margins are north of 20%, new equipment is less than 10%. This is a company that you know what you're going to get. They aren’t a fast grower, but they generate cash, they return that cash to shareholders, and it is a really interesting company for someone who is income oriented or looking for a dividend payer. Sciple: Yeah, Otis is a really interesting company to me. The elevator industry, very sleepy, old industry, has been around for 100 years. When you look at the market share in the industry, it's really, kind of, there's a lot of players, but really there's four dominant people in the industry. There's Otis that is the leader in market share. And then there's Schindler, Kone, and ThyssenKrupp that kind of round out that top four. And they really, really dominate this market. So you have a tight oligopoly market. And then, as well, something that helps this business, you mention the servicing aspect of the business, which gives them an opportunity to earn revenue that is much higher margin than you would expect from someone making these giant industrial products like elevators. And so that's an opportunity for growth and recurring revenue for them over time. There's a flywheel of you install the elevator, and then you have servicing that creates dependable revenue over time. But what's particularly interesting about the servicing to me is given the safety concerns throughout elevators, they’re in lots of buildings, there are requirements, regulatory requirements, to have these machines serviced on a regular, consistent schedule. So you've got this industry that's very consolidated, that gives this opportunity for servicing revenue, and then your customers are required to pay for that servicing. Whiteman: In good times and in bad too. In this environment right now, all of the Fortune 500 are looking for ways that they can save money, nobody is going to say, “Let's just put off servicing the elevators for a couple of years.” [laughs] Sciple: Exactly. One of the greatest things to have as a business is a revenue stream that the law says, “Your customer must pay.” And there's a few of them out there. You look in the financial services industry, you know, you're not going to stop getting your trash collected. There's a few out there. And I think Otis is in one of those categories. And you know, one of the things I have joked about when I’ve talked about this company in the past, is you throw this servicing in there, it's an EV-as-a-service, right? It's elevator-as-a-service, which you know, when you have an elevator company, you don't think of recurring revenue and all these sorts of things. You did mention, Lou, that this is the type of stock that could be good for someone who is interested in income. When you look at the dividend for Otis today, does anything stand out to you about that at all? Whiteman: Well, I mean, their commitment to the dividend I think is worth mentioning. You know they are a new company, so they had to lay out what they see for the future. Their goal is a 40% dividend payout ratio. So basically 40% of their net income is going to go to the dividend. The bad news there is, there's not a lot of R&D going on, there's not a lot of growth potential there. As you say, this is an industry that has consolidated down. You're not going to see a big jump when they get bought out by a competitor. There's not much chance they're going to buy a competitor. But I mean, their revenue is not going to grow year to year that much, but they have money coming through the door, and they are very good at turning around and giving that money back to shareholders. Sciple: Right. Yeah. So particularly on the equipment side of the market, there's not going to be a lot of room for growth just because we're not throwing up tall buildings every other day. There is demand for replacement on this equipment, you know, as these things are getting more modern. They’ve actually talked about -- I think in recentearnings callwere talking about that they’re getting some software-as-a-service revenue from things like these updated elevators, where if you want to be able to call the elevator for your apartment on your phone while you're still in your apartment, that they can charge servicing revenue. So I think the real opportunities for them are going to be -- another thing to note as well is that the servicing market is a little bit more fragmented than the original equipment manufacturing market. So it's not just these big four players that are playing in the servicing market. But I think, really, the story for this company is that, you know, the equipment side of the market, actually, physically making the elevators is going to be pretty steady over time, I don't think it's going to change. Where they could have some outsized returns will be if they could grab market share in servicing. And I think if you look -- you know, we talked about earlier, when you come out of these spinoffs, increased focus on the core business can be an advantage. And I think if you look over the past several years, Otis has trailed its competitors in sales growth, that sort of thing. Maybe that's because it was already very large, and so there's just limits in how much more you can grow, but there are some prospects for this company now that's spun off, independent, on its own to maybe pick up some of that lost ground on its competitors when it comes to growth rate and that sort of thing. We'll have to see, but I think this is one of those companies that you can see how on its own it can be a little bit more attractive than when you have this asset buried inside with lots of other assets, because you can't really see some of these flywheels from the recurring revenue and that sort of thing. Whiteman: Sure. Yeah, and I do think there is opportunity. I mean they haven’t -- China is where the growth is for the industry, and I don't think that they would consider themselves -- I think they can do a better job in China with the new equipment sales, and that, of course, could trickle down to more servicing. So there is incremental growth. And as you say, with better focus, there are opportunities. Sciple: Yeah. We shall see. So moving along in our framework of good, bad, and ugly from this spinoff, who would be the bad in this framework for you, Lou? Whiteman: Well, with the bad, we're going to have to go with Carrier. And being in Georgia, I can't really say too much bad about Willis Carrier, the guy who invented the air conditioner and the reason we're all here. Carrier is that HVAC company to this day: They are heating, ventilation, air conditioning, cooling. They have expanded into, they're already selling building owners and building managers, building construction. So they also sell other tools for the building. They have a fire and security. They have diversified into commercial refrigeration of the air conditioning. This is an $18 billion company. HVAC is about 50% of sales. They are pretty well diversified globally. About half of their business is in the Americas and another 30% Europe. This is also an industry that should benefit from a lot of so-called megatrends. We're urbanizing, which is bigger buildings, more commercial air conditioning systems. The middle class; the emerging middle class around the world, air conditioning is something that you associate with people coming into the middle class. Global warming, both as an opportunity of the world is getting hotter but also on the regulation side, we need more efficient systems and it's causing older buildings to need to overhaul their HVAC. There's a lot going for this industry in the addressable market. Unfortunately, this is also sort of viewed as the weak link inside United Technologies. This company, for one, they're coming out with a lot of debt. They’re going to have about $11 billion, $11.4 billion in gross debt. This is a company that was in need of a turnaround. They'll now have the attention on it. Management hopes to take out about $600 million in costs by 2022; that was prior to the pandemic, and who knows what that means now. But this is a company in an interesting market, but a company that is in need of a turnaround or needs a fresh start. Sciple: So Lou, when we talked about Otis just a second ago, we mentioned that consolidation in the market. Are there any similar dynamics at play in this air conditioning market that the Carrier plays in in the HVAC market? Whiteman: I think there is potential there. We have seen some deals. I mean, I've been covering United Technologies for years. I believe they shopped Carrier pretty heavily before the spinout. There's some language in some of the regulatory filings that almost suggests that, I mean we can't prove that, but suggests that. You know, the issue for them -- I just talked about their debt. In this macroeconomic environment and with their debt, they can't be a buyer, and they're not very attractive as a target. I mean, I think they would work so well with the newly reconstructed Johnson Controls. Johnson Controls has shed their auto business, they've shed a lot of their conglomerate. That's another interesting spinoff that we get into sometimes. Johnson Controls would fit in very well with what Carrier is doing and create a real powerhouse that, kind of, goes well in this industry. It's hard to imagine that happening for a few years. I still think that could happen, but you know, for now, this is an industrial manufacturer in need of a restructuring and a high debt load heading into a potential recession. And that's a tough place to be. Sciple: Yeah, Lou, you mentioned that picture, obviously, relayed only at the bad in this case. So of these three, probably the least excited about owning, I would say, Carrier would be. However, you know, we were talking before the show. Stephen Tusa, who's an analyst at JPMorgan Chase, has done some great work on GE over the years, has come out with a note a week or two ago. Where he called Carrier “once-in-a-generation opportunity, focusing on its trading at a significant discount to its peers.” Calling out that Carrier as a brand is very well-known in its space, you know, a very strong company. One of the important tenets of his once-in-a-generation opportunity thesis, however, is that Carrier could be divesting some assets to get that debt picture under control. So I know you've read some of Stephen Tusa’s analysis, what are your thoughts on his arguments that this actually could be a great opportunity to buy Carrier today? Whiteman: Well, first of all, I should say, Tusa has been right about GE every step of the way, and people should follow him very closely there. And I have all the respect in the world for him. All I'd say about his report is, I think his quote was, “Management has some wood to chop,” was how we put it. And, yeah, I think he's right. If everything goes well, he called the balance sheet stretched today and recommended divestitures, recommended a lot of work. Yes, he is correct. If all goes well, if they get the debt down, maybe if they trim some assets, maybe if they find some opportunities, this is a strong brand and can be a good company. Just don't underestimate the word “if” in that sentence; there is a lot of work to do to get there. Not saying Carrier should be shorted down to zero. Of these three, though, clearly, to me, this is the least attractive to hold for the next few years. Sciple: Yeah, I agree with you much, Lou. By process of elimination, good, bad, and the ugly. Well, we've already gone through two, so that means the ugly is Raytheon Technologies, the company that is formed out of the merger of Raytheon and the aerospace division of United Technologies. When you look at this company, why is it the ugly, Lou? Whiteman: This is by far the biggest of the three companies. With the Raytheon assets included, this is a $74 billion company. And interestingly enough, United Technologies -- we talked about Honeywell was the target of activism. United Technologies was too. Bill Ackman was very much involved in what was going on. And Ackman really liked the aerospace business and really didn't want to see the Raytheon deal done, because he thought we were going to dirty this commercial business with a lot of defense business. And boy! Has the world changed [laughs] in a short amount of time there. United Technologies makes Pratt & Whitney engines. We know about that very well. A few years ago, they bought Rockwell Collins. So they also are very big in commercial, especially interiors, but also the cockpit systems for defense applications. Raytheon was missiles, sensors, a lot of space. Raytheon is the rare defense contractor that doesn't make a lot of heavy equipment, but they do make a lot of the brains and a lot of the sensors that go into this equipment. The argument for this deal was, we would combine a strong commercial business with a strong defense business to have a more stable long-term play. The commercial people didn't like it, the defense people didn't like it. United Technologies looks really smart doing this, Raytheon maybe not so much, because with this pandemic, we're seeing aircraft demand go to near zero. We've been talking a lot about Boeing. Boeing is seeing three to five years before commercial airspace recovers. All of a sudden, this is still a great business. Pratt & Whitney engines aren't going anywhere, but all of a sudden, this legacy United Technologies aerospace business has just got a difficult road ahead. I mean, a lot of these commercial suppliers are down 50% or more year to date. Having this Raytheon asset, this is a great time for them to have it. It’s attractive, it's interesting, but for the next couple of years between the integration and the commercial slowdown, it could be ugly. Sciple: Yeah, well, on the commercial part of this business, the analogy I keep thinking about is like, you know, when you go out for New Year's Eve and you get really dressed up and, you know, you're going to be really fancy and you’re going to go out to your New Year's Eve party and you’re having a good time. Whiteman: No, I have no idea about that, but go ahead. [laughs] Sciple: Yeah. Well, and you have a really good time on New Year's Eve, and then you wake up New Year's Day, maybe 11:00, 12:00, maybe if you had a really good time, 1:00 in the afternoon, and you're looking really rough. I would explain that analogy of, like, the pre- and post-COVID of what these United Technologies assets are really. I mean, it’s the same assets, but you went from looking as best as you possibly could with airline travel probably as good as it's been in years, the economy going on all cylinders, to nobody's going anywhere, everything is shut down, and just overnight how quickly that narrative shifted. When you look at the debt profile of these companies as well, you had some notes on how these sing together. The commercial part of the business was much more levered up than the defense part of the business of Raytheon. Can you talk about that a little bit? Whiteman: Yeah, I think coming into the deal, the legacy United Technologies, they had brought about $24 billion worth of debt to the combination. Raytheon had about $2 billion, so that's $26 billion in total debt on about $75 billion of sales; it’s manageable. But yeah, no, I mean, imagine this business, as you said, the hangover or the morning after, if United Technologies stand-alone commercial was out there today with $35 billion, $40 billion in mostly commercial sales and $24 billion in debt, and really just falling off a cliff revenue-wise for the next few years, that would be a very different situation. Now, suddenly, you have a +$70 billion military backlog to fall back on. The new Raytheon Technologies just beat out Lockheed Martin in a big missile competition. The Pentagon ended it two years early because they were winning. So let's get going with it. The combination looks pretty darn good right now versus United Technologies stand-alone. I would argue for Raytheon holders 5, 10 years down the line, commercial will come back and you'll be glad you're part of this business then too. But the payoff for United Technologies holders is immediate. Sciple: And then the question I have, Lou, is obviously, we've labeled this Raytheon Technologies companies, the ticker is RTX, I just want to note that, because there's been a change since the merger was completed. But, obviously, we've labeled it the ugly. There's a lot of uncertainty around when commercial air travel could return to where it was pre-coronavirus or if it ever will return to that peak after this, but when you're -- you know, obviously, there's a scale. How ugly would you say this business is right now, given those question marks? You know, how much would you have to hold your nose to go buy the stock right now? Whiteman: So I have no doubt commercial air traffic will return, and feel free to email me on that, because [laughs] I know it’s far from certain, but it will return. It is going to take time. To buy it today, here's how I would look at it. And I follow airspace pretty closely. I look at, you know, some of my favorites, Lockheed Martin, I look at General Dynamics that is somewhat beaten down due to Gulfstream, so they have some of these issues too, but they are in a much better place. Raytheon Technologies today, for the next year, holding it in next year to two years when these other opportunities are out there is pretty unattractive to me. Over the long-term, if you have these shares, I would hold it. I really believe that the combined company, they will get it right, and over the long term this will be an outperformer. But you know, it's a 3 or 4 out of 10, tops, as far as just buying in now instead of buying some of these other companies that just don't have the challenge. You know, the integration alone, even in good times would be, you know, a challenge, and who knows how those go, add in this commercial issue. Why sit on these shares for now? You’ll probably buy them for the same price a year from now? Sciple: That's a great point -- the integration. You think about, you’re coming together with your new coworkers and, you know, all your offices are closed and all that sort of thing. I mean, that's got to add a whole 'nother layer of complexity to this. As far as holding your stock, what you would do going forward, to go back to Vinny's question off the top of the show; if you're someone who held United Technologies coming into this spinoff, given the discussions we've given around Otis, Carrier, and Raytheon Technologies, the successor company, you get these spun-off shares, what are you doing with them right now? Are you holding them all? Are there any that you're selling? What would you do? Whiteman: You know for me, personally, if there's any I sold, it would probably be the Otis, just because that's not the profile of a company that I'm interested in. I don't necessarily think I'd be in a hurry to sell any of them. I wouldn't be in a hurry to buy any of them, because again, the dividend play with Otis is not really what I'm looking for. But there isn't a stinker in this bunch. I don't think this is going to be a repeat of what we saw with Honeywell and its spinoffs. And I think over time, all of these businesses can become something. I mean, even in the worst case, I think Carrier will end up in the arms of someone else, or it will work out. So I would probably just hold tight to all three and see how it goes. They may not be the best performers for the next six months, but that's not the game we're playing. Sciple: Absolutely. Long term is the only game that matters. So finally, Lou, before we go away, I know you follow a lot of different stocks, a lot of different spinoffs. Any other of those, any other spinoff companies that our listeners should be aware of to keep on their radar? Whiteman: So here's one for the radar only, because you should not buy this company right now, period, today, based on what we just talked about with commercial airspace. But it's a company called Howmet Aerospace, HWM is the ticker. And you don't know this company, but you know it's legacy. Alcoa, the aluminum maker, last decade had this idea that they wanted to get into more finished products. So instead of just making the raw material, they bought up a lot of companies that make things with aluminum, including a lot of aerospace assets. That didn't go so well, so they spun that off into something called Arconic, which also didn't do so well, so now Arconic has split in two, and Howmet is the remaining aerospace business. They were always good assets. The guy in-charge of Alcoa, way back when they put it together, did a terrible job integrating them. This is a turnaround story in a bad environment, but long term, I really like the assets they have and it should have worked out; with better management, quite frankly, it would have worked out better back in the beginning. And I think there is great potential for this business. I just don't really have any desire to buy into a commercial-focused airspace business until we have more clarity about what's going on. Sciple: Right. So Howmet Aerospace -- can you give us that ticker one more time? Whiteman: HWM. Brand new in the last few weeks. Sciple: HWM. All right, folks, add that one to your watch list. Lou, thanks for coming on the show, as always. Whiteman: Thank you. Sciple: As always, people on the program may own companies discussed on the show, and The Motley Fool may have formal recommendations for or against the stocks discussed, so don't buy or sell anything based solely on what you hear. Thanks to Austin Morgan for his work behind the glass. For Lou Whiteman, I’m Nick Sciple. Thanks for listening, and Fool on! Lou Whiteman owns shares of General Dynamics and Lockheed Martin. Nick Sciple has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Twitter. The Motley Fool has a disclosure policy. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	The middle class; the emerging middle class around the world, air conditioning is something that you associate with people coming into the middle class. There's a lot going for this industry in the addressable market. All of a sudden, this is still a great business.	The middle class; the emerging middle class around the world, air conditioning is something that you associate with people coming into the middle class. There's a lot going for this industry in the addressable market. All of a sudden, this is still a great business.	The middle class; the emerging middle class around the world, air conditioning is something that you associate with people coming into the middle class. There's a lot going for this industry in the addressable market. All of a sudden, this is still a great business.	The middle class; the emerging middle class around the world, air conditioning is something that you associate with people coming into the middle class. There's a lot going for this industry in the addressable market. All of a sudden, this is still a great business.	fb3d1ec1-bc02-4d83-addd-21e6d24940ed
716280.0	2020-05-05 00:00:00 UTC	BUZZ-U.S. STOCKS ON THE MOVE-Oil and gas stocks, banks, Tesla, tankers	DD	https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-oil-and-gas-stocks-banks-tesla-tankers-2020-05-05	nan	nan	Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: http://tmsnrt.rs/2ggOmBi The Morning News Call newsletter: http://tmsnrt.rs/2fwPLTh Wall Street's main indexes jumped on Tuesday as a recovery in oil prices lifted battered energy stocks and a slew of countries eased coronavirus-induced restrictions in an attempt to revive their economies. .N At 12:59 ET, the Dow Jones Industrial Average .DJI was up 1.41% at 24,083.9. The S&P 500 .SPX was up 1.65% at 2,889.78 and the Nasdaq Composite .IXIC was up 1.86% at 8,872.609. The top three S&P 500 .PG.INX percentage gainers: IPG Photonics Corp IPGP.O, up 18.1 % Mosaic Company MOS.N, up 8.3 % Sealed Air Corp SEE.N, up 7.9 % The top three S&P 500 .PL.INX percentage losers: Norwegian Cruise Line Holdings Ltd NCLH.N, down 21.1 % Westrock Company WRK.N, down 14.4 % Leggett & Platt LEG.N, down 8.5 % The top two NYSE .PG.N percentage gainers: Indonesia Energy Corp Ltd INDO.N, up 73.8 % Chegg Inc CHGG.N, up 38.1 % The top NYSE .PL.N percentage loser: Medley Llc MDLQ.N, down 23.5 % The top three Nasdaq .PG.O percentage gainers: Portola Pharmaceuticals Inc PTLA.O, up 130.1 % Clensprk Inc CLSK.O, up 128.7 % Genprex Inc GNPX.O, up 70.1 % The top two Nasdaq .PL.O percentage losers: Capitala Finance CPTA.O, down 17.6 % Oxford Immunotec OXFD.O, down 16.8 % Chevron Corp CVX.N: up 3.6% Exxon Mobil Corp XOM.N: up 1.5% ConocoPhillips COP.N: up 3.3% Concho Resources CXO.N: up 3.8% Pioneer Natural Resources PXD.N: up 3.0% WPX Energy WPX.N: up 2.1% Cabot Oil & Gas COG.N: up 1.6% Hess Corp HES.N: up 3.1% Occidental Petroleum OXY.N: up 4.4% Apache Corp APA.N: up 4.1% Halliburton Co HAL.N: up 1.7% Schlumberger NV SLB.N: up 2.8% Baker Hughes BKR.N: up 1.9% ProPetro Holding PUMP.N: up 6.6% BUZZ-Oil and gas stocks rise on demand hopes as lockdowns ease Goldman Sachs Group Inc GS.N: up 2.7% JPMorgan Chase & Co JPM.N: up 1.4% Citigroup Inc C.N: up 0.3% Bank of America Corp BAC.N: up 1.3% Morgan Stanley MS.N: up 1.3% BUZZ-Big banks: Rise as U.S. treasury yields edge higher Pfizer Inc PFE.N: up 2.8% BioNTech SE BNTX.O: up 6.6% BUZZ-Pfizer, BioNTech: Up after starting trials for COVID-19 vaccine Portola Pharmaceuticals PTLA.O: up 130.1% Alexion Pharmaceuticals Inc ALXN.O: down 5.2% BUZZ-Rises after Alexion to buy co in $1.41 bln deal Centennial Resource Development Inc CDEV.O: down 9.4% BUZZ-Tumbles as Q1 loss widens on impairment charge Compass Diversified Holdings CODI.N: down 11.0% BUZZ-Drops on stock offering U.S. Concrete Inc USCR.O: up 4.8% BUZZ-Rises after reporting better-than-expected results Skyworks Solutions Inc SWKS.O: up 5.0% BUZZ-Gains on Q2 revenue and profit beat Capricor Therapeutics Inc CAPR.O: down 8.4% BUZZ-Falls on planned $40 mln equity raise after shares triple Livongo Health Inc LVGO.O: up 6.0% Healthcare Inc ONEM.O: up 4.3% Teladoc Health Inc TDOC.N: down 2.7% BUZZ- Virtual care here to stay post COVID-19 - Piper Sandler Chembio Diagnostics Inc CEMI.O: up 11.4% BUZZ-Jumps on getting CE marking for COVID-19 test Owens & Minor OMI.N: down 3.7% BUZZ-Baird downgrades Owens & Minor on higher risk in times of COVID-19 DuPont de Nemours Inc DD.N: up 1.1% BUZZ-Climbs on doubling cost-savings target, curbing expenses Chegg Inc CHGG.N: up 38.1% BUZZ-Eyes record high, reaps benefits of digital learning shift Regeneron Pharmaceuticals Inc REGN.O: up 5.7% BUZZ-Rises after Q1 profit, revenue beat Bloomin' Brands Inc BLMN.O: down 6.1% BUZZ-Falls as Q1 profit likely to miss estimates TG Therapeutics Inc TGTX.O: up 25.9% BUZZ-Surges after late-stage trial meets main goal Marathon Petroleum Corp MPC.N: up 0.3% BUZZ-Gains on smaller-than-expected loss, 2020 capex cut Akebia Therapeutics Inc AKBA.O: up 32.0% BUZZ-Up on positive data for anemia treatment in dialysis patients Tesla Inc TSLA.O: up 1.6% BUZZ-Rebounds as Musk eyes big payday Insmed Inc INSM.O: down 3.4% BUZZ-Insmed slips on $225 mln share offering SG Blocks Inc SGBX.O: up 1.6% BUZZ-Surges on Osang HealthCare deal to distribute COVID-19 test kits Westrock Co WRK.N: down 14.4% BUZZ-Falls as Q2 rev misses estimates on lower selling price Diffusion Pharmaceuticals Inc DFFN.O: up 23.6% BUZZ-Gains as FDA accelerates review of COVID-19 treatment plan Aptiv Plc APTV.N: up 2.5% BUZZ-Gains on better-than-expected results Henry Schein Inc HSIC.O: up 3.0% BUZZ-Rises on better-than-feared quarterly results Fiat Chrysler Automobiles NV FCAU.N: down 0.5% BUZZ-Rises as PSA deal on course despite pandemic woes Norwegian Cruise Line Holdings NCLH.N: down 21.1% Carnival Corp CCL.N: down 6.0% Royal Caribbean Cruises RCL.N: down 6.3% BUZZ-Norwegian Cruise sinks on going concern warning, $1.6 bln capital raise plans Alaska Air Group Inc ALK.N: up 3.9% BUZZ-Alaska Air jumps on lower cash burn forecast for June Wayfair Inc W.N: up 22.8% BUZZ-Hits record high as 20% sales jump helps beat estimates AmerisourceBergen ABC.N: up 2.6% Walgreens Boots Alliance Inc WBA.O: down 0.4% BUZZ-Reported deal between AmerisourceBergen, Walgreens could help both cos - brokerage AerCap Holdings N.V. AER.N: up 3.4% BUZZ-Climbs after results show strong liquidity to battle downturn Mosaic Co MOS.N: up 8.3% BUZZ-Climbs on Q1 sales beat, sees strong fertilizer demand Coresite Realty Corp COR.N: down 1.4% BUZZ-Data center REIT CoreSite dips as top holder Carlyle cuts stake Sysco Corp SYY.N: down 5.1% BUZZ-Falls on Q3 miss as COVID-19 hits foodservice sales Genprex Inc GNPX.O: up 70.1% BUZZ-Up on gene therapy patent for cancer treatments XPO Logistics Inc XPO.N: up 8.2% BUZZ-Jumps as e-commerce business thrives Scorpio Tankers STNG.N: down 6.5% DHT Holdings Inc DHT.N: down 7.2% International Seaways INSW.N: down 9.6% Teekay Tankers TNK.N: down 9.5% Ardmore Shipping ASC.N: down 11.0% Diamond S Shipping DSSI.N: down 10.6% BUZZ-Tankers sink in u-turn from Monday's rally as crude advances Parsley Energy PE.N: up 3.0% BUZZ-Rises on cost cutting measures, profit beat New Residential Investment Corp NRZ.N: up 14.0% BUZZ-New Residential jumps after mortgage REIT reports surprise profit, reduces leverage EverQuote Inc EVER.O: up 25.8% BUZZ-EverQuote hits record high on raised outlook, upbeat Q1 ** Tenet Healthcare THC.N: up 9.4% BUZZ-Up on profit beat; warns of COVID-19 impact in Q2 The 11 major S&P 500 sectors: Communication Services .SPLRCL up 1.48% Consumer Discretionary .SPLRCD up 1.02% Consumer Staples .SPLRCS up 0.77% Energy .SPNY up 2.24% Financial .SPSY up 1.24% Health .SPXHC up 2.38% Industrial .SPLRCI up 1.18% Information Technology .SPLRCT up 2.12% Materials .SPLRCM up 1.02% Real Estate .SPLRCR up 1.64% Utilities .SPLRCU up 1.47% (Compiled by Trisha Roy in Bengaluru) ((Trisha.Roy@thomsonreuters.com; within U.S. +1 646 223 8780, outside U.S. +91 80 6182 3635;)) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	Concrete Inc USCR.O: up 4.8% BUZZ-Rises after reporting better-than-expected results Skyworks Solutions Inc SWKS.O: up 5.0% BUZZ-Gains on Q2 revenue and profit beat Capricor Therapeutics Inc CAPR.O: down 8.4% BUZZ-Falls on planned $40 mln equity raise after shares triple Livongo Health Inc LVGO.O: up 6.0% Healthcare Inc ONEM.O: up 4.3% Teladoc Health Inc TDOC.N: down 2.7% BUZZ- Virtual care here to stay post COVID-19 - Piper Sandler Chembio Diagnostics Inc CEMI.O: up 11.4% BUZZ-Jumps on getting CE marking for COVID-19 test Owens & Minor OMI.N: down 3.7% BUZZ-Baird downgrades Owens & Minor on higher risk in times of COVID-19 DuPont de Nemours Inc DD.N: up 1.1% BUZZ-Climbs on doubling cost-savings target, curbing expenses Chegg Inc CHGG.N: up 38.1% BUZZ-Eyes record high, reaps benefits of digital learning shift Regeneron Pharmaceuticals Inc REGN.O: up 5.7% BUZZ-Rises after Q1 profit, revenue beat Bloomin' Brands Inc BLMN.O: down 6.1% BUZZ-Falls as Q1 profit likely to miss estimates TG Therapeutics Inc TGTX.O: up 25.9% BUZZ-Surges after late-stage trial meets main goal Marathon Petroleum Corp MPC.N: up 0.3% BUZZ-Gains on smaller-than-expected loss, 2020 capex cut Akebia Therapeutics Inc AKBA.O: up 32.0% BUZZ-Up on positive data for anemia treatment in dialysis patients Tesla Inc TSLA.O: up 1.6% BUZZ-Rebounds as Musk eyes big payday Insmed Inc INSM.O: down 3.4% BUZZ-Insmed slips on $225 mln share offering SG Blocks Inc SGBX.O: up 1.6% BUZZ-Surges on Osang HealthCare deal to distribute COVID-19 test kits Westrock Co WRK.N: down 14.4% BUZZ-Falls as Q2 rev misses estimates on lower selling price Diffusion Pharmaceuticals Inc DFFN.O: up 23.6% BUZZ-Gains as FDA accelerates review of COVID-19 treatment plan Aptiv Plc APTV.N: up 2.5% BUZZ-Gains on better-than-expected results Henry Schein Inc HSIC.O: up 3.0% BUZZ-Rises on better-than-feared quarterly results Fiat Chrysler Automobiles NV FCAU.N: down 0.5% BUZZ-Rises as PSA deal on course despite pandemic woes Norwegian Cruise Line Holdings NCLH.N: down 21.1% Carnival Corp CCL.N: down 6.0% Royal Caribbean Cruises RCL.N: down 6.3% BUZZ-Norwegian Cruise sinks on going concern warning, $1.6 bln capital raise plans Alaska Air Group Inc ALK.N: up 3.9% BUZZ-Alaska Air jumps on lower cash burn forecast for June Wayfair Inc W.N: up 22.8% BUZZ-Hits record high as 20% sales jump helps beat estimates AmerisourceBergen ABC.N: up 2.6% Walgreens Boots Alliance Inc WBA.O: down 0.4% BUZZ-Reported deal between AmerisourceBergen, Walgreens could help both cos - brokerage AerCap Holdings N.V. AER.N: up 3.4% BUZZ-Climbs after results show strong liquidity to battle downturn Mosaic Co MOS.N: up 8.3% BUZZ-Climbs on Q1 sales beat, sees strong fertilizer demand Coresite Realty Corp COR.N: down 1.4% BUZZ-Data center REIT CoreSite dips as top holder Carlyle cuts stake Sysco Corp SYY.N: down 5.1% BUZZ-Falls on Q3 miss as COVID-19 hits foodservice sales Genprex Inc GNPX.O: up 70.1% BUZZ-Up on gene therapy patent for cancer treatments XPO Logistics Inc XPO.N: up 8.2% BUZZ-Jumps as e-commerce business thrives Scorpio Tankers STNG.N: down 6.5% DHT Holdings Inc DHT.N: down 7.2% International Seaways INSW.N: down 9.6% Teekay Tankers TNK.N: down 9.5% Ardmore Shipping ASC.N: down 11.0% Diamond S Shipping DSSI.N: down 10.6% BUZZ-Tankers sink in u-turn from Monday's rally as crude advances Parsley Energy PE.N: up 3.0% BUZZ-Rises on cost cutting measures, profit beat New Residential Investment Corp NRZ.N: up 14.0% BUZZ-New Residential jumps after mortgage REIT reports surprise profit, reduces leverage EverQuote Inc EVER.O: up 25.8% BUZZ-EverQuote hits record high on raised outlook, upbeat Q1 Tenet Healthcare THC.N: up 9.4% BUZZ-Up on profit beat; warns of COVID-19 impact in Q2 The 11 major S&P 500 sectors: Communication Services Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: http://tmsnrt.rs/2ggOmBi The Morning News Call newsletter: http://tmsnrt.rs/2fwPLTh Wall Street's main indexes jumped on Tuesday as a recovery in oil prices lifted battered energy stocks and a slew of countries eased coronavirus-induced restrictions in an attempt to revive their economies. The top three S&P 500 .PG.INX percentage gainers: IPG Photonics Corp IPGP.O, up 18.1 % Mosaic Company MOS.N, up 8.3 % Sealed Air Corp SEE.N, up 7.9 % The top three S&P 500 .PL.INX percentage losers: Norwegian Cruise Line Holdings Ltd NCLH.N, down 21.1 % Westrock Company WRK.N, down 14.4 % Leggett & Platt LEG.N, down 8.5 % The top two NYSE .PG.N percentage gainers: Indonesia Energy Corp Ltd INDO.N, up 73.8 % Chegg Inc CHGG.N, up 38.1 % The top NYSE .PL.N percentage loser: Medley Llc MDLQ.N, down 23.5 % The top three Nasdaq .PG.O percentage gainers: Portola Pharmaceuticals Inc PTLA.O, up 130.1 % Clensprk Inc CLSK.O, up 128.7 % Genprex Inc GNPX.O, up 70.1 % The top two Nasdaq .PL.O percentage losers: Capitala Finance CPTA.O, down 17.6 % Oxford Immunotec OXFD.O, down 16.8 % Chevron Corp CVX.N: up 3.6% Exxon Mobil Corp XOM.N: up 1.5% ConocoPhillips COP.N: up 3.3% Concho Resources CXO.N: up 3.8% Pioneer Natural Resources PXD.N: up 3.0% WPX Energy WPX.N: up 2.1% Cabot Oil & Gas COG.N: up 1.6% Hess Corp HES.N: up 3.1% Occidental Petroleum OXY.N: up 4.4% Apache Corp APA.N: up 4.1% Halliburton Co HAL.N: up 1.7% Schlumberger NV SLB.N: up 2.8% Baker Hughes BKR.N: up 1.9% ProPetro Holding PUMP.N: up 6.6% BUZZ-Oil and gas stocks rise on demand hopes as lockdowns ease Goldman Sachs Group Inc GS.N: up 2.7% JPMorgan Chase & Co JPM.N: up 1.4% Citigroup Inc C.N: up 0.3% Bank of America Corp BAC.N: up 1.3% Morgan Stanley MS.N: up 1.3% BUZZ-Big banks: Rise as U.S. treasury yields edge higher Pfizer Inc PFE.N: up 2.8% BioNTech SE BNTX.O: up 6.6% BUZZ-Pfizer, BioNTech: Up after starting trials for COVID-19 vaccine Portola Pharmaceuticals PTLA.O: up 130.1% Alexion Pharmaceuticals Inc ALXN.O: down 5.2% BUZZ-Rises after Alexion to buy co in $1.41 bln deal Centennial Resource Development Inc CDEV.O: down 9.4% BUZZ-Tumbles as Q1 loss widens on impairment charge Compass Diversified Holdings CODI.N: down 11.0% BUZZ-Drops on stock offering ** U.S.	Concrete Inc USCR.O: up 4.8% BUZZ-Rises after reporting better-than-expected results Skyworks Solutions Inc SWKS.O: up 5.0% BUZZ-Gains on Q2 revenue and profit beat Capricor Therapeutics Inc CAPR.O: down 8.4% BUZZ-Falls on planned $40 mln equity raise after shares triple Livongo Health Inc LVGO.O: up 6.0% Healthcare Inc ONEM.O: up 4.3% Teladoc Health Inc TDOC.N: down 2.7% BUZZ- Virtual care here to stay post COVID-19 - Piper Sandler Chembio Diagnostics Inc CEMI.O: up 11.4% BUZZ-Jumps on getting CE marking for COVID-19 test Owens & Minor OMI.N: down 3.7% BUZZ-Baird downgrades Owens & Minor on higher risk in times of COVID-19 DuPont de Nemours Inc DD.N: up 1.1% BUZZ-Climbs on doubling cost-savings target, curbing expenses Chegg Inc CHGG.N: up 38.1% BUZZ-Eyes record high, reaps benefits of digital learning shift Regeneron Pharmaceuticals Inc REGN.O: up 5.7% BUZZ-Rises after Q1 profit, revenue beat Bloomin' Brands Inc BLMN.O: down 6.1% BUZZ-Falls as Q1 profit likely to miss estimates TG Therapeutics Inc TGTX.O: up 25.9% BUZZ-Surges after late-stage trial meets main goal Marathon Petroleum Corp MPC.N: up 0.3% BUZZ-Gains on smaller-than-expected loss, 2020 capex cut Akebia Therapeutics Inc AKBA.O: up 32.0% BUZZ-Up on positive data for anemia treatment in dialysis patients Tesla Inc TSLA.O: up 1.6% BUZZ-Rebounds as Musk eyes big payday Insmed Inc INSM.O: down 3.4% BUZZ-Insmed slips on $225 mln share offering SG Blocks Inc SGBX.O: up 1.6% BUZZ-Surges on Osang HealthCare deal to distribute COVID-19 test kits Westrock Co WRK.N: down 14.4% BUZZ-Falls as Q2 rev misses estimates on lower selling price Diffusion Pharmaceuticals Inc DFFN.O: up 23.6% BUZZ-Gains as FDA accelerates review of COVID-19 treatment plan Aptiv Plc APTV.N: up 2.5% BUZZ-Gains on better-than-expected results Henry Schein Inc HSIC.O: up 3.0% BUZZ-Rises on better-than-feared quarterly results Fiat Chrysler Automobiles NV FCAU.N: down 0.5% BUZZ-Rises as PSA deal on course despite pandemic woes Norwegian Cruise Line Holdings NCLH.N: down 21.1% Carnival Corp CCL.N: down 6.0% Royal Caribbean Cruises RCL.N: down 6.3% BUZZ-Norwegian Cruise sinks on going concern warning, $1.6 bln capital raise plans Alaska Air Group Inc ALK.N: up 3.9% BUZZ-Alaska Air jumps on lower cash burn forecast for June Wayfair Inc W.N: up 22.8% BUZZ-Hits record high as 20% sales jump helps beat estimates AmerisourceBergen ABC.N: up 2.6% Walgreens Boots Alliance Inc WBA.O: down 0.4% BUZZ-Reported deal between AmerisourceBergen, Walgreens could help both cos - brokerage AerCap Holdings N.V. AER.N: up 3.4% BUZZ-Climbs after results show strong liquidity to battle downturn Mosaic Co MOS.N: up 8.3% BUZZ-Climbs on Q1 sales beat, sees strong fertilizer demand Coresite Realty Corp COR.N: down 1.4% BUZZ-Data center REIT CoreSite dips as top holder Carlyle cuts stake Sysco Corp SYY.N: down 5.1% BUZZ-Falls on Q3 miss as COVID-19 hits foodservice sales Genprex Inc GNPX.O: up 70.1% BUZZ-Up on gene therapy patent for cancer treatments XPO Logistics Inc XPO.N: up 8.2% BUZZ-Jumps as e-commerce business thrives Scorpio Tankers STNG.N: down 6.5% DHT Holdings Inc DHT.N: down 7.2% International Seaways INSW.N: down 9.6% Teekay Tankers TNK.N: down 9.5% Ardmore Shipping ASC.N: down 11.0% Diamond S Shipping DSSI.N: down 10.6% BUZZ-Tankers sink in u-turn from Monday's rally as crude advances Parsley Energy PE.N: up 3.0% BUZZ-Rises on cost cutting measures, profit beat New Residential Investment Corp NRZ.N: up 14.0% BUZZ-New Residential jumps after mortgage REIT reports surprise profit, reduces leverage EverQuote Inc EVER.O: up 25.8% BUZZ-EverQuote hits record high on raised outlook, upbeat Q1 Tenet Healthcare THC.N: up 9.4% BUZZ-Up on profit beat; warns of COVID-19 impact in Q2 The 11 major S&P 500 sectors: Communication Services Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: http://tmsnrt.rs/2ggOmBi The Morning News Call newsletter: http://tmsnrt.rs/2fwPLTh Wall Street's main indexes jumped on Tuesday as a recovery in oil prices lifted battered energy stocks and a slew of countries eased coronavirus-induced restrictions in an attempt to revive their economies. The top three S&P 500 .PG.INX percentage gainers: IPG Photonics Corp IPGP.O, up 18.1 % Mosaic Company MOS.N, up 8.3 % Sealed Air Corp SEE.N, up 7.9 % The top three S&P 500 .PL.INX percentage losers: Norwegian Cruise Line Holdings Ltd NCLH.N, down 21.1 % Westrock Company WRK.N, down 14.4 % Leggett & Platt LEG.N, down 8.5 % The top two NYSE .PG.N percentage gainers: Indonesia Energy Corp Ltd INDO.N, up 73.8 % Chegg Inc CHGG.N, up 38.1 % The top NYSE .PL.N percentage loser: Medley Llc MDLQ.N, down 23.5 % The top three Nasdaq .PG.O percentage gainers: Portola Pharmaceuticals Inc PTLA.O, up 130.1 % Clensprk Inc CLSK.O, up 128.7 % Genprex Inc GNPX.O, up 70.1 % The top two Nasdaq .PL.O percentage losers: Capitala Finance CPTA.O, down 17.6 % Oxford Immunotec OXFD.O, down 16.8 % Chevron Corp CVX.N: up 3.6% Exxon Mobil Corp XOM.N: up 1.5% ConocoPhillips COP.N: up 3.3% Concho Resources CXO.N: up 3.8% Pioneer Natural Resources PXD.N: up 3.0% WPX Energy WPX.N: up 2.1% Cabot Oil & Gas COG.N: up 1.6% Hess Corp HES.N: up 3.1% Occidental Petroleum OXY.N: up 4.4% Apache Corp APA.N: up 4.1% Halliburton Co HAL.N: up 1.7% Schlumberger NV SLB.N: up 2.8% Baker Hughes BKR.N: up 1.9% ProPetro Holding PUMP.N: up 6.6% BUZZ-Oil and gas stocks rise on demand hopes as lockdowns ease Goldman Sachs Group Inc GS.N: up 2.7% JPMorgan Chase & Co JPM.N: up 1.4% Citigroup Inc C.N: up 0.3% Bank of America Corp BAC.N: up 1.3% Morgan Stanley MS.N: up 1.3% BUZZ-Big banks: Rise as U.S. treasury yields edge higher Pfizer Inc PFE.N: up 2.8% BioNTech SE BNTX.O: up 6.6% BUZZ-Pfizer, BioNTech: Up after starting trials for COVID-19 vaccine Portola Pharmaceuticals PTLA.O: up 130.1% Alexion Pharmaceuticals Inc ALXN.O: down 5.2% BUZZ-Rises after Alexion to buy co in $1.41 bln deal Centennial Resource Development Inc CDEV.O: down 9.4% BUZZ-Tumbles as Q1 loss widens on impairment charge Compass Diversified Holdings CODI.N: down 11.0% BUZZ-Drops on stock offering ** U.S.	Concrete Inc USCR.O: up 4.8% BUZZ-Rises after reporting better-than-expected results Skyworks Solutions Inc SWKS.O: up 5.0% BUZZ-Gains on Q2 revenue and profit beat Capricor Therapeutics Inc CAPR.O: down 8.4% BUZZ-Falls on planned $40 mln equity raise after shares triple Livongo Health Inc LVGO.O: up 6.0% Healthcare Inc ONEM.O: up 4.3% Teladoc Health Inc TDOC.N: down 2.7% BUZZ- Virtual care here to stay post COVID-19 - Piper Sandler Chembio Diagnostics Inc CEMI.O: up 11.4% BUZZ-Jumps on getting CE marking for COVID-19 test Owens & Minor OMI.N: down 3.7% BUZZ-Baird downgrades Owens & Minor on higher risk in times of COVID-19 DuPont de Nemours Inc DD.N: up 1.1% BUZZ-Climbs on doubling cost-savings target, curbing expenses Chegg Inc CHGG.N: up 38.1% BUZZ-Eyes record high, reaps benefits of digital learning shift Regeneron Pharmaceuticals Inc REGN.O: up 5.7% BUZZ-Rises after Q1 profit, revenue beat Bloomin' Brands Inc BLMN.O: down 6.1% BUZZ-Falls as Q1 profit likely to miss estimates TG Therapeutics Inc TGTX.O: up 25.9% BUZZ-Surges after late-stage trial meets main goal Marathon Petroleum Corp MPC.N: up 0.3% BUZZ-Gains on smaller-than-expected loss, 2020 capex cut Akebia Therapeutics Inc AKBA.O: up 32.0% BUZZ-Up on positive data for anemia treatment in dialysis patients Tesla Inc TSLA.O: up 1.6% BUZZ-Rebounds as Musk eyes big payday Insmed Inc INSM.O: down 3.4% BUZZ-Insmed slips on $225 mln share offering SG Blocks Inc SGBX.O: up 1.6% BUZZ-Surges on Osang HealthCare deal to distribute COVID-19 test kits Westrock Co WRK.N: down 14.4% BUZZ-Falls as Q2 rev misses estimates on lower selling price Diffusion Pharmaceuticals Inc DFFN.O: up 23.6% BUZZ-Gains as FDA accelerates review of COVID-19 treatment plan Aptiv Plc APTV.N: up 2.5% BUZZ-Gains on better-than-expected results Henry Schein Inc HSIC.O: up 3.0% BUZZ-Rises on better-than-feared quarterly results Fiat Chrysler Automobiles NV FCAU.N: down 0.5% BUZZ-Rises as PSA deal on course despite pandemic woes Norwegian Cruise Line Holdings NCLH.N: down 21.1% Carnival Corp CCL.N: down 6.0% Royal Caribbean Cruises RCL.N: down 6.3% BUZZ-Norwegian Cruise sinks on going concern warning, $1.6 bln capital raise plans Alaska Air Group Inc ALK.N: up 3.9% BUZZ-Alaska Air jumps on lower cash burn forecast for June Wayfair Inc W.N: up 22.8% BUZZ-Hits record high as 20% sales jump helps beat estimates AmerisourceBergen ABC.N: up 2.6% Walgreens Boots Alliance Inc WBA.O: down 0.4% BUZZ-Reported deal between AmerisourceBergen, Walgreens could help both cos - brokerage AerCap Holdings N.V. AER.N: up 3.4% BUZZ-Climbs after results show strong liquidity to battle downturn Mosaic Co MOS.N: up 8.3% BUZZ-Climbs on Q1 sales beat, sees strong fertilizer demand Coresite Realty Corp COR.N: down 1.4% BUZZ-Data center REIT CoreSite dips as top holder Carlyle cuts stake Sysco Corp SYY.N: down 5.1% BUZZ-Falls on Q3 miss as COVID-19 hits foodservice sales Genprex Inc GNPX.O: up 70.1% BUZZ-Up on gene therapy patent for cancer treatments XPO Logistics Inc XPO.N: up 8.2% BUZZ-Jumps as e-commerce business thrives Scorpio Tankers STNG.N: down 6.5% DHT Holdings Inc DHT.N: down 7.2% International Seaways INSW.N: down 9.6% Teekay Tankers TNK.N: down 9.5% Ardmore Shipping ASC.N: down 11.0% Diamond S Shipping DSSI.N: down 10.6% BUZZ-Tankers sink in u-turn from Monday's rally as crude advances Parsley Energy PE.N: up 3.0% BUZZ-Rises on cost cutting measures, profit beat New Residential Investment Corp NRZ.N: up 14.0% BUZZ-New Residential jumps after mortgage REIT reports surprise profit, reduces leverage EverQuote Inc EVER.O: up 25.8% BUZZ-EverQuote hits record high on raised outlook, upbeat Q1 Tenet Healthcare THC.N: up 9.4% BUZZ-Up on profit beat; warns of COVID-19 impact in Q2 The 11 major S&P 500 sectors: Communication Services .N At 12:59 ET, the Dow Jones Industrial Average .DJI was up 1.41% at 24,083.9. The top three S&P 500 .PG.INX percentage gainers: IPG Photonics Corp IPGP.O, up 18.1 % Mosaic Company MOS.N, up 8.3 % Sealed Air Corp SEE.N, up 7.9 % The top three S&P 500 .PL.INX percentage losers: Norwegian Cruise Line Holdings Ltd NCLH.N, down 21.1 % Westrock Company WRK.N, down 14.4 % Leggett & Platt LEG.N, down 8.5 % The top two NYSE .PG.N percentage gainers: Indonesia Energy Corp Ltd INDO.N, up 73.8 % Chegg Inc CHGG.N, up 38.1 % The top NYSE .PL.N percentage loser: Medley Llc MDLQ.N, down 23.5 % The top three Nasdaq .PG.O percentage gainers: Portola Pharmaceuticals Inc PTLA.O, up 130.1 % Clensprk Inc CLSK.O, up 128.7 % Genprex Inc GNPX.O, up 70.1 % The top two Nasdaq .PL.O percentage losers: Capitala Finance CPTA.O, down 17.6 % Oxford Immunotec OXFD.O, down 16.8 % Chevron Corp CVX.N: up 3.6% Exxon Mobil Corp XOM.N: up 1.5% ConocoPhillips COP.N: up 3.3% Concho Resources CXO.N: up 3.8% Pioneer Natural Resources PXD.N: up 3.0% WPX Energy WPX.N: up 2.1% Cabot Oil & Gas COG.N: up 1.6% Hess Corp HES.N: up 3.1% Occidental Petroleum OXY.N: up 4.4% Apache Corp APA.N: up 4.1% Halliburton Co HAL.N: up 1.7% Schlumberger NV SLB.N: up 2.8% Baker Hughes BKR.N: up 1.9% ProPetro Holding PUMP.N: up 6.6% BUZZ-Oil and gas stocks rise on demand hopes as lockdowns ease Goldman Sachs Group Inc GS.N: up 2.7% JPMorgan Chase & Co JPM.N: up 1.4% Citigroup Inc C.N: up 0.3% Bank of America Corp BAC.N: up 1.3% Morgan Stanley MS.N: up 1.3% BUZZ-Big banks: Rise as U.S. treasury yields edge higher Pfizer Inc PFE.N: up 2.8% BioNTech SE BNTX.O: up 6.6% BUZZ-Pfizer, BioNTech: Up after starting trials for COVID-19 vaccine Portola Pharmaceuticals PTLA.O: up 130.1% Alexion Pharmaceuticals Inc ALXN.O: down 5.2% BUZZ-Rises after Alexion to buy co in $1.41 bln deal Centennial Resource Development Inc CDEV.O: down 9.4% BUZZ-Tumbles as Q1 loss widens on impairment charge Compass Diversified Holdings CODI.N: down 11.0% BUZZ-Drops on stock offering ** U.S.	Concrete Inc USCR.O: up 4.8% BUZZ-Rises after reporting better-than-expected results Skyworks Solutions Inc SWKS.O: up 5.0% BUZZ-Gains on Q2 revenue and profit beat Capricor Therapeutics Inc CAPR.O: down 8.4% BUZZ-Falls on planned $40 mln equity raise after shares triple Livongo Health Inc LVGO.O: up 6.0% Healthcare Inc ONEM.O: up 4.3% Teladoc Health Inc TDOC.N: down 2.7% BUZZ- Virtual care here to stay post COVID-19 - Piper Sandler Chembio Diagnostics Inc CEMI.O: up 11.4% BUZZ-Jumps on getting CE marking for COVID-19 test Owens & Minor OMI.N: down 3.7% BUZZ-Baird downgrades Owens & Minor on higher risk in times of COVID-19 DuPont de Nemours Inc DD.N: up 1.1% BUZZ-Climbs on doubling cost-savings target, curbing expenses Chegg Inc CHGG.N: up 38.1% BUZZ-Eyes record high, reaps benefits of digital learning shift Regeneron Pharmaceuticals Inc REGN.O: up 5.7% BUZZ-Rises after Q1 profit, revenue beat Bloomin' Brands Inc BLMN.O: down 6.1% BUZZ-Falls as Q1 profit likely to miss estimates TG Therapeutics Inc TGTX.O: up 25.9% BUZZ-Surges after late-stage trial meets main goal Marathon Petroleum Corp MPC.N: up 0.3% BUZZ-Gains on smaller-than-expected loss, 2020 capex cut Akebia Therapeutics Inc AKBA.O: up 32.0% BUZZ-Up on positive data for anemia treatment in dialysis patients Tesla Inc TSLA.O: up 1.6% BUZZ-Rebounds as Musk eyes big payday Insmed Inc INSM.O: down 3.4% BUZZ-Insmed slips on $225 mln share offering SG Blocks Inc SGBX.O: up 1.6% BUZZ-Surges on Osang HealthCare deal to distribute COVID-19 test kits Westrock Co WRK.N: down 14.4% BUZZ-Falls as Q2 rev misses estimates on lower selling price Diffusion Pharmaceuticals Inc DFFN.O: up 23.6% BUZZ-Gains as FDA accelerates review of COVID-19 treatment plan Aptiv Plc APTV.N: up 2.5% BUZZ-Gains on better-than-expected results Henry Schein Inc HSIC.O: up 3.0% BUZZ-Rises on better-than-feared quarterly results Fiat Chrysler Automobiles NV FCAU.N: down 0.5% BUZZ-Rises as PSA deal on course despite pandemic woes Norwegian Cruise Line Holdings NCLH.N: down 21.1% Carnival Corp CCL.N: down 6.0% Royal Caribbean Cruises RCL.N: down 6.3% BUZZ-Norwegian Cruise sinks on going concern warning, $1.6 bln capital raise plans Alaska Air Group Inc ALK.N: up 3.9% BUZZ-Alaska Air jumps on lower cash burn forecast for June Wayfair Inc W.N: up 22.8% BUZZ-Hits record high as 20% sales jump helps beat estimates AmerisourceBergen ABC.N: up 2.6% Walgreens Boots Alliance Inc WBA.O: down 0.4% BUZZ-Reported deal between AmerisourceBergen, Walgreens could help both cos - brokerage AerCap Holdings N.V. AER.N: up 3.4% BUZZ-Climbs after results show strong liquidity to battle downturn Mosaic Co MOS.N: up 8.3% BUZZ-Climbs on Q1 sales beat, sees strong fertilizer demand Coresite Realty Corp COR.N: down 1.4% BUZZ-Data center REIT CoreSite dips as top holder Carlyle cuts stake Sysco Corp SYY.N: down 5.1% BUZZ-Falls on Q3 miss as COVID-19 hits foodservice sales Genprex Inc GNPX.O: up 70.1% BUZZ-Up on gene therapy patent for cancer treatments XPO Logistics Inc XPO.N: up 8.2% BUZZ-Jumps as e-commerce business thrives Scorpio Tankers STNG.N: down 6.5% DHT Holdings Inc DHT.N: down 7.2% International Seaways INSW.N: down 9.6% Teekay Tankers TNK.N: down 9.5% Ardmore Shipping ASC.N: down 11.0% Diamond S Shipping DSSI.N: down 10.6% BUZZ-Tankers sink in u-turn from Monday's rally as crude advances Parsley Energy PE.N: up 3.0% BUZZ-Rises on cost cutting measures, profit beat New Residential Investment Corp NRZ.N: up 14.0% BUZZ-New Residential jumps after mortgage REIT reports surprise profit, reduces leverage EverQuote Inc EVER.O: up 25.8% BUZZ-EverQuote hits record high on raised outlook, upbeat Q1 ** Tenet Healthcare THC.N: up 9.4% BUZZ-Up on profit beat; warns of COVID-19 impact in Q2 The 11 major S&P 500 sectors: Communication Services Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: http://tmsnrt.rs/2ggOmBi The Morning News Call newsletter: http://tmsnrt.rs/2fwPLTh Wall Street's main indexes jumped on Tuesday as a recovery in oil prices lifted battered energy stocks and a slew of countries eased coronavirus-induced restrictions in an attempt to revive their economies. .N At 12:59 ET, the Dow Jones Industrial Average .DJI was up 1.41% at 24,083.9.	f4bdc953-ab3e-45d8-a2b1-6fa608da8b5c
716281.0	2020-05-05 00:00:00 UTC	BUZZ-U.S. STOCKS ON THE MOVE-Tesla, banks, Pfizer, Regeneron	DD	https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-tesla-banks-pfizer-regeneron-2020-05-05-0	nan	nan	Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: http://tmsnrt.rs/2ggOmBi The Morning News Call newsletter: http://tmsnrt.rs/2fwPLTh Wall Street's main indexes jumped on Tuesday as a recovery in oil prices lifted battered energy stocks and a slew of countries eased coronavirus-induced restrictions in an attempt to revive their economies. .N At 11:38 ET, the Dow Jones Industrial Average .DJI was up 1.60% at 24,129.11. The S&P 500 .SPX was up 1.70% at 2,891.13 and the Nasdaq Composite .IXIC was up 1.81% at 8,868.795. The top three S&P 500 .PG.INX percentage gainers: IPG Photonics Corp IPGP.O, up 15.8% Mosaic Company MOS.N, up 10.4% Hanesbrands Inc HBI.N, up 8.7% The top three S&P 500 .PL.INX percentage losers: Norwegian Cruise Line Holdings Ltd NCLH.N, down 19.5% Westrock Company WRK.N, down 13.2% Unum Group UNM.N, down 8.5% The top NYSE .PG.N percentage gainer: Chegg Inc CHGG.N, up 31.4% The top NYSE .PL.N percentage loser: Norwegian Cruise Line Holdings Ltd NCLH.N, down 19.% The top three Nasdaq .PG.O percentage gainers: Gan Ltd. GAN.O, up 321.8% Portola Pharmaceuticals Inc PTLA.O, up 129.3% Clensprk Inc CLSK.O, up 96.3% The top three Nasdaq .PL.O percentage losers: Fulgent Genetics Inc FLGT.O, down 20.2% Itron Inc ITRI.O, down 19.4% Capitala Finance CPTA.O, down 17.7% Goldman Sachs Group Inc GS.N: up 3.1% JPMorgan Chase & Co JPM.N: up 2.0% Citigroup Inc C.N: up 1.5% Bank of America Corp BAC.N: up 2.0% Morgan Stanley MS.N: up 1.8% BUZZ-Big banks: Rise as U.S. treasury yields edge higher Pfizer Inc PFE.N: up 2.9% BioNTech SE BNTX.O: up 6.2% BUZZ-Pfizer, BioNTech: Up after starting trials for COVID-19 vaccine Portola Pharmaceuticals PTLA.O: up 129.3% Alexion Pharmaceuticals Inc ALXN.O: down 4.7% BUZZ-Rises after Alexion to buy co in $1.41 bln deal ONEOK Inc OKE.N: up 1.7% BUZZ-Credit Suisse downgrades to 'neutral' Centennial Resource Development Inc CDEV.O: down 9.7% BUZZ-Tumbles as Q1 loss widens on impairment charge Compass Diversified Holdings CODI.N: down 11.2% BUZZ-Drops on stock offering U.S. Concrete Inc USCR.O: up 4.7% BUZZ-Rises after reporting better-than-expected results Skyworks Solutions Inc SWKS.O: up 5.7% BUZZ-Gains on Q2 revenue and profit beat Capricor Therapeutics Inc CAPR.O: down 11.9% BUZZ-Falls on planned $40 mln equity raise after shares triple Livongo Health Inc LVGO.O: up 5.0% Healthcare Inc ONEM.O: up 2.9% BUZZ- Virtual care here to stay post COVID-19 - Piper Sandler Chembio Diagnostics Inc CEMI.O: up 6.6% BUZZ-Jumps on getting CE marking for COVID-19 test Owens & Minor OMI.N: down 4.7% BUZZ-Baird downgrades Owens & Minor on higher risk in times of COVID-19 DuPont de Nemours Inc DD.N: up 2.3% BUZZ-Climbs on doubling cost-savings target, curbing expenses Chegg Inc CHGG.N: up 31.4% BUZZ-Eyes record high, reaps benefits of digital learning shift Regeneron Pharmaceuticals Inc REGN.O: up 6.5% BUZZ-Rises after Q1 profit, revenue beat Bloomin' Brands Inc BLMN.O: down 9.2% BUZZ-Falls as Q1 profit likely to miss estimates TG Therapeutics Inc TGTX.O: up 27.1% BUZZ-Surges after late-stage trial meets main goal Akebia Therapeutics Inc AKBA.O: up 32.9% BUZZ-Up on positive data for anemia treatment in dialysis patients Tesla Inc TSLA.O: up 2.0% BUZZ-Rebounds as Musk eyes big payday Applied DNA APDN.O: up 1.6% BUZZ-Applied DNA surge continues on potential COVID-19 vaccine Insmed Inc INSM.O: down 4.4% BUZZ-Insmed slips on $225 mln share offering SG Blocks Inc SGBX.O: up 13.5% BUZZ-Surges on Osang HealthCare deal to distribute COVID-19 test kits Westrock Co WRK.N: down 13.2% BUZZ-Falls as Q2 rev misses estimates on lower selling price Diffusion Pharmaceuticals Inc DFFN.O: up 23.5% BUZZ-Gains as FDA accelerates review of COVID-19 treatment plan Aptiv Plc APTV.N: up 3.8% BUZZ-Gains on better-than-expected results Henry Schein Inc HSIC.O: up 1.0% BUZZ-Rises on better-than-feared quarterly results Norwegian Cruise Line Holdings NCLH.N: down 19.5% Carnival Corp CCL.N: down 4.0% Royal Caribbean Cruises RCL.N: down 5.1% BUZZ-Norwegian Cruise sinks on going concern warning, $1.6 bln capital raise plans Alaska Air Group Inc ALK.N: up 1.3% BUZZ-Alaska Air jumps on lower cash burn forecast for June Wayfair Inc W.N: up 20.7% BUZZ-Hits record high as 20% sales jump helps beat estimates AmerisourceBergen ABC.N: up 2.6% Walgreens Boots Alliance Inc WBA.O: down 0.4% BUZZ-Reported deal between AmerisourceBergen, Walgreens could help both cos - brokerage AerCap Holdings N.V. AER.N: up 7.5% BUZZ-Climbs after results show strong liquidity to battle downturn Mosaic Co MOS.N: up 10.4% BUZZ-Climbs on Q1 sales beat, sees strong fertilizer demand ** Coresite Realty Corp COR.N: down 2.4% BUZZ-Data center REIT CoreSite dips as top holder Carlyle cuts stake The 11 major S&P 500 sectors: Communication Services .SPLRCL up 1.58% Consumer Discretionary .SPLRCD up 1.18% Consumer Staples .SPLRCS up 0.69% Energy .SPNY up 2.67% Financial .SPSY up 1.71% Health .SPXHC up 2.25% Industrial .SPLRCI up 1.30% Information Technology .SPLRCT up 1.97% Materials .SPLRCM up 1.32% Real Estate .SPLRCR up 1.77% Utilities .SPLRCU up 1.61% (Compiled by Trisha Roy in Bengaluru) ((Trisha.Roy@thomsonreuters.com; within U.S. +1 646 223 8780, outside U.S. +91 80 6182 3635;)) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	Concrete Inc USCR.O: up 4.7% BUZZ-Rises after reporting better-than-expected results Skyworks Solutions Inc SWKS.O: up 5.7% BUZZ-Gains on Q2 revenue and profit beat Capricor Therapeutics Inc CAPR.O: down 11.9% BUZZ-Falls on planned $40 mln equity raise after shares triple Livongo Health Inc LVGO.O: up 5.0% Healthcare Inc ONEM.O: up 2.9% BUZZ- Virtual care here to stay post COVID-19 - Piper Sandler Chembio Diagnostics Inc CEMI.O: up 6.6% BUZZ-Jumps on getting CE marking for COVID-19 test Owens & Minor OMI.N: down 4.7% BUZZ-Baird downgrades Owens & Minor on higher risk in times of COVID-19 DuPont de Nemours Inc DD.N: up 2.3% BUZZ-Climbs on doubling cost-savings target, curbing expenses Chegg Inc CHGG.N: up 31.4% BUZZ-Eyes record high, reaps benefits of digital learning shift Regeneron Pharmaceuticals Inc REGN.O: up 6.5% BUZZ-Rises after Q1 profit, revenue beat Bloomin' Brands Inc BLMN.O: down 9.2% BUZZ-Falls as Q1 profit likely to miss estimates TG Therapeutics Inc TGTX.O: up 27.1% BUZZ-Surges after late-stage trial meets main goal Akebia Therapeutics Inc AKBA.O: up 32.9% BUZZ-Up on positive data for anemia treatment in dialysis patients Tesla Inc TSLA.O: up 2.0% BUZZ-Rebounds as Musk eyes big payday Applied DNA APDN.O: up 1.6% BUZZ-Applied DNA surge continues on potential COVID-19 vaccine Insmed Inc INSM.O: down 4.4% BUZZ-Insmed slips on $225 mln share offering SG Blocks Inc SGBX.O: up 13.5% BUZZ-Surges on Osang HealthCare deal to distribute COVID-19 test kits Westrock Co WRK.N: down 13.2% BUZZ-Falls as Q2 rev misses estimates on lower selling price Diffusion Pharmaceuticals Inc DFFN.O: up 23.5% BUZZ-Gains as FDA accelerates review of COVID-19 treatment plan Aptiv Plc APTV.N: up 3.8% BUZZ-Gains on better-than-expected results Henry Schein Inc HSIC.O: up 1.0% BUZZ-Rises on better-than-feared quarterly results Norwegian Cruise Line Holdings NCLH.N: down 19.5% Carnival Corp CCL.N: down 4.0% Royal Caribbean Cruises RCL.N: down 5.1% BUZZ-Norwegian Cruise sinks on going concern warning, $1.6 bln capital raise plans Alaska Air Group Inc ALK.N: up 1.3% BUZZ-Alaska Air jumps on lower cash burn forecast for June Wayfair Inc W.N: up 20.7% BUZZ-Hits record high as 20% sales jump helps beat estimates AmerisourceBergen ABC.N: up 2.6% Walgreens Boots Alliance Inc WBA.O: down 0.4% BUZZ-Reported deal between AmerisourceBergen, Walgreens could help both cos - brokerage AerCap Holdings N.V. AER.N: up 7.5% BUZZ-Climbs after results show strong liquidity to battle downturn Mosaic Co MOS.N: up 10.4% BUZZ-Climbs on Q1 sales beat, sees strong fertilizer demand Coresite Realty Corp COR.N: down 2.4% BUZZ-Data center REIT CoreSite dips as top holder Carlyle cuts stake The 11 major S&P 500 sectors: Communication Services Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: http://tmsnrt.rs/2ggOmBi The Morning News Call newsletter: http://tmsnrt.rs/2fwPLTh Wall Street's main indexes jumped on Tuesday as a recovery in oil prices lifted battered energy stocks and a slew of countries eased coronavirus-induced restrictions in an attempt to revive their economies. The top three S&P 500 .PG.INX percentage gainers: IPG Photonics Corp IPGP.O, up 15.8% Mosaic Company MOS.N, up 10.4% Hanesbrands Inc HBI.N, up 8.7% The top three S&P 500 .PL.INX percentage losers: Norwegian Cruise Line Holdings Ltd NCLH.N, down 19.5% Westrock Company WRK.N, down 13.2% Unum Group UNM.N, down 8.5% The top NYSE .PG.N percentage gainer: Chegg Inc CHGG.N, up 31.4% The top NYSE .PL.N percentage loser: Norwegian Cruise Line Holdings Ltd NCLH.N, down 19.% The top three Nasdaq .PG.O percentage gainers: Gan Ltd. GAN.O, up 321.8% Portola Pharmaceuticals Inc PTLA.O, up 129.3% Clensprk Inc CLSK.O, up 96.3% The top three Nasdaq .PL.O percentage losers: Fulgent Genetics Inc FLGT.O, down 20.2% Itron Inc ITRI.O, down 19.4% Capitala Finance CPTA.O, down 17.7% Goldman Sachs Group Inc GS.N: up 3.1% JPMorgan Chase & Co JPM.N: up 2.0% Citigroup Inc C.N: up 1.5% Bank of America Corp BAC.N: up 2.0% Morgan Stanley MS.N: up 1.8% BUZZ-Big banks: Rise as U.S. treasury yields edge higher Pfizer Inc PFE.N: up 2.9% BioNTech SE BNTX.O: up 6.2% BUZZ-Pfizer, BioNTech: Up after starting trials for COVID-19 vaccine Portola Pharmaceuticals PTLA.O: up 129.3% Alexion Pharmaceuticals Inc ALXN.O: down 4.7% BUZZ-Rises after Alexion to buy co in $1.41 bln deal ONEOK Inc OKE.N: up 1.7% BUZZ-Credit Suisse downgrades to 'neutral' Centennial Resource Development Inc CDEV.O: down 9.7% BUZZ-Tumbles as Q1 loss widens on impairment charge Compass Diversified Holdings CODI.N: down 11.2% BUZZ-Drops on stock offering ** U.S.	Concrete Inc USCR.O: up 4.7% BUZZ-Rises after reporting better-than-expected results Skyworks Solutions Inc SWKS.O: up 5.7% BUZZ-Gains on Q2 revenue and profit beat Capricor Therapeutics Inc CAPR.O: down 11.9% BUZZ-Falls on planned $40 mln equity raise after shares triple Livongo Health Inc LVGO.O: up 5.0% Healthcare Inc ONEM.O: up 2.9% BUZZ- Virtual care here to stay post COVID-19 - Piper Sandler Chembio Diagnostics Inc CEMI.O: up 6.6% BUZZ-Jumps on getting CE marking for COVID-19 test Owens & Minor OMI.N: down 4.7% BUZZ-Baird downgrades Owens & Minor on higher risk in times of COVID-19 DuPont de Nemours Inc DD.N: up 2.3% BUZZ-Climbs on doubling cost-savings target, curbing expenses Chegg Inc CHGG.N: up 31.4% BUZZ-Eyes record high, reaps benefits of digital learning shift Regeneron Pharmaceuticals Inc REGN.O: up 6.5% BUZZ-Rises after Q1 profit, revenue beat Bloomin' Brands Inc BLMN.O: down 9.2% BUZZ-Falls as Q1 profit likely to miss estimates TG Therapeutics Inc TGTX.O: up 27.1% BUZZ-Surges after late-stage trial meets main goal Akebia Therapeutics Inc AKBA.O: up 32.9% BUZZ-Up on positive data for anemia treatment in dialysis patients Tesla Inc TSLA.O: up 2.0% BUZZ-Rebounds as Musk eyes big payday Applied DNA APDN.O: up 1.6% BUZZ-Applied DNA surge continues on potential COVID-19 vaccine Insmed Inc INSM.O: down 4.4% BUZZ-Insmed slips on $225 mln share offering SG Blocks Inc SGBX.O: up 13.5% BUZZ-Surges on Osang HealthCare deal to distribute COVID-19 test kits Westrock Co WRK.N: down 13.2% BUZZ-Falls as Q2 rev misses estimates on lower selling price Diffusion Pharmaceuticals Inc DFFN.O: up 23.5% BUZZ-Gains as FDA accelerates review of COVID-19 treatment plan Aptiv Plc APTV.N: up 3.8% BUZZ-Gains on better-than-expected results Henry Schein Inc HSIC.O: up 1.0% BUZZ-Rises on better-than-feared quarterly results Norwegian Cruise Line Holdings NCLH.N: down 19.5% Carnival Corp CCL.N: down 4.0% Royal Caribbean Cruises RCL.N: down 5.1% BUZZ-Norwegian Cruise sinks on going concern warning, $1.6 bln capital raise plans Alaska Air Group Inc ALK.N: up 1.3% BUZZ-Alaska Air jumps on lower cash burn forecast for June Wayfair Inc W.N: up 20.7% BUZZ-Hits record high as 20% sales jump helps beat estimates AmerisourceBergen ABC.N: up 2.6% Walgreens Boots Alliance Inc WBA.O: down 0.4% BUZZ-Reported deal between AmerisourceBergen, Walgreens could help both cos - brokerage AerCap Holdings N.V. AER.N: up 7.5% BUZZ-Climbs after results show strong liquidity to battle downturn Mosaic Co MOS.N: up 10.4% BUZZ-Climbs on Q1 sales beat, sees strong fertilizer demand Coresite Realty Corp COR.N: down 2.4% BUZZ-Data center REIT CoreSite dips as top holder Carlyle cuts stake The 11 major S&P 500 sectors: Communication Services Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: http://tmsnrt.rs/2ggOmBi The Morning News Call newsletter: http://tmsnrt.rs/2fwPLTh Wall Street's main indexes jumped on Tuesday as a recovery in oil prices lifted battered energy stocks and a slew of countries eased coronavirus-induced restrictions in an attempt to revive their economies. The top three S&P 500 .PG.INX percentage gainers: IPG Photonics Corp IPGP.O, up 15.8% Mosaic Company MOS.N, up 10.4% Hanesbrands Inc HBI.N, up 8.7% The top three S&P 500 .PL.INX percentage losers: Norwegian Cruise Line Holdings Ltd NCLH.N, down 19.5% Westrock Company WRK.N, down 13.2% Unum Group UNM.N, down 8.5% The top NYSE .PG.N percentage gainer: Chegg Inc CHGG.N, up 31.4% The top NYSE .PL.N percentage loser: Norwegian Cruise Line Holdings Ltd NCLH.N, down 19.% The top three Nasdaq .PG.O percentage gainers: Gan Ltd. GAN.O, up 321.8% Portola Pharmaceuticals Inc PTLA.O, up 129.3% Clensprk Inc CLSK.O, up 96.3% The top three Nasdaq .PL.O percentage losers: Fulgent Genetics Inc FLGT.O, down 20.2% Itron Inc ITRI.O, down 19.4% Capitala Finance CPTA.O, down 17.7% Goldman Sachs Group Inc GS.N: up 3.1% JPMorgan Chase & Co JPM.N: up 2.0% Citigroup Inc C.N: up 1.5% Bank of America Corp BAC.N: up 2.0% Morgan Stanley MS.N: up 1.8% BUZZ-Big banks: Rise as U.S. treasury yields edge higher Pfizer Inc PFE.N: up 2.9% BioNTech SE BNTX.O: up 6.2% BUZZ-Pfizer, BioNTech: Up after starting trials for COVID-19 vaccine Portola Pharmaceuticals PTLA.O: up 129.3% Alexion Pharmaceuticals Inc ALXN.O: down 4.7% BUZZ-Rises after Alexion to buy co in $1.41 bln deal ONEOK Inc OKE.N: up 1.7% BUZZ-Credit Suisse downgrades to 'neutral' Centennial Resource Development Inc CDEV.O: down 9.7% BUZZ-Tumbles as Q1 loss widens on impairment charge Compass Diversified Holdings CODI.N: down 11.2% BUZZ-Drops on stock offering ** U.S.	Concrete Inc USCR.O: up 4.7% BUZZ-Rises after reporting better-than-expected results Skyworks Solutions Inc SWKS.O: up 5.7% BUZZ-Gains on Q2 revenue and profit beat Capricor Therapeutics Inc CAPR.O: down 11.9% BUZZ-Falls on planned $40 mln equity raise after shares triple Livongo Health Inc LVGO.O: up 5.0% Healthcare Inc ONEM.O: up 2.9% BUZZ- Virtual care here to stay post COVID-19 - Piper Sandler Chembio Diagnostics Inc CEMI.O: up 6.6% BUZZ-Jumps on getting CE marking for COVID-19 test Owens & Minor OMI.N: down 4.7% BUZZ-Baird downgrades Owens & Minor on higher risk in times of COVID-19 DuPont de Nemours Inc DD.N: up 2.3% BUZZ-Climbs on doubling cost-savings target, curbing expenses Chegg Inc CHGG.N: up 31.4% BUZZ-Eyes record high, reaps benefits of digital learning shift Regeneron Pharmaceuticals Inc REGN.O: up 6.5% BUZZ-Rises after Q1 profit, revenue beat Bloomin' Brands Inc BLMN.O: down 9.2% BUZZ-Falls as Q1 profit likely to miss estimates TG Therapeutics Inc TGTX.O: up 27.1% BUZZ-Surges after late-stage trial meets main goal Akebia Therapeutics Inc AKBA.O: up 32.9% BUZZ-Up on positive data for anemia treatment in dialysis patients Tesla Inc TSLA.O: up 2.0% BUZZ-Rebounds as Musk eyes big payday Applied DNA APDN.O: up 1.6% BUZZ-Applied DNA surge continues on potential COVID-19 vaccine Insmed Inc INSM.O: down 4.4% BUZZ-Insmed slips on $225 mln share offering SG Blocks Inc SGBX.O: up 13.5% BUZZ-Surges on Osang HealthCare deal to distribute COVID-19 test kits Westrock Co WRK.N: down 13.2% BUZZ-Falls as Q2 rev misses estimates on lower selling price Diffusion Pharmaceuticals Inc DFFN.O: up 23.5% BUZZ-Gains as FDA accelerates review of COVID-19 treatment plan Aptiv Plc APTV.N: up 3.8% BUZZ-Gains on better-than-expected results Henry Schein Inc HSIC.O: up 1.0% BUZZ-Rises on better-than-feared quarterly results Norwegian Cruise Line Holdings NCLH.N: down 19.5% Carnival Corp CCL.N: down 4.0% Royal Caribbean Cruises RCL.N: down 5.1% BUZZ-Norwegian Cruise sinks on going concern warning, $1.6 bln capital raise plans Alaska Air Group Inc ALK.N: up 1.3% BUZZ-Alaska Air jumps on lower cash burn forecast for June Wayfair Inc W.N: up 20.7% BUZZ-Hits record high as 20% sales jump helps beat estimates AmerisourceBergen ABC.N: up 2.6% Walgreens Boots Alliance Inc WBA.O: down 0.4% BUZZ-Reported deal between AmerisourceBergen, Walgreens could help both cos - brokerage AerCap Holdings N.V. AER.N: up 7.5% BUZZ-Climbs after results show strong liquidity to battle downturn Mosaic Co MOS.N: up 10.4% BUZZ-Climbs on Q1 sales beat, sees strong fertilizer demand Coresite Realty Corp COR.N: down 2.4% BUZZ-Data center REIT CoreSite dips as top holder Carlyle cuts stake The 11 major S&P 500 sectors: Communication Services .N At 11:38 ET, the Dow Jones Industrial Average .DJI was up 1.60% at 24,129.11. The top three S&P 500 .PG.INX percentage gainers: IPG Photonics Corp IPGP.O, up 15.8% Mosaic Company MOS.N, up 10.4% Hanesbrands Inc HBI.N, up 8.7% The top three S&P 500 .PL.INX percentage losers: Norwegian Cruise Line Holdings Ltd NCLH.N, down 19.5% Westrock Company WRK.N, down 13.2% Unum Group UNM.N, down 8.5% The top NYSE .PG.N percentage gainer: Chegg Inc CHGG.N, up 31.4% The top NYSE .PL.N percentage loser: Norwegian Cruise Line Holdings Ltd NCLH.N, down 19.% The top three Nasdaq .PG.O percentage gainers: Gan Ltd. GAN.O, up 321.8% Portola Pharmaceuticals Inc PTLA.O, up 129.3% Clensprk Inc CLSK.O, up 96.3% The top three Nasdaq .PL.O percentage losers: Fulgent Genetics Inc FLGT.O, down 20.2% Itron Inc ITRI.O, down 19.4% Capitala Finance CPTA.O, down 17.7% Goldman Sachs Group Inc GS.N: up 3.1% JPMorgan Chase & Co JPM.N: up 2.0% Citigroup Inc C.N: up 1.5% Bank of America Corp BAC.N: up 2.0% Morgan Stanley MS.N: up 1.8% BUZZ-Big banks: Rise as U.S. treasury yields edge higher Pfizer Inc PFE.N: up 2.9% BioNTech SE BNTX.O: up 6.2% BUZZ-Pfizer, BioNTech: Up after starting trials for COVID-19 vaccine Portola Pharmaceuticals PTLA.O: up 129.3% Alexion Pharmaceuticals Inc ALXN.O: down 4.7% BUZZ-Rises after Alexion to buy co in $1.41 bln deal ONEOK Inc OKE.N: up 1.7% BUZZ-Credit Suisse downgrades to 'neutral' Centennial Resource Development Inc CDEV.O: down 9.7% BUZZ-Tumbles as Q1 loss widens on impairment charge Compass Diversified Holdings CODI.N: down 11.2% BUZZ-Drops on stock offering ** U.S.	Concrete Inc USCR.O: up 4.7% BUZZ-Rises after reporting better-than-expected results Skyworks Solutions Inc SWKS.O: up 5.7% BUZZ-Gains on Q2 revenue and profit beat Capricor Therapeutics Inc CAPR.O: down 11.9% BUZZ-Falls on planned $40 mln equity raise after shares triple Livongo Health Inc LVGO.O: up 5.0% Healthcare Inc ONEM.O: up 2.9% BUZZ- Virtual care here to stay post COVID-19 - Piper Sandler Chembio Diagnostics Inc CEMI.O: up 6.6% BUZZ-Jumps on getting CE marking for COVID-19 test Owens & Minor OMI.N: down 4.7% BUZZ-Baird downgrades Owens & Minor on higher risk in times of COVID-19 DuPont de Nemours Inc DD.N: up 2.3% BUZZ-Climbs on doubling cost-savings target, curbing expenses Chegg Inc CHGG.N: up 31.4% BUZZ-Eyes record high, reaps benefits of digital learning shift Regeneron Pharmaceuticals Inc REGN.O: up 6.5% BUZZ-Rises after Q1 profit, revenue beat Bloomin' Brands Inc BLMN.O: down 9.2% BUZZ-Falls as Q1 profit likely to miss estimates TG Therapeutics Inc TGTX.O: up 27.1% BUZZ-Surges after late-stage trial meets main goal Akebia Therapeutics Inc AKBA.O: up 32.9% BUZZ-Up on positive data for anemia treatment in dialysis patients Tesla Inc TSLA.O: up 2.0% BUZZ-Rebounds as Musk eyes big payday Applied DNA APDN.O: up 1.6% BUZZ-Applied DNA surge continues on potential COVID-19 vaccine Insmed Inc INSM.O: down 4.4% BUZZ-Insmed slips on $225 mln share offering SG Blocks Inc SGBX.O: up 13.5% BUZZ-Surges on Osang HealthCare deal to distribute COVID-19 test kits Westrock Co WRK.N: down 13.2% BUZZ-Falls as Q2 rev misses estimates on lower selling price Diffusion Pharmaceuticals Inc DFFN.O: up 23.5% BUZZ-Gains as FDA accelerates review of COVID-19 treatment plan Aptiv Plc APTV.N: up 3.8% BUZZ-Gains on better-than-expected results Henry Schein Inc HSIC.O: up 1.0% BUZZ-Rises on better-than-feared quarterly results Norwegian Cruise Line Holdings NCLH.N: down 19.5% Carnival Corp CCL.N: down 4.0% Royal Caribbean Cruises RCL.N: down 5.1% BUZZ-Norwegian Cruise sinks on going concern warning, $1.6 bln capital raise plans Alaska Air Group Inc ALK.N: up 1.3% BUZZ-Alaska Air jumps on lower cash burn forecast for June Wayfair Inc W.N: up 20.7% BUZZ-Hits record high as 20% sales jump helps beat estimates AmerisourceBergen ABC.N: up 2.6% Walgreens Boots Alliance Inc WBA.O: down 0.4% BUZZ-Reported deal between AmerisourceBergen, Walgreens could help both cos - brokerage AerCap Holdings N.V. AER.N: up 7.5% BUZZ-Climbs after results show strong liquidity to battle downturn Mosaic Co MOS.N: up 10.4% BUZZ-Climbs on Q1 sales beat, sees strong fertilizer demand Coresite Realty Corp COR.N: down 2.4% BUZZ-Data center REIT CoreSite dips as top holder Carlyle cuts stake The 11 major S&P 500 sectors: Communication Services Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: http://tmsnrt.rs/2ggOmBi The Morning News Call newsletter: http://tmsnrt.rs/2fwPLTh Wall Street's main indexes jumped on Tuesday as a recovery in oil prices lifted battered energy stocks and a slew of countries eased coronavirus-induced restrictions in an attempt to revive their economies. .N At 11:38 ET, the Dow Jones Industrial Average .DJI was up 1.60% at 24,129.11.	a1a4b25a-a131-4cc6-b80f-8cf035147e8e
716282.0	2020-05-05 00:00:00 UTC	DuPont slashes capital expenses, increase cost savings	DD	https://www.nasdaq.com/articles/dupont-slashes-capital-expenses-increase-cost-savings-2020-05-05	nan	nan	May 5 (Reuters) - Industrial materials maker DuPont DD.N on Tuesday slashed its capital expenditure by about $500 million and raised its annual cost-savings target to counter global trade uncertainties brought on by the coronavirus outbreak. The industrial giant now expects to save $180 million this year from incremental actions it had announced earlier. The company's adjusted earnings, in line with preliminary results released earlier, came in at 84 cents per share for the first quarter, beating analysts' raised estimates of 75 cents, according to Refinitiv IBES. (Reporting by Taru Jain; Editing by Maju Samuel) ((Taru.Jain@thomsonreuters.com;)) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	May 5 (Reuters) - Industrial materials maker DuPont DD.N on Tuesday slashed its capital expenditure by about $500 million and raised its annual cost-savings target to counter global trade uncertainties brought on by the coronavirus outbreak. The industrial giant now expects to save $180 million this year from incremental actions it had announced earlier. The company's adjusted earnings, in line with preliminary results released earlier, came in at 84 cents per share for the first quarter, beating analysts' raised estimates of 75 cents, according to Refinitiv IBES.	May 5 (Reuters) - Industrial materials maker DuPont DD.N on Tuesday slashed its capital expenditure by about $500 million and raised its annual cost-savings target to counter global trade uncertainties brought on by the coronavirus outbreak. The company's adjusted earnings, in line with preliminary results released earlier, came in at 84 cents per share for the first quarter, beating analysts' raised estimates of 75 cents, according to Refinitiv IBES. (Reporting by Taru Jain; Editing by Maju Samuel) ((Taru.Jain@thomsonreuters.com;)) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	May 5 (Reuters) - Industrial materials maker DuPont DD.N on Tuesday slashed its capital expenditure by about $500 million and raised its annual cost-savings target to counter global trade uncertainties brought on by the coronavirus outbreak. The company's adjusted earnings, in line with preliminary results released earlier, came in at 84 cents per share for the first quarter, beating analysts' raised estimates of 75 cents, according to Refinitiv IBES. (Reporting by Taru Jain; Editing by Maju Samuel) ((Taru.Jain@thomsonreuters.com;)) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	May 5 (Reuters) - Industrial materials maker DuPont DD.N on Tuesday slashed its capital expenditure by about $500 million and raised its annual cost-savings target to counter global trade uncertainties brought on by the coronavirus outbreak. The industrial giant now expects to save $180 million this year from incremental actions it had announced earlier. The company's adjusted earnings, in line with preliminary results released earlier, came in at 84 cents per share for the first quarter, beating analysts' raised estimates of 75 cents, according to Refinitiv IBES.	68d9c23e-51d5-42be-bd51-05f21cf12c66
716283.0	2020-05-05 00:00:00 UTC	DuPont Provides Update On COVID-19 Impact On Business - Quick Facts	DD	https://www.nasdaq.com/articles/dupont-provides-update-on-covid-19-impact-on-business-quick-facts-2020-05-05	nan	nan	(RTTNews) - While reporting financial results for the first quarter on Tuesday, DuPont (DD) said it has issued $2.0 billion bond to refinance debt maturities due in November 2020 and replaced the $2.0 billion 364-day delayed-draw facility. It also continues to advance the separation of the Nutrition & Biosciences business in preparation for merger with IFF in the first quarter of 2021. Meanwhile, the company has implemented initiatives to mitigate the impact of COVID-19 including actions to deliver more than $500 million of working capital improvement and reducing capital expenditures by about $500 million versus the prior year. On April 20, DuPont had suspended its financial guidance for the full-year 2020, due to global softening in automotive, oil & gas and select industrial end-markets as well as the unknown duration and intensity of the COVID-19 pandemic. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	(RTTNews) - While reporting financial results for the first quarter on Tuesday, DuPont (DD) said it has issued $2.0 billion bond to refinance debt maturities due in November 2020 and replaced the $2.0 billion 364-day delayed-draw facility. It also continues to advance the separation of the Nutrition & Biosciences business in preparation for merger with IFF in the first quarter of 2021. On April 20, DuPont had suspended its financial guidance for the full-year 2020, due to global softening in automotive, oil & gas and select industrial end-markets as well as the unknown duration and intensity of the COVID-19 pandemic.	(RTTNews) - While reporting financial results for the first quarter on Tuesday, DuPont (DD) said it has issued $2.0 billion bond to refinance debt maturities due in November 2020 and replaced the $2.0 billion 364-day delayed-draw facility. Meanwhile, the company has implemented initiatives to mitigate the impact of COVID-19 including actions to deliver more than $500 million of working capital improvement and reducing capital expenditures by about $500 million versus the prior year. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	(RTTNews) - While reporting financial results for the first quarter on Tuesday, DuPont (DD) said it has issued $2.0 billion bond to refinance debt maturities due in November 2020 and replaced the $2.0 billion 364-day delayed-draw facility. Meanwhile, the company has implemented initiatives to mitigate the impact of COVID-19 including actions to deliver more than $500 million of working capital improvement and reducing capital expenditures by about $500 million versus the prior year. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	(RTTNews) - While reporting financial results for the first quarter on Tuesday, DuPont (DD) said it has issued $2.0 billion bond to refinance debt maturities due in November 2020 and replaced the $2.0 billion 364-day delayed-draw facility. It also continues to advance the separation of the Nutrition & Biosciences business in preparation for merger with IFF in the first quarter of 2021. Meanwhile, the company has implemented initiatives to mitigate the impact of COVID-19 including actions to deliver more than $500 million of working capital improvement and reducing capital expenditures by about $500 million versus the prior year.	e3b91e58-96fb-4e71-b215-4e29508493ce
716284.0	2020-05-05 00:00:00 UTC	EI DuPont De Nemours & Co. Q1 adjusted earnings Beat Estimates	DD	https://www.nasdaq.com/articles/ei-dupont-de-nemours-co.-q1-adjusted-earnings-beat-estimates-2020-05-05	nan	nan	(RTTNews) - Below are the earnings highlights for EI DuPont De Nemours & Co. (DD): -Earnings: -$616 million in Q1 vs. $521 million in the same period last year. -EPS: -$0.83 in Q1 vs. $0.69 in the same period last year. -Excluding items, EI DuPont De Nemours & Co. reported adjusted earnings of $617 million or $0.84 per share for the period. -Analysts projected $0.75 per share -Revenue: $5.22 billion in Q1 vs. $5.41 billion in the same period last year. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	(RTTNews) - Below are the earnings highlights for EI DuPont De Nemours & Co. (DD): -Earnings: -$616 million in Q1 vs. $521 million in the same period last year. -Excluding items, EI DuPont De Nemours & Co. reported adjusted earnings of $617 million or $0.84 per share for the period. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	(RTTNews) - Below are the earnings highlights for EI DuPont De Nemours & Co. (DD): -Earnings: -$616 million in Q1 vs. $521 million in the same period last year. -Excluding items, EI DuPont De Nemours & Co. reported adjusted earnings of $617 million or $0.84 per share for the period. -Analysts projected $0.75 per share -Revenue: $5.22 billion in Q1 vs. $5.41 billion in the same period last year.	(RTTNews) - Below are the earnings highlights for EI DuPont De Nemours & Co. (DD): -Earnings: -$616 million in Q1 vs. $521 million in the same period last year. -Excluding items, EI DuPont De Nemours & Co. reported adjusted earnings of $617 million or $0.84 per share for the period. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	(RTTNews) - Below are the earnings highlights for EI DuPont De Nemours & Co. (DD): -Earnings: -$616 million in Q1 vs. $521 million in the same period last year. -EPS: -$0.83 in Q1 vs. $0.69 in the same period last year. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	e1261acd-1a5b-4ac4-a4de-054509e33ad6
716285.0	2020-05-05 00:00:00 UTC	BUZZ-U.S. STOCKS ON THE MOVE-Tesla, banks, Pfizer, Regeneron	DD	https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-tesla-banks-pfizer-regeneron-2020-05-05	nan	nan	Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: http://tmsnrt.rs/2ggOmBi The Morning News Call newsletter: http://tmsnrt.rs/2fwPLTh U.S. stock indexes were set to rise at the open on Tuesday as oil prices staged a recovery and a slew of countries eased coronavirus-led restrictions in an attempt to revive their economies. .N At 9:02 ET, Dow e-minis 1YMc1 were up 1.23% at 23,860. S&P 500 e-minis ESc1 were up 1.25% at 2,860.5, while Nasdaq 100 e-minis NQc1 were up 1.28% at 8,908.5. The top three NYSE percentage gainers premarket .PRPG.NQ: TETRA Technologies Inc TTI.N, up 57.4% Wayfair Inc W.N, up 21.2% Natural Gas Services Group Inc NGS.N, up 19.1% The top three NYSE percentage losers premarket .PRPL.NQ: Hertz Global Holdings Inc HTZ.N, down 13.6% Compass Diversified Holdings CODI.N, down 11.1% Unum Group UNM.N, down 10.3% The top three Nasdaq percentage gainers premarket .PRPG.O: Portola Pharmaceuticals Inc PTLA.O, up 0.0% Alpine Immune Sciences Inc ALPN.O, up 61.0% Sg Blocks Inc SGBX.O, up 47.1% The top three Nasdaq percentage losers premarket .PRPL.O: Amerco UHAL.O, down 33.6% Aemetis Inc AMTX.O, down 16.2% Centennial Resource Development Inc CDEV.O, down 15.5% Goldman Sachs Group Inc GS.N: up 1.7% premarket JPMorgan Chase & Co JPM.N: up 1.9% premarket Citigroup Inc C.N: up 2.4% premarket Wells Fargo & Co WFC.N: up 1.2% premarket Bank of America Corp BAC.N: up 2.4% premarket Morgan Stanley MS.N: up 1.9% premarket BUZZ-Big banks: Rise as U.S. treasury yields edge higher Pfizer Inc PFE.N: up 1.8% premarket BioNTech SE BNTX.O: up 4.2% premarket BUZZ-Pfizer, BioNTech: Up after starting trials for COVID-19 vaccine Portola Pharmaceuticals PTLA.O: up 130.7% premarket Alexion Pharmaceuticals Inc ALXN.O: down 2.7% premarket BUZZ-Rises after Alexion to buy co in $1.41 bln deal Tesla Inc TSLA.O: up 3.3% premarket BUZZ-Rebounds as Musk eyes big payday Centennial Resource Development Inc CDEV.O: down 15.5% premarket BUZZ-Tumbles as Q1 loss widens on impairment charge Compass Diversified Holdings CODI.N: down 11.1% premarket BUZZ-Drops on stock offering U.S. Concrete Inc USCR.O: up 4.3% premarket BUZZ-Rises after reporting better-than-expected results Skyworks Solutions Inc SWKS.O: up 3.4% premarket BUZZ-Gains on Q2 revenue and profit beat Capricor Therapeutics Inc CAPR.O: down 8.6% premarket BUZZ-Falls on planned $40 mln equity raise after shares triple Chembio Diagnostics Inc CEMI.O: up 15.5% premarket BUZZ-Jumps on getting CE marking for COVID-19 test DuPont de Nemours Inc DD.N: up 2.0% premarket BUZZ-Climbs on doubling cost-savings target, curbing expenses Chegg Inc CHGG.N: up 18.2% premarket BUZZ-Eyes record high, reaps benefits of digital learning shift Regeneron Pharmaceuticals Inc REGN.O: up 4.1% premarket BUZZ-Rises after Q1 profit, revenue beat Bloomin' Brands Inc BLMN.O: down 5.5% premarket BUZZ-Falls as Q1 profit likely to miss estimates TG Therapeutics Inc TGTX.O: up 24.2% premarket BUZZ-Surges after late-stage trial meets main goal Marathon Petroleum Corp MPC.N: up 5.3% premarket BUZZ-Gains on smaller-than-expected loss, 2020 capex cut Akebia Therapeutics Inc AKBA.O: up 15.6% premarket BUZZ-Up on positive data for anemia treatment in dialysis patients (Compiled by Trisha Roy in Bengaluru) ((Trisha.Roy@thomsonreuters.com; within U.S. +1 646 223 8780, outside U.S. +91 80 6182 3635;)) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	Concrete Inc USCR.O: up 4.3% premarket BUZZ-Rises after reporting better-than-expected results Skyworks Solutions Inc SWKS.O: up 3.4% premarket BUZZ-Gains on Q2 revenue and profit beat Capricor Therapeutics Inc CAPR.O: down 8.6% premarket BUZZ-Falls on planned $40 mln equity raise after shares triple Chembio Diagnostics Inc CEMI.O: up 15.5% premarket BUZZ-Jumps on getting CE marking for COVID-19 test DuPont de Nemours Inc DD.N: up 2.0% premarket BUZZ-Climbs on doubling cost-savings target, curbing expenses Chegg Inc CHGG.N: up 18.2% premarket BUZZ-Eyes record high, reaps benefits of digital learning shift Regeneron Pharmaceuticals Inc REGN.O: up 4.1% premarket BUZZ-Rises after Q1 profit, revenue beat Bloomin' Brands Inc BLMN.O: down 5.5% premarket BUZZ-Falls as Q1 profit likely to miss estimates TG Therapeutics Inc TGTX.O: up 24.2% premarket BUZZ-Surges after late-stage trial meets main goal Marathon Petroleum Corp MPC.N: up 5.3% premarket BUZZ-Gains on smaller-than-expected loss, 2020 capex cut Akebia Therapeutics Inc AKBA.O: up 15.6% premarket BUZZ-Up on positive data for anemia treatment in dialysis patients (Compiled by Trisha Roy in Bengaluru) ((Trisha.Roy@thomsonreuters.com; within U.S. +1 646 223 8780, outside U.S. +91 80 6182 3635;)) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: http://tmsnrt.rs/2ggOmBi The Morning News Call newsletter: http://tmsnrt.rs/2fwPLTh U.S. stock indexes were set to rise at the open on Tuesday as oil prices staged a recovery and a slew of countries eased coronavirus-led restrictions in an attempt to revive their economies. The top three NYSE percentage gainers premarket .PRPG.NQ: TETRA Technologies Inc TTI.N, up 57.4% Wayfair Inc W.N, up 21.2% Natural Gas Services Group Inc NGS.N, up 19.1% The top three NYSE percentage losers premarket .PRPL.NQ: Hertz Global Holdings Inc HTZ.N, down 13.6% Compass Diversified Holdings CODI.N, down 11.1% Unum Group UNM.N, down 10.3% The top three Nasdaq percentage gainers premarket .PRPG.O: Portola Pharmaceuticals Inc PTLA.O, up 0.0% Alpine Immune Sciences Inc ALPN.O, up 61.0% Sg Blocks Inc SGBX.O, up 47.1% The top three Nasdaq percentage losers premarket .PRPL.O: Amerco UHAL.O, down 33.6% Aemetis Inc AMTX.O, down 16.2% Centennial Resource Development Inc CDEV.O, down 15.5% Goldman Sachs Group Inc GS.N: up 1.7% premarket JPMorgan Chase & Co JPM.N: up 1.9% premarket Citigroup Inc C.N: up 2.4% premarket Wells Fargo & Co WFC.N: up 1.2% premarket Bank of America Corp BAC.N: up 2.4% premarket Morgan Stanley MS.N: up 1.9% premarket BUZZ-Big banks: Rise as U.S. treasury yields edge higher Pfizer Inc PFE.N: up 1.8% premarket BioNTech SE BNTX.O: up 4.2% premarket BUZZ-Pfizer, BioNTech: Up after starting trials for COVID-19 vaccine Portola Pharmaceuticals PTLA.O: up 130.7% premarket Alexion Pharmaceuticals Inc ALXN.O: down 2.7% premarket BUZZ-Rises after Alexion to buy co in $1.41 bln deal Tesla Inc TSLA.O: up 3.3% premarket BUZZ-Rebounds as Musk eyes big payday Centennial Resource Development Inc CDEV.O: down 15.5% premarket BUZZ-Tumbles as Q1 loss widens on impairment charge Compass Diversified Holdings CODI.N: down 11.1% premarket BUZZ-Drops on stock offering U.S.	Concrete Inc USCR.O: up 4.3% premarket BUZZ-Rises after reporting better-than-expected results Skyworks Solutions Inc SWKS.O: up 3.4% premarket BUZZ-Gains on Q2 revenue and profit beat Capricor Therapeutics Inc CAPR.O: down 8.6% premarket BUZZ-Falls on planned $40 mln equity raise after shares triple Chembio Diagnostics Inc CEMI.O: up 15.5% premarket BUZZ-Jumps on getting CE marking for COVID-19 test DuPont de Nemours Inc DD.N: up 2.0% premarket BUZZ-Climbs on doubling cost-savings target, curbing expenses Chegg Inc CHGG.N: up 18.2% premarket BUZZ-Eyes record high, reaps benefits of digital learning shift Regeneron Pharmaceuticals Inc REGN.O: up 4.1% premarket BUZZ-Rises after Q1 profit, revenue beat Bloomin' Brands Inc BLMN.O: down 5.5% premarket BUZZ-Falls as Q1 profit likely to miss estimates TG Therapeutics Inc TGTX.O: up 24.2% premarket BUZZ-Surges after late-stage trial meets main goal Marathon Petroleum Corp MPC.N: up 5.3% premarket BUZZ-Gains on smaller-than-expected loss, 2020 capex cut Akebia Therapeutics Inc AKBA.O: up 15.6% premarket BUZZ-Up on positive data for anemia treatment in dialysis patients (Compiled by Trisha Roy in Bengaluru) ((Trisha.Roy@thomsonreuters.com; within U.S. +1 646 223 8780, outside U.S. +91 80 6182 3635;)) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: http://tmsnrt.rs/2ggOmBi The Morning News Call newsletter: http://tmsnrt.rs/2fwPLTh U.S. stock indexes were set to rise at the open on Tuesday as oil prices staged a recovery and a slew of countries eased coronavirus-led restrictions in an attempt to revive their economies. The top three NYSE percentage gainers premarket .PRPG.NQ: TETRA Technologies Inc TTI.N, up 57.4% Wayfair Inc W.N, up 21.2% Natural Gas Services Group Inc NGS.N, up 19.1% The top three NYSE percentage losers premarket .PRPL.NQ: Hertz Global Holdings Inc HTZ.N, down 13.6% Compass Diversified Holdings CODI.N, down 11.1% Unum Group UNM.N, down 10.3% The top three Nasdaq percentage gainers premarket .PRPG.O: Portola Pharmaceuticals Inc PTLA.O, up 0.0% Alpine Immune Sciences Inc ALPN.O, up 61.0% Sg Blocks Inc SGBX.O, up 47.1% The top three Nasdaq percentage losers premarket .PRPL.O: Amerco UHAL.O, down 33.6% Aemetis Inc AMTX.O, down 16.2% Centennial Resource Development Inc CDEV.O, down 15.5% Goldman Sachs Group Inc GS.N: up 1.7% premarket JPMorgan Chase & Co JPM.N: up 1.9% premarket Citigroup Inc C.N: up 2.4% premarket Wells Fargo & Co WFC.N: up 1.2% premarket Bank of America Corp BAC.N: up 2.4% premarket Morgan Stanley MS.N: up 1.9% premarket BUZZ-Big banks: Rise as U.S. treasury yields edge higher Pfizer Inc PFE.N: up 1.8% premarket BioNTech SE BNTX.O: up 4.2% premarket BUZZ-Pfizer, BioNTech: Up after starting trials for COVID-19 vaccine Portola Pharmaceuticals PTLA.O: up 130.7% premarket Alexion Pharmaceuticals Inc ALXN.O: down 2.7% premarket BUZZ-Rises after Alexion to buy co in $1.41 bln deal Tesla Inc TSLA.O: up 3.3% premarket BUZZ-Rebounds as Musk eyes big payday Centennial Resource Development Inc CDEV.O: down 15.5% premarket BUZZ-Tumbles as Q1 loss widens on impairment charge Compass Diversified Holdings CODI.N: down 11.1% premarket BUZZ-Drops on stock offering U.S.	Concrete Inc USCR.O: up 4.3% premarket BUZZ-Rises after reporting better-than-expected results Skyworks Solutions Inc SWKS.O: up 3.4% premarket BUZZ-Gains on Q2 revenue and profit beat Capricor Therapeutics Inc CAPR.O: down 8.6% premarket BUZZ-Falls on planned $40 mln equity raise after shares triple Chembio Diagnostics Inc CEMI.O: up 15.5% premarket BUZZ-Jumps on getting CE marking for COVID-19 test DuPont de Nemours Inc DD.N: up 2.0% premarket BUZZ-Climbs on doubling cost-savings target, curbing expenses Chegg Inc CHGG.N: up 18.2% premarket BUZZ-Eyes record high, reaps benefits of digital learning shift Regeneron Pharmaceuticals Inc REGN.O: up 4.1% premarket BUZZ-Rises after Q1 profit, revenue beat Bloomin' Brands Inc BLMN.O: down 5.5% premarket BUZZ-Falls as Q1 profit likely to miss estimates TG Therapeutics Inc TGTX.O: up 24.2% premarket BUZZ-Surges after late-stage trial meets main goal Marathon Petroleum Corp MPC.N: up 5.3% premarket BUZZ-Gains on smaller-than-expected loss, 2020 capex cut Akebia Therapeutics Inc AKBA.O: up 15.6% premarket BUZZ-Up on positive data for anemia treatment in dialysis patients (Compiled by Trisha Roy in Bengaluru) ((Trisha.Roy@thomsonreuters.com; within U.S. +1 646 223 8780, outside U.S. +91 80 6182 3635;)) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. S&P 500 e-minis ESc1 were up 1.25% at 2,860.5, while Nasdaq 100 e-minis NQc1 were up 1.28% at 8,908.5. The top three NYSE percentage gainers premarket .PRPG.NQ: TETRA Technologies Inc TTI.N, up 57.4% Wayfair Inc W.N, up 21.2% Natural Gas Services Group Inc NGS.N, up 19.1% The top three NYSE percentage losers premarket .PRPL.NQ: Hertz Global Holdings Inc HTZ.N, down 13.6% Compass Diversified Holdings CODI.N, down 11.1% Unum Group UNM.N, down 10.3% The top three Nasdaq percentage gainers premarket .PRPG.O: Portola Pharmaceuticals Inc PTLA.O, up 0.0% Alpine Immune Sciences Inc ALPN.O, up 61.0% Sg Blocks Inc SGBX.O, up 47.1% The top three Nasdaq percentage losers premarket .PRPL.O: Amerco UHAL.O, down 33.6% Aemetis Inc AMTX.O, down 16.2% Centennial Resource Development Inc CDEV.O, down 15.5% Goldman Sachs Group Inc GS.N: up 1.7% premarket JPMorgan Chase & Co JPM.N: up 1.9% premarket Citigroup Inc C.N: up 2.4% premarket Wells Fargo & Co WFC.N: up 1.2% premarket Bank of America Corp BAC.N: up 2.4% premarket Morgan Stanley MS.N: up 1.9% premarket BUZZ-Big banks: Rise as U.S. treasury yields edge higher Pfizer Inc PFE.N: up 1.8% premarket BioNTech SE BNTX.O: up 4.2% premarket BUZZ-Pfizer, BioNTech: Up after starting trials for COVID-19 vaccine Portola Pharmaceuticals PTLA.O: up 130.7% premarket Alexion Pharmaceuticals Inc ALXN.O: down 2.7% premarket BUZZ-Rises after Alexion to buy co in $1.41 bln deal Tesla Inc TSLA.O: up 3.3% premarket BUZZ-Rebounds as Musk eyes big payday Centennial Resource Development Inc CDEV.O: down 15.5% premarket BUZZ-Tumbles as Q1 loss widens on impairment charge Compass Diversified Holdings CODI.N: down 11.1% premarket BUZZ-Drops on stock offering U.S.	Concrete Inc USCR.O: up 4.3% premarket BUZZ-Rises after reporting better-than-expected results Skyworks Solutions Inc SWKS.O: up 3.4% premarket BUZZ-Gains on Q2 revenue and profit beat Capricor Therapeutics Inc CAPR.O: down 8.6% premarket BUZZ-Falls on planned $40 mln equity raise after shares triple Chembio Diagnostics Inc CEMI.O: up 15.5% premarket BUZZ-Jumps on getting CE marking for COVID-19 test DuPont de Nemours Inc DD.N: up 2.0% premarket BUZZ-Climbs on doubling cost-savings target, curbing expenses Chegg Inc CHGG.N: up 18.2% premarket BUZZ-Eyes record high, reaps benefits of digital learning shift Regeneron Pharmaceuticals Inc REGN.O: up 4.1% premarket BUZZ-Rises after Q1 profit, revenue beat Bloomin' Brands Inc BLMN.O: down 5.5% premarket BUZZ-Falls as Q1 profit likely to miss estimates TG Therapeutics Inc TGTX.O: up 24.2% premarket BUZZ-Surges after late-stage trial meets main goal Marathon Petroleum Corp MPC.N: up 5.3% premarket BUZZ-Gains on smaller-than-expected loss, 2020 capex cut Akebia Therapeutics Inc AKBA.O: up 15.6% premarket BUZZ-Up on positive data for anemia treatment in dialysis patients (Compiled by Trisha Roy in Bengaluru) ((Trisha.Roy@thomsonreuters.com; within U.S. +1 646 223 8780, outside U.S. +91 80 6182 3635;)) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: http://tmsnrt.rs/2ggOmBi The Morning News Call newsletter: http://tmsnrt.rs/2fwPLTh U.S. stock indexes were set to rise at the open on Tuesday as oil prices staged a recovery and a slew of countries eased coronavirus-led restrictions in an attempt to revive their economies. .N At 9:02 ET, Dow e-minis 1YMc1 were up 1.23% at 23,860.	2d4027eb-5ff1-4fbe-a7f2-3e2dcdcf28fd
716286.0	2020-04-27 00:00:00 UTC	Trump to meet with textile makers as companies shift to masks, gowns -Navarro	DD	https://www.nasdaq.com/articles/trump-to-meet-with-textile-makers-as-companies-shift-to-masks-gowns-navarro-2020-04-27	nan	nan	WASHINGTON, April 27 (Reuters) - U.S. President Donald Trump will meet with American textile industry representatives on Monday as clothiers seek to shift their production lines to face masks and other critical items amid the coronavirus outbreak, the White House said. White House trade adviser Peter Navarro, in an interview on Fox News, said the Republican president would meet with the National Council of Textile Organizations, whose members include companies such as HanesBrands Inc HBI.N, Under Armour Inc UAA.N and Bershire Hathaway Co's BRKa.N Fruit of the Loom. DuPont DD.N unit DuPont Protection Technologies, Cargill Cotton and privately held companies such as Jockey International Inc and the Lycra Co are also council members. Such companies are aiming "to repurpose their factories from making things like T-shirts into gowns and masks and things like cotton swabs" used for coronavirus testing, much like General Motors has moved to use its auto factories to make ventilators for patients with difficulty breathing, Navarro said. Trump is scheduled to meet with "industry representatives" at 2 p.m.(1800 GMT), according to a schedule released by the White House. A severe lack of U.S. medical supplies has hampered healthcare workers on the front lines treating coronavirus patients, leaving hospitals and states scrambling for protective gear. The Centers for Disease Control and Prevention has also urged Americans to wear masks to help prevent the spread of the disease, but it has encouraged using homemade and other varieties to keep medical-grade ones available for first responders and healthcare workers. Navarro also said the administration is focusing on protocols to keep U.S. factories in general open during the outbreak, including screening workers for potential cases. "We're trying to figure out the best protocols to keep our factories going," he said. "We're going to have to use appropriate protocols, different social distancing. You're going to have to reconfigure factories. You're going to have to use things like thermoscanners to check (for) fever as they come in." (Reporting by Susan Heavey; Editing by Toby Chopra and Jonathan Oatis) ((202-898-8300; Reuters Messaging: susan.heavey.thomsonreuters.com@reuters.net)) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	DuPont DD.N unit DuPont Protection Technologies, Cargill Cotton and privately held companies such as Jockey International Inc and the Lycra Co are also council members. WASHINGTON, April 27 (Reuters) - U.S. President Donald Trump will meet with American textile industry representatives on Monday as clothiers seek to shift their production lines to face masks and other critical items amid the coronavirus outbreak, the White House said. White House trade adviser Peter Navarro, in an interview on Fox News, said the Republican president would meet with the National Council of Textile Organizations, whose members include companies such as HanesBrands Inc HBI.N, Under Armour Inc UAA.N and Bershire Hathaway Co's BRKa.N Fruit of the Loom.	DuPont DD.N unit DuPont Protection Technologies, Cargill Cotton and privately held companies such as Jockey International Inc and the Lycra Co are also council members. WASHINGTON, April 27 (Reuters) - U.S. President Donald Trump will meet with American textile industry representatives on Monday as clothiers seek to shift their production lines to face masks and other critical items amid the coronavirus outbreak, the White House said. White House trade adviser Peter Navarro, in an interview on Fox News, said the Republican president would meet with the National Council of Textile Organizations, whose members include companies such as HanesBrands Inc HBI.N, Under Armour Inc UAA.N and Bershire Hathaway Co's BRKa.N Fruit of the Loom.	DuPont DD.N unit DuPont Protection Technologies, Cargill Cotton and privately held companies such as Jockey International Inc and the Lycra Co are also council members. WASHINGTON, April 27 (Reuters) - U.S. President Donald Trump will meet with American textile industry representatives on Monday as clothiers seek to shift their production lines to face masks and other critical items amid the coronavirus outbreak, the White House said. White House trade adviser Peter Navarro, in an interview on Fox News, said the Republican president would meet with the National Council of Textile Organizations, whose members include companies such as HanesBrands Inc HBI.N, Under Armour Inc UAA.N and Bershire Hathaway Co's BRKa.N Fruit of the Loom.	DuPont DD.N unit DuPont Protection Technologies, Cargill Cotton and privately held companies such as Jockey International Inc and the Lycra Co are also council members. WASHINGTON, April 27 (Reuters) - U.S. President Donald Trump will meet with American textile industry representatives on Monday as clothiers seek to shift their production lines to face masks and other critical items amid the coronavirus outbreak, the White House said. Such companies are aiming "to repurpose their factories from making things like T-shirts into gowns and masks and things like cotton swabs" used for coronavirus testing, much like General Motors has moved to use its auto factories to make ventilators for patients with difficulty breathing, Navarro said.	f17f5841-dc12-4857-a287-c38be99546db
716287.0	2020-04-24 00:00:00 UTC	DuPont doubles output of protective gowns to 30 mln per month	DD	https://www.nasdaq.com/articles/dupont-doubles-output-of-protective-gowns-to-30-mln-per-month-2020-04-24	nan	nan	By Taru Jain and Arathy S Nair April 24 (Reuters) - Industrial materials maker DuPont DD.N is doubling production of protective garments it makes from its Tyvek material to about 30 million a month to help meet increased demand due to the coronavirus outbreak. The spread of the pandemic across Europe and the United States has led to a worldwide scramble for protective masks, gowns and gloves worn by healthcare and other workers battling to curb the spread of the virus. Johns Hopkins Center for Health Security estimated this month that a single 100-day COVID-19 wave would create a need for 321 million more isolation gowns, such as those made by Dupont, in the United States alone. Before the coronavirus crisis, theglobal marketfor personal protective equipment (PPE) was valued at about $40 billion annually, with Dupont and U.S. peers Honeywell International Inc HON.N and 3M Co MMM.N among the biggest players. That will now increase. "We're producing up to almost two times the number of garments per month to help support the demand that's currently in front of us," John Richard, vice president of DuPont's safety business told Reuters. DuPont's Tyvek, a fabric used in gowns and coveralls for protective use, has been a silver lining for the company as it faces steep declines in demand for its products in the auto sector and other industries hammered by the virus outbreak. The company pulled its full-year forecast on Monday, but estimated first-quarter profit would top Wall Street estimates on demand for products such as Tyvek and those used in water filtration. The industrial giant, a top player in the PPE market with other products such as protective gloves, flame-resistant and chemical protective clothing, said everything it was producing was being sold promptly. The company expects the heightened demand to continue at least until later this year as industries resume operations and bring back workers using additional safety measures. DuPont, which makes Tyvek in Richmond, Virginia and Luxembourg, has re-purposed its manufacturing operations and simplified some designs to eke out more pieces per square area of the fabric. Dow DOW.N, part of the erstwhile DowDupont conglomerate before a split last year, has also started making sanitizers and face shields to meet growing demand. (Reporting by Taru Jain and Arathy S Nair in Bengaluru; Editing by Shounak Dasgupta) ((arathys.nair@thomsonreuters.com; +1 646 223 8780 (Extn 2726); Twitter: https://twitter.com/ArathySom)) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	By Taru Jain and Arathy S Nair April 24 (Reuters) - Industrial materials maker DuPont DD.N is doubling production of protective garments it makes from its Tyvek material to about 30 million a month to help meet increased demand due to the coronavirus outbreak. The company expects the heightened demand to continue at least until later this year as industries resume operations and bring back workers using additional safety measures. Johns Hopkins Center for Health Security estimated this month that a single 100-day COVID-19 wave would create a need for 321 million more isolation gowns, such as those made by Dupont, in the United States alone.	By Taru Jain and Arathy S Nair April 24 (Reuters) - Industrial materials maker DuPont DD.N is doubling production of protective garments it makes from its Tyvek material to about 30 million a month to help meet increased demand due to the coronavirus outbreak. The company expects the heightened demand to continue at least until later this year as industries resume operations and bring back workers using additional safety measures. The industrial giant, a top player in the PPE market with other products such as protective gloves, flame-resistant and chemical protective clothing, said everything it was producing was being sold promptly.	By Taru Jain and Arathy S Nair April 24 (Reuters) - Industrial materials maker DuPont DD.N is doubling production of protective garments it makes from its Tyvek material to about 30 million a month to help meet increased demand due to the coronavirus outbreak. The company expects the heightened demand to continue at least until later this year as industries resume operations and bring back workers using additional safety measures. DuPont's Tyvek, a fabric used in gowns and coveralls for protective use, has been a silver lining for the company as it faces steep declines in demand for its products in the auto sector and other industries hammered by the virus outbreak.	By Taru Jain and Arathy S Nair April 24 (Reuters) - Industrial materials maker DuPont DD.N is doubling production of protective garments it makes from its Tyvek material to about 30 million a month to help meet increased demand due to the coronavirus outbreak. The company expects the heightened demand to continue at least until later this year as industries resume operations and bring back workers using additional safety measures. The spread of the pandemic across Europe and the United States has led to a worldwide scramble for protective masks, gowns and gloves worn by healthcare and other workers battling to curb the spread of the virus.	ee2f9d61-42d7-4a1b-8262-7ca8c72e33ec
716288.0	2020-04-23 00:00:00 UTC	June 5th Options Now Available For DuPont (DD)	DD	https://www.nasdaq.com/articles/june-5th-options-now-available-for-dupont-dd-2020-04-23	nan	nan	Investors in DuPont (Symbol: DD) saw new options begin trading today, for the June 5th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the DD options chain for the new June 5th contracts and identified one put and one call contract of particular interest. The put contract at the $39.00 strike price has a current bid of $2.21. If an investor was to sell-to-open that put contract, they are committing to purchase the stock at $39.00, but will also collect the premium, putting the cost basis of the shares at $36.79 (before broker commissions). To an investor already interested in purchasing shares of DD, that could represent an attractive alternative to paying $41.64/share today. Because the $39.00 strike represents an approximate 6% discount to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the put contract would expire worthless. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 67%. Stock Options Channel will track those odds over time to see how they change, publishing a chart of those numbers on our website under the contract detail page for this contract. Should the contract expire worthless, the premium would represent a 5.67% return on the cash commitment, or 48.10% annualized — at Stock Options Channel we call this the YieldBoost. Below is a chart showing the trailing twelve month trading history for DuPont, and highlighting in green where the $39.00 strike is located relative to that history: Turning to the calls side of the option chain, the call contract at the $42.00 strike price has a current bid of $2.24. If an investor was to purchase shares of DD stock at the current price level of $41.64/share, and then sell-to-open that call contract as a "covered call," they are committing to sell the stock at $42.00. Considering the call seller will also collect the premium, that would drive a total return (excluding dividends, if any) of 6.24% if the stock gets called away at the June 5th expiration (before broker commissions). Of course, a lot of upside could potentially be left on the table if DD shares really soar, which is why looking at the trailing twelve month trading history for DuPont, as well as studying the business fundamentals becomes important. Below is a chart showing DD's trailing twelve month trading history, with the $42.00 strike highlighted in red: Considering the fact that the $42.00 strike represents an approximate 1% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 49%. On our website under the contract detail page for this contract, Stock Options Channel will track those odds over time to see how they change and publish a chart of those numbers (the trading history of the option contract will also be charted). Should the covered call contract expire worthless, the premium would represent a 5.38% boost of extra return to the investor, or 45.66% annualized, which we refer to as the YieldBoost. The implied volatility in the put contract example is 76%, while the implied volatility in the call contract example is 60%. Meanwhile, we calculate the actual trailing twelve month volatility (considering the last 252 trading day closing values as well as today's price of $41.64) to be 52%. For more put and call options contract ideas worth looking at, visit StockOptionsChannel.com. Top YieldBoost Calls of the S&P 500 » The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	Of course, a lot of upside could potentially be left on the table if DD shares really soar, which is why looking at the trailing twelve month trading history for DuPont, as well as studying the business fundamentals becomes important. Below is a chart showing DD's trailing twelve month trading history, with the $42.00 strike highlighted in red: Considering the fact that the $42.00 strike represents an approximate 1% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected. Investors in DuPont (Symbol: DD) saw new options begin trading today, for the June 5th expiration.	The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 67%. Below is a chart showing DD's trailing twelve month trading history, with the $42.00 strike highlighted in red: Considering the fact that the $42.00 strike represents an approximate 1% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 49%.	Below is a chart showing DD's trailing twelve month trading history, with the $42.00 strike highlighted in red: Considering the fact that the $42.00 strike represents an approximate 1% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected. On our website under the contract detail page for this contract, Stock Options Channel will track those odds over time to see how they change and publish a chart of those numbers (the trading history of the option contract will also be charted). Investors in DuPont (Symbol: DD) saw new options begin trading today, for the June 5th expiration.	At Stock Options Channel, our YieldBoost formula has looked up and down the DD options chain for the new June 5th contracts and identified one put and one call contract of particular interest. Below is a chart showing DD's trailing twelve month trading history, with the $42.00 strike highlighted in red: Considering the fact that the $42.00 strike represents an approximate 1% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected. Investors in DuPont (Symbol: DD) saw new options begin trading today, for the June 5th expiration.	fc8a049f-cd93-4e64-8f67-4b385554a788
716289.0	2020-04-21 00:00:00 UTC	3M Stock Has Secure Dividends and Ample Cash Flow	DD	https://www.nasdaq.com/articles/3m-stock-has-secure-dividends-and-ample-cash-flow-2020-04-21	nan	nan	InvestorPlace - Stock Market News, Stock Advice & Trading Tips Despite what critics have said of late, 3M (NYSE:MMM) is actually a very solid and safe company for investors. MMM stock has at least 45% upside from current prices based on its dividend-paying track record and solid cash flow. Source: r.classen / Shutterstock.com The company has been in the news lately due to its production of masks and other products used to fight the novel coronavirus. The company faced criticism from the President and others for exporting some of its N95 respirator masks. It got to the point where the Wall Street Journal felt the need to step in, writing in an editorial that 3M aren’t villains here. MMM Stock Dividend Is Secure Value investors have learned to catch stock bargains when a company has trouble that is temporary in nature. MMM stock really seems to be in one of those temporary binds. For example, last year 3M generated $7.07 billion in cash flow from operations (CFFO). It spent just $1.7 billion in capex. So its free cash flow, available to be spent on dividends, was $5.37 billion. 7 Real Estate Stocks to Watch as the Long-Term Impact of the Virus Looms But here’s the thing. 3M’s dividend, currently at $5.88 per share (dividend yield is 4%), costs the company just $3.32 billion annually. So the company, based on last year’s cash flow, can absorb a big hit to earnings and still afford the dividend. In fact, CFFO would have to fall by as much as $2 billion, or 38% before the dividend literally could not be covered by existing FCF. Moreover, this assumes that 3M’s capex will stay at the same level. But the company has already indicated it will cut operating costs. In January the company said it was eliminating 1,500 jobs as part of an ongoing restructuring. This will save the company a further $120 million, according to the Wall Street Journal. So despite the likelihood that its revenue, earnings and cash flow will be lower this quarter, investors need not worry that the company won’t pay its regular quarterly dividend. MMM Stock Is Worth 45% More Based On Its Historical Dividend Yield On Feb. 4, 3M raised its annual dividend for the 62nd consecutive year. The quarterly dividend is now $1.47 per share or $5.88 on an annualized basis. At today’s price of $146.66 per share, that gives MMM stock a dividend yield of 4%. But, according to Seeking Alpha, the average dividend yield for the past four years for 3M has been 2.75%. One way to value MMM stock is to divide the regular dividend by its historical dividend yield. In this case, $5.88 in dividends per share divided by 2.75% equals $213.82 per share. That means that MMM stock is worth at least $67.16 more than today’s price, or 45.8%. Moreover, this assumes that the company will not only keep on paying the same dividend but that it will revert to its average historical yield. Remember that an average means the price will sometimes be higher than the target price, giving MMM stock an even lower yield at points. There is no guarantee that this will occur anytime soon. Certainly, it will probably take a while until the U.S. and global economy return to their normal growth trajectories. Nevertheless, looking at MMM stock from a value investing standpoint, despite the company being out of favor, 3M stock looks like a bargain. What To Do Next With MMM Stock Back in February, analyst Scott Davis of Melius Research upgraded MMM stock to the equivalent of a “Buy” recommendation. He set his price target at $205 per share, just a little below my $213 valuation. Other analysts weren’t as ebullient over MMM stock. Their main concern in the company’s potential liabilities regarding PFAS-related lawsuits. PFAS stands for “per- and poly-fluoroalkyl substances.” The Nov. 2019 movie “Dark Waters” recently chronicled a 15-year legal saga which ultimately led to a class-action lawsuit against DuPont (NYSE:DD) over PFAS. CNBC reported late last year that 3M could also face significant risks over PFAS. Barron’s says the PFAS issue has kept other analysts away from 3M stock. So a lone analyst is recommending a “Buy” for 3M when other sell-side analysts are saying “Hold.” I have a pretty strict rule. Do the opposite of what sell-side analysts recommend. So I like Mr. Davis’s call on MMM stock. 3M is scheduled to report earnings and its upcoming dividend at the end of this month. The stock is likely to take a hit after expected lower earnings come out. That might be a good time to take another look at the stock. As of this writing, Mark Hake, CFA does not hold a position in any of the aforementioned securities. Mark Hake runs the Total Yield Value Guide which you can review here. The post 3M Stock Has Secure Dividends and Ample Cash Flow appeared first on InvestorPlace. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	PFAS stands for “per- and poly-fluoroalkyl substances.” The Nov. 2019 movie “Dark Waters” recently chronicled a 15-year legal saga which ultimately led to a class-action lawsuit against DuPont (NYSE:DD) over PFAS. MMM stock has at least 45% upside from current prices based on its dividend-paying track record and solid cash flow. It got to the point where the Wall Street Journal felt the need to step in, writing in an editorial that 3M aren’t villains here.	PFAS stands for “per- and poly-fluoroalkyl substances.” The Nov. 2019 movie “Dark Waters” recently chronicled a 15-year legal saga which ultimately led to a class-action lawsuit against DuPont (NYSE:DD) over PFAS. 3M’s dividend, currently at $5.88 per share (dividend yield is 4%), costs the company just $3.32 billion annually. MMM Stock Is Worth 45% More Based On Its Historical Dividend Yield On Feb. 4, 3M raised its annual dividend for the 62nd consecutive year.	PFAS stands for “per- and poly-fluoroalkyl substances.” The Nov. 2019 movie “Dark Waters” recently chronicled a 15-year legal saga which ultimately led to a class-action lawsuit against DuPont (NYSE:DD) over PFAS. MMM Stock Dividend Is Secure Value investors have learned to catch stock bargains when a company has trouble that is temporary in nature. MMM Stock Is Worth 45% More Based On Its Historical Dividend Yield On Feb. 4, 3M raised its annual dividend for the 62nd consecutive year.	PFAS stands for “per- and poly-fluoroalkyl substances.” The Nov. 2019 movie “Dark Waters” recently chronicled a 15-year legal saga which ultimately led to a class-action lawsuit against DuPont (NYSE:DD) over PFAS. For example, last year 3M generated $7.07 billion in cash flow from operations (CFFO). 3M’s dividend, currently at $5.88 per share (dividend yield is 4%), costs the company just $3.32 billion annually.	9fcd8edb-a15d-48d8-9ee6-0619911c32ad
716290.0	2020-04-20 00:00:00 UTC	BUZZ-U.S. STOCKS ON THE MOVE-Co-Diagnostics, Xeris Pharma, Cyclacel Pharma	DD	https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-co-diagnostics-xeris-pharma-cyclacel-pharma-2020-04-20	nan	nan	Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: http://tmsnrt.rs/2ggOmBi The Morning News Call newsletter: http://tmsnrt.rs/2fwPLTh The S&P 500 and the Dow Jones headed lower on Monday following a strong two-week rally as oil prices crashed and investors grew cautious at the start of a week that is likely to bring more dismal quarterly earnings reports and economic data..N At 17:55 ET, the Dow Jones Industrial Average .DJI was down 0.92% at 24,020.4. The S&P 500 .SPX was down 0.33% at 2,865.2 and the Nasdaq Composite .IXIC was up 0.30% at 8,676.165. The top three S&P 500 .PG.INX percentage gainers: FLIR Systems Inc , up 14.7% Carrier Global Corp , up 6.6% Howmet Aerospace Inc , up 6.4% The top three S&P 500 .PL.INX percentage losers: L Brands Inc , down 7.5% Vornado Realty Trust , down 6.3% Occidental Petroleum Corp , down 6% The top three NYSE .PG.N percentage gainers: Regional Health Properties Inc , up 36.5% Pacer Developed Markets International Cash CWS , up 23.2% Montage Resources Corp , up 23% The top three NYSE .PL.N percentage losers: Invesco Mortgage Capital Inc , down 22.5% Direxion Daily S&P Biotech Bear 3X Shares , down 16.5% Independence Contract Drilling Inc , down 11.9% The top three Nasdaq .PG.O percentage gainers: Benitec Biopharma Limited , up 107.4% Cyclacel Pharmaceuticals Inc , up 103.8% Novavax Inc , up 32.9% The top three Nasdaq .PL.O percentage losers: Vericity Inc , down 19.5% Akazoo SA , down 19% Liberty TripAdvisor Holdings Inc , down 17.9% Aytu BioScience Inc AYTU.O: up 3.6% BUZZ-Aytu: Rises on gaining exclusive license to potential COVID-19 treatment Redhill Biopharma RDHL.O: up 12.5% BUZZ-Redhill Biopharma: Rises on agreement with NIAID to test cancer drug for COVID-19 Atossa Therapeutics Inc ATOS.O: up 5.6% BUZZ-Atossa Therapeutics up as co seeks FDA nod to begin COVID-19 study Gilead Sciences Inc GILD.O: down 1.3% BUZZ-Gilead: Brokerages downgrade on uncertainty over commercial value of COVID-19 drug Seattle Genetics Inc SGEN.O: up 5.1% BUZZ-Street View: Seattle Genetics' breast cancer therapy approval brings some cheer Campbell Soup Co CPB.N: up 3.4% BUZZ-Campbell Soup: Rises on strong retail demand Incyte Corp INCY.O: up 1.4% BUZZ-Incyte: Touches fresh 2-yr high after FDA approval of cancer therapy ViaSat Inc VSAT.O: up 2.5% BUZZ-ViaSat Inc: Rises as brokerage upgrades on higher residential internet demand 2U Inc TWOU.O: down 7.4% BUZZ-2U drops ahead of $300 mln convertible debt deal Masimo Corp MASI.O: down 0.4% BUZZ-Masimo Corp: Needham downgrades on likely slow 2H20 growth Avalon GloboCare Corp AVCO.O: up 7.9% BUZZ-Avalon GloboCare: Rises as therapy shows promise in combating cytokine storm - Reuters News Shake Shack Inc SHAK.N: up 5.9% BUZZ-Shake Shack beefs up capital, gives back government loan; shares dip Exelixis Inc EXEL.O: up 23.5% BUZZ-Exelixis jumps as cancer drug combo shows promise in study AGNC Investment Corp AGNC.O: down 0.5% Annaly Capital Management Inc NLY.N: down 1.8% Apollo CRE Finance ARI.N: down 4.9% Blackstone Mortgage Trust Inc BXMT.N: down 3.1% Ladder Capital Corp LADR.N: down 3.4% Starwood Property Trust Inc STWD.N: down 3.9% TPG RE Finance Trust Inc TRTX.N: down 3.8% BUZZ-U.S. mortgage REITs: DB cuts PT citing "stressed scenarios" INmune Bio Inc INMB.O: up 9.3% BUZZ-INmune Bio Inc: Rises on plans to begin COVID-19 trial Mustang Bio Inc MBIO.O: up 1.4% BUZZ-Mustang Bio: Rises after EMA's favorable classification of "bubble boy" therapy Meredith Corp MDP.N: down 6.5% BUZZ-Meredith Corp: Falls on withdrawing 2020 outlook as ad sales get hit Lennox International LII.N: up 2.0% BUZZ-Lennox International: Falls on weak Q1, warns of 20% hit from coronavirus Ducommun Inc DCO.N: up 3.6% BUZZ-Ducommun: Jumps as Q1 revenue forecast higher than Wall Street estimates Alexion Pharmaceuticals Inc ALXN.O: up 4.9% BUZZ-Alexion rises on study to test blood disorder drug for COVID-19 Clorox Co CLX.N: up 1.8% BUZZ-Clorox: Up as Deutsche Bank expects strong Q3 helped by coronavirus Peloton Interative Inc PTON.O: down 3.2% BUZZ-Peloton skids as BMO slaps with first "sell" rating since IPO Terex Corp TEX.N: down 4.2% Manitowoc Company Inc MTW.N: down 3.4% BUZZ-GS removes Terex and Manitowoc from "buy list", downgrades to "neutral" Anixa Biosciences Inc ANIX.O: up 10.6% BUZZ-Anixa Biosciences: Rises on partnership for potential treatment of COVID-19 Cyclacel Pharmaceutical Inc CYCC.O: up 103.8% BUZZ-Cyclacel: Jumps on deal to study drugs to treat COVID-19 patients Boeing Co BA.N: down 4.9% BUZZ-Benchmark sees Boeing cut 787 production by 30%; lowers PT Eros International EROS.N: down 0.2% BUZZ-Eros International: Soars after deal to merge with STX Entertainment Medpace Holdings Inc MEDP.O: down 0.8% ICON Plc ICLR.O: down 0.4% BUZZ-Baird downgrades two contract research organizations on COVID-19 impact Xeris Pharmaceutical Inc XERS.O: up 15.1% BUZZ-Xeris Pharma: Rises on positive results from seizure medication study United Airlines Holdings Inc UAL.O: down 3.4% BUZZ-United Airlines drops on estimated quarterly loss, dour outlook Walt Disney Co DIS.N: down 2.3% BUZZ-Disney: Falls as brokerages move to sidelines citing hit to theme parks Cheesecake Factory Inc CAKE.O: up 5.9% BUZZ-Cheesecake Factory: Rises on $200 mln investment from Roark Capital Exxon Mobil Corp XOM.N: down 3.0% Chevron Corp CVX.N: down 1.8% Devon Energy Corp DVN.N: down 0.4% Callon Petroleum Co CPE.N: down 3.4% Chesapeake Energy Corp CHK.N: down 1.5% Occidental Petroleum Corp OXY.N: down 6.1% Schlumberger NV SLB.N: flat Halliburton Co HAL.N: up 0.1% TechnipFMC Plc FTI.N: down 1.4% BUZZ-Oil stocks drop as concerns over rising crude storage weigh on prices BUZZ-Street View: Schlumberger's dividend cut the first step on road to recovery BUZZ-Halliburton: Falls on $1.1 bln impairment charges Safe-T Group SFET.O: up 18.2% BUZZ-Safe-T Group: Jumps on upbeat Q1 revenue forecast AbbVie Inc ABBV.N: up 1.8% BUZZ-AbbVie Inc: RBC expects rebound in 2021, upgrades to "outperform" Facebook Inc FB.O: flat BUZZ-Facebook: Credit Suisse cuts PT as coronavirus impacts ad revenue Biogen Inc BIIB.O: up 1.3% BUZZ-Biogen Inc: Alzheimer's drug in focus ahead of Q1, not earnings Abbott Laboratories ABT.N: up 3.9% BUZZ-Abbott, Roche to benefit from surging demand for COVID-19 antibody tests - analyst DuPont de Nemours Inc DD.N: up 5.5% BUZZ-DuPont: Rises on expectations of stronger Q1 from coronavirus-driven demand Co-Diagnostics Inc CODX.O: up 17.4% BUZZ-Co-Diagnostics: Rises on increased U.S. sales of COVID-19 testing kits Acadia Healthcare Co Inc ACHC.O: down 0.1% Brookdale Senior Living Inc BKD.N: down 3.2% Ensign Group Inc ENSG.O: down 0.4% Select Medical Holdings Corp SEM.N: down 4.1% BUZZ-Strong headwinds imminent for facility-based health care providers - Analyst General Motors Co GM.N: flat Ford Motor Co F.N: down 1.7% BUZZ-CS cuts PT on Ford, GM on heavy cash burn in H1 2020 Royal Caribbean Cruises Ltd RCL.N: down 3.4% Norwegian Cruise Line Holdings Ltd NCLH.N: down 4.9% ** Carnival Corp CCL.N: down 1.4% BUZZ-J.P. Morgan slashes cruise operators' PT on virus impact The 11 major S&P 500 sectors: Communication Services .SPLRCL flat Consumer Discretionary .SPLRCD up 0.09% Consumer Staples .SPLRCS down 0.41% Energy .SPNY down 1.63% Financial .SPSY down 0.99% Health .SPXHC up 0.49% Industrial .SPLRCI down 1.01% Information Technology .SPLRCT down 0.40% Materials .SPLRCM down 0.52% Real Estate .SPLRCR down 1.92% Utilities .SPLRCU down 1.79% (Compiled by Amal S in Bengaluru) ((Amal.S@thomsonreuters.com; within U.S.+1 646 223 8780; outside U.S. +91 80 6749 3677;)) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	The top three S&P 500 .PG.INX percentage gainers: FLIR Systems Inc , up 14.7% Carrier Global Corp , up 6.6% Howmet Aerospace Inc , up 6.4% The top three S&P 500 .PL.INX percentage losers: L Brands Inc , down 7.5% Vornado Realty Trust , down 6.3% Occidental Petroleum Corp , down 6% The top three NYSE .PG.N percentage gainers: Regional Health Properties Inc , up 36.5% Pacer Developed Markets International Cash CWS , up 23.2% Montage Resources Corp , up 23% The top three NYSE .PL.N percentage losers: Invesco Mortgage Capital Inc , down 22.5% Direxion Daily S&P Biotech Bear 3X Shares , down 16.5% Independence Contract Drilling Inc , down 11.9% The top three Nasdaq .PG.O percentage gainers: Benitec Biopharma Limited , up 107.4% Cyclacel Pharmaceuticals Inc , up 103.8% Novavax Inc , up 32.9% The top three Nasdaq .PL.O percentage losers: Vericity Inc , down 19.5% Akazoo SA , down 19% Liberty TripAdvisor Holdings Inc , down 17.9% Aytu BioScience Inc AYTU.O: up 3.6% BUZZ-Aytu: Rises on gaining exclusive license to potential COVID-19 treatment Redhill Biopharma RDHL.O: up 12.5% BUZZ-Redhill Biopharma: Rises on agreement with NIAID to test cancer drug for COVID-19 Atossa Therapeutics Inc ATOS.O: up 5.6% BUZZ-Atossa Therapeutics up as co seeks FDA nod to begin COVID-19 study Gilead Sciences Inc GILD.O: down 1.3% BUZZ-Gilead: Brokerages downgrade on uncertainty over commercial value of COVID-19 drug Seattle Genetics Inc SGEN.O: up 5.1% BUZZ-Street View: Seattle Genetics' breast cancer therapy approval brings some cheer Campbell Soup Co CPB.N: up 3.4% BUZZ-Campbell Soup: Rises on strong retail demand Incyte Corp INCY.O: up 1.4% BUZZ-Incyte: Touches fresh 2-yr high after FDA approval of cancer therapy ViaSat Inc VSAT.O: up 2.5% BUZZ-ViaSat Inc: Rises as brokerage upgrades on higher residential internet demand 2U Inc TWOU.O: down 7.4% BUZZ-2U drops ahead of $300 mln convertible debt deal Masimo Corp MASI.O: down 0.4% BUZZ-Masimo Corp: Needham downgrades on likely slow 2H20 growth Avalon GloboCare Corp AVCO.O: up 7.9% BUZZ-Avalon GloboCare: Rises as therapy shows promise in combating cytokine storm - Reuters News Shake Shack Inc SHAK.N: up 5.9% BUZZ-Shake Shack beefs up capital, gives back government loan; shares dip Exelixis Inc EXEL.O: up 23.5% BUZZ-Exelixis jumps as cancer drug combo shows promise in study AGNC Investment Corp AGNC.O: down 0.5% Annaly Capital Management Inc NLY.N: down 1.8% Apollo CRE Finance ARI.N: down 4.9% Blackstone Mortgage Trust Inc BXMT.N: down 3.1% Ladder Capital Corp LADR.N: down 3.4% Starwood Property Trust Inc STWD.N: down 3.9% TPG RE Finance Trust Inc TRTX.N: down 3.8% BUZZ-U.S. mortgage REITs: DB cuts PT citing "stressed scenarios" INmune Bio Inc INMB.O: up 9.3% BUZZ-INmune Bio Inc: Rises on plans to begin COVID-19 trial Mustang Bio Inc MBIO.O: up 1.4% BUZZ-Mustang Bio: Rises after EMA's favorable classification of "bubble boy" therapy Meredith Corp MDP.N: down 6.5% BUZZ-Meredith Corp: Falls on withdrawing 2020 outlook as ad sales get hit Lennox International LII.N: up 2.0% BUZZ-Lennox International: Falls on weak Q1, warns of 20% hit from coronavirus Ducommun Inc DCO.N: up 3.6% BUZZ-Ducommun: Jumps as Q1 revenue forecast higher than Wall Street estimates Alexion Pharmaceuticals Inc ALXN.O: up 4.9% BUZZ-Alexion rises on study to test blood disorder drug for COVID-19 Clorox Co CLX.N: up 1.8% BUZZ-Clorox: Up as Deutsche Bank expects strong Q3 helped by coronavirus Peloton Interative Inc PTON.O: down 3.2% BUZZ-Peloton skids as BMO slaps with first "sell" rating since IPO Terex Corp TEX.N: down 4.2% Manitowoc Company Inc MTW.N: down 3.4% BUZZ-GS removes Terex and Manitowoc from "buy list", downgrades to "neutral" Anixa Biosciences Inc ANIX.O: up 10.6% BUZZ-Anixa Biosciences: Rises on partnership for potential treatment of COVID-19 Cyclacel Pharmaceutical Inc CYCC.O: up 103.8% BUZZ-Cyclacel: Jumps on deal to study drugs to treat COVID-19 patients Boeing Co BA.N: down 4.9% BUZZ-Benchmark sees Boeing cut 787 production by 30%; lowers PT Eros International EROS.N: down 0.2% BUZZ-Eros International: Soars after deal to merge with STX Entertainment Medpace Holdings Inc MEDP.O: down 0.8% ICON Plc ICLR.O: down 0.4% BUZZ-Baird downgrades two contract research organizations on COVID-19 impact Xeris Pharmaceutical Inc XERS.O: up 15.1% BUZZ-Xeris Pharma: Rises on positive results from seizure medication study United Airlines Holdings Inc UAL.O: down 3.4% BUZZ-United Airlines drops on estimated quarterly loss, dour outlook Walt Disney Co DIS.N: down 2.3% BUZZ-Disney: Falls as brokerages move to sidelines citing hit to theme parks Cheesecake Factory Inc CAKE.O: up 5.9% BUZZ-Cheesecake Factory: Rises on $200 mln investment from Roark Capital Exxon Mobil Corp XOM.N: down 3.0% Chevron Corp CVX.N: down 1.8% Devon Energy Corp DVN.N: down 0.4% Callon Petroleum Co CPE.N: down 3.4% Chesapeake Energy Corp CHK.N: down 1.5% Occidental Petroleum Corp OXY.N: down 6.1% Schlumberger NV SLB.N: flat Halliburton Co HAL.N: up 0.1% TechnipFMC Plc FTI.N: down 1.4% BUZZ-Oil stocks drop as concerns over rising crude storage weigh on prices BUZZ-Street View: Schlumberger's dividend cut the first step on road to recovery BUZZ-Halliburton: Falls on $1.1 bln impairment charges Safe-T Group SFET.O: up 18.2% BUZZ-Safe-T Group: Jumps on upbeat Q1 revenue forecast AbbVie Inc ABBV.N: up 1.8% BUZZ-AbbVie Inc: RBC expects rebound in 2021, upgrades to "outperform" Facebook Inc FB.O: flat BUZZ-Facebook: Credit Suisse cuts PT as coronavirus impacts ad revenue Biogen Inc BIIB.O: up 1.3% BUZZ-Biogen Inc: Alzheimer's drug in focus ahead of Q1, not earnings Abbott Laboratories ABT.N: up 3.9% BUZZ-Abbott, Roche to benefit from surging demand for COVID-19 antibody tests - analyst DuPont de Nemours Inc DD.N: up 5.5% BUZZ-DuPont: Rises on expectations of stronger Q1 from coronavirus-driven demand Co-Diagnostics Inc CODX.O: up 17.4% BUZZ-Co-Diagnostics: Rises on increased U.S. sales of COVID-19 testing kits Acadia Healthcare Co Inc ACHC.O: down 0.1% Brookdale Senior Living Inc BKD.N: down 3.2% Ensign Group Inc ENSG.O: down 0.4% Select Medical Holdings Corp SEM.N: down 4.1% BUZZ-Strong headwinds imminent for facility-based health care providers - Analyst General Motors Co GM.N: flat Ford Motor Co F.N: down 1.7% BUZZ-CS cuts PT on Ford, GM on heavy cash burn in H1 2020 Royal Caribbean Cruises Ltd RCL.N: down 3.4% Norwegian Cruise Line Holdings Ltd NCLH.N: down 4.9% ** Carnival Corp CCL.N: down 1.4% BUZZ-J.P. Morgan slashes cruise operators' PT on virus impact The 11 major S&P 500 sectors: Communication Services Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: http://tmsnrt.rs/2ggOmBi The Morning News Call newsletter: http://tmsnrt.rs/2fwPLTh The S&P 500 and the Dow Jones headed lower on Monday following a strong two-week rally as oil prices crashed and investors grew cautious at the start of a week that is likely to bring more dismal quarterly earnings reports and economic data..N At 17:55 ET, the Dow Jones Industrial Average .DJI was down 0.92% at 24,020.4. down 1.79% (Compiled by Amal S in Bengaluru) ((Amal.S@thomsonreuters.com; within U.S.+1 646 223 8780; outside U.S. +91 80 6749 3677;)) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	The top three S&P 500 .PG.INX percentage gainers: FLIR Systems Inc , up 14.7% Carrier Global Corp , up 6.6% Howmet Aerospace Inc , up 6.4% The top three S&P 500 .PL.INX percentage losers: L Brands Inc , down 7.5% Vornado Realty Trust , down 6.3% Occidental Petroleum Corp , down 6% The top three NYSE .PG.N percentage gainers: Regional Health Properties Inc , up 36.5% Pacer Developed Markets International Cash CWS , up 23.2% Montage Resources Corp , up 23% The top three NYSE .PL.N percentage losers: Invesco Mortgage Capital Inc , down 22.5% Direxion Daily S&P Biotech Bear 3X Shares , down 16.5% Independence Contract Drilling Inc , down 11.9% The top three Nasdaq .PG.O percentage gainers: Benitec Biopharma Limited , up 107.4% Cyclacel Pharmaceuticals Inc , up 103.8% Novavax Inc , up 32.9% The top three Nasdaq .PL.O percentage losers: Vericity Inc , down 19.5% Akazoo SA , down 19% Liberty TripAdvisor Holdings Inc , down 17.9% Aytu BioScience Inc AYTU.O: up 3.6% BUZZ-Aytu: Rises on gaining exclusive license to potential COVID-19 treatment Redhill Biopharma RDHL.O: up 12.5% BUZZ-Redhill Biopharma: Rises on agreement with NIAID to test cancer drug for COVID-19 Atossa Therapeutics Inc ATOS.O: up 5.6% BUZZ-Atossa Therapeutics up as co seeks FDA nod to begin COVID-19 study Gilead Sciences Inc GILD.O: down 1.3% BUZZ-Gilead: Brokerages downgrade on uncertainty over commercial value of COVID-19 drug Seattle Genetics Inc SGEN.O: up 5.1% BUZZ-Street View: Seattle Genetics' breast cancer therapy approval brings some cheer Campbell Soup Co CPB.N: up 3.4% BUZZ-Campbell Soup: Rises on strong retail demand Incyte Corp INCY.O: up 1.4% BUZZ-Incyte: Touches fresh 2-yr high after FDA approval of cancer therapy ViaSat Inc VSAT.O: up 2.5% BUZZ-ViaSat Inc: Rises as brokerage upgrades on higher residential internet demand 2U Inc TWOU.O: down 7.4% BUZZ-2U drops ahead of $300 mln convertible debt deal Masimo Corp MASI.O: down 0.4% BUZZ-Masimo Corp: Needham downgrades on likely slow 2H20 growth Avalon GloboCare Corp AVCO.O: up 7.9% BUZZ-Avalon GloboCare: Rises as therapy shows promise in combating cytokine storm - Reuters News Shake Shack Inc SHAK.N: up 5.9% BUZZ-Shake Shack beefs up capital, gives back government loan; shares dip Exelixis Inc EXEL.O: up 23.5% BUZZ-Exelixis jumps as cancer drug combo shows promise in study AGNC Investment Corp AGNC.O: down 0.5% Annaly Capital Management Inc NLY.N: down 1.8% Apollo CRE Finance ARI.N: down 4.9% Blackstone Mortgage Trust Inc BXMT.N: down 3.1% Ladder Capital Corp LADR.N: down 3.4% Starwood Property Trust Inc STWD.N: down 3.9% TPG RE Finance Trust Inc TRTX.N: down 3.8% BUZZ-U.S. mortgage REITs: DB cuts PT citing "stressed scenarios" INmune Bio Inc INMB.O: up 9.3% BUZZ-INmune Bio Inc: Rises on plans to begin COVID-19 trial Mustang Bio Inc MBIO.O: up 1.4% BUZZ-Mustang Bio: Rises after EMA's favorable classification of "bubble boy" therapy Meredith Corp MDP.N: down 6.5% BUZZ-Meredith Corp: Falls on withdrawing 2020 outlook as ad sales get hit Lennox International LII.N: up 2.0% BUZZ-Lennox International: Falls on weak Q1, warns of 20% hit from coronavirus Ducommun Inc DCO.N: up 3.6% BUZZ-Ducommun: Jumps as Q1 revenue forecast higher than Wall Street estimates Alexion Pharmaceuticals Inc ALXN.O: up 4.9% BUZZ-Alexion rises on study to test blood disorder drug for COVID-19 Clorox Co CLX.N: up 1.8% BUZZ-Clorox: Up as Deutsche Bank expects strong Q3 helped by coronavirus Peloton Interative Inc PTON.O: down 3.2% BUZZ-Peloton skids as BMO slaps with first "sell" rating since IPO Terex Corp TEX.N: down 4.2% Manitowoc Company Inc MTW.N: down 3.4% BUZZ-GS removes Terex and Manitowoc from "buy list", downgrades to "neutral" Anixa Biosciences Inc ANIX.O: up 10.6% BUZZ-Anixa Biosciences: Rises on partnership for potential treatment of COVID-19 Cyclacel Pharmaceutical Inc CYCC.O: up 103.8% BUZZ-Cyclacel: Jumps on deal to study drugs to treat COVID-19 patients Boeing Co BA.N: down 4.9% BUZZ-Benchmark sees Boeing cut 787 production by 30%; lowers PT Eros International EROS.N: down 0.2% BUZZ-Eros International: Soars after deal to merge with STX Entertainment Medpace Holdings Inc MEDP.O: down 0.8% ICON Plc ICLR.O: down 0.4% BUZZ-Baird downgrades two contract research organizations on COVID-19 impact Xeris Pharmaceutical Inc XERS.O: up 15.1% BUZZ-Xeris Pharma: Rises on positive results from seizure medication study United Airlines Holdings Inc UAL.O: down 3.4% BUZZ-United Airlines drops on estimated quarterly loss, dour outlook Walt Disney Co DIS.N: down 2.3% BUZZ-Disney: Falls as brokerages move to sidelines citing hit to theme parks Cheesecake Factory Inc CAKE.O: up 5.9% BUZZ-Cheesecake Factory: Rises on $200 mln investment from Roark Capital Exxon Mobil Corp XOM.N: down 3.0% Chevron Corp CVX.N: down 1.8% Devon Energy Corp DVN.N: down 0.4% Callon Petroleum Co CPE.N: down 3.4% Chesapeake Energy Corp CHK.N: down 1.5% Occidental Petroleum Corp OXY.N: down 6.1% Schlumberger NV SLB.N: flat Halliburton Co HAL.N: up 0.1% TechnipFMC Plc FTI.N: down 1.4% BUZZ-Oil stocks drop as concerns over rising crude storage weigh on prices BUZZ-Street View: Schlumberger's dividend cut the first step on road to recovery BUZZ-Halliburton: Falls on $1.1 bln impairment charges Safe-T Group SFET.O: up 18.2% BUZZ-Safe-T Group: Jumps on upbeat Q1 revenue forecast AbbVie Inc ABBV.N: up 1.8% BUZZ-AbbVie Inc: RBC expects rebound in 2021, upgrades to "outperform" Facebook Inc FB.O: flat BUZZ-Facebook: Credit Suisse cuts PT as coronavirus impacts ad revenue Biogen Inc BIIB.O: up 1.3% BUZZ-Biogen Inc: Alzheimer's drug in focus ahead of Q1, not earnings Abbott Laboratories ABT.N: up 3.9% BUZZ-Abbott, Roche to benefit from surging demand for COVID-19 antibody tests - analyst DuPont de Nemours Inc DD.N: up 5.5% BUZZ-DuPont: Rises on expectations of stronger Q1 from coronavirus-driven demand Co-Diagnostics Inc CODX.O: up 17.4% BUZZ-Co-Diagnostics: Rises on increased U.S. sales of COVID-19 testing kits Acadia Healthcare Co Inc ACHC.O: down 0.1% Brookdale Senior Living Inc BKD.N: down 3.2% Ensign Group Inc ENSG.O: down 0.4% Select Medical Holdings Corp SEM.N: down 4.1% BUZZ-Strong headwinds imminent for facility-based health care providers - Analyst General Motors Co GM.N: flat Ford Motor Co F.N: down 1.7% BUZZ-CS cuts PT on Ford, GM on heavy cash burn in H1 2020 Royal Caribbean Cruises Ltd RCL.N: down 3.4% Norwegian Cruise Line Holdings Ltd NCLH.N: down 4.9% ** Carnival Corp CCL.N: down 1.4% BUZZ-J.P. Morgan slashes cruise operators' PT on virus impact The 11 major S&P 500 sectors: Communication Services Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: http://tmsnrt.rs/2ggOmBi The Morning News Call newsletter: http://tmsnrt.rs/2fwPLTh The S&P 500 and the Dow Jones headed lower on Monday following a strong two-week rally as oil prices crashed and investors grew cautious at the start of a week that is likely to bring more dismal quarterly earnings reports and economic data..N At 17:55 ET, the Dow Jones Industrial Average .DJI was down 0.92% at 24,020.4. flat Consumer Discretionary	The top three S&P 500 .PG.INX percentage gainers: FLIR Systems Inc , up 14.7% Carrier Global Corp , up 6.6% Howmet Aerospace Inc , up 6.4% The top three S&P 500 .PL.INX percentage losers: L Brands Inc , down 7.5% Vornado Realty Trust , down 6.3% Occidental Petroleum Corp , down 6% The top three NYSE .PG.N percentage gainers: Regional Health Properties Inc , up 36.5% Pacer Developed Markets International Cash CWS , up 23.2% Montage Resources Corp , up 23% The top three NYSE .PL.N percentage losers: Invesco Mortgage Capital Inc , down 22.5% Direxion Daily S&P Biotech Bear 3X Shares , down 16.5% Independence Contract Drilling Inc , down 11.9% The top three Nasdaq .PG.O percentage gainers: Benitec Biopharma Limited , up 107.4% Cyclacel Pharmaceuticals Inc , up 103.8% Novavax Inc , up 32.9% The top three Nasdaq .PL.O percentage losers: Vericity Inc , down 19.5% Akazoo SA , down 19% Liberty TripAdvisor Holdings Inc , down 17.9% Aytu BioScience Inc AYTU.O: up 3.6% BUZZ-Aytu: Rises on gaining exclusive license to potential COVID-19 treatment Redhill Biopharma RDHL.O: up 12.5% BUZZ-Redhill Biopharma: Rises on agreement with NIAID to test cancer drug for COVID-19 Atossa Therapeutics Inc ATOS.O: up 5.6% BUZZ-Atossa Therapeutics up as co seeks FDA nod to begin COVID-19 study Gilead Sciences Inc GILD.O: down 1.3% BUZZ-Gilead: Brokerages downgrade on uncertainty over commercial value of COVID-19 drug Seattle Genetics Inc SGEN.O: up 5.1% BUZZ-Street View: Seattle Genetics' breast cancer therapy approval brings some cheer Campbell Soup Co CPB.N: up 3.4% BUZZ-Campbell Soup: Rises on strong retail demand Incyte Corp INCY.O: up 1.4% BUZZ-Incyte: Touches fresh 2-yr high after FDA approval of cancer therapy ViaSat Inc VSAT.O: up 2.5% BUZZ-ViaSat Inc: Rises as brokerage upgrades on higher residential internet demand 2U Inc TWOU.O: down 7.4% BUZZ-2U drops ahead of $300 mln convertible debt deal Masimo Corp MASI.O: down 0.4% BUZZ-Masimo Corp: Needham downgrades on likely slow 2H20 growth Avalon GloboCare Corp AVCO.O: up 7.9% BUZZ-Avalon GloboCare: Rises as therapy shows promise in combating cytokine storm - Reuters News Shake Shack Inc SHAK.N: up 5.9% BUZZ-Shake Shack beefs up capital, gives back government loan; shares dip Exelixis Inc EXEL.O: up 23.5% BUZZ-Exelixis jumps as cancer drug combo shows promise in study AGNC Investment Corp AGNC.O: down 0.5% Annaly Capital Management Inc NLY.N: down 1.8% Apollo CRE Finance ARI.N: down 4.9% Blackstone Mortgage Trust Inc BXMT.N: down 3.1% Ladder Capital Corp LADR.N: down 3.4% Starwood Property Trust Inc STWD.N: down 3.9% TPG RE Finance Trust Inc TRTX.N: down 3.8% BUZZ-U.S. mortgage REITs: DB cuts PT citing "stressed scenarios" INmune Bio Inc INMB.O: up 9.3% BUZZ-INmune Bio Inc: Rises on plans to begin COVID-19 trial Mustang Bio Inc MBIO.O: up 1.4% BUZZ-Mustang Bio: Rises after EMA's favorable classification of "bubble boy" therapy Meredith Corp MDP.N: down 6.5% BUZZ-Meredith Corp: Falls on withdrawing 2020 outlook as ad sales get hit Lennox International LII.N: up 2.0% BUZZ-Lennox International: Falls on weak Q1, warns of 20% hit from coronavirus Ducommun Inc DCO.N: up 3.6% BUZZ-Ducommun: Jumps as Q1 revenue forecast higher than Wall Street estimates Alexion Pharmaceuticals Inc ALXN.O: up 4.9% BUZZ-Alexion rises on study to test blood disorder drug for COVID-19 Clorox Co CLX.N: up 1.8% BUZZ-Clorox: Up as Deutsche Bank expects strong Q3 helped by coronavirus Peloton Interative Inc PTON.O: down 3.2% BUZZ-Peloton skids as BMO slaps with first "sell" rating since IPO Terex Corp TEX.N: down 4.2% Manitowoc Company Inc MTW.N: down 3.4% BUZZ-GS removes Terex and Manitowoc from "buy list", downgrades to "neutral" Anixa Biosciences Inc ANIX.O: up 10.6% BUZZ-Anixa Biosciences: Rises on partnership for potential treatment of COVID-19 Cyclacel Pharmaceutical Inc CYCC.O: up 103.8% BUZZ-Cyclacel: Jumps on deal to study drugs to treat COVID-19 patients Boeing Co BA.N: down 4.9% BUZZ-Benchmark sees Boeing cut 787 production by 30%; lowers PT Eros International EROS.N: down 0.2% BUZZ-Eros International: Soars after deal to merge with STX Entertainment Medpace Holdings Inc MEDP.O: down 0.8% ICON Plc ICLR.O: down 0.4% BUZZ-Baird downgrades two contract research organizations on COVID-19 impact Xeris Pharmaceutical Inc XERS.O: up 15.1% BUZZ-Xeris Pharma: Rises on positive results from seizure medication study United Airlines Holdings Inc UAL.O: down 3.4% BUZZ-United Airlines drops on estimated quarterly loss, dour outlook Walt Disney Co DIS.N: down 2.3% BUZZ-Disney: Falls as brokerages move to sidelines citing hit to theme parks Cheesecake Factory Inc CAKE.O: up 5.9% BUZZ-Cheesecake Factory: Rises on $200 mln investment from Roark Capital Exxon Mobil Corp XOM.N: down 3.0% Chevron Corp CVX.N: down 1.8% Devon Energy Corp DVN.N: down 0.4% Callon Petroleum Co CPE.N: down 3.4% Chesapeake Energy Corp CHK.N: down 1.5% Occidental Petroleum Corp OXY.N: down 6.1% Schlumberger NV SLB.N: flat Halliburton Co HAL.N: up 0.1% TechnipFMC Plc FTI.N: down 1.4% BUZZ-Oil stocks drop as concerns over rising crude storage weigh on prices BUZZ-Street View: Schlumberger's dividend cut the first step on road to recovery BUZZ-Halliburton: Falls on $1.1 bln impairment charges Safe-T Group SFET.O: up 18.2% BUZZ-Safe-T Group: Jumps on upbeat Q1 revenue forecast AbbVie Inc ABBV.N: up 1.8% BUZZ-AbbVie Inc: RBC expects rebound in 2021, upgrades to "outperform" Facebook Inc FB.O: flat BUZZ-Facebook: Credit Suisse cuts PT as coronavirus impacts ad revenue Biogen Inc BIIB.O: up 1.3% BUZZ-Biogen Inc: Alzheimer's drug in focus ahead of Q1, not earnings Abbott Laboratories ABT.N: up 3.9% BUZZ-Abbott, Roche to benefit from surging demand for COVID-19 antibody tests - analyst DuPont de Nemours Inc DD.N: up 5.5% BUZZ-DuPont: Rises on expectations of stronger Q1 from coronavirus-driven demand Co-Diagnostics Inc CODX.O: up 17.4% BUZZ-Co-Diagnostics: Rises on increased U.S. sales of COVID-19 testing kits Acadia Healthcare Co Inc ACHC.O: down 0.1% Brookdale Senior Living Inc BKD.N: down 3.2% Ensign Group Inc ENSG.O: down 0.4% Select Medical Holdings Corp SEM.N: down 4.1% BUZZ-Strong headwinds imminent for facility-based health care providers - Analyst General Motors Co GM.N: flat Ford Motor Co F.N: down 1.7% BUZZ-CS cuts PT on Ford, GM on heavy cash burn in H1 2020 Royal Caribbean Cruises Ltd RCL.N: down 3.4% Norwegian Cruise Line Holdings Ltd NCLH.N: down 4.9% ** Carnival Corp CCL.N: down 1.4% BUZZ-J.P. Morgan slashes cruise operators' PT on virus impact The 11 major S&P 500 sectors: Communication Services down 1.01% Information Technology down 0.52% Real Estate	The top three S&P 500 .PG.INX percentage gainers: FLIR Systems Inc , up 14.7% Carrier Global Corp , up 6.6% Howmet Aerospace Inc , up 6.4% The top three S&P 500 .PL.INX percentage losers: L Brands Inc , down 7.5% Vornado Realty Trust , down 6.3% Occidental Petroleum Corp , down 6% The top three NYSE .PG.N percentage gainers: Regional Health Properties Inc , up 36.5% Pacer Developed Markets International Cash CWS , up 23.2% Montage Resources Corp , up 23% The top three NYSE .PL.N percentage losers: Invesco Mortgage Capital Inc , down 22.5% Direxion Daily S&P Biotech Bear 3X Shares , down 16.5% Independence Contract Drilling Inc , down 11.9% The top three Nasdaq .PG.O percentage gainers: Benitec Biopharma Limited , up 107.4% Cyclacel Pharmaceuticals Inc , up 103.8% Novavax Inc , up 32.9% The top three Nasdaq .PL.O percentage losers: Vericity Inc , down 19.5% Akazoo SA , down 19% Liberty TripAdvisor Holdings Inc , down 17.9% Aytu BioScience Inc AYTU.O: up 3.6% BUZZ-Aytu: Rises on gaining exclusive license to potential COVID-19 treatment Redhill Biopharma RDHL.O: up 12.5% BUZZ-Redhill Biopharma: Rises on agreement with NIAID to test cancer drug for COVID-19 Atossa Therapeutics Inc ATOS.O: up 5.6% BUZZ-Atossa Therapeutics up as co seeks FDA nod to begin COVID-19 study Gilead Sciences Inc GILD.O: down 1.3% BUZZ-Gilead: Brokerages downgrade on uncertainty over commercial value of COVID-19 drug Seattle Genetics Inc SGEN.O: up 5.1% BUZZ-Street View: Seattle Genetics' breast cancer therapy approval brings some cheer Campbell Soup Co CPB.N: up 3.4% BUZZ-Campbell Soup: Rises on strong retail demand Incyte Corp INCY.O: up 1.4% BUZZ-Incyte: Touches fresh 2-yr high after FDA approval of cancer therapy ViaSat Inc VSAT.O: up 2.5% BUZZ-ViaSat Inc: Rises as brokerage upgrades on higher residential internet demand 2U Inc TWOU.O: down 7.4% BUZZ-2U drops ahead of $300 mln convertible debt deal Masimo Corp MASI.O: down 0.4% BUZZ-Masimo Corp: Needham downgrades on likely slow 2H20 growth Avalon GloboCare Corp AVCO.O: up 7.9% BUZZ-Avalon GloboCare: Rises as therapy shows promise in combating cytokine storm - Reuters News Shake Shack Inc SHAK.N: up 5.9% BUZZ-Shake Shack beefs up capital, gives back government loan; shares dip Exelixis Inc EXEL.O: up 23.5% BUZZ-Exelixis jumps as cancer drug combo shows promise in study AGNC Investment Corp AGNC.O: down 0.5% Annaly Capital Management Inc NLY.N: down 1.8% Apollo CRE Finance ARI.N: down 4.9% Blackstone Mortgage Trust Inc BXMT.N: down 3.1% Ladder Capital Corp LADR.N: down 3.4% Starwood Property Trust Inc STWD.N: down 3.9% TPG RE Finance Trust Inc TRTX.N: down 3.8% BUZZ-U.S. mortgage REITs: DB cuts PT citing "stressed scenarios" INmune Bio Inc INMB.O: up 9.3% BUZZ-INmune Bio Inc: Rises on plans to begin COVID-19 trial Mustang Bio Inc MBIO.O: up 1.4% BUZZ-Mustang Bio: Rises after EMA's favorable classification of "bubble boy" therapy Meredith Corp MDP.N: down 6.5% BUZZ-Meredith Corp: Falls on withdrawing 2020 outlook as ad sales get hit Lennox International LII.N: up 2.0% BUZZ-Lennox International: Falls on weak Q1, warns of 20% hit from coronavirus Ducommun Inc DCO.N: up 3.6% BUZZ-Ducommun: Jumps as Q1 revenue forecast higher than Wall Street estimates Alexion Pharmaceuticals Inc ALXN.O: up 4.9% BUZZ-Alexion rises on study to test blood disorder drug for COVID-19 Clorox Co CLX.N: up 1.8% BUZZ-Clorox: Up as Deutsche Bank expects strong Q3 helped by coronavirus Peloton Interative Inc PTON.O: down 3.2% BUZZ-Peloton skids as BMO slaps with first "sell" rating since IPO Terex Corp TEX.N: down 4.2% Manitowoc Company Inc MTW.N: down 3.4% BUZZ-GS removes Terex and Manitowoc from "buy list", downgrades to "neutral" Anixa Biosciences Inc ANIX.O: up 10.6% BUZZ-Anixa Biosciences: Rises on partnership for potential treatment of COVID-19 Cyclacel Pharmaceutical Inc CYCC.O: up 103.8% BUZZ-Cyclacel: Jumps on deal to study drugs to treat COVID-19 patients Boeing Co BA.N: down 4.9% BUZZ-Benchmark sees Boeing cut 787 production by 30%; lowers PT Eros International EROS.N: down 0.2% BUZZ-Eros International: Soars after deal to merge with STX Entertainment Medpace Holdings Inc MEDP.O: down 0.8% ICON Plc ICLR.O: down 0.4% BUZZ-Baird downgrades two contract research organizations on COVID-19 impact Xeris Pharmaceutical Inc XERS.O: up 15.1% BUZZ-Xeris Pharma: Rises on positive results from seizure medication study United Airlines Holdings Inc UAL.O: down 3.4% BUZZ-United Airlines drops on estimated quarterly loss, dour outlook Walt Disney Co DIS.N: down 2.3% BUZZ-Disney: Falls as brokerages move to sidelines citing hit to theme parks Cheesecake Factory Inc CAKE.O: up 5.9% BUZZ-Cheesecake Factory: Rises on $200 mln investment from Roark Capital Exxon Mobil Corp XOM.N: down 3.0% Chevron Corp CVX.N: down 1.8% Devon Energy Corp DVN.N: down 0.4% Callon Petroleum Co CPE.N: down 3.4% Chesapeake Energy Corp CHK.N: down 1.5% Occidental Petroleum Corp OXY.N: down 6.1% Schlumberger NV SLB.N: flat Halliburton Co HAL.N: up 0.1% TechnipFMC Plc FTI.N: down 1.4% BUZZ-Oil stocks drop as concerns over rising crude storage weigh on prices BUZZ-Street View: Schlumberger's dividend cut the first step on road to recovery BUZZ-Halliburton: Falls on $1.1 bln impairment charges Safe-T Group SFET.O: up 18.2% BUZZ-Safe-T Group: Jumps on upbeat Q1 revenue forecast AbbVie Inc ABBV.N: up 1.8% BUZZ-AbbVie Inc: RBC expects rebound in 2021, upgrades to "outperform" Facebook Inc FB.O: flat BUZZ-Facebook: Credit Suisse cuts PT as coronavirus impacts ad revenue Biogen Inc BIIB.O: up 1.3% BUZZ-Biogen Inc: Alzheimer's drug in focus ahead of Q1, not earnings Abbott Laboratories ABT.N: up 3.9% BUZZ-Abbott, Roche to benefit from surging demand for COVID-19 antibody tests - analyst DuPont de Nemours Inc DD.N: up 5.5% BUZZ-DuPont: Rises on expectations of stronger Q1 from coronavirus-driven demand Co-Diagnostics Inc CODX.O: up 17.4% BUZZ-Co-Diagnostics: Rises on increased U.S. sales of COVID-19 testing kits Acadia Healthcare Co Inc ACHC.O: down 0.1% Brookdale Senior Living Inc BKD.N: down 3.2% Ensign Group Inc ENSG.O: down 0.4% Select Medical Holdings Corp SEM.N: down 4.1% BUZZ-Strong headwinds imminent for facility-based health care providers - Analyst General Motors Co GM.N: flat Ford Motor Co F.N: down 1.7% BUZZ-CS cuts PT on Ford, GM on heavy cash burn in H1 2020 Royal Caribbean Cruises Ltd RCL.N: down 3.4% Norwegian Cruise Line Holdings Ltd NCLH.N: down 4.9% ** Carnival Corp CCL.N: down 1.4% BUZZ-J.P. Morgan slashes cruise operators' PT on virus impact The 11 major S&P 500 sectors: Communication Services Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: http://tmsnrt.rs/2ggOmBi The Morning News Call newsletter: http://tmsnrt.rs/2fwPLTh The S&P 500 and the Dow Jones headed lower on Monday following a strong two-week rally as oil prices crashed and investors grew cautious at the start of a week that is likely to bring more dismal quarterly earnings reports and economic data..N At 17:55 ET, the Dow Jones Industrial Average .DJI was down 0.92% at 24,020.4. The S&P 500 .SPX was down 0.33% at 2,865.2 and the Nasdaq Composite .IXIC was up 0.30% at 8,676.165.	d1c525db-30f4-4b8b-b130-fbd791bc481b
716291.0	2020-04-20 00:00:00 UTC	BUZZ-U.S. STOCKS ON THE MOVE-DuPont, Occidental Petroleum, Safe-T Group	DD	https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-dupont-occidental-petroleum-safe-t-group-2020-04-20	nan	nan	Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: http://tmsnrt.rs/2ggOmBi The Morning News Call newsletter: http://tmsnrt.rs/2fwPLTh A slide in energy stocks weighed on Wall Street on Monday as crude prices crashed at the start of a week packed with quarterly earnings reports and economic data likely to underline the damage from the coronavirus outbreak..N At 16:05 ET, the Dow Jones Industrial Average .DJI was down 0.94% at 24,014.95. The S&P 500 .SPX was down 0.65% at 2,855.74 and the Nasdaq Composite .IXIC was up 0.13% at 8,661.651. The top three S&P 500 .PG.INX percentage gainers: FLIR Systems Inc , up 14.1% Carrier Global Corp , up 6.6% DuPont de Nemours Inc, up 5% The top three S&P 500 .PL.INX percentage losers: Vornado Realty Trust , down 4.9% Lennar Corporation , down 4.7% Occidental Petroleum Corp , down 4.7% The top three NYSE .PG.N percentage gainers: Regional Health Properties Inc , up 41.6% Montage Resources Corp , up 26.8% Build-A-Bear Workshop Inc , up 26.2% The top three NYSE .PL.N percentage losers: Invesco Mortgage Capital Inc , down 19.5% Direxion Daily S&P Biotech Bear 3X Shares , down 13% Manning & Napier Inc , down 12.7% The top three Nasdaq .PG.O percentage gainers: Cyclacel Pharmaceuticals Inc , up 89.5% American Virtual Cloud Technologies Inc , up 43.8% Benitec Biopharma Limited , up 42.9% The top three Nasdaq .PL.O percentage losers: Liberty TripAdvisor Holdings Inc , down 18.4% BiondVax Pharmaceuticals Equity Warrants , down 15% Green Plains Partners LP , down 14% Avalon GloboCare Corp AVCO.O: up 12.9% BUZZ-Avalon GloboCare: Rises as therapy shows promise in combating cytokine storm Shake Shack Inc SHAK.N: up 6.3% BUZZ-Shake Shack beefs up capital, gives back government loan Exelixis Inc EXEL.O: up 25.5% BUZZ-Exelixis jumps as cancer drug combo shows promise in study AGNC Investment Corp AGNC.O: up 0.1% Annaly Capital Management Inc NLY.N: up 0.2% Apollo CRE Finance ARI.N: down 3.7% Blackstone Mortgage Trust Inc BXMT.N: down 3.0% Ladder Capital Corp LADR.N: flat Starwood Property Trust Inc STWD.N: down 2.1% TPG RE Finance Trust Inc TRTX.N: down 3.0% BUZZ-U.S. mortgage REITs: DB cuts PT citing "stressed scenarios" INmune Bio Inc INMB.O: up 7.1% BUZZ-INmune Bio Inc: Rises on plans to begin COVID-19 trial Mustang Bio Inc MBIO.O: up 2.4% BUZZ-Mustang Bio: Rises after EMA's favorable classification of "bubble boy" therapy Meredith Corp MDP.N: down 9.7% BUZZ-Meredith Corp: Falls on withdrawing 2020 outlook as ad sales get hit Ducommun Inc DCO.N: up 4.6% BUZZ-Ducommun: Jumps as Q1 revenue forecast higher than Wall Street estimates Alexion Pharmaceuticals Inc ALXN.O: up 4.4% BUZZ-Alexion rises on study to test blood disorder drug for COVID-19 Clorox Co CLX.N: up 1.9% BUZZ-Clorox: Up as Deutsche Bank expects strong Q3 helped by coronavirus Peloton Interative Inc PTON.O: down 4.5% BUZZ-Peloton skids as BMO slaps first "sell" rating since IPO Terex Corp TEX.N: down 4.7% Manitowoc Company Inc MTW.N: down 2.5% BUZZ-GS removes Terex and Manitowoc from "buy list", downgrades to "neutral" Anixa Biosciences Inc ANIX.O: up 11.6% BUZZ-Anixa Biosciences: Rises on partnership for potential treatment of COVID-19 Cyclacel Pharmaceutical Inc CYCC.O: up 89.5% BUZZ-Cyclacel: Jumps on deal to study drugs to treat COVID-19 patients Boeing Co BA.N: down 3.1% BUZZ-Benchmark sees Boeing cut 787 production by 30%; lowers PT Eros International EROS.N: up 9.0% BUZZ-Eros International: Soars after deal to merge with STX Entertainment Medpace Holdings Inc MEDP.O: down 1.9% ICON Plc ICLR.O: up 0.1% BUZZ-Baird downgrades two contract research organizations on COVID-19 impact Xeris Pharmaceutical Inc XERS.O: up 10.2% BUZZ-Xeris Pharma: Rises on positive results from seizure medication study United Airlines Holdings Inc UAL.O: down 3.2% BUZZ-United Airlines drops on estimated quarterly loss, dour outlook Walt Disney Co DIS.N: down 2.8% BUZZ-Disney: Falls as brokerages move to sidelines citing hit to theme parks Cheesecake Factory Inc CAKE.O: up 7.6% BUZZ-Cheesecake Factory: Rises on $200 mln investment from Roark Capital Exxon Mobil Corp XOM.N: down 2.2% Chevron Corp CVX.N: down 1.0% Devon Energy Corp DVN.N: up 1.1% Callon Petroleum Co CPE.N: down 2.5% Chesapeake Energy Corp CHK.N: down 1.0% Occidental Petroleum Corp OXY.N: down 4.8% Schlumberger NV SLB.N: up 0.4% Halliburton Co HAL.N: up 3.5% TechnipFMC Plc FTI.N: down 0.5% BUZZ-Oil stocks drop as concerns over rising crude storage weigh on prices BUZZ-Street View: Schlumberger's dividend cut the first step on road to recovery BUZZ-Halliburton: Falls on $1.1 bln impairment charges Safe-T Group SFET.O: up 17.6% BUZZ-Safe-T Group: Jumps on upbeat Q1 revenue forecast AbbVie Inc ABBV.N: up 0.3% BUZZ-AbbVie Inc: RBC expects rebound in 2021, upgrades to "outperform" Facebook Inc FB.O: up 0.3% BUZZ-Facebook: Credit Suisse cuts PT as coronavirus impacts ad revenue Biogen Inc BIIB.O: up 1.5% BUZZ-Biogen Inc: Alzheimer's drug in focus ahead of Q1, not earnings Abbott Laboratories ABT.N: up 1.0% BUZZ-Abbott, Roche to benefit from surging demand for COVID-19 antibody tests - analyst DuPont de Nemours Inc DD.N: up 5.0% BUZZ-DuPont: Rises on expectations of stronger Q1 from coronavirus-driven demand Co-Diagnostics Inc CODX.O: up 13.8% BUZZ-Co-Diagnostics: Rises on increased U.S. sales of COVID-19 testing kits Acadia Healthcare Co Inc ACHC.O: up 0.4% Brookdale Senior Living Inc BKD.N: down 1.8% Ensign Group Inc ENSG.O: down 1.2% Select Medical Holdings Corp SEM.N: down 3.6% BUZZ-Strong headwinds imminent for facility-based health care providers - Analyst General Motors Co GM.N: down 0.3% Ford Motor Co F.N: down 1.2% BUZZ-CS cuts PT on Ford, GM on heavy cash burn in H1 2020 Royal Caribbean Cruises Ltd RCL.N: down 1.6% Norwegian Cruise Line Holdings Ltd NCLH.N: down 2.7% Carnival Corp CCL.N: down 1.4% BUZZ-J.P. Morgan slashes cruise operators' PT on virus impact The 11 major S&P 500 sectors: Communication Services .SPLRCL down 0.15% Consumer Discretionary .SPLRCD up 0.32% Consumer Staples .SPLRCS down 0.63% Energy .SPNY down 0.82% Financial .SPSY down 0.67% Health .SPXHC down 0.29% Industrial .SPLRCI down 1.05% Information Technology .SPLRCT down 0.55% Materials .SPLRCM down 0.60% Real Estate .SPLRCR down 2.25% Utilities .SPLRCU down 1.98% (Compiled by Amal S in Bengaluru) ((Amal.S@thomsonreuters.com; within U.S.+1 646 223 8780; outside U.S. +91 80 6749 3677;)) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	The top three S&P 500 .PG.INX percentage gainers: FLIR Systems Inc , up 14.1% Carrier Global Corp , up 6.6% DuPont de Nemours Inc, up 5% The top three S&P 500 .PL.INX percentage losers: Vornado Realty Trust , down 4.9% Lennar Corporation , down 4.7% Occidental Petroleum Corp , down 4.7% The top three NYSE .PG.N percentage gainers: Regional Health Properties Inc , up 41.6% Montage Resources Corp , up 26.8% Build-A-Bear Workshop Inc , up 26.2% The top three NYSE .PL.N percentage losers: Invesco Mortgage Capital Inc , down 19.5% Direxion Daily S&P Biotech Bear 3X Shares , down 13% Manning & Napier Inc , down 12.7% The top three Nasdaq .PG.O percentage gainers: Cyclacel Pharmaceuticals Inc , up 89.5% American Virtual Cloud Technologies Inc , up 43.8% Benitec Biopharma Limited , up 42.9% The top three Nasdaq .PL.O percentage losers: Liberty TripAdvisor Holdings Inc , down 18.4% BiondVax Pharmaceuticals Equity Warrants , down 15% Green Plains Partners LP , down 14% Avalon GloboCare Corp AVCO.O: up 12.9% BUZZ-Avalon GloboCare: Rises as therapy shows promise in combating cytokine storm Shake Shack Inc SHAK.N: up 6.3% BUZZ-Shake Shack beefs up capital, gives back government loan Exelixis Inc EXEL.O: up 25.5% BUZZ-Exelixis jumps as cancer drug combo shows promise in study AGNC Investment Corp AGNC.O: up 0.1% Annaly Capital Management Inc NLY.N: up 0.2% Apollo CRE Finance ARI.N: down 3.7% Blackstone Mortgage Trust Inc BXMT.N: down 3.0% Ladder Capital Corp LADR.N: flat Starwood Property Trust Inc STWD.N: down 2.1% TPG RE Finance Trust Inc TRTX.N: down 3.0% BUZZ-U.S. mortgage REITs: DB cuts PT citing "stressed scenarios" INmune Bio Inc INMB.O: up 7.1% BUZZ-INmune Bio Inc: Rises on plans to begin COVID-19 trial Mustang Bio Inc MBIO.O: up 2.4% BUZZ-Mustang Bio: Rises after EMA's favorable classification of "bubble boy" therapy Meredith Corp MDP.N: down 9.7% BUZZ-Meredith Corp: Falls on withdrawing 2020 outlook as ad sales get hit Ducommun Inc DCO.N: up 4.6% BUZZ-Ducommun: Jumps as Q1 revenue forecast higher than Wall Street estimates Alexion Pharmaceuticals Inc ALXN.O: up 4.4% BUZZ-Alexion rises on study to test blood disorder drug for COVID-19 Clorox Co CLX.N: up 1.9% BUZZ-Clorox: Up as Deutsche Bank expects strong Q3 helped by coronavirus Peloton Interative Inc PTON.O: down 4.5% BUZZ-Peloton skids as BMO slaps first "sell" rating since IPO Terex Corp TEX.N: down 4.7% Manitowoc Company Inc MTW.N: down 2.5% BUZZ-GS removes Terex and Manitowoc from "buy list", downgrades to "neutral" Anixa Biosciences Inc ANIX.O: up 11.6% BUZZ-Anixa Biosciences: Rises on partnership for potential treatment of COVID-19 Cyclacel Pharmaceutical Inc CYCC.O: up 89.5% BUZZ-Cyclacel: Jumps on deal to study drugs to treat COVID-19 patients Boeing Co BA.N: down 3.1% BUZZ-Benchmark sees Boeing cut 787 production by 30%; lowers PT Eros International EROS.N: up 9.0% BUZZ-Eros International: Soars after deal to merge with STX Entertainment Medpace Holdings Inc MEDP.O: down 1.9% ICON Plc ICLR.O: up 0.1% BUZZ-Baird downgrades two contract research organizations on COVID-19 impact Xeris Pharmaceutical Inc XERS.O: up 10.2% BUZZ-Xeris Pharma: Rises on positive results from seizure medication study United Airlines Holdings Inc UAL.O: down 3.2% BUZZ-United Airlines drops on estimated quarterly loss, dour outlook Walt Disney Co DIS.N: down 2.8% BUZZ-Disney: Falls as brokerages move to sidelines citing hit to theme parks Cheesecake Factory Inc CAKE.O: up 7.6% BUZZ-Cheesecake Factory: Rises on $200 mln investment from Roark Capital Exxon Mobil Corp XOM.N: down 2.2% Chevron Corp CVX.N: down 1.0% Devon Energy Corp DVN.N: up 1.1% Callon Petroleum Co CPE.N: down 2.5% Chesapeake Energy Corp CHK.N: down 1.0% Occidental Petroleum Corp OXY.N: down 4.8% Schlumberger NV SLB.N: up 0.4% Halliburton Co HAL.N: up 3.5% TechnipFMC Plc FTI.N: down 0.5% BUZZ-Oil stocks drop as concerns over rising crude storage weigh on prices BUZZ-Street View: Schlumberger's dividend cut the first step on road to recovery BUZZ-Halliburton: Falls on $1.1 bln impairment charges Safe-T Group SFET.O: up 17.6% BUZZ-Safe-T Group: Jumps on upbeat Q1 revenue forecast AbbVie Inc ABBV.N: up 0.3% BUZZ-AbbVie Inc: RBC expects rebound in 2021, upgrades to "outperform" Facebook Inc FB.O: up 0.3% BUZZ-Facebook: Credit Suisse cuts PT as coronavirus impacts ad revenue Biogen Inc BIIB.O: up 1.5% BUZZ-Biogen Inc: Alzheimer's drug in focus ahead of Q1, not earnings Abbott Laboratories ABT.N: up 1.0% BUZZ-Abbott, Roche to benefit from surging demand for COVID-19 antibody tests - analyst DuPont de Nemours Inc DD.N: up 5.0% BUZZ-DuPont: Rises on expectations of stronger Q1 from coronavirus-driven demand Co-Diagnostics Inc CODX.O: up 13.8% BUZZ-Co-Diagnostics: Rises on increased U.S. sales of COVID-19 testing kits Acadia Healthcare Co Inc ACHC.O: up 0.4% Brookdale Senior Living Inc BKD.N: down 1.8% Ensign Group Inc ENSG.O: down 1.2% Select Medical Holdings Corp SEM.N: down 3.6% BUZZ-Strong headwinds imminent for facility-based health care providers - Analyst General Motors Co GM.N: down 0.3% Ford Motor Co F.N: down 1.2% BUZZ-CS cuts PT on Ford, GM on heavy cash burn in H1 2020 Royal Caribbean Cruises Ltd RCL.N: down 1.6% Norwegian Cruise Line Holdings Ltd NCLH.N: down 2.7% Carnival Corp CCL.N: down 1.4% BUZZ-J.P. Morgan slashes cruise operators' PT on virus impact The 11 major S&P 500 sectors: Communication Services Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: http://tmsnrt.rs/2ggOmBi The Morning News Call newsletter: http://tmsnrt.rs/2fwPLTh A slide in energy stocks weighed on Wall Street on Monday as crude prices crashed at the start of a week packed with quarterly earnings reports and economic data likely to underline the damage from the coronavirus outbreak..N At 16:05 ET, the Dow Jones Industrial Average .DJI was down 0.94% at 24,014.95. down 1.98% (Compiled by Amal S in Bengaluru) ((Amal.S@thomsonreuters.com; within U.S.+1 646 223 8780; outside U.S. +91 80 6749 3677;)) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	The top three S&P 500 .PG.INX percentage gainers: FLIR Systems Inc , up 14.1% Carrier Global Corp , up 6.6% DuPont de Nemours Inc, up 5% The top three S&P 500 .PL.INX percentage losers: Vornado Realty Trust , down 4.9% Lennar Corporation , down 4.7% Occidental Petroleum Corp , down 4.7% The top three NYSE .PG.N percentage gainers: Regional Health Properties Inc , up 41.6% Montage Resources Corp , up 26.8% Build-A-Bear Workshop Inc , up 26.2% The top three NYSE .PL.N percentage losers: Invesco Mortgage Capital Inc , down 19.5% Direxion Daily S&P Biotech Bear 3X Shares , down 13% Manning & Napier Inc , down 12.7% The top three Nasdaq .PG.O percentage gainers: Cyclacel Pharmaceuticals Inc , up 89.5% American Virtual Cloud Technologies Inc , up 43.8% Benitec Biopharma Limited , up 42.9% The top three Nasdaq .PL.O percentage losers: Liberty TripAdvisor Holdings Inc , down 18.4% BiondVax Pharmaceuticals Equity Warrants , down 15% Green Plains Partners LP , down 14% Avalon GloboCare Corp AVCO.O: up 12.9% BUZZ-Avalon GloboCare: Rises as therapy shows promise in combating cytokine storm Shake Shack Inc SHAK.N: up 6.3% BUZZ-Shake Shack beefs up capital, gives back government loan Exelixis Inc EXEL.O: up 25.5% BUZZ-Exelixis jumps as cancer drug combo shows promise in study AGNC Investment Corp AGNC.O: up 0.1% Annaly Capital Management Inc NLY.N: up 0.2% Apollo CRE Finance ARI.N: down 3.7% Blackstone Mortgage Trust Inc BXMT.N: down 3.0% Ladder Capital Corp LADR.N: flat Starwood Property Trust Inc STWD.N: down 2.1% TPG RE Finance Trust Inc TRTX.N: down 3.0% BUZZ-U.S. mortgage REITs: DB cuts PT citing "stressed scenarios" INmune Bio Inc INMB.O: up 7.1% BUZZ-INmune Bio Inc: Rises on plans to begin COVID-19 trial Mustang Bio Inc MBIO.O: up 2.4% BUZZ-Mustang Bio: Rises after EMA's favorable classification of "bubble boy" therapy Meredith Corp MDP.N: down 9.7% BUZZ-Meredith Corp: Falls on withdrawing 2020 outlook as ad sales get hit Ducommun Inc DCO.N: up 4.6% BUZZ-Ducommun: Jumps as Q1 revenue forecast higher than Wall Street estimates Alexion Pharmaceuticals Inc ALXN.O: up 4.4% BUZZ-Alexion rises on study to test blood disorder drug for COVID-19 Clorox Co CLX.N: up 1.9% BUZZ-Clorox: Up as Deutsche Bank expects strong Q3 helped by coronavirus Peloton Interative Inc PTON.O: down 4.5% BUZZ-Peloton skids as BMO slaps first "sell" rating since IPO Terex Corp TEX.N: down 4.7% Manitowoc Company Inc MTW.N: down 2.5% BUZZ-GS removes Terex and Manitowoc from "buy list", downgrades to "neutral" Anixa Biosciences Inc ANIX.O: up 11.6% BUZZ-Anixa Biosciences: Rises on partnership for potential treatment of COVID-19 Cyclacel Pharmaceutical Inc CYCC.O: up 89.5% BUZZ-Cyclacel: Jumps on deal to study drugs to treat COVID-19 patients Boeing Co BA.N: down 3.1% BUZZ-Benchmark sees Boeing cut 787 production by 30%; lowers PT Eros International EROS.N: up 9.0% BUZZ-Eros International: Soars after deal to merge with STX Entertainment Medpace Holdings Inc MEDP.O: down 1.9% ICON Plc ICLR.O: up 0.1% BUZZ-Baird downgrades two contract research organizations on COVID-19 impact Xeris Pharmaceutical Inc XERS.O: up 10.2% BUZZ-Xeris Pharma: Rises on positive results from seizure medication study United Airlines Holdings Inc UAL.O: down 3.2% BUZZ-United Airlines drops on estimated quarterly loss, dour outlook Walt Disney Co DIS.N: down 2.8% BUZZ-Disney: Falls as brokerages move to sidelines citing hit to theme parks Cheesecake Factory Inc CAKE.O: up 7.6% BUZZ-Cheesecake Factory: Rises on $200 mln investment from Roark Capital Exxon Mobil Corp XOM.N: down 2.2% Chevron Corp CVX.N: down 1.0% Devon Energy Corp DVN.N: up 1.1% Callon Petroleum Co CPE.N: down 2.5% Chesapeake Energy Corp CHK.N: down 1.0% Occidental Petroleum Corp OXY.N: down 4.8% Schlumberger NV SLB.N: up 0.4% Halliburton Co HAL.N: up 3.5% TechnipFMC Plc FTI.N: down 0.5% BUZZ-Oil stocks drop as concerns over rising crude storage weigh on prices BUZZ-Street View: Schlumberger's dividend cut the first step on road to recovery BUZZ-Halliburton: Falls on $1.1 bln impairment charges Safe-T Group SFET.O: up 17.6% BUZZ-Safe-T Group: Jumps on upbeat Q1 revenue forecast AbbVie Inc ABBV.N: up 0.3% BUZZ-AbbVie Inc: RBC expects rebound in 2021, upgrades to "outperform" Facebook Inc FB.O: up 0.3% BUZZ-Facebook: Credit Suisse cuts PT as coronavirus impacts ad revenue Biogen Inc BIIB.O: up 1.5% BUZZ-Biogen Inc: Alzheimer's drug in focus ahead of Q1, not earnings Abbott Laboratories ABT.N: up 1.0% BUZZ-Abbott, Roche to benefit from surging demand for COVID-19 antibody tests - analyst DuPont de Nemours Inc DD.N: up 5.0% BUZZ-DuPont: Rises on expectations of stronger Q1 from coronavirus-driven demand Co-Diagnostics Inc CODX.O: up 13.8% BUZZ-Co-Diagnostics: Rises on increased U.S. sales of COVID-19 testing kits Acadia Healthcare Co Inc ACHC.O: up 0.4% Brookdale Senior Living Inc BKD.N: down 1.8% Ensign Group Inc ENSG.O: down 1.2% Select Medical Holdings Corp SEM.N: down 3.6% BUZZ-Strong headwinds imminent for facility-based health care providers - Analyst General Motors Co GM.N: down 0.3% Ford Motor Co F.N: down 1.2% BUZZ-CS cuts PT on Ford, GM on heavy cash burn in H1 2020 Royal Caribbean Cruises Ltd RCL.N: down 1.6% Norwegian Cruise Line Holdings Ltd NCLH.N: down 2.7% Carnival Corp CCL.N: down 1.4% BUZZ-J.P. Morgan slashes cruise operators' PT on virus impact The 11 major S&P 500 sectors: Communication Services Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: http://tmsnrt.rs/2ggOmBi The Morning News Call newsletter: http://tmsnrt.rs/2fwPLTh A slide in energy stocks weighed on Wall Street on Monday as crude prices crashed at the start of a week packed with quarterly earnings reports and economic data likely to underline the damage from the coronavirus outbreak..N At 16:05 ET, the Dow Jones Industrial Average .DJI was down 0.94% at 24,014.95. down 1.98% (Compiled by Amal S in Bengaluru) ((Amal.S@thomsonreuters.com; within U.S.+1 646 223 8780; outside U.S. +91 80 6749 3677;)) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	The top three S&P 500 .PG.INX percentage gainers: FLIR Systems Inc , up 14.1% Carrier Global Corp , up 6.6% DuPont de Nemours Inc, up 5% The top three S&P 500 .PL.INX percentage losers: Vornado Realty Trust , down 4.9% Lennar Corporation , down 4.7% Occidental Petroleum Corp , down 4.7% The top three NYSE .PG.N percentage gainers: Regional Health Properties Inc , up 41.6% Montage Resources Corp , up 26.8% Build-A-Bear Workshop Inc , up 26.2% The top three NYSE .PL.N percentage losers: Invesco Mortgage Capital Inc , down 19.5% Direxion Daily S&P Biotech Bear 3X Shares , down 13% Manning & Napier Inc , down 12.7% The top three Nasdaq .PG.O percentage gainers: Cyclacel Pharmaceuticals Inc , up 89.5% American Virtual Cloud Technologies Inc , up 43.8% Benitec Biopharma Limited , up 42.9% The top three Nasdaq .PL.O percentage losers: Liberty TripAdvisor Holdings Inc , down 18.4% BiondVax Pharmaceuticals Equity Warrants , down 15% Green Plains Partners LP , down 14% Avalon GloboCare Corp AVCO.O: up 12.9% BUZZ-Avalon GloboCare: Rises as therapy shows promise in combating cytokine storm Shake Shack Inc SHAK.N: up 6.3% BUZZ-Shake Shack beefs up capital, gives back government loan Exelixis Inc EXEL.O: up 25.5% BUZZ-Exelixis jumps as cancer drug combo shows promise in study AGNC Investment Corp AGNC.O: up 0.1% Annaly Capital Management Inc NLY.N: up 0.2% Apollo CRE Finance ARI.N: down 3.7% Blackstone Mortgage Trust Inc BXMT.N: down 3.0% Ladder Capital Corp LADR.N: flat Starwood Property Trust Inc STWD.N: down 2.1% TPG RE Finance Trust Inc TRTX.N: down 3.0% BUZZ-U.S. mortgage REITs: DB cuts PT citing "stressed scenarios" INmune Bio Inc INMB.O: up 7.1% BUZZ-INmune Bio Inc: Rises on plans to begin COVID-19 trial Mustang Bio Inc MBIO.O: up 2.4% BUZZ-Mustang Bio: Rises after EMA's favorable classification of "bubble boy" therapy Meredith Corp MDP.N: down 9.7% BUZZ-Meredith Corp: Falls on withdrawing 2020 outlook as ad sales get hit Ducommun Inc DCO.N: up 4.6% BUZZ-Ducommun: Jumps as Q1 revenue forecast higher than Wall Street estimates Alexion Pharmaceuticals Inc ALXN.O: up 4.4% BUZZ-Alexion rises on study to test blood disorder drug for COVID-19 Clorox Co CLX.N: up 1.9% BUZZ-Clorox: Up as Deutsche Bank expects strong Q3 helped by coronavirus Peloton Interative Inc PTON.O: down 4.5% BUZZ-Peloton skids as BMO slaps first "sell" rating since IPO Terex Corp TEX.N: down 4.7% Manitowoc Company Inc MTW.N: down 2.5% BUZZ-GS removes Terex and Manitowoc from "buy list", downgrades to "neutral" Anixa Biosciences Inc ANIX.O: up 11.6% BUZZ-Anixa Biosciences: Rises on partnership for potential treatment of COVID-19 Cyclacel Pharmaceutical Inc CYCC.O: up 89.5% BUZZ-Cyclacel: Jumps on deal to study drugs to treat COVID-19 patients Boeing Co BA.N: down 3.1% BUZZ-Benchmark sees Boeing cut 787 production by 30%; lowers PT Eros International EROS.N: up 9.0% BUZZ-Eros International: Soars after deal to merge with STX Entertainment Medpace Holdings Inc MEDP.O: down 1.9% ICON Plc ICLR.O: up 0.1% BUZZ-Baird downgrades two contract research organizations on COVID-19 impact Xeris Pharmaceutical Inc XERS.O: up 10.2% BUZZ-Xeris Pharma: Rises on positive results from seizure medication study United Airlines Holdings Inc UAL.O: down 3.2% BUZZ-United Airlines drops on estimated quarterly loss, dour outlook Walt Disney Co DIS.N: down 2.8% BUZZ-Disney: Falls as brokerages move to sidelines citing hit to theme parks Cheesecake Factory Inc CAKE.O: up 7.6% BUZZ-Cheesecake Factory: Rises on $200 mln investment from Roark Capital Exxon Mobil Corp XOM.N: down 2.2% Chevron Corp CVX.N: down 1.0% Devon Energy Corp DVN.N: up 1.1% Callon Petroleum Co CPE.N: down 2.5% Chesapeake Energy Corp CHK.N: down 1.0% Occidental Petroleum Corp OXY.N: down 4.8% Schlumberger NV SLB.N: up 0.4% Halliburton Co HAL.N: up 3.5% TechnipFMC Plc FTI.N: down 0.5% BUZZ-Oil stocks drop as concerns over rising crude storage weigh on prices BUZZ-Street View: Schlumberger's dividend cut the first step on road to recovery BUZZ-Halliburton: Falls on $1.1 bln impairment charges Safe-T Group SFET.O: up 17.6% BUZZ-Safe-T Group: Jumps on upbeat Q1 revenue forecast AbbVie Inc ABBV.N: up 0.3% BUZZ-AbbVie Inc: RBC expects rebound in 2021, upgrades to "outperform" Facebook Inc FB.O: up 0.3% BUZZ-Facebook: Credit Suisse cuts PT as coronavirus impacts ad revenue Biogen Inc BIIB.O: up 1.5% BUZZ-Biogen Inc: Alzheimer's drug in focus ahead of Q1, not earnings Abbott Laboratories ABT.N: up 1.0% BUZZ-Abbott, Roche to benefit from surging demand for COVID-19 antibody tests - analyst DuPont de Nemours Inc DD.N: up 5.0% BUZZ-DuPont: Rises on expectations of stronger Q1 from coronavirus-driven demand Co-Diagnostics Inc CODX.O: up 13.8% BUZZ-Co-Diagnostics: Rises on increased U.S. sales of COVID-19 testing kits Acadia Healthcare Co Inc ACHC.O: up 0.4% Brookdale Senior Living Inc BKD.N: down 1.8% Ensign Group Inc ENSG.O: down 1.2% Select Medical Holdings Corp SEM.N: down 3.6% BUZZ-Strong headwinds imminent for facility-based health care providers - Analyst General Motors Co GM.N: down 0.3% Ford Motor Co F.N: down 1.2% BUZZ-CS cuts PT on Ford, GM on heavy cash burn in H1 2020 Royal Caribbean Cruises Ltd RCL.N: down 1.6% Norwegian Cruise Line Holdings Ltd NCLH.N: down 2.7% Carnival Corp CCL.N: down 1.4% BUZZ-J.P. Morgan slashes cruise operators' PT on virus impact The 11 major S&P 500 sectors: Communication Services down 0.15% Consumer Discretionary up 0.32% Consumer Staples	The top three S&P 500 .PG.INX percentage gainers: FLIR Systems Inc , up 14.1% Carrier Global Corp , up 6.6% DuPont de Nemours Inc, up 5% The top three S&P 500 .PL.INX percentage losers: Vornado Realty Trust , down 4.9% Lennar Corporation , down 4.7% Occidental Petroleum Corp , down 4.7% The top three NYSE .PG.N percentage gainers: Regional Health Properties Inc , up 41.6% Montage Resources Corp , up 26.8% Build-A-Bear Workshop Inc , up 26.2% The top three NYSE .PL.N percentage losers: Invesco Mortgage Capital Inc , down 19.5% Direxion Daily S&P Biotech Bear 3X Shares , down 13% Manning & Napier Inc , down 12.7% The top three Nasdaq .PG.O percentage gainers: Cyclacel Pharmaceuticals Inc , up 89.5% American Virtual Cloud Technologies Inc , up 43.8% Benitec Biopharma Limited , up 42.9% The top three Nasdaq .PL.O percentage losers: Liberty TripAdvisor Holdings Inc , down 18.4% BiondVax Pharmaceuticals Equity Warrants , down 15% Green Plains Partners LP , down 14% Avalon GloboCare Corp AVCO.O: up 12.9% BUZZ-Avalon GloboCare: Rises as therapy shows promise in combating cytokine storm Shake Shack Inc SHAK.N: up 6.3% BUZZ-Shake Shack beefs up capital, gives back government loan Exelixis Inc EXEL.O: up 25.5% BUZZ-Exelixis jumps as cancer drug combo shows promise in study AGNC Investment Corp AGNC.O: up 0.1% Annaly Capital Management Inc NLY.N: up 0.2% Apollo CRE Finance ARI.N: down 3.7% Blackstone Mortgage Trust Inc BXMT.N: down 3.0% Ladder Capital Corp LADR.N: flat Starwood Property Trust Inc STWD.N: down 2.1% TPG RE Finance Trust Inc TRTX.N: down 3.0% BUZZ-U.S. mortgage REITs: DB cuts PT citing "stressed scenarios" INmune Bio Inc INMB.O: up 7.1% BUZZ-INmune Bio Inc: Rises on plans to begin COVID-19 trial Mustang Bio Inc MBIO.O: up 2.4% BUZZ-Mustang Bio: Rises after EMA's favorable classification of "bubble boy" therapy Meredith Corp MDP.N: down 9.7% BUZZ-Meredith Corp: Falls on withdrawing 2020 outlook as ad sales get hit Ducommun Inc DCO.N: up 4.6% BUZZ-Ducommun: Jumps as Q1 revenue forecast higher than Wall Street estimates Alexion Pharmaceuticals Inc ALXN.O: up 4.4% BUZZ-Alexion rises on study to test blood disorder drug for COVID-19 Clorox Co CLX.N: up 1.9% BUZZ-Clorox: Up as Deutsche Bank expects strong Q3 helped by coronavirus Peloton Interative Inc PTON.O: down 4.5% BUZZ-Peloton skids as BMO slaps first "sell" rating since IPO Terex Corp TEX.N: down 4.7% Manitowoc Company Inc MTW.N: down 2.5% BUZZ-GS removes Terex and Manitowoc from "buy list", downgrades to "neutral" Anixa Biosciences Inc ANIX.O: up 11.6% BUZZ-Anixa Biosciences: Rises on partnership for potential treatment of COVID-19 Cyclacel Pharmaceutical Inc CYCC.O: up 89.5% BUZZ-Cyclacel: Jumps on deal to study drugs to treat COVID-19 patients Boeing Co BA.N: down 3.1% BUZZ-Benchmark sees Boeing cut 787 production by 30%; lowers PT Eros International EROS.N: up 9.0% BUZZ-Eros International: Soars after deal to merge with STX Entertainment Medpace Holdings Inc MEDP.O: down 1.9% ICON Plc ICLR.O: up 0.1% BUZZ-Baird downgrades two contract research organizations on COVID-19 impact Xeris Pharmaceutical Inc XERS.O: up 10.2% BUZZ-Xeris Pharma: Rises on positive results from seizure medication study United Airlines Holdings Inc UAL.O: down 3.2% BUZZ-United Airlines drops on estimated quarterly loss, dour outlook Walt Disney Co DIS.N: down 2.8% BUZZ-Disney: Falls as brokerages move to sidelines citing hit to theme parks Cheesecake Factory Inc CAKE.O: up 7.6% BUZZ-Cheesecake Factory: Rises on $200 mln investment from Roark Capital Exxon Mobil Corp XOM.N: down 2.2% Chevron Corp CVX.N: down 1.0% Devon Energy Corp DVN.N: up 1.1% Callon Petroleum Co CPE.N: down 2.5% Chesapeake Energy Corp CHK.N: down 1.0% Occidental Petroleum Corp OXY.N: down 4.8% Schlumberger NV SLB.N: up 0.4% Halliburton Co HAL.N: up 3.5% TechnipFMC Plc FTI.N: down 0.5% BUZZ-Oil stocks drop as concerns over rising crude storage weigh on prices BUZZ-Street View: Schlumberger's dividend cut the first step on road to recovery BUZZ-Halliburton: Falls on $1.1 bln impairment charges Safe-T Group SFET.O: up 17.6% BUZZ-Safe-T Group: Jumps on upbeat Q1 revenue forecast AbbVie Inc ABBV.N: up 0.3% BUZZ-AbbVie Inc: RBC expects rebound in 2021, upgrades to "outperform" Facebook Inc FB.O: up 0.3% BUZZ-Facebook: Credit Suisse cuts PT as coronavirus impacts ad revenue Biogen Inc BIIB.O: up 1.5% BUZZ-Biogen Inc: Alzheimer's drug in focus ahead of Q1, not earnings Abbott Laboratories ABT.N: up 1.0% BUZZ-Abbott, Roche to benefit from surging demand for COVID-19 antibody tests - analyst DuPont de Nemours Inc DD.N: up 5.0% BUZZ-DuPont: Rises on expectations of stronger Q1 from coronavirus-driven demand Co-Diagnostics Inc CODX.O: up 13.8% BUZZ-Co-Diagnostics: Rises on increased U.S. sales of COVID-19 testing kits Acadia Healthcare Co Inc ACHC.O: up 0.4% Brookdale Senior Living Inc BKD.N: down 1.8% Ensign Group Inc ENSG.O: down 1.2% Select Medical Holdings Corp SEM.N: down 3.6% BUZZ-Strong headwinds imminent for facility-based health care providers - Analyst General Motors Co GM.N: down 0.3% Ford Motor Co F.N: down 1.2% BUZZ-CS cuts PT on Ford, GM on heavy cash burn in H1 2020 Royal Caribbean Cruises Ltd RCL.N: down 1.6% Norwegian Cruise Line Holdings Ltd NCLH.N: down 2.7% Carnival Corp CCL.N: down 1.4% BUZZ-J.P. Morgan slashes cruise operators' PT on virus impact The 11 major S&P 500 sectors: Communication Services Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: http://tmsnrt.rs/2ggOmBi The Morning News Call newsletter: http://tmsnrt.rs/2fwPLTh A slide in energy stocks weighed on Wall Street on Monday as crude prices crashed at the start of a week packed with quarterly earnings reports and economic data likely to underline the damage from the coronavirus outbreak..N At 16:05 ET, the Dow Jones Industrial Average .DJI was down 0.94% at 24,014.95. The S&P 500 .SPX was down 0.65% at 2,855.74 and the Nasdaq Composite .IXIC was up 0.13% at 8,661.651.	370ad079-530c-44a3-9b88-dfd5fbc21418
716292.0	2020-04-20 00:00:00 UTC	S&P 500 Movers: OXY, FLIR	DD	https://www.nasdaq.com/articles/sp-500-movers%3A-oxy-flir-2020-04-20	nan	nan	In early trading on Monday, shares of FLIR Systems, topped the list of the day's best performing components of the S&P 500 index, trading up 4.5%. Year to date, FLIR Systems has lost about 31.5% of its value. And the worst performing S&P 500 component thus far on the day is Occidental Petroleum, trading down 8.7%. Occidental Petroleum is lower by about 69.8% looking at the year to date performance. Two other components making moves today are Helmerich & Payne, trading down 7.8%, and DuPont, trading up 3.5% on the day. VIDEO: S&P 500 Movers: OXY, FLIR The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	And the worst performing S&P 500 component thus far on the day is Occidental Petroleum, trading down 8.7%. Occidental Petroleum is lower by about 69.8% looking at the year to date performance. VIDEO: S&P 500 Movers: OXY, FLIR The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	In early trading on Monday, shares of FLIR Systems, topped the list of the day's best performing components of the S&P 500 index, trading up 4.5%. Year to date, FLIR Systems has lost about 31.5% of its value. And the worst performing S&P 500 component thus far on the day is Occidental Petroleum, trading down 8.7%.	In early trading on Monday, shares of FLIR Systems, topped the list of the day's best performing components of the S&P 500 index, trading up 4.5%. And the worst performing S&P 500 component thus far on the day is Occidental Petroleum, trading down 8.7%. Two other components making moves today are Helmerich & Payne, trading down 7.8%, and DuPont, trading up 3.5% on the day.	In early trading on Monday, shares of FLIR Systems, topped the list of the day's best performing components of the S&P 500 index, trading up 4.5%. And the worst performing S&P 500 component thus far on the day is Occidental Petroleum, trading down 8.7%. VIDEO: S&P 500 Movers: OXY, FLIR The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	4ec759ac-44aa-4a83-8786-f77aa1081c42
716293.0	2020-04-20 00:00:00 UTC	DuPont sees quarterly profit above expectations on coronavirus-led demand	DD	https://www.nasdaq.com/articles/dupont-sees-quarterly-profit-above-expectations-on-coronavirus-led-demand-2020-04-20	nan	nan	Adds details on outlook, background April 20 (Reuters) - Industrial materials maker DuPont DD.N on Monday estimated first-quarter profit above Wall Street's expectations, as the coronavirus outbreak lifted demand for its products used in personal protection and water filtration. The company, however, suspended its forecast for full-year sales and adjusted earnings, citing uncertainty caused by the COVID-19 pandemic. DuPont, which makes everything from brake fluid to fabric used in protective garments, is expected to have mixed impact from the virus outbreak. Demand for the company's products such as Tyvek, used in protective garments has risen, while one of its key end markets - the automotive sector - has been among the hardest hit as the pandemic hampered global travel. DuPont also said it had delayed some capital investment and idled production at several manufacturing sites, mainly production plants that fall under its the transportation and industrial business. Shares of the company were up 4.3% at $40 in pre-market trading. DuPont said it expects first-quarter adjusted earnings per share between 82 cents and 84 cents on net sales of about $5.2 billion. Analysts on average had estimated profit of 68 cents per share on revenue of $5.01 billion, according to Refinitiv Eikon data. Dupont said in March it expected full-year adjusted earnings of $3.70 per share to $3.90 per share on sales of $21.3 billion to $21.8 billion. (Reporting by Arathy S Nair in Bengaluru; Editing by Aditya Soni) ((arathys.nair@thomsonreuters.com; +1 646 223 8780 (Extn 2726); Twitter: https://twitter.com/ArathySom;)) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	Adds details on outlook, background April 20 (Reuters) - Industrial materials maker DuPont DD.N on Monday estimated first-quarter profit above Wall Street's expectations, as the coronavirus outbreak lifted demand for its products used in personal protection and water filtration. DuPont, which makes everything from brake fluid to fabric used in protective garments, is expected to have mixed impact from the virus outbreak. Demand for the company's products such as Tyvek, used in protective garments has risen, while one of its key end markets - the automotive sector - has been among the hardest hit as the pandemic hampered global travel.	Adds details on outlook, background April 20 (Reuters) - Industrial materials maker DuPont DD.N on Monday estimated first-quarter profit above Wall Street's expectations, as the coronavirus outbreak lifted demand for its products used in personal protection and water filtration. DuPont said it expects first-quarter adjusted earnings per share between 82 cents and 84 cents on net sales of about $5.2 billion. Dupont said in March it expected full-year adjusted earnings of $3.70 per share to $3.90 per share on sales of $21.3 billion to $21.8 billion.	Adds details on outlook, background April 20 (Reuters) - Industrial materials maker DuPont DD.N on Monday estimated first-quarter profit above Wall Street's expectations, as the coronavirus outbreak lifted demand for its products used in personal protection and water filtration. DuPont said it expects first-quarter adjusted earnings per share between 82 cents and 84 cents on net sales of about $5.2 billion. Dupont said in March it expected full-year adjusted earnings of $3.70 per share to $3.90 per share on sales of $21.3 billion to $21.8 billion.	Adds details on outlook, background April 20 (Reuters) - Industrial materials maker DuPont DD.N on Monday estimated first-quarter profit above Wall Street's expectations, as the coronavirus outbreak lifted demand for its products used in personal protection and water filtration. DuPont said it expects first-quarter adjusted earnings per share between 82 cents and 84 cents on net sales of about $5.2 billion. Dupont said in March it expected full-year adjusted earnings of $3.70 per share to $3.90 per share on sales of $21.3 billion to $21.8 billion.	853cc53e-61b2-49ed-9a1a-2d6d3b2d2d8e
716294.0	2020-04-20 00:00:00 UTC	DuPont Suspends FY20 Forecast, But Boosts Q1 Adj. EPS Outlook - Quick Facts	DD	https://www.nasdaq.com/articles/dupont-suspends-fy20-forecast-but-boosts-q1-adj.-eps-outlook-quick-facts-2020-04-20	nan	nan	(RTTNews) - Providing an update on current business conditions amid the ongoing coronavirus (COVID-19) outbreak, DuPont (DD) announced Monday that it is suspending its financial guidance for the full-year 2020, due to global softening in automotive, oil & gas and select industrial end-markets as well as the unknown duration and intensity of the pandemic. However, the company raised its adjusted earnings outlook for the first quarter of fiscal 2020, reflecting the strong demand for its materials into personal protection, water filtration, food & beverage, probiotics and electronics markets. For the first quarter, the company now expects a loss in a range of $1.00 to $0.70 per share and adjusted earnings in a range of $0.82 to $0.84 per share on net sales of approximately $5.2 billion. Previously, the company expected adjusted earnings in the range of $0.70 to $0.74 per share on net sales decline of in the mid-single digits. On average, analysts polled by Thomson Reuters expect the company to report earnings of $0.68 per share on net sales of $5.02 billion for the quarter. Analysts' estimates typically exclude special items. The company said it remains intently focused on the levers within its control, including delivering on cost saving targets. It is implementing initiatives to address significant uncertainty in select end-markets, including conserving cash and improving working capital. It has also idled production at several manufacturing sites, predominantly production plants within the Transportation and Industrial segment, due to the current global automotive environment. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	(RTTNews) - Providing an update on current business conditions amid the ongoing coronavirus (COVID-19) outbreak, DuPont (DD) announced Monday that it is suspending its financial guidance for the full-year 2020, due to global softening in automotive, oil & gas and select industrial end-markets as well as the unknown duration and intensity of the pandemic. It is implementing initiatives to address significant uncertainty in select end-markets, including conserving cash and improving working capital. However, the company raised its adjusted earnings outlook for the first quarter of fiscal 2020, reflecting the strong demand for its materials into personal protection, water filtration, food & beverage, probiotics and electronics markets.	(RTTNews) - Providing an update on current business conditions amid the ongoing coronavirus (COVID-19) outbreak, DuPont (DD) announced Monday that it is suspending its financial guidance for the full-year 2020, due to global softening in automotive, oil & gas and select industrial end-markets as well as the unknown duration and intensity of the pandemic. It is implementing initiatives to address significant uncertainty in select end-markets, including conserving cash and improving working capital. For the first quarter, the company now expects a loss in a range of $1.00 to $0.70 per share and adjusted earnings in a range of $0.82 to $0.84 per share on net sales of approximately $5.2 billion.	(RTTNews) - Providing an update on current business conditions amid the ongoing coronavirus (COVID-19) outbreak, DuPont (DD) announced Monday that it is suspending its financial guidance for the full-year 2020, due to global softening in automotive, oil & gas and select industrial end-markets as well as the unknown duration and intensity of the pandemic. It is implementing initiatives to address significant uncertainty in select end-markets, including conserving cash and improving working capital. For the first quarter, the company now expects a loss in a range of $1.00 to $0.70 per share and adjusted earnings in a range of $0.82 to $0.84 per share on net sales of approximately $5.2 billion.	(RTTNews) - Providing an update on current business conditions amid the ongoing coronavirus (COVID-19) outbreak, DuPont (DD) announced Monday that it is suspending its financial guidance for the full-year 2020, due to global softening in automotive, oil & gas and select industrial end-markets as well as the unknown duration and intensity of the pandemic. It is implementing initiatives to address significant uncertainty in select end-markets, including conserving cash and improving working capital. However, the company raised its adjusted earnings outlook for the first quarter of fiscal 2020, reflecting the strong demand for its materials into personal protection, water filtration, food & beverage, probiotics and electronics markets.	d66bd211-3b9f-497b-a0d4-40c07a112364
716295.0	2020-04-20 00:00:00 UTC	DuPont sees better-than-expected quarterly results on coronavirus-led demand	DD	https://www.nasdaq.com/articles/dupont-sees-better-than-expected-quarterly-results-on-coronavirus-led-demand-2020-04-20	nan	nan	April 20 (Reuters) - Industrial materials maker DuPont DD.N said on Monday it expects to report first-quarter results well above analysts' estimates, as the coronavirus outbreak lifted demand for its products used in personal protection and water filtration. DuPont said it expects first-quarter adjusted earnings per share between 82 cents and 84 cents on net sales of about $5.2 billion. Analysts on average had estimated profit of 68 cents per share on revenue of $5.01 billion, according to Refinitiv Eikon data. (Reporting by Arathy S Nair in Bengaluru; Editing by Aditya Soni) ((arathys.nair@thomsonreuters.com; +1 646 223 8780 (Extn 2726); Twitter: https://twitter.com/ArathySom;)) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	April 20 (Reuters) - Industrial materials maker DuPont DD.N said on Monday it expects to report first-quarter results well above analysts' estimates, as the coronavirus outbreak lifted demand for its products used in personal protection and water filtration. Analysts on average had estimated profit of 68 cents per share on revenue of $5.01 billion, according to Refinitiv Eikon data. (Reporting by Arathy S Nair in Bengaluru; Editing by Aditya Soni) ((arathys.nair@thomsonreuters.com; +1 646 223 8780 (Extn 2726); Twitter: https://twitter.com/ArathySom;)) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	April 20 (Reuters) - Industrial materials maker DuPont DD.N said on Monday it expects to report first-quarter results well above analysts' estimates, as the coronavirus outbreak lifted demand for its products used in personal protection and water filtration. DuPont said it expects first-quarter adjusted earnings per share between 82 cents and 84 cents on net sales of about $5.2 billion. Analysts on average had estimated profit of 68 cents per share on revenue of $5.01 billion, according to Refinitiv Eikon data.	April 20 (Reuters) - Industrial materials maker DuPont DD.N said on Monday it expects to report first-quarter results well above analysts' estimates, as the coronavirus outbreak lifted demand for its products used in personal protection and water filtration. DuPont said it expects first-quarter adjusted earnings per share between 82 cents and 84 cents on net sales of about $5.2 billion. (Reporting by Arathy S Nair in Bengaluru; Editing by Aditya Soni) ((arathys.nair@thomsonreuters.com; +1 646 223 8780 (Extn 2726); Twitter: https://twitter.com/ArathySom;)) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	April 20 (Reuters) - Industrial materials maker DuPont DD.N said on Monday it expects to report first-quarter results well above analysts' estimates, as the coronavirus outbreak lifted demand for its products used in personal protection and water filtration. DuPont said it expects first-quarter adjusted earnings per share between 82 cents and 84 cents on net sales of about $5.2 billion. Analysts on average had estimated profit of 68 cents per share on revenue of $5.01 billion, according to Refinitiv Eikon data.	8e862eb3-063a-40d8-a31e-4556b30046a7
716296.0	2020-04-13 00:00:00 UTC	DD Dividend Yield Pushes Past 3%	DD	https://www.nasdaq.com/articles/dd-dividend-yield-pushes-past-3-2020-04-13	nan	nan	Looking at the universe of stocks we cover at Dividend Channel, in trading on Monday, shares of DuPont (Symbol: DD) were yielding above the 3% mark based on its quarterly dividend (annualized to $1.2), with the stock changing hands as low as $38.14 on the day. Dividends are particularly important for investors to consider, because historically speaking dividends have provided a considerable share of the stock market's total return. To illustrate, suppose for example you purchased shares of the S&P 500 ETF (SPY) back on 12/31/1999 — you would have paid $146.88 per share. Fast forward to 12/31/2012 and each share was worth $142.41 on that date, a decrease of $4.67/share over all those years. But now consider that you collected a whopping $25.98 per share in dividends over the same period, for a positive total return of 23.36%. Even with dividends reinvested, that only amounts to an average annual total return of about 1.6%; so by comparison collecting a yield above 3% would appear considerably attractive if that yield is sustainable. DuPont (Symbol: DD) is an S&P 500 company, giving it special status as one of the large-cap companies making up the S&P 500 Index. In general, dividend amounts are not always predictable and tend to follow the ups and downs of profitability at each company. In the case of DuPont, looking at the history chart for DD below can help in judging whether the most recent dividend is likely to continue, and in turn whether it is a reasonable expectation to expect a 3% annual yield. Click here to find out which 9 other dividend stocks just recently went on sale » The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	Looking at the universe of stocks we cover at Dividend Channel, in trading on Monday, shares of DuPont (Symbol: DD) were yielding above the 3% mark based on its quarterly dividend (annualized to $1.2), with the stock changing hands as low as $38.14 on the day. DuPont (Symbol: DD) is an S&P 500 company, giving it special status as one of the large-cap companies making up the S&P 500 Index. In the case of DuPont, looking at the history chart for DD below can help in judging whether the most recent dividend is likely to continue, and in turn whether it is a reasonable expectation to expect a 3% annual yield.	Looking at the universe of stocks we cover at Dividend Channel, in trading on Monday, shares of DuPont (Symbol: DD) were yielding above the 3% mark based on its quarterly dividend (annualized to $1.2), with the stock changing hands as low as $38.14 on the day. DuPont (Symbol: DD) is an S&P 500 company, giving it special status as one of the large-cap companies making up the S&P 500 Index. In the case of DuPont, looking at the history chart for DD below can help in judging whether the most recent dividend is likely to continue, and in turn whether it is a reasonable expectation to expect a 3% annual yield.	Looking at the universe of stocks we cover at Dividend Channel, in trading on Monday, shares of DuPont (Symbol: DD) were yielding above the 3% mark based on its quarterly dividend (annualized to $1.2), with the stock changing hands as low as $38.14 on the day. DuPont (Symbol: DD) is an S&P 500 company, giving it special status as one of the large-cap companies making up the S&P 500 Index. In the case of DuPont, looking at the history chart for DD below can help in judging whether the most recent dividend is likely to continue, and in turn whether it is a reasonable expectation to expect a 3% annual yield.	DuPont (Symbol: DD) is an S&P 500 company, giving it special status as one of the large-cap companies making up the S&P 500 Index. Looking at the universe of stocks we cover at Dividend Channel, in trading on Monday, shares of DuPont (Symbol: DD) were yielding above the 3% mark based on its quarterly dividend (annualized to $1.2), with the stock changing hands as low as $38.14 on the day. In the case of DuPont, looking at the history chart for DD below can help in judging whether the most recent dividend is likely to continue, and in turn whether it is a reasonable expectation to expect a 3% annual yield.	4cc2c364-f157-4035-88c3-3f50df7eab41
716297.0	2020-04-08 00:00:00 UTC	Is DuPont Stock a Buy?	DD	https://www.nasdaq.com/articles/is-dupont-stock-a-buy-2020-04-08	nan	nan	Last week marked the one-year anniversary of the long-anticipated breakup of the world's largest chemical conglomerate, DowDuPont. Executed in the hope that each of the three new businesses -- DuPont (NYSE: DD); Dow (NYSE: DOW); and Corteva (NYSE: CTVA) -- would operate more efficiently by themselves, the break-off couldn't have come at a worse time. Given DuPont's 50% year-to-date (YTD) decline, it's a good time to gauge whether DuPont is a buy or if its headwinds are too severe to look past. DD data by YCharts Bad timing Although the DowDuPont breakup is probably for the best over the long run, its timing only complicates the many issues DuPont is facing unrelated to its structure. Falling commodity prices, from oil and natural gas to more impactful commodities to DuPont's business like nylon, severely impact DuPont's earnings. Before the widespread outbreak of the novel coronavirus, DuPont had already anticipated a slow start to 2020. Headwinds in nylon were expected to reduce the company's 2020 earnings by $0.23 per share. That blow is significant when you factor in another $0.28 per share reduction from other discrete items, such as the costly and ongoing dispute over environmental issues that DuPont is handling with Chemours (NYSE: CC) Image Source: Getty Images. Rough 2019 DuPont is entering a challenging 2020 on the backs of a difficult 2019. To put it plainly, "the past year was a challenge given macro conditions negatively impacting about 40% of our portfolio, which led to weaker results versus our expectations going into the year," said DuPont CEO Marc Doyle during the company's fourth-quarter 2019 conference call. Even worse 2020 As one of the oldest industrial conglomerates with a rich legacy that helped define the industrialization of the 20th century, DuPont is no stranger to market cycles. But what DuPont is a stranger to is the combination of lower commodity prices, a structural turnaround with synergies that are expected to take the entire year to payout, production constraints from COVID-19, and a massive drop in discretionary spending throughout the global economy. DuPont's business is exposed to the transportation and industrial sectors, slowing auto sales, lower home builds, and several of the many side effects of a slowing economy. DuPont's forecast for 2020 was bleak even before the onset of COVID-19. Challenges with commodity prices and other items counteract all of the organic growth, efficiencies, divestments, and cost actions that DuPont was expecting in 2020. When the dust settles, DuPont was forecasting $3.70 to $3.90 earnings per share (EPS) in 2020, which represents no growth compared to $3.80 of actual EPS in 2019. The coronavirus's severity is painfully apparent in the way it has altered all of our daily lives. One can only imagine how much it's going to hurt a company like DuPont, which was already dealing with a lot of problems before the coronavirus even began. One of the few positives for DuPont had been its strong free cash flow (FCF). DuPont reported more than 100% FCF conversion for the third and fourth quarters of 2019 and expects greater than 90% FCF conversion for 2020. FCF conversion is a percentage expressed as FCF over net income. It's essentially how much of a company's net income could be converted into valuable FCF that can be used to pay down debt and grow dividend distributions, among other things. The problem is that DuPont's FCF is inconsistent, sometimes exceeding and sometimes well under dividend obligations. Assuming that DuPont's free cash flow will be weaker this year than last, it's likely the company's dividend will be strained. Pair the hit to FCF with the company's $18 billion in debt, and DuPont is likely to have another rough year. Bad luck In many ways, DuPont's timing, more than its strategy or efficiency as a business, is what's hurting it in 2019 and 2020. The decision to spin off from DowDuPont added unnecessary headache to DuPont in the midst of falling commodity prices. Now, with production likely to slow and discretionary spending falling by the wayside, DuPont's organic growth and cash flow improvements from 2019 can do little to protect the company from a hard 2020. Even though DuPont's stock has taken a beating, the risk-reward just isn't there right now, especially when you consider its dividend could be in jeopardy if the global economy faces a prolonged slide. 10 stocks we like better than DowDuPont Inc. When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.* David and Tom just revealed what they believe are the ten best stocks for investors to buy right now... and DowDuPont Inc. wasn't one of them! That's right -- they think these 10 stocks are even better buys. See the 10 stocks *Stock Advisor returns as of March 18, 2020 Daniel Foelber has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	Executed in the hope that each of the three new businesses -- DuPont (NYSE: DD); Dow (NYSE: DOW); and Corteva (NYSE: CTVA) -- would operate more efficiently by themselves, the break-off couldn't have come at a worse time. DD data by YCharts Bad timing Although the DowDuPont breakup is probably for the best over the long run, its timing only complicates the many issues DuPont is facing unrelated to its structure. The decision to spin off from DowDuPont added unnecessary headache to DuPont in the midst of falling commodity prices.	Executed in the hope that each of the three new businesses -- DuPont (NYSE: DD); Dow (NYSE: DOW); and Corteva (NYSE: CTVA) -- would operate more efficiently by themselves, the break-off couldn't have come at a worse time. DD data by YCharts Bad timing Although the DowDuPont breakup is probably for the best over the long run, its timing only complicates the many issues DuPont is facing unrelated to its structure. The decision to spin off from DowDuPont added unnecessary headache to DuPont in the midst of falling commodity prices.	Executed in the hope that each of the three new businesses -- DuPont (NYSE: DD); Dow (NYSE: DOW); and Corteva (NYSE: CTVA) -- would operate more efficiently by themselves, the break-off couldn't have come at a worse time. DD data by YCharts Bad timing Although the DowDuPont breakup is probably for the best over the long run, its timing only complicates the many issues DuPont is facing unrelated to its structure. The decision to spin off from DowDuPont added unnecessary headache to DuPont in the midst of falling commodity prices.	Executed in the hope that each of the three new businesses -- DuPont (NYSE: DD); Dow (NYSE: DOW); and Corteva (NYSE: CTVA) -- would operate more efficiently by themselves, the break-off couldn't have come at a worse time. DD data by YCharts Bad timing Although the DowDuPont breakup is probably for the best over the long run, its timing only complicates the many issues DuPont is facing unrelated to its structure. The decision to spin off from DowDuPont added unnecessary headache to DuPont in the midst of falling commodity prices.	9f0d3ccf-16a6-4805-a3e8-08b996834700
716298.0	2020-04-06 00:00:00 UTC	Cummins and DuPont Partner to Make N95 Mask Alternative	DD	https://www.nasdaq.com/articles/cummins-and-dupont-partner-to-make-n95-mask-alternative-2020-04-06	nan	nan	The acute global shortage of N95 respirator masks after the coronavirus outbreak has encouraged several companies to join the fight against the COVID-19 pandemic and contribute to help tackle the shortage. Engines manufacturer Cummins (NYSE: CMI) is the latest to join the bandwagon, partnering with diversified chemicals company DuPont de Nemours (NYSE: DD) to manufacture viable alternatives to help "address the nation's shortage of N95 respirator masks." What exactly are Cummins and DuPont making? On April 6, Cummins announced that it is evaluating its "supply base and manufacturing capabilities" to identify ways to support healthcare workers through the provision of personal protective equipment (PPE), or equipment critical for healthcare professionals to prevent exposure to hazards as they deal with coronavirus patients. The N95 mask is a common particulate-filtering face respirator mask, preventing 95% of airborne particles from entering the wearer's mouth and nose when properly fitted. Currently, 3M and Honeywell are leading N95 respirator mask producers, and both companies are scrambling to ramp up production to meet unprecedented demand. Image source: Getty Images. Cummins believes its NanoNet and NanoForce Media filter technology, together with DuPont's Hybrid Membrane Technology (HMT), can be effectively used to make viable "mask options, including both a disposable and reusable option." To give you some perspective, Cummins' NanoNet is primarily a lube filtration technology, and NanoForce an air filtration technology that the company's filtration business unit uses to manufacture filtration parts for engines. Cummins typically integrates DuPont's HMT with its fibers to safeguard engine components. As HMT spins material using continuous sub-micron fibers, it can create "membrane-like" sheets that can not only filter particulates but also allow easy breathability -- two essentials of N95 masks. N95 prototype samples sent, awaiting regulatory approval Cummins's first N95 mask prototypes were assembled in March by teams from the University of Minnesota. Cummins said while it has already sent samples to mask manufacturers worldwide to test their effectiveness, it's awaiting vetting and approval from the National Institute for Occupational Safety and Health's (NIOSH) to certify the use of its materials to manufacture masks on scale at manufacturing facilities prepared for the job. 10 stocks we like better than Cummins When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.* David and Tom just revealed what they believe are the ten best stocks for investors to buy right now... and Cummins wasn't one of them! That's right -- they think these 10 stocks are even better buys. See the 10 stocks *Stock Advisor returns as of March 18, 2020 Neha Chamaria has no position in any of the stocks mentioned. The Motley Fool recommends 3M and Cummins. The Motley Fool has a disclosure policy. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	Engines manufacturer Cummins (NYSE: CMI) is the latest to join the bandwagon, partnering with diversified chemicals company DuPont de Nemours (NYSE: DD) to manufacture viable alternatives to help "address the nation's shortage of N95 respirator masks." On April 6, Cummins announced that it is evaluating its "supply base and manufacturing capabilities" to identify ways to support healthcare workers through the provision of personal protective equipment (PPE), or equipment critical for healthcare professionals to prevent exposure to hazards as they deal with coronavirus patients. Currently, 3M and Honeywell are leading N95 respirator mask producers, and both companies are scrambling to ramp up production to meet unprecedented demand.	Engines manufacturer Cummins (NYSE: CMI) is the latest to join the bandwagon, partnering with diversified chemicals company DuPont de Nemours (NYSE: DD) to manufacture viable alternatives to help "address the nation's shortage of N95 respirator masks." Cummins believes its NanoNet and NanoForce Media filter technology, together with DuPont's Hybrid Membrane Technology (HMT), can be effectively used to make viable "mask options, including both a disposable and reusable option." To give you some perspective, Cummins' NanoNet is primarily a lube filtration technology, and NanoForce an air filtration technology that the company's filtration business unit uses to manufacture filtration parts for engines.	Engines manufacturer Cummins (NYSE: CMI) is the latest to join the bandwagon, partnering with diversified chemicals company DuPont de Nemours (NYSE: DD) to manufacture viable alternatives to help "address the nation's shortage of N95 respirator masks." Cummins believes its NanoNet and NanoForce Media filter technology, together with DuPont's Hybrid Membrane Technology (HMT), can be effectively used to make viable "mask options, including both a disposable and reusable option." Cummins said while it has already sent samples to mask manufacturers worldwide to test their effectiveness, it's awaiting vetting and approval from the National Institute for Occupational Safety and Health's (NIOSH) to certify the use of its materials to manufacture masks on scale at manufacturing facilities prepared for the job.	Engines manufacturer Cummins (NYSE: CMI) is the latest to join the bandwagon, partnering with diversified chemicals company DuPont de Nemours (NYSE: DD) to manufacture viable alternatives to help "address the nation's shortage of N95 respirator masks." Cummins believes its NanoNet and NanoForce Media filter technology, together with DuPont's Hybrid Membrane Technology (HMT), can be effectively used to make viable "mask options, including both a disposable and reusable option." After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.	2ccc578c-7313-4bb7-aa41-a0fab13378d3
716299.0	2020-03-31 00:00:00 UTC	Why Shares of Chemours Were Down Today	DD	https://www.nasdaq.com/articles/why-shares-of-chemours-were-down-today-2020-03-31	nan	nan	What happened Shares of Chemours (NYSE: CC) fell more than 8% on Tuesday, and were down more than 10% earlier in the day, after the chemical company's lawsuit against its former parent was dismissed on technical grounds. Chemours has vowed to fight on, but the decision is a setback in its battle to escape some of the environmental liability costs it currently faces. So what Chemours, a major supplier of titanium dioxide, was spun out of DuPont (NYSE: DD) in 2015 and held on to a lot of legacy environmental liabilities as part of the separation agreement. Chemours has argued that DuPont's estimates of how much its former subsidiary would be on the hook for were off base and were not prepared in good faith. And so Chemours had gone to court to try to get DuPont to foot more of the bill. Image source: Getty Images. Chemours had sought to "uncap" DuPont's liabilities related to PFOA, a chemical once used in nonstick coatings and other products, or require DuPont to pay back a $3.9 billion special dividend paid by Chemours to DuPont in 2015. Delaware Chancery Court Judge Sam Glasscock III on Monday granted DuPont's request to dismiss the lawsuit, ruling that he had no jurisdiction to hear the case because the separation agreement between the companies states that all disputes arising from the spinoff are subject to binding arbitration. Chemours said it will appeal the ruling to the Delaware Supreme Court. Now what This isn't over, with the appeals process still to play out, but the ruling is a major victory for DuPont and a setback for Chemours. Even without the litigation worries, Chemours is in a tough spot right now. Its core titanium dioxide product, which is used in sunscreens and as a white pigment in paint, is likely to see light industrial demand in the first half of 2020 (if not beyond) due to the global COVID-19 pandemic slowdown. If we end up in a recession, demand could be weak well into 2021. Given all that Chemours has to manage right now, it is no wonder investors are heading for the exits. 10 stocks we like better than Chemours When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.* David and Tom just revealed what they believe are the ten best stocks for investors to buy right now... and Chemours wasn't one of them! That's right -- they think these 10 stocks are even better buys. See the 10 stocks *Stock Advisor returns as of March 18, 2020 Lou Whiteman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.	So what Chemours, a major supplier of titanium dioxide, was spun out of DuPont (NYSE: DD) in 2015 and held on to a lot of legacy environmental liabilities as part of the separation agreement. What happened Shares of Chemours (NYSE: CC) fell more than 8% on Tuesday, and were down more than 10% earlier in the day, after the chemical company's lawsuit against its former parent was dismissed on technical grounds. Delaware Chancery Court Judge Sam Glasscock III on Monday granted DuPont's request to dismiss the lawsuit, ruling that he had no jurisdiction to hear the case because the separation agreement between the companies states that all disputes arising from the spinoff are subject to binding arbitration.	So what Chemours, a major supplier of titanium dioxide, was spun out of DuPont (NYSE: DD) in 2015 and held on to a lot of legacy environmental liabilities as part of the separation agreement. What happened Shares of Chemours (NYSE: CC) fell more than 8% on Tuesday, and were down more than 10% earlier in the day, after the chemical company's lawsuit against its former parent was dismissed on technical grounds. Its core titanium dioxide product, which is used in sunscreens and as a white pigment in paint, is likely to see light industrial demand in the first half of 2020 (if not beyond) due to the global COVID-19 pandemic slowdown.	So what Chemours, a major supplier of titanium dioxide, was spun out of DuPont (NYSE: DD) in 2015 and held on to a lot of legacy environmental liabilities as part of the separation agreement. Chemours had sought to "uncap" DuPont's liabilities related to PFOA, a chemical once used in nonstick coatings and other products, or require DuPont to pay back a $3.9 billion special dividend paid by Chemours to DuPont in 2015. 10 stocks we like better than Chemours When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen.	So what Chemours, a major supplier of titanium dioxide, was spun out of DuPont (NYSE: DD) in 2015 and held on to a lot of legacy environmental liabilities as part of the separation agreement. * David and Tom just revealed what they believe are the ten best stocks for investors to buy right now... and Chemours wasn't one of them! See the 10 stocks *Stock Advisor returns as of March 18, 2020 Lou Whiteman has no position in any of the stocks mentioned.	0b7fb0b0-ce63-476d-be8a-b7fb431238af

Subsets and Splits

No community queries yet

The top public SQL queries from the community will appear here once available.